<SEC-DOCUMENT>0001437749-25-013543.txt : 20250429
<SEC-HEADER>0001437749-25-013543.hdr.sgml : 20250429
<ACCEPTANCE-DATETIME>20250429162636
ACCESSION NUMBER:		0001437749-25-013543
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20250623
FILED AS OF DATE:		20250429
DATE AS OF CHANGE:		20250429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CervoMed Inc.
		CENTRAL INDEX KEY:			0001053691
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				300645032
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37942
		FILM NUMBER:		25888113

	BUSINESS ADDRESS:	
		STREET 1:		20 PARK PLAZA
		STREET 2:		SUITE 424
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		(617) 744-4400

	MAIL ADDRESS:	
		STREET 1:		20 PARK PLAZA
		STREET 2:		SUITE 424
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Diffusion Pharmaceuticals Inc.
		DATE OF NAME CHANGE:	20160115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	RestorGenex Corp
		DATE OF NAME CHANGE:	20140307

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stratus Media Group, Inc
		DATE OF NAME CHANGE:	20080722
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>crvo20250425_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:srt-types="http://fasb.org/srt-types/2017-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:crvo="http://www.diffusionpharma.com/20241231" xmlns:rr="http://xbrl.sec.gov/rr/2023" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"><head>
	<title>crvo20250425_def14a.htm</title>


	<!-- Generated by ThunderDome Portal - 4/29/2025 8:07:20 PM -->
<meta http-equiv="Content-Type" content="text/html"/></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none;"><ix:header><ix:hidden>
<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="dei:AmendmentFlag" id="ixv-5676">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="dei:EntityCentralIndexKey" id="ixv-5677">0001053691</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:MnpiDiscTimedForCompValFlag" id="c12" format="ixt:fixed-false">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:AwardTmgMnpiCnsdrdFlag" id="c11" format="ixt:fixed-true">true</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:AwardTmgPredtrmndFlag" id="c10" format="ixt:fixed-true">true</ix:nonNumeric>
<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="dei:DocumentType" id="c2">DEF 14A</ix:nonNumeric></ix:hidden>
<ix:references>
<link:schemaRef xlink:href="crvo-20241231.xsd" xlink:type="simple"/></ix:references>
<ix:resources>
<xbrli:context id="d_2024-01-01_2024-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit>
<xbrli:context id="d_2023-01-01_2023-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2024-01-01_2024-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2023-01-01_2023-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:context id="d_2022-01-01_2022-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001053691</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context>
<xbrli:unit id="NonApplicable"><xbrli:measure>thunderdome:item</xbrli:measure></xbrli:unit></ix:resources>
</ix:header></div>
<div>&#160;</div>

<div>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b><br/>
<b>SECURITIES AND EXCHANGE COMMISSION</b><br/>
<b>Washington, D.C. 20549</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="-sec-ix-hidden:c2">SCHEDULE 14A</span></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Proxy Statement Pursuant to Section 14(a) of<br/>
the Securities Exchange Act of 1934 (Amendment No. &#160;&#160;&#160;&#160;)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:24.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by the Registrant&#160;&#160;&#9746;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:24.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by a Party other than the Registrant&#160;&#160;&#9744;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:24.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box:</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Preliminary Proxy Statement</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9746;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Definitive Proxy Statement</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Definitive Additional Materials</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Soliciting Material under &#167;240.14a-12</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;"><img alt="logo.jpg" src="logo.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="dei:EntityRegistrantName" id="c3">CervoMed Inc.</ix:nonNumeric></b></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of Registrant as Specified In Its Charter)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Not Applicable</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0"/>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Payment of Filing Fee (Check the appropriate box):</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9746;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No fee required</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fee paid previously with preliminary materials</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="vertical-align:top;width:auto;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</div>

<div>&#160;</div>

<div style="text-align: center;"><img alt="mini.jpg" src="mini.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>CervoMed Inc.</b><br/>
<b>20 Park Plaza, Suite 424</b><br/>
<b>Boston, Massachusetts 02116</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">April 29, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dear Fellow Stockholders:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We are pleased to invite you to join us for the CervoMed Inc. 2025 Annual Meeting of Stockholders to be held on Monday, June 23, 2025, at 9:00 a.m., Eastern Time. The Annual Meeting will be conducted as a virtual meeting hosted by means of a live webcast. Stockholders will be able to listen, vote, and submit questions from their home or any location with internet connectivity. You or your proxyholder will be able to attend the Annual Meeting online, vote, and submit questions by following the instructions provided in the accompanying Notice Regarding the Availability of Proxy Materials and proxy statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">It is important that your shares be represented at the meeting, regardless of the number of shares you hold. Accordingly, please exercise your right to vote by completing, signing, dating, and returning your proxy card, by using Internet or telephone voting as described in the accompanying proxy statement, or by following the other instructions for voting on the accompanying Notice Regarding the Availability of Proxy Materials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">At the Annual Meeting, seven persons will be elected to our Board of Directors. In addition, we will ask stockholders to ratify the appointment of RSM US LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025, approve, on an advisory basis, the compensation of our named executive officers during the year ended December 31, 2024, and approve the CervoMed Inc. 2025 Equity Incentive Plan. Such other business will be transacted as may properly come before the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">On behalf of the Board of Directors and management of CervoMed Inc., it is my pleasure to express our appreciation for your support.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sincerely,</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">/s/ John Alam, M.D.</span></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">John Alam, M.D.<br/>
<i>President &amp; Chief Executive Officer</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>Your vote is important. Please exercise your right to vote as soon as possible by completing, signing, dating, and returning your proxy card, by using Internet or telephone voting as described in the accompanying proxy statement, or by following the other instructions for voting on the accompanying Notice Regarding the Availability of Proxy Materials.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>You can help us make a difference by eliminating paper proxy mailings. With your consent, we will provide all future proxy materials electronically. Instructions for consenting to electronic delivery can be found on your proxy card. Your consent to receive stockholder materials electronically will remain in effect until canceled.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;"><img alt="mini.jpg" src="mini.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">20 PARK PLAZA, SUITE 424</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">BOSTON, MA 02116</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS</b><br/>
<b>TO BE HELD ON</b>&#160;<b>FRIDAY, JUNE 23, 2025</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the Stockholders of CervoMed Inc.:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of CervoMed Inc., a Delaware corporation, will be held virtually on Monday, June 23, 2025, at 9:00 a.m. Eastern Time by means of a live webcast for the following purposes:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To elect seven persons to serve as directors until our next annual meeting of stockholders or until their respective successors are elected and qualified;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To ratify the selection of RSM US LLP as our independent registered public accounting firm for the year ending December 31, 2025;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To approve, on an advisory basis, the compensation of our named executive officers during the year ended December 31, 2024, as disclosed in the accompanying proxy statement;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To approve the CervoMed Inc. 2025 Equity Incentive Plan; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To transact such other business as may properly come before the meeting or any adjournment of the meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">You will be able to submit questions in advance of the meeting, listen to the meeting live, and vote online. To access and participate in the virtual meeting, registered stockholders and beneficial stockholders (those holding shares through a stock brokerage account or by a bank or other holder of record) will need to follow the applicable instructions provided in the proxy statement that follows.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The meeting webcast will begin promptly at 9:00 a.m. Eastern Time. We encourage you to access the meeting prior to the start time. Online check-in will begin at 8:45 a.m. Eastern Time, and you should allow ample time for the check-in procedures. If you experience technical difficulties during the check-in process or during the Annual Meeting, please call the number on the virtual meeting portal landing page for assistance. For additional information on how you can attend and participate in the Annual Meeting, please see the instructions beginning on page 1 of the accompanying proxy statement. As the Annual Meeting will be a completely virtual meeting, there will be no physical location for stockholders to attend.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Only stockholders of record at the close of business on April 24, 2025, will be entitled to notice of, and to vote at, the meeting and any adjournments thereof. A stockholder list will be available beginning June 13, 2025, the date which is ten days prior to the date of the meeting, during normal business hours for examination by any stockholder registered on CervoMed Inc.&#8217;s stock ledger as of the record date for any purpose germane to the meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:23.1%;">&#160;</td>
			<td style="vertical-align:middle;width:23.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By Order of the Board of Directors,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">/s/ William Elder</span></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">William Elder</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>Chief Financial Officer, General Counsel &amp; Corporate Secretary</i></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">April 29, 2025<br/>
Boston, Massachusetts</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TABLE OF CONTENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:38.8%;">&#160;</td>
			<td style="vertical-align:bottom;width:7.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Page</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">1</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CORPORATE GOVERNANCE</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">6</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PROPOSAL NO. 1: ELECTION OF DIRECTORS</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">14</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PROPOSAL NO. 2: RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">15</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">AUDIT COMMITTEE REPORT</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">16</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EXECUTIVE OFFICERS</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">17</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EXECUTIVE COMPENSATION</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">18</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PROPOSAL NO. 3: ADVISORY VOTE ON EXECUTIVE COMPENSATION</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">22</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">DIRECTOR COMPENSATION</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">23</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">25</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PAY VERSUS PERFORMANCE</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">28</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EQUITY COMPENSATION PLAN INFORMATION</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">31</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PROPOSAL NO. 4: APPROVAL OF CERVOMED INC. 2025 EQUITY INCENTIVE PLAN</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">32</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CERTAIN RELATIONSHIPS AND RELATED PARTY INFORMATION</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">42</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:38.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">OTHER MATTERS</p>
			</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">44</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:38.8%;">CervoMed Inc. 2025 Equity Incentive Plan</td>
			<td style="vertical-align: bottom; width: 7.5%; text-align: center;">A-1</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>INTRODUCTORY NOTES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Note Regarding Company References and Other Defined Terms</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As previously disclosed in our Current Report on Form 8-K filed on August 17, 2023 with the SEC, on August 16, 2023, the Delaware corporation formerly known as &#8220;Diffusion Pharmaceuticals Inc.&#8221; completed a merger transaction in accordance with the terms and conditions of the Agreement and Plan of Merger, dated March 30, 2023 (the &#8220;Merger Agreement&#8221;) by and among Diffusion Pharmaceuticals Inc. (&#8220;Diffusion&#8221;), Dawn Merger Inc., a wholly-owned subsidiary of Diffusion (&#8220;Merger Sub&#8221;) and EIP Pharma, Inc. (&#8220;EIP&#8221;), pursuant to which Merger Sub merged with and into EIP, with EIP surviving the Merger a wholly-owned subsidiary of Diffusion (the &#8220;Merger&#8221;). Additionally, on August 16, 2023, Diffusion changed its name from &#8220;Diffusion Pharmaceuticals Inc.&#8221; to &#8220;CervoMed Inc.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Prior to the Effective Time (as defined below), in connection with the transactions contemplated by the Merger Agreement, Diffusion effected a reverse stock split of the Company&#8217;s common stock, par value $0.001 per share (&#8220;common stock&#8221;), at a ratio of 1-for-1.5 (the &#8220;Reverse Stock Split&#8221;). At the Effective Time, each outstanding share of EIP capital stock was converted into the right to receive 0.1151 shares of Company common stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For accounting purposes, the Merger is treated as a reverse recapitalization under U.S. generally accepted accounting principles and EIP is considered the accounting acquirer. Accordingly, EIP&#8217;s historical results of operations are deemed the Company&#8217;s historical results of operations for all periods prior to the Merger and, for all periods following the Merger, the results of operations of the combined company will be included in the Company&#8217;s financial statements. Following the completion of the Merger, the business conducted by the Company became primarily the business conducted by EIP.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Accordingly, unless the context otherwise requires, all references in this proxy statement to (i) &#8220;CervoMed,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us,&#8221; refer to EIP for all dates and periods prior to August 16, 2023 and to the business of CervoMed Inc. for all dates and periods subsequent to (and including) August 16, 2023 and (ii) &#8220;common stock&#8221; refers to the common stock, par value $0.001 per share, of the Company, after giving effect to the Reverse Stock Split. Historical share and per share figures of EIP have been retroactively restated based upon the Exchange Ratio of 0.1151.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We have also used several other defined terms in this proxy statement, many of which are explained or defined below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:bottom;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Term</b></p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Definition</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2015 Equity Plan</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CervoMed Inc. 2015 Equity Incentive Plan, as amended</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2018 Equity Plan</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CervoMed Inc. 2018 Employee, Director and Consultant Equity Incentive Plan, as amended</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2020 Notes</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the previously outstanding convertible promissory notes of EIP, dated as of December 4, 2020, as amended</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2021 Notes</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the previously outstanding convertible promissory notes of EIP, dated as of December 10, 2021, as amended</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2024 Private Placement</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">our private placement of an aggregate of 2,532,285 units, each consisting of (i) (A) one share of common stock or (B) one Pre-Funded Warrant in lieu thereof and (ii) one Series A Warrant, for aggregate gross proceeds of up to approximately $149.4 million, announced March 28, 2024, and completed on April 1, 2024</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">401(k) Plan</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CervoMed Inc. 401(k) Defined Contribution Plan</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Alpine Rewards</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Alpine Rewards LLC, independent outside consultant to the Compensation Committee</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Annual Meeting</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the 2025 Annual Meeting of Stockholders of the Company</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Annual Report</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 17, 2025</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">ASC</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounting Standard Codification of the Financial Accounting Standards Board</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Audit Committee</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the Audit Committee of the Board</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Boger Trust</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the Joshua S. Boger 2021 Trust DTD 12/09/2021</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the board of directors of the Company</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Bylaws</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the Bylaws, as amended, of the Company</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Code</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the Internal Revenue Code of 1986, as amended</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Compensation Committee</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the Compensation Committee of the Board</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Computershare</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Computershare, Inc., our transfer agent</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Effective Time</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the effective time of the Merger on August 16, 2023</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EIP Common Stock</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the common stock, par&#160;value $0.001, of EIP issued and outstanding prior to the Merger</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EIP Convertible Notes</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">collectively, the 2020 Notes and the 2021 Notes</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exchange Act</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Securities Exchange Act of 1934, as amended</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exchange Ratio</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">the &#8220;Exchange Ratio&#8221;&#160;as defined in the Merger Agreement</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Nasdaq</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Nasdaq Stock Market, LLC</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">NEO</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">named executive officer</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PEO</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">principal executive officer</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Proxy Statement</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">this definitive proxy statement on Schedule 14A for our 2025 Annual Meeting of Stockholders</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Record Date</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">April 24, 2025</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Regulation S-K</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Regulation S-K promulgated under the Securities Act of 1933, as amended</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">RSUs</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Restricted Stock Units</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SEC</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S. Securities and Exchange Commission</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Separation Agreement</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">the form of Separation Agreement by and between the Company and Robert J. Cobuzzi, Jr., Ph.D.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">TSR</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">total shareholder return</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S.</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">United States of America</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:14.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vertex Pharmaceuticals</p>
			</td>
			<td style="vertical-align:bottom;width:31.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Vertex Pharmaceuticals Incorporated</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;"><img alt="mini.jpg" src="mini.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>20 Park Plaza, Suite 424</b><br/>
<b>Boston, Massachusetts 02116</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto"/>
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b>PROXY STATEMENT FOR CERVOMED INC.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2025 ANNUAL MEETING OF STOCKHOLDERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TO BE HELD ON</b>&#160;<b>MONDAY JUNE 23, 2025</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<hr style="text-align: center; height: 1px; color: #000000; background-color: #000000; width: 25%; border: none; margin: 3pt auto"/>
<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board is using this Proxy Statement to solicit your proxy for use at the CervoMed Inc. 2025 Annual Meeting of Stockholders to be held virtually at 9:00 a.m., Eastern Time, on Monday, June 23, 2025. The Board expects to make available electronically or to send to our stockholders the Notice of Annual Meeting of Stockholders, this Proxy Statement and a form of proxy on or about May 12, 2025.</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:36pt;"><b>IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON</b>&#160;<b>MONDAY, JUNE 23, 2025</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our Proxy Statement and annual report to stockholders, which includes our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2024, will be made available electronically as described in the enclosed materials. Additionally, you can find a copy of our Annual Report on Form 10-K, which includes our financial statements for the fiscal year ended December 31, 2024, on the website of the SEC at www.sec.gov, or in the &#8220;Financial Information&#8221; section of the &#8220;Investor Relations&#8221; section of our website at <span style="text-decoration: underline; ">www.cervomed.com</span>. You may also obtain a printed copy of our Annual Report, including our financial statements, free of charge, from us by sending a written request to: proxy@cervomed.com. Exhibits will be provided upon written request and payment of an appropriate processing fee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>GENERAL INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Why am I receiving these materials?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We have sent you this Proxy Statement and the enclosed proxy card because the Board is soliciting your proxy to vote at the Annual Meeting. The Annual Meeting will be conducted online only. You are invited to virtually attend the Annual Meeting to vote on the proposals described in this Proxy Statement by following the instructions included in this Proxy Statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card, or follow the instructions below to submit your proxy over the telephone or on the Internet.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>When and where will the Annual Meeting be held?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Annual Meeting will be held online via live webcast on Monday, June 23, 2025, at 9:00 a.m., Eastern Time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How do I attend the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Annual Meeting will be a virtual meeting of stockholders conducted exclusively by live webcast. No physical meeting will be held.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">You will be able to attend the Annual Meeting online by visiting meetnow.global/MHPKTG7. You also will be able to vote your shares online by attending the Annual Meeting webcast. To participate in the Annual Meeting, you will need to review the information included on your Notice, on your proxy card, or on the instructions that accompanied your proxy materials.<b> If you hold your shares through an intermediary, such as a bank or broker, you must register in advance using the instructions below</b>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The online meeting will begin promptly at 9:00 a.m. Eastern Time on June 23, 2025. We encourage you to access the meeting approximately 15 minutes prior to the start time in order to leave ample time for the check-in. Please follow the registration instructions as outlined in this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Do I need to register to attend the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you are a registered shareholder (i.e., you hold your shares through our transfer agent, Computershare), you do not need to register to attend the Annual Meeting virtually on the Internet. Please follow the instructions on the notice or proxy card that you received.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you hold your shares through an intermediary, such as a bank or broker, you must register in advance to attend the Annual Meeting virtually on the Internet.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">To register to attend the Annual Meeting online by webcast you must submit proof of your proxy power (legal proxy) reflecting your holdings along with your name and email address to Computershare. Requests for registration must be labeled as &#8220;Legal Proxy&#8221; and be received no later than 5:00 p.m., Eastern Time, on June 20, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">You will receive a confirmation of your registration by e-mail after Computershare receives your registration materials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Requests for registration should be directed to Computershare through the following means:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">By email: Forward the email from your broker, or attach an image of your legal proxy, to legalproxy@computershare.com</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:36pt;">By mail:&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 108pt;text-indent:36pt;">Computershare</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 108pt;text-indent:36pt;">CervoMed Inc. &#8211; Legal Proxy</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 108pt;text-indent:36pt;">P.O. Box 43001</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 108pt;text-indent:36pt;">Providence, RI 02940-3001</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Do I have the option of calling in to the Annual Meeting instead of attending the live webcast?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">No. Stockholders will not have the option to call in to the virtual meeting and listen by telephone. To participate in the Annual Meeting, stockholders must stream the Annual Meeting live via webcast.</p>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How do I submit questions for the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">You can submit questions germane to matters on the agenda at the Annual Meeting only if you are a stockholder of record of the Company at the close of business on the Record Date or if you were a beneficial owner as of the Record Date and you registered in advance to attend the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you wish to submit a question, you may log into the virtual Annual Meeting website beginning 15 minutes prior to the start of the Annual Meeting and submit questions online. Once past the login screen, click on the &#8220;Q&amp;A&#8221; icon at the top of the screen to submit your question. Stockholders may also submit questions prior to the date of the Annual Meeting by e-mailing them to proxy@cervomed.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In accordance with the rules of order for the Annual Meeting, a copy of which will be available during the meeting, only questions germane to matters on the meeting agenda (the proposals being voted upon) will be answered. The Company reserves the right to not address any questions that are repetitious, irrelevant to the Company&#8217;s business, related to pending or threatened litigation, derogatory in nature, related to personal grievances, or otherwise inappropriate in the Company&#8217;s sole discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">During the Annual Meeting, we are committed to acknowledging each appropriate question in the order in which it was received. When submitting questions, stockholders should identify themselves and provide contact information in the event follow up is necessary. Each stockholder who submits a question will be identified before his or her question is answered. Any questions relevant to the business of the Annual Meeting that cannot be answered due to time constraints can be submitted to CervoMed Investor Relations by e-mailing proxy@cervomed.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Stockholders participating in the virtual meeting will be in a listen-only mode and will not be able to speak during the webcast.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Whom do I contact if I am encountering difficulties attending the Annual Meeting online?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you encounter technical difficulties accessing or during the virtual Annual Meeting, you may call Computershare at 1-877-373-6374 (or, for individuals outside the U.S., +1 781-575-2879) or the telephone number provided on the login page if you need additional assistance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>What is the purpose of the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The purpose of the Annual Meeting is to vote on the following proposals:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To elect seven persons to serve as directors until our next annual meeting of stockholders or until their respective successors are elected and qualified;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To ratify the selection of RSM US LLP as our independent registered public accounting firm for the year ending December 31, 2025;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To approve, on an advisory basis, the compensation of our named executive officers during the year ended December 31, 2024, as disclosed in the accompanying Proxy Statement;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">&#160;</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&#160;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To approve the CervoMed Inc. 2025 Equity Incentive Plan; and</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">To transact such other business as may properly come before the meeting or any adjournment of the meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Who is entitled to vote at the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Stockholders of record at the close of business on April 24, 2025, the Record Date, will be entitled to notice of and to vote at the meeting or any adjournment of the Annual Meeting. As of the Record Date, there were 8,702,719 shares of our common stock outstanding. Each share of our common stock is entitled to one vote on each matter to be voted on at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How do I vote my shares?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Your vote is important. Whether you hold shares directly as a stockholder of record or beneficially in &#8220;street name&#8221; (through a broker, bank, or other nominee), you may vote your shares without attending the Annual Meeting. You may vote by granting a proxy or, for shares held in street name, by submitting voting instructions to your broker or nominee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you are a stockholder whose shares are registered in your name, you may vote your shares by one of the following methods:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>Virtually</i></b>, by joining the Annual Meeting and following the voting instructions available on the meeting portal during the meeting.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>Vote by Internet</i></b>, by going to the web address www.envisionreports.com/CRVO and following the instructions for Internet voting shown on your proxy card.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>Vote by Telephone</i></b>, if you are located within the U.S., U.S. territories or Canada, by dialing 1-800-652-8683 and following the instructions for telephone voting shown on your proxy card.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b><i>Vote by Proxy Card</i></b>, by completing, signing, dating, and mailing the enclosed proxy card in the envelope provided. If you vote by Internet or telephone, please do not mail your proxy card.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Please note that voting by Internet and/or telephone may not be available until after this Proxy Statement and the form of proxy is first sent and/or made available electronically on or about May 12, 2025</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If your shares are held in street name, you may receive a separate voting instruction form or you may need to contact your broker, bank, or other nominee to determine whether you will be able to vote virtually at the Annual Meeting or electronically using the Internet or telephone.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The deadline for voting by telephone or by using the Internet is 11:59 p.m. Eastern Time on Sunday, June 22, 2025. Please see your proxy card or the information your bank, broker or other holder of record provided to you for more information on your voting options.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How will my shares be voted?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you return your signed proxy card or use Internet or telephone voting before the Annual Meeting, the named proxies will vote your shares as you direct.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">For Proposal No.&#160;1&#8212;Election of Directors, you may:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Vote&#160;<b>FOR</b>&#160;all seven of the nominees for director;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>WITHHOLD</b>&#160;your vote from all seven of the nominees for director; or</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>WITHHOLD</b>&#160;your vote from one or more of the seven nominees for director that you designate.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">For Proposal No.&#160;2&#8212;Ratification of Selection of Independent Registered Public Accounting Firm, Proposal No. 3&#8212;Advisory Vote on Executive Compensation, and Proposal No. 4&#8212;Approval of the CervoMed Inc. 2025 Equity Plan, you may:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Vote&#160;<b>FOR</b>&#160;the proposal;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Vote&#160;<b>AGAINST</b>&#160;the proposal; or</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>ABSTAIN</b>&#160;from voting on the proposal.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">If you send in your proxy card or use Internet or telephone voting, but you do not specify how you want to vote your shares, the proxies will vote your shares in accordance with the Board&#8217;s recommendations set forth below and in the accompanying Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How does the Board recommend that I vote?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board recommends that you vote:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>FOR</b>&#160;all seven of the nominees for director in Proposal No. 1&#8212;Election of Directors;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>FOR</b>&#160;Proposal No. 2&#8212;Ratification of Selection of Independent Registered Public Accounting Firm;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>FOR</b>&#160;Proposal No. 3&#8212;Advisory Vote on Executive Compensation;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><b>FOR</b>&#160;Proposal No. 4&#8212;Approval of the CervoMed Inc. 2025 Equity Plan.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How can I revoke or change my vote?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you are a stockholder whose shares are registered in your name, you may revoke your proxy at any time before it is voted by one of the following methods:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Submitting another proper proxy with a more recent date than that of the proxy first given by following the Internet or telephone voting instructions or completing, signing, dating and returning a proxy card to us;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Sending timely written notice of revocation to our Chief Financial Officer, General Counsel &amp; Corporate Secretary; or</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Attending the Annual Meeting and voting virtually.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you hold your shares through a broker, bank or other nominee, you may revoke your proxy by following instructions your broker, bank or other nominee provides.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Who is paying for this proxy solicitation?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Company will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors, officers and other employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We will also reimburse brokerage firms, banks, and other agents for the certain reasonable costs of forwarding proxy materials to beneficial owners.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How many shares must be present to hold the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The presence at the Annual Meeting, virtually or by proxy, of the holders of at least 33.4% of the outstanding shares of our common stock as of the Record Date will constitute a quorum for the transaction of business at the Annual Meeting. In general, shares of our common stock represented by a properly signed and returned proxy card will be counted as shares present and entitled to vote at the Annual Meeting for purposes of determining a quorum. Shares represented by proxies marked &#8220;Abstain&#8221; and &#8220;broker non-votes&#8221; are counted in determining whether a quorum is present. A &#8220;broker non-vote&#8221; is a proxy returned by a broker on behalf of its beneficial owner customer that is not voted on a particular matter because voting instructions have not been received by the broker from the customer, and the broker does not have discretionary authority to vote on behalf of such customer on such matter. If there is not a quorum, a majority of the shares of our common stock present at the Annual Meeting may adjourn the Annual Meeting to a later date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>What vote is required for each proposal to be approved?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Assuming a quorum is present at the Annual Meeting, the following table summarizes the vote threshold required for approval of each proposal and the effect on the outcome of the vote of abstentions and uninstructed shares by brokers (i.e., broker non-votes).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proposal</b><br/>
			<b>Number</b></p>
			</td>
			<td style="vertical-align:top;width:12.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Item</b></p>
			</td>
			<td style="vertical-align:top;width:12.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Vote Required for</b><br/>
			<b>Approval</b></p>
			</td>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Effect of</b><br/>
			<b>Abstentions</b></p>
			</td>
			<td style="vertical-align:top;width:11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Effect of Broker</b><br/>
			<b>Non-Vote</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1</p>
			</td>
			<td style="vertical-align:top;width:12.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Election of Directors</p>
			</td>
			<td style="vertical-align:top;width:12.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote</p>
			</td>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">No effect</p>
			</td>
			<td style="vertical-align:top;width:11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Not voted/No effect</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2</p>
			</td>
			<td style="vertical-align:top;width:12.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ratification of Selection of Independent Registered Public Accounting Firm</p>
			</td>
			<td style="vertical-align:top;width:12.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Majority of shares present in person or represented by proxy at the meeting and entitled to vote</p>
			</td>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Counted &#8220;against&#8221;</p>
			</td>
			<td style="vertical-align:top;width:11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Shares may be voted by brokers in their discretion, but any non-votes have no effect</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">3</p>
			</td>
			<td style="vertical-align:top;width:12.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Advisory Vote on Executive Compensation</p>
			</td>
			<td style="vertical-align:top;width:12.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Majority of shares present in person or represented by proxy at the meeting and entitled to vote</p>
			</td>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Counted &#8220;against&#8221;</p>
			</td>
			<td style="vertical-align:top;width:11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Not voted/No effect</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:3.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">4</p>
			</td>
			<td style="vertical-align:top;width:12.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Approval of the CervoMed 2025 Equity Incentive Plan</p>
			</td>
			<td style="vertical-align:top;width:12.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Majority of shares present in person or represented by proxy at the meeting and entitled to vote</p>
			</td>
			<td style="vertical-align:top;width:6.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Counted &#8220;against&#8221;</p>
			</td>
			<td style="vertical-align:top;width:11.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Not voted/No effect</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Where can I find the voting results of the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">The preliminary voting results will be announced at the Annual Meeting, and we will publish preliminary, or final results if available, in a Current Report on Form 8-K within four business days of the Annual Meeting. If final results are unavailable at the time we file the Form 8-K, then we will file an amended report on Form 8-K to disclose the final voting results within four business days after the final voting results are known.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Who will count the votes at the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We currently expect that Computershare will tabulate the votes and our Chief Financial Officer, General Counsel &amp; Corporate Secretary will be our inspector of elections for the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Whom do I contact if I have questions regarding the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If you have questions about the Annual Meeting or would like additional copies of this Proxy Statement, you should contact us via e-mail at proxy@cervomed.com or Computershare via mail at:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 108pt;text-indent:36pt;">Computershare</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 108pt;text-indent:36pt;">CervoMed Inc. &#8211; Legal Proxy</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 108pt;text-indent:36pt;">P.O. Box 43001</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 108pt;text-indent:36pt;">Providence, RI 02940-3001</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Are there any matters to be voted on at the Annual Meeting that are not included in this Proxy Statement?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We currently are not aware of any business to be acted upon at the Annual Meeting other than that described in this Proxy Statement. If, however, other matters are properly brought before the Annual Meeting, or any adjournment or postponement of the Annual Meeting, your proxy includes discretionary authority on the part of the individuals appointed to vote your shares or act on those matters according to their best judgment, including to adjourn the Annual Meeting if a quorum is not present.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>How will business be conducted at the Annual Meeting?</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The presiding officer at the Annual Meeting will determine how business at the meeting will be conducted. Only nominations and other proposals brought before the Annual Meeting in accordance with the advance notice and information requirements of our Bylaws will be considered, and no such nominations or other proposals were received. In order for a stockholder proposal to have been included in our Proxy Statement for the Annual Meeting, our Chief Financial Officer, General Counsel &amp; Corporate Secretary must have received such proposal a reasonable period of time before we began to print and send our proxy materials. In accordance with our Bylaws, any such nomination or proposal must have been received on or before the close of business on March 16, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Householding of Annual Disclosure Documents</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Some brokers or other nominee record holders may be sending you a single set of our proxy materials if multiple Company stockholders live in your household. This practice, which has been approved by the SEC, is called &#8220;householding.&#8221; Once you receive notice from your broker or other nominee record holder that it will be &#8220;householding&#8221; our proxy materials, the practice will continue until you are otherwise notified or until you notify them that you no longer want to participate in the practice. Stockholders who participate in householding will continue to have access to and utilize separate proxy voting instructions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We will promptly deliver a separate copy of our Notice or if applicable, our proxy materials to you if you write or call our Corporate Secretary at: CervoMed Inc., 20 Park Plaza, Suite 424, Boston, Massachusetts 02116, or (617) 744-4400. If you want to receive your own set of our proxy materials in the future or, if you share an address with another stockholder and together both of you would like to receive only a single set of proxy materials, you should contact your broker or other nominee record holder directly or you may contact us at the above address and phone number.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Electronic Delivery of Company Stockholder Communications</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">Most stockholders can elect to view or receive copies of future proxy materials over the Internet instead of receiving paper copies in the mail.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:25pt;">You can choose this option and save us the cost of producing and mailing these documents by:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">following the instructions provided on your proxy card; or</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">following the instructions provided when you vote over the Internet</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">5</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CORPORATE GOVERNANCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Introduction</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our common stock is currently listed for quotation on the Nasdaq Capital Market under the symbol &#8220;CRVO.&#8221; As required by the Listing Rules of the Nasdaq Capital Market, the Board has adopted certain governance standards, including its standard of independence.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Corporate Governance Guidelines</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our Board has adopted Corporate Governance Guidelines, a copy of which can be found on the Investor Relations&#8212;Corporate Governance section of our corporate website at&#160;<span style="text-decoration: underline; ">www.cervomed.com</span>. Among the topics addressed in our Corporate Governance Guidelines are:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board size, composition and qualifications;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Retirement and resignation policy;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Selection of directors;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board compensation;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board leadership;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Loans to directors and executive officers;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board committees;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Executive Officer evaluation;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board and committee meetings;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board and committee evaluations;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Executive sessions of outside directors;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director continuing education;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Meeting attendance by directors and non-directors;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Succession planning;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Appropriate information and access;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Related person transactions;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ability to retain advisors;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Communication with directors;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Conflicts of interest and director independence;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Director attendance at annual meetings of stockholders; and</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board interaction with corporate constituencies;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Change of principal occupation and board memberships.</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Stock ownership by directors and executive officers;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">&#160;</td>
			<td style="vertical-align:middle;width:11.9%;">&#160;</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:0.5%;">
			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="vertical-align:middle;width:11.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Retirement and term limits;</p>
			</td>
			<td style="vertical-align:middle;width:0.5%;">&#160;</td>
			<td style="vertical-align:middle;width:11.9%;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Directors &amp; Director Independence</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Nasdaq rules generally require that independent directors must comprise a majority of the listed company&#8217;s board of directors. Based upon information requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships, the Board has determined that five of our eight current directors &#8212; Joshua S. Boger, Ph.D., Jane H. Hollingsworth, J.D., Jeff Poulton, Marwan Sabbagh, M.D., and Frank Zavrl &#8212; are &#8220;independent directors&#8221; as that term is defined under the applicable rules and regulations of the SEC and under the Listing Rules of the Nasdaq Capital Market.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;"><b><i>Certain Family Relationships</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Dr. Alam and Dr. Gr&#233;goire are married and therefore "immediate family members" as defined in Item 404 of Regulation S-K. Other than their relationship, there are no family relationships among any of our directors or executive officers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Our Board of Directors</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The table below sets forth, as of the date of this Proxy Statement, certain information that has been furnished to us by each current director.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Director Since</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">John Alam, M.D.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">63</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Joshua S. Boger, Ph.D.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">74</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2024</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Robert J. Cobuzzi, Ph.D.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">60</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sylvie Gr&#233;goire, PharmD.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">63</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jane H. Hollingsworth, J.D.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">67</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jeff Poulton</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">57</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Marwan Sabbagh, M.D.</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">59</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:31.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Frank Zavrl</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">59</p>
			</td>
			<td style="vertical-align:top;width:0.5%;">&#160;</td>
			<td style="vertical-align:top;width:6.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The paragraphs below provide information about each current director and/or director nominee, including all positions he or she holds, his or her principal occupation and business experience for the past five years, and the names of other publicly held companies of which he or she currently serves as a director or served as a director during the past five years. We believe that all of our directors and director nominees display personal and professional integrity; satisfactory levels of education and/or business experience; broad-based business acumen; an appropriate level of understanding of our business and its industry and other industries relevant to our business; the ability and willingness to devote adequate time to the work of the Board and its committees; a fit of skills and personality with those of our other directors that helps build a board of directors that is effective, collegial and responsive to the needs of our Company; strategic thinking and a willingness to share ideas; a range of experiences, expertise and background; and the ability to represent the interests of all of our stockholders. The information presented below regarding each director and nominee for director also sets forth specific experience, qualifications, attributes and skills that, among other things, led the Board to the conclusion that he or she should serve as a director in light of our business and structure.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">There are no arrangements or understandings with another person under which the Company&#8217;s directors and executive officers were or are to be selected as a director or executive officer. Additionally, no director or executive officer of the Company is involved in legal proceedings which require disclosure under Item 401 of Regulation S-K.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>John Alam, M.D., </i></b>has served as our President and Chief Executive Officer and as a director since August 2023. Dr. Alam was EIP&#8217;s co-founder and served as EIP&#8217;s President and Chief Executive Officer and as a member of EIP&#8217;s board of directors from April 2018 to August 2023. Prior to that, Dr. Alam served as a managing member of EIP Pharma, LLC, EIP&#8217;s predecessor entity, from its inception in 2010. From January 2011 to August 2014, Dr. Alam served as therapeutic area head for diseases of aging at Sanofi S.A. (NASDAQ: SNY), a global pharmaceutical company. From 1997 until 2008, he held positions of increasing responsibility at Vertex Pharmaceuticals (NASDAQ: VRTX), most recently as Chief Medical Officer and Executive Vice President, Medicines Development. From 1991 to 1997, Dr. Alam worked at Biogen Inc. (NASDAQ: BIIB), where he led the clinical development of Avonex, a drug that treats multiple sclerosis. From 2014 to 2022, Dr. Alam served as a member of the board of directors of the Alliance for Aging Research, a non-profit organization dedicated to promoting innovation to address the healthcare needs of older Americans. Dr. Alam received an S.B. in chemical engineering from the Massachusetts Institute of Technology and a M.D. from Northwestern University School of Medicine. Dr. Alam completed an internal medicine residency at Brigham and Women&#8217;s Hospital and a post-doctoral fellowship at Dana-Farber Cancer Institute.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board believes that Dr. Alam is qualified to serve as a director due to his service as the Company&#8217;s and EIP&#8217;s president and chief executive officer and his extensive knowledge of our Company and significant background in pharmaceutical research and development.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Joshua S. Boger, Ph.D.,</i></b> has served as a director and the Chair of the Board since February 2024. Dr. Boger is the founder of Vertex Pharmaceuticals (NASDAQ: VRTX) and served as its Chief Executive Officer from 1992 to May 2009, as chairman of its board of directors from 1997 to 2006, and as a director from 1989 until his retirement from the Vertex Pharmaceuticals board of directors in 2017. Prior to founding Vertex Pharmaceuticals in 1989, Dr. Boger held the position of Senior Director of Basic Chemistry at Merck Sharp &amp; Dohme Research Laboratories in Rahway, New Jersey, where he headed both the Department of Medicinal Chemistry of Immunology &amp; Inflammation and the Department of Biophysical Chemistry. Dr. Boger currently serves as chairman of the board of directors of Alkeus Pharmaceuticals, Inc., a privately-held biotechnology company focused on treating degenerative eye diseases, and is an Investor Director of a UK-based, privately-held medical device company, mOm Incubators Ltd. Dr. Boger holds a B.A. in chemistry and philosophy from Wesleyan University and M.S. and Ph.D. degrees in chemistry from Harvard University. His postdoctoral research in molecular recognition was performed in the laboratories of the Nobel-prize winning chemist, Jean-Marie Lehn in Strasbourg, France. He is the author of over 50 scientific publications and holds 32 issued U.S. patents in pharmaceutical discovery and development.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board believes that Dr. Boger is qualified to serve as a director due to his management experience in the pharmaceutical and biotechnology sector and his extensive knowledge of our Company and significant background in pharmaceutical research and development.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Robert J. Cobuzzi, Jr., Ph.D., </i></b>has served as our Chief Operating Officer since August 2023 and as a director since November 2023. Dr. Cobuzzi previously served as Diffusion&#8217;s President and Chief Executive Officer from September 2020 to August 2023 and was a member of Diffusion&#8217;s board of directors from January 2020 until August 2023. Dr. Cobuzzi also currently serves as a Venture Partner and Chairman of the Business Development Board for Sunstone Life Science Ventures, an independent European venture capital investment firm focused on life science therapeutic innovations. Previously, Dr. Cobuzzi served as an Advisor to the Mitochondrial Disease Research Program at the Children&#8217;s Hospital of Philadelphia, an internationally recognized hospital and research center devoted to children, from January 2019 to April 2020, and as President and Chief Executive Officer of MitoCUREia, Inc., an affiliated company, from July 2019 to July 2020. From 2005 to 2018, Dr. Cobuzzi served in various roles at Endo International PLC, a specialty branded and generic pharmaceuticals manufacturer, most recently serving as President of Endo Ventures Limited. Dr. Cobuzzi received his Bachelor of Arts in Biochemistry and Art History from Colby College and his Ph.D. in Molecular and Cellular Biochemistry from Loyola University Chicago. He served as a Post-doctoral Fellow in Experimental Therapeutics at Roswell Park Cancer Institute.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board believes Dr. Cobuzzi is qualified to serve as a director due to his experience and insight with drug development and business development and funding, both in the U.S. and abroad, as well as his experience and background as an executive and director.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Sylvie Gr</i></b>&#233;<b><i>goire, Pharm.D., </i></b>has served as a director since August 2023 and previously served as Chair of the Board from August 2023 to February 2024. Dr. Gr&#233;goire was EIP&#8217;s co-founder and served as EIP&#8217;s Executive Chair and as a member of EIP&#8217;s board of directors from April 2018 to August 2023. Dr. Gr&#233;goire serves on the board of directors of Novo Nordisk A/S (NYSE: NVO), a global pharmaceutical company, where she sits on the audit committee, the nomination committee and the research and development committee, and, since July 2024, Dr. Gr&#233;goire chairs the board of directors of Abivax SA (NASDAQ: ABVX), a company developing treatments for inflammatory bowel diseases. Dr Gr&#233;goire has also served on the board of F2G Ltd, a privately held company developing treatments for severe rare mold infections since December 2021 where she is also the chair of the Commercial Committee. From May 2013 to May 2019, Dr. Gr&#233;goire served as a director for Vifor Pharma AG (SIX: VIFN), a global pharmaceutical company focused on treatments for renal disease. From September 2007 to May 2013, Dr. Gr&#233;goire served as President of the Human Genetic Therapies division of Shire plc, a global biopharmaceutical company acquired by Takeda Pharmaceutical Company Limited. From 2005 to 2008, she served as a director of IDM Pharma, Inc., a publicly traded biotechnology company that now operates as a subsidiary of Takeda Pharmaceuticals Company Limited, including serving as its Executive Chair from August 2006 to October 2007. From 2004 to 2005, Dr. Gr&#233;goire served as President, Chief Executive Officer and Executive Member of the board of directors of GlycoFi, Inc., a private biotechnology company now part of Merck and Co., Inc. Prior to that, Dr. Gr&#233;goire held various leadership positions at Biogen, Inc. (NASDAQ: BIIB), including Vice-President (head) of Regulatory Affairs, Vice-President (head) of Manufacturing, and as Executive Vice President of Technical Operations. Dr. Gr&#233;goire also served at Merck and Co., Inc. in the U.S. and internationally in clinical research and regulatory affairs. Dr. Gr&#233;goire has also previously served on the board of directors of Revvity Inc (NASDAQ: RVTY) (previously PerkinElmer, Inc. (NYSE: PKI)), a publicly traded company and a provider of products, services and solutions for the diagnostics, life sciences and applied markets, from 2015 to 2024. In addition, Dr. Gr&#233;goire served as chair of the board of directors of Corvidia Therapeutics, Inc., from 2016 to 2020, a private company focused on treatments for cardio-renal diseases. Corvidia was sold to NovoNordisk in 2020. Dr. Gr&#233;goire received a bachelor&#8217;s degree in Pharmacy from Laval University and a doctoral degree in Pharmacy from the State University of New York at Buffalo.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board believes that Dr. Gr&#233;goire is qualified to serve as director due to her management experience in the pharmaceutical and biotechnology sector and her broad experience of service on other boards of directors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Jane H. Hollingsworth, J.D., </i></b>has served as a director since September 2020. Ms. Hollingsworth previously served as Chair of Diffusion&#8217;s board of directors from June 2021 to August 2023. She currently serves as the founding Managing Partner of Militia Hill Ventures, an organization that creates, builds, and invests in life sciences companies, a role she has held since 2013. While at Militia Hill, Jane co-founded and currently serves as Executive Chair of Eliksa Therapeutics, a regenerative medicine company, co-founded and served as Executive Chair of Spirovant Sciences, a gene therapy company sold to Sumitomo Dainippon Pharma, and served as Executive Chair and CEO of Immunome Inc. (NASDAQ: IMNM), a cancer immunotherapy company. Prior to founding Militia Hill, Ms. Hollingsworth co-founded and served as Chief Executive Officer of NuPathe, Inc., a neuroscience focused biopharmaceutical company. She also co-founded and served as EVP of Auxilium Pharmaceuticals, a urology and rare disease focused biopharmaceutical company. Ms. Hollingsworth also currently serves on the boards of the life science companies Afimmune Ltd. and Ribonova, and various industry and community organizations, including the University City Science Center, the Kimmel Center for the Performing Arts and Breastcancer.Org. Ms. Hollingsworth received her B.A. from Gettysburg College and her J.D. from Villanova University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board believes that Ms. Hollingsworth is qualified to serve as a director due to her industry perspective and experience, including as chief executive officer and director of a publicly-traded biopharmaceutical company, as well as her depth of her other operating and senior management experience in the industry and educational background.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Jeff Poulton </i></b>has served as a director since August 2023. Mr. Poulton previously served on EIP&#8217;s board of directors from April 2018 to August 2023. Since July 2019, Mr. Poulton has served as Chief Financial Officer at Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a global biopharmaceutical company based in Cambridge, Massachusetts. From January 2018 to April 2019, Mr. Poulton served as chief financial officer at Indigo Agriculture, a plant microbiome company. From September 1998 to December 2017, Mr. Poulton held various roles of increasing responsibility at Shire plc, a biotechnology company, culminating in his service as chief financial officer from July 2014 to December 2017 and a member of Shire&#8217;s executive committee and board of directors from January 2015 to December 2017. During his tenure at Shire, Mr. Poulton also led Shire&#8217;s rare disease US/APAC and LATAM commercial operations, as well as Shire&#8217;s rare disease business unit. Prior to his tenure at Shire, Mr. Poulton led corporate finance and business development initiatives in both the gas and electric utilities industry and the materials manufacturing sector, serving in financial leadership positions at Cinergy Corporation and PPG Industries, Inc. Mr. Poulton also served as a U.S. Navy Commissioned Officer aboard the USS Peoria. Mr. Poulton holds a B.A. in Economics from Duke University and an M.B.A. in Finance from the Kelly School of Business at Indiana University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board believes that Mr. Poulton is qualified to serve as a director due to his significant financial and operational experience in the life sciences industry.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Marwan Sabbagh, M.D., </i></b>has served as a director since August 2023. Dr. Sabbagh previously served as a member of EIP&#8217;s board of directors from November 2021 to August 2023. Since October 2021, Dr. Sabbagh has served as a professor in the Department of Neurology, and recently became Vice Chairman for Research, at the Barrow Neurological Institute. Dr. Sabbagh is board certified in neurology by the American Board of Psychiatry and Neurology and is a fellow of the American Academy of Neurology. Previously, from May 2018 to October 2021, Dr. Sabbagh was a neurologist and director at the Cleveland Clinic Lou Ruvo Center for Brain Health. Prior to his time at the Cleveland Clinic, Dr. Sabbagh was a director and neurologist at the Banner Sun Health Research Institute from 2000 to 2015. Dr. Sabbagh served on the board of directors of Quince Therapeutics, Inc. (f/k/a/ Cortexyme, Inc.) (NASDAQ: QNCX) from March 2022 to September 2022. Dr. Sabbagh earned his medical degree from the University of Arizona College of Medicine and his undergraduate degree from the University of California Berkeley. He completed his neurology residency at Baylor College of Medicine and a geriatric neurology and dementia fellowship at the University of California San Diego School of Medicine.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The Board believes that Dr. Sabbagh is qualified to serve as a director due to his expertise in neurological diseases and extensive clinical development experience.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Frank Zavrl </i></b>has served as a director since August 2023. Mr. Zavrl previously served as a member of EIP&#8217;s board of directors from April 2018 to August 2023. From September 2017 to March 2018, Mr. Zavrl served as a member of the board of directors of EIP Pharma, LLC. Prior to that, Mr. Zavrl served on the board of directors of Puma Biotechnology, Inc. (NASDAQ: PBYI), a publicly-traded company focused on the treatment of cancer, from September 2015 to July 2020. From 2002 to 2011, Mr. Zavrl served as a Partner at Adage Capital Management, L.P., an asset management company, where Mr. Zavrl specialized in biotechnology investments. From 1999 to 2002, Mr. Zavrl served as a Portfolio Manager at Merlin BioMed Group, a healthcare investment firm. Prior to that, Mr. Zavrl served from 1998 to 1999 as an analyst at Scudder Kemper Investments Inc., focusing on biotechnology investments. Mr. Zavrl received a B.S. in Biochemistry from the University of California, Berkeley and an M.B.A. from the Tuck School of Business at Dartmouth College.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board believes that Mr. Zavrl is qualified to serve as a director due to his significant investment experience in pharmaceutical and biotechnology companies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Leadership Structure</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board believes that our stockholders are best served if the Board retains the flexibility to adapt its leadership structure to applicable facts and circumstances, which necessarily change over time. Accordingly, under our Corporate Governance Guidelines, the office of Chair of the Board and Chief Executive Officer may or may not be held by one person. The Board believes it is best not to have a fixed policy on this issue and that it should be free to make this determination based on what it believes is best under the circumstances.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Currently, Joshua S. Boger, Ph.D., serves the Chair of the Board and John Alam, M.D. serves as our President and Chief Executive Officer; Dr. Gr&#233;goire served as Chair of the Board until Dr. Boger&#8217;s appointment to the Board and as Chair, effective February 7, 2024. The Board believes that it is currently in the best interests of the Company&#8217;s stockholders to separate these offices. This separation allows for our Board Chair to act as a bridge between the Board and the operating organization, while our President and Chief Executive Officer focuses on running the Company&#8217;s business. The Board believes that this separation allows for a more effective utilization of the proven leadership capabilities, breadth of industry experience and business success of the individuals holding both positions, and that the Company and its stockholders are best currently served by this leadership structure.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Executive Sessions</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Generally, at regular meetings of the Board, our independent directors meet in executive session with no company management present during a portion of the meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Meetings and Attendance</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">During 2024, the Board held ten&#160;meetings, including two joint meetings with certain of its standing committees. Each of the directors on the Board during 2024 attended 75 percent or more of the aggregate meetings of the Board and all committees on which he or she served for the period during 2024 in which he or she served as a director. In addition, the Company&#8217;s directors are expected to attend annual meetings of stockholders, if their schedules permit.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Committees</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board has three standing committees: the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee. Each of these committees has the composition and responsibilities described below. The Board, from time to time, may establish other committees to facilitate the management of the Company or oversight of certain affairs, and may change the composition and the responsibilities of the existing committees. Each of the three standing committees has a charter which can be found on the Investor Relations&#8212;Corporate Governance section of our corporate website at www.cervomed.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Audit Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;"><b><i>Responsibilities</i></b>. The primary responsibilities of the Audit Committee include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">overseeing our accounting and financial reporting processes, systems of internal control over financial reporting and disclosure controls and procedures on behalf of the Board and reporting the results or findings of its oversight activities to the Board;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">having sole authority to appoint, retain and oversee the work of our independent registered public accounting firm and establishing compensation to be paid to the independent registered public accounting firm;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">establishing procedures for the receipt, retention and treatment of complaints regarding accounting, internal accounting controls and/or auditing matters and for the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">reviewing and pre-approving all audit services and permissible non-audit services to be performed for us by our independent registered public accounting firm as provided under the federal securities laws and rules and regulations of the SEC;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">overseeing our system to monitor and manage risk, and legal and ethical compliance programs, including the establishment and administration (including the grant of any waiver from) a written code of ethics applicable to each of our principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">oversight of cybersecurity risks.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Audit Committee has the authority to engage the services of outside experts and advisors as it deems necessary or appropriate to carry out its duties and responsibilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Composition and Audit Committee Financial Expert</i></b>. The current members of the Audit Committee are Ms. Hollingsworth, Mr. Poulton, and Mr. Zavrl. Mr.&#160;Poulton is the chair of the Audit Committee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Each current member of the Audit Committee qualifies as &#8220;independent&#8221; for purposes of membership on audit committees under the Listing Rules of the Nasdaq Capital Market and the rules and regulations of the SEC and is &#8220;financially literate&#8221; under the Listing Rules of the Nasdaq Capital Market. In addition, the Board has determined that Mr. Poulton qualifies as an &#8220;audit committee financial expert&#8221; as defined by the rules and regulations of the SEC and meets the qualifications of &#8220;financial sophistication&#8221; under the Listing Rules of the Nasdaq Capital Market as a result of his experience in senior financial positions. Stockholders should understand that these designations related to the Audit Committee members&#8217; experience and understanding with respect to certain accounting and auditing matters are disclosure requirements of the SEC and the Nasdaq Capital Market and do not impose upon any of them any duties, obligations or liabilities that are greater than those generally imposed on a member of the Audit Committee or of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Meetings</i></b>. The Audit Committee met four times during 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Processes and Procedures for Complaints</i></b><i>.</i>&#160;The Audit Committee has established procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls, or auditing matters, and the submission by our employees, on a confidential and anonymous basis, of concerns regarding questionable accounting or auditing matters. Our personnel with such concerns are encouraged to discuss their concerns with their supervisor first, who in turn will be responsible for informing our President and Chief Executive Officer of any concerns raised. If an employee prefers not to discuss a particular matter with his or her own supervisor, the employee may instead discuss such matter with our President and Chief Executive Officer. If an individual prefers not to discuss a matter with the President and Chief Executive Officer or if the President and Chief Executive Officer is unavailable and the matter is urgent, the individual is encouraged to contact the Chair of the Audit Committee, Mr. Poulton.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">A copy of the Audit Committee&#8217;s written charter is publicly available on our website at www.cervomed.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Compensation Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Responsibilities</i></b>. The primary responsibilities of the Compensation Committee include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">determining the annual salaries, incentive compensation, long-term incentive compensation, special or supplemental benefits or perquisites and any and all other compensation applicable to our Chief Executive Officer and other executive officers;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">determiing any revisions to corporate goals and objectives with respect to compensation for our Chief Executive Officer and other executive officers and establishing and leading a process for the full Board to evaluate the performance of our Chief Executive Officer and other executive officers in light of those gals and objectives;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">administering our equity-based compensation plans, including determining specific grants of options and other awards for executive officers and other employees under our equity-based compensation plans; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">establishing and leading a process for determination of the compensation applicable to the non-employee directors on the Board.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Compensation Committee has the authority to engage the services of outside experts and advisors as it deems necessary or appropriate to carry out its duties and responsibilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Composition</i></b>. The current members of the Compensation Committee are Ms. Hollingsworth, Mr. Poulton, and Mr. Zavrl.&#160;Mr.&#160;Zavrl is the chair of the Compensation Committee. Each of the three current members of the Compensation Committee is an &#8220;independent director&#8221; under the Listing Rules&#160;of the Nasdaq Capital Market and a &#8220;non-employee director&#8221; within the meaning of Rule&#160;16b-3 under the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Meetings</i></b>. The Compensation Committee met five times during 2024, including one joint meeting with the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Processes and Procedures for Consideration and Determination of Executive Compensation</i></b>. The Compensation Committee has authority to determine all compensation applicable to our executive officers. In setting executive compensation for our executive officers, the Compensation Committee considers, among other things, the following factors: each executive&#8217;s position within the Company and the level of responsibility; the ability of the executive to affect key business initiatives; the executive&#8217;s individual experience and qualifications; compensation paid to executives of comparable positions by companies similar to our Company; Company and individual performance; and the executive&#8217;s current and historical compensation levels. The Compensation Committee has also from time to time &#8211; including during 2024 &#8211;retained the services of an independent consulting firm to provide advice with respect to executive compensation, such as developing a group of comparable peer companies and reviewing executive and director compensation levels. In making decisions regarding the form and amount of compensation to be paid to our executives, the Compensation Committee may consider information gathered by, and the recommendations of, its current outside compensation consultant, Alpine Rewards, when necessary and appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In making decisions regarding the form and amount of compensation to be paid to our executive officers other than our Chief Executive Officer, the Compensation Committee considers and gives weight to the recommendations of our Chief Executive Officer recognizing that due to his reporting and otherwise close relationship with each executive, the Chief Executive Officer often is in a better position than the Compensation Committee to evaluate the performance of each executive (other than himself). In making decisions regarding the form and amount of compensation to be paid to our Chief Executive Officer, the Compensation Committee considers the recommendation of the Chief Executive Officer with respect to his own compensation and the Compensation Committee&#8217;s own assessment of the Chief Executive Officer&#8217;s annual performance and input from other Board members. The Compensation Committee meets in executive session regularly and makes all executive compensation decisions about the Chief Executive Officer without the presence of the Chief Executive Officer or any executive or employee of our Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Processes and Procedures for Consideration and Determination of Director Compensation</i></b>. The Board has delegated to the Compensation Committee the responsibility, among other things, to establish and lead a process for determining compensation payable to our non-employee directors. The Compensation Committee makes recommendations regarding compensation payable to our non-employee directors to the entire Board, which then makes the final decision. In making decisions regarding compensation to be paid to our non-employee directors, the Board considers factors such as its own views as to the form and amount of compensation to be paid, the current and anticipated time demands placed on non-employee directors and other factors that may be relevant, including the recommendations of Alpine Rewards, when necessary and appropriate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">A copy of the Compensation Committee&#8217;s written charter is publicly available on our website at www.cervomed.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nominating and Corporate Governance Committee</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Responsibilities</i></b>. The primary responsibilities of the Nominating and Corporate Governance Committee are:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">identifying individuals qualified to become Board members;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">recommending director nominees for each annual meeting of our stockholders and director nominees to fill any vacancies that may occur between meetings of stockholders;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">being aware of best practices in corporate governance and developing and recommending to the Board a set of corporate governance standards to govern the Board, its committees, our Company and our employees in the conduct of our business and affairs;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">developing and overseeing a Board and Board committee evaluation process; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">reviewing and discussing with our Chief Executive Officer and reporting periodically to the Board plans for executive officer development and succession plans for the Chief Executive Officer and other key executive officers and employees.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Nominating and Corporate Governance Committee has the authority to engage the services of outside experts and advisors as it deems necessary or appropriate to carry out its duties and responsibilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Composition</i></b>. The current members of the Nominating and Corporate Governance Committee are Ms. Hollingsworth, Dr. Sabbagh and Mr. Zavrl. Ms. Hollingsworth is the chair of the Nominating and Corporate Governance Committee. Each of the three current members of the Nominating and Corporate Governance Committee is an &#8220;independent director&#8221; within the meaning of the Listing Rules&#160;of the Nasdaq Capital Market.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Meetings</i></b>. The Nominating and Corporate Governance Committee met three times during 2024, including two joint meetings with the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Processes and Procedures for Consideration Director Nominations</i></b>. In selecting nominees for the Board, the Nominating and Corporate Governance Committee first determines whether the incumbent directors are qualified to serve, and wish to continue to serve, on the Board. The Nominating and Corporate Governance Committee believes that our Company and stockholders benefit from the continued service of certain qualified incumbent directors because those directors have familiarity with and insight into our Company&#8217;s affairs that they have accumulated during their tenure with the Company, in addition to the qualifications and expertise contributing to such director&#8217;s original appointment to the Board. Appropriate continuity of Board membership also contributes to the Board&#8217;s ability to work as a collective body. Accordingly, it is the practice of the Nominating and Corporate Governance Committee, in general, to re-nominate an incumbent director at the upcoming annual meeting of stockholders if the director wishes to continue his or her service with the Board, the director continues to satisfy the Nominating and Corporate Governance Committee&#8217;s criteria for membership on the Board, the Nominating and Corporate Governance Committee believes the director continues to make important contributions to the Board and there are no special, countervailing considerations against re-nomination of the director.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In identifying and evaluating new candidates for election to the Board, the Nominating and Corporate Governance Committee generally first solicits recommendations for nominees from persons whom the Nominating and Corporate Governance Committee believes are likely to be familiar with candidates having the qualifications, skills and characteristics required for Board nominees. Such persons may include members of the Board and senior management of the Company or other individuals within the personal networks of Company leadership. In addition, the Nominating and Corporate Governance Committee may engage a search firm to assist it in identifying qualified candidates. The Nominating and Corporate Governance Committee then reviews and evaluates each candidate whom it believes merits serious consideration, taking into account available information concerning the candidate, any qualifications or criteria for Board membership established by the Nominating and Corporate Governance Committee, the existing composition of the Board, and other factors that it deems relevant. In conducting its review and evaluation, the Nominating and Corporate Governance Committee may solicit the views of our management, other Board members and any other individuals it believes may have insight into a candidate. The Nominating and Corporate Governance Committee may designate one or more of its members and/or other Board members to interview any proposed candidate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Nominating and Corporate Governance Committee will consider recommendations for the nomination of directors submitted by our stockholders. The Nominating and Corporate Governance Committee will evaluate candidates recommended by stockholders in the same manner as those recommended described above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">There are no formal requirements or minimum qualifications that a candidate must meet in order for the Nominating and Corporate Governance Committee to recommend the candidate to the Board. The Nominating and Corporate Governance Committee believes that each nominee should be evaluated based on his or her merits as an individual, taking into account the needs of the Company and the Board. However, in evaluating candidates, there are a number of criteria that the Nominating and Corporate Governance Committee generally views as relevant and is likely to consider. Some of these factors include:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">whether the candidate is an &#8220;independent director&#8221;&#160;under applicable independence tests under the federal securities laws and rules and regulations of the SEC;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">whether the candidate is &#8220;financially sophisticated&#8221;&#160;and otherwise meets the requirements for serving as a member of an audit committee;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">whether the candidate is an &#8220;audit committee financial expert&#8221;&#160;under the rules and regulations of the SEC for purposes of serving as a member of the Audit Committee;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the needs of the Company with respect to the particular talents and experience of our directors;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the personal and professional integrity and reputation of the candidate;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the candidate&#8217;s level of education and business experience;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the candidate&#8217;s business acumen;</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the candidate&#8217;s level of understanding of our business and industry and other industries relevant to our business;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the candidate&#8217;s ability and willingness to devote adequate time to the work of the Board and its committees;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the fit of the candidate&#8217;s skills and personality with those of other directors and potential directors in building a board of directors that is effective, collegial and responsive to the needs of our Company;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">whether the candidate possesses strategic thinking and a willingness to share ideas;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the candidate&#8217;s range of experiences, expertise and background, in general and as compared to other directors on the Board; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the candidate&#8217;s ability to represent the interests of all stockholders and not a particular interest group.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Nominating and Corporate Governance Committee seeks nominees with a broad range of experience, expertise, and backgrounds. The Nominating and Corporate Governance Committee does not assign specific weights to particular criteria and no particular criterion is necessarily applicable to all prospective nominees. We believe that the backgrounds and qualifications of the directors, considered as a group, should provide a significant mix of experience, knowledge and abilities that will allow the Board to fulfill its responsibilities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">A copy of the Nominating and Corporate Governance Committee&#8217;s written charter is publicly available on our website at www.cervomed.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Oversight of Risk</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board as a whole has responsibility for risk oversight, with more in-depth reviews of certain areas of risk being conducted by the relevant Board committees that report on their deliberations to the full Board. The oversight responsibility of the Board and its committees is enabled by management reporting processes that are designed to provide information to the Board about the identification, assessment and management of critical risks and management&#8217;s risk mitigation strategies. The areas of risk that we focus on include regulatory, operational, financial (accounting, credit, liquidity and tax), cybersecurity, legal, compensation, competitive, health, safety and environment, economic, political and reputational risks.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The committees of the Board oversee risks associated with their respective principal areas of focus. The Audit Committee&#8217;s role includes a particular focus on the qualitative aspects of financial reporting to stockholders, our processes for the management of business and financial risk, our financial reporting obligations, cybersecurity and information technology matters, and our compliance with significant applicable legal, ethical and regulatory requirements. The Audit Committee, along with management, is also responsible for developing and participating in a process for review of important financial and operating topics that present potential significant risk to our Company. The Compensation Committee is responsible for overseeing risks and exposures associated with our compensation programs and arrangements, including our executive and director compensation programs and arrangements. The Nominating and Corporate Governance Committee oversees risks relating to our corporate governance matters and policies and management and director succession planning.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We recognize that a fundamental part of risk management is understanding not only the risks a company faces and what steps management is taking to manage those risks, but also understanding what level of risk is appropriate for our Company. The involvement of the full Board in setting our business strategy is a key part of the Board&#8217;s assessment of management&#8217;s appetite for risk and also a determination of what constitutes an appropriate level of risk for our Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We believe our current Board leadership structure is appropriate and helps ensure proper risk oversight for our Company for a number of reasons, including: (1) general risk oversight by the full Board in connection with its role in reviewing our key long-term and short-term business strategies and monitoring on an on-going basis the implementation of our key business strategies; (2) more detailed oversight by our Board committees that are currently comprised of and chaired by our independent directors and (3) the focus of our Chair of the Board and standing committee chairs on allocating appropriate Board and Board committee agenda time for discussion regarding the implementation of our key business strategies and specifically risk management.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Code of Business Conduct and Ethics</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our Code of Business Conduct and Ethics applies to all of our directors, executive officers and other employees, and meets the requirements of the SEC. A copy of our Code of Business Conduct and Ethics is available on the Investor Relations&#8212;Corporate Governance&#8212;Code of Business Conduct and Ethics section of our corporate website at&#160;<span style="text-decoration: underline; ">www.cervomed.com</span>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Process Regarding Stockholder Communications with Board</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Stockholders may communicate with the Board or any one particular director by sending correspondence, to our Chief Financial Officer, General Counsel &amp; Corporate Secretary via e-mail to proxy@cervomed.com or via mail to 20 Park Plaza, Suite 424, Boston, Massachusetts 02116, with an instruction to forward the communication to the Board or one or more particular directors. Our Chief Financial Officer, General Counsel &amp; Corporate Secretary will forward promptly all such stockholder communications to the Board or the one or more particular directors, with the exception of any advertisements, solicitations for periodical or other subscriptions, and other similar or otherwise inappropriate communications.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<div>
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Policy Prohibiting Hedging - Insider Trading Policy</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">We maintain an Insider Trading Policy that <ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="c6" format="ixt:fixed-false">prohibits</ix:nonNumeric> our officers, directors, and employees from, among other things, engaging in speculative transactions in our securities, including by way of the purchase or sale of a put option, a call option or a short sale (including a short sale &#8220;against the box&#8221;), or engaging in hedging transactions, including prepaid variable forward contracts, equity swaps, collars and exchange funds. A copy of the Insider Trading Policy is filed as an exhibit to our Annual Report for the year ended December 31, 2024, as filed with the SEC.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:20pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">13</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</div>

<div>&#160;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL NO. 1</b><br/>
<b>ELECTION OF DIRECTORS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Number of Directors</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our Bylaws provide that the Board will consist of at least one member, or such other number as may be determined by the Board or our stockholders. The Board has currently fixed the number of directors at eight. However, the Board has adopted a resolution pursuant to which, immediately upon the conclusion of the Annual Meeting, the number of directors shall be fixed at seven.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Nominees for Director</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board has nominated the following seven individuals to serve as our directors until the next annual meeting of our stockholders or until their successors are elected and qualified. All of the nominees named below are current members of the Board. Dr. Cobuzzi&#8217;s term will expire at the Annual Meeting and thereafter the Board will consist of seven members.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">John Alam, M.D.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Joshua S. Boger, Ph.D.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Sylvie Gr&#233;goire, PharmD.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Jane H. Hollingsworth, J.D.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Jeff Poulton</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Marwan Sabbagh, M.D.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Frank Zavrl</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Proxies only can be voted for the number of persons named as nominees in this Proxy Statement, which is seven. If prior to the Annual Meeting, the Board should learn that any nominee will be unable to serve for any reason, the proxies that otherwise would have been voted for this nominee will be voted for a substitute nominee as selected by the Board. Alternatively, the proxies, at the discretion of the Board, may be voted for that fewer number of nominees as results from the inability of any nominee to serve. The Board has no reason to believe that any of the nominees will be unable to serve.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">A plurality of the votes of the shares present in person or represented by proxy at the meeting and entitled to vote is required to elect each nominee as a director.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Recommendation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE </b><b><span style="text-decoration: underline; ">FOR</span></b><b> THE ELECTION OF ALL SEVEN OF THE NOMINEES FOR DIRECTOR NAMED IN THIS PROXY STATEMENT.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">14</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL NO. 2</b><br/>
<b>RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selection of Independent Registered Public Accounting Firm</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our Audit Committee has selected RSM US LLP as our independent registered public accounting firm for the fiscal year ending December&#160;31, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Neither our Bylaws nor other governing documents or law require stockholder ratification of the selection of RSM US LLP as our independent registered public accounting firm. However, the Audit Committee is submitting the selection of RSM US LLP to our stockholders for ratification as a matter of good corporate practice. If our stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain RSM US LLP. Even if the selection is ratified, the Audit Committee, in its discretion, may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in our best interests and the best interests of our stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Representatives of RSM US LLP are expected to be present at the Annual Meeting to respond to appropriate questions.&#160;They also will have an opportunity to make a statement if they wish to do so.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Independent Auditor</b>&#8217;<b>s Fees</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The table below presents fees billed to us for professional services rendered by RSM US LLP, our current independent registered public accounting firm, for the years ended December 31, 2024 and 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="border-collapse: collapse; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Aggregate Amount Billed</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
		</tr>
		<tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2024</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>2023</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit Fees</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">482,271</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">706,537</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit-Related Fees</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Tax Fees</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">21,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">All Other Fees</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
			<td style="width: 12%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;">&#8212;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total</b></p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">482,271</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">727,537</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">On August 16, 2023, we completed the Merger. For financial reporting purposes, EIP was determined to be the accounting acquirer in the transaction and, accordingly, for all periods prior to the Merger, EIP&#8217;s historical financial statements and results of operations replace and are deemed to be the Company&#8217;s financial statements and results of operations for such periods. Prior to the Merger, EIP was a private, non-reporting operating company. Accordingly, audit fees for the year ended December 31, 2023, include, in addition to fees related to the audit of our consolidated financial statements for the year then-ended and related quarterly reviews, (i) fees related to the review of quarterly financial statements for the year ended December 31, 2022, (ii) fees related to the filing of our Registration Statement on Form S-4, as amended, in connection with the Merger and (iii) fees related to the filing of our Registration Statement on Form S-8, filed with the SEC on September 29, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Audit fees for the year ended December 31, 2024, include, in addition to fees related to the audit of our consolidated financial statements for the year then-ended and related quarterly reviews, (i) fees related to the filing of our Registration Statement on Form S-1, as amended, in connection with the 2024 Private Placement, including a post-effective amendment converting such Registration Statement on Form&#160;S-1 into a Registration Statement on Form&#160;S-3, (ii) fees related to the filing of our Registration Statement on Form S-3, as amended, filed with the SEC on October 3, 2024, and (iii) fees related to the filing of our Registration Statement on Form S-8, filed with the SEC on August 9, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Pre-Approval Policies and Procedures</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Audit Committee has adopted procedures pursuant to which all audit, audit-related and tax services and all permissible non-audit services provided by our independent registered public accounting firm must be pre-approved by the Audit Committee. All services rendered by RSM US LLP during 2024 and 2023 were permissible under applicable laws and regulations and were approved in advance by the Audit Committee in accordance with the rules&#160;adopted by the SEC in order to implement requirements of the Sarbanes-Oxley Act of 2002.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The affirmative vote of a majority of the shares present in person or represented by proxy at the meeting and entitled to vote is required to ratify the appointment of the independent registered public accounting firm.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Recommendation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>THE</b>&#160;<b>BOARD UNANIMOUSLY RECOMMENDS A VOTE </b><b><span style="text-decoration: underline; ">FOR</span></b><b> RATIFICATION OF THE SELECTION OF RSM US LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER</b>&#160;<b>31, 2025.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">15</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>AUDIT COMMITTEE REPORT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This report is furnished by the Audit Committee of the Board with respect to our consolidated financial statements for the year ended December&#160;31, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">One of the purposes of the Audit Committee is to oversee our accounting and financial reporting processes and the audit of our annual financial statements. Our management is responsible for the preparation and presentation of complete and accurate financial statements. Our independent registered public accounting firm is responsible for performing an independent audit of our consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight Board (U.S.) and for issuing a report on their audit.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In performing its oversight role, the Audit Committee has reviewed and discussed our audited consolidated financial statements for the year ended December&#160;31, 2024, with our management. Management represented to the Audit Committee that our consolidated financial statements were prepared in accordance with generally accepted accounting principles. The Audit Committee has discussed with RSM US LLP, our independent registered public accounting firm for the year ended December 31, 2024, the matters required to be discussed under Public Company Accounting Oversight Board standards. The Audit Committee has received the written disclosures and the letter from our independent registered public accounting firm required by the applicable requirements of the Public Company Accounting Oversight Board regarding communications with audit committees concerning independence. The Audit Committee has discussed with RSM US LLP its independence and concluded that the independent registered public accounting firm is independent from our Company and our management.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Based on the review and discussions of the Audit Committee described above, the Audit Committee recommended to the Board that our audited consolidated financial statements for the year ended December&#160;31, 2024, be included in our Annual Report for the year ended December&#160;31, 2024, for filing with the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 72pt;"><i>Audit Committee</i><br/>
Jeff Poulton, Chair<br/>
Jane H. Hollingsworth, J.D.<br/>
Frank Zavrl</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">16</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXECUTIVE OFFICERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The table below sets forth, as of the date of this Proxy Statement, certain information concerning our executive officers who are also not directors. Biographical information for Drs. Alam and Cobuzzi is included under the heading, &#8220;<i>Corporate Governance</i>&#8212;<i>Our Board of Directors</i>&#8221;. On April 14, 2025, the Board approved the terms of the Separation Agreement with Dr. Cobuzzi, pursuant to which his employment with the Company will conclude effective July 1, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:15.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:4.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:25.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Position with CervoMed</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:15.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">William R. Elder</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:4.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">42</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:25.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Chief Financial Officer, General Counsel &amp; Corporate Secretary</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:bottom;width:15.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Kelly Blackburn, M.H.A.</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:4.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">61</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:25.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Executive Vice President, Clinical Development</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:bottom;width:15.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark De Rosch, Ph.D., FRAPS</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:4.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">61</p>
			</td>
			<td style="vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="vertical-align:bottom;width:25.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Executive Vice President, Regulatory and Government Affairs and Program Management</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>William Elder</i></b> has served as the Company&#8217;s General Counsel &amp; Corporate Secretary since September 2020 and as the Company&#8217;s Chief Financial Officer since June 2024. Mr. Elder has also served as our Principal Financial Officer since March 2024, previously served as Diffusion&#8217;s Principal Financial Officer from June 2023 to August 2023 and also served as a part-time consultant to Diffusion from July 2020 to September 2020. Prior to joining Diffusion, Mr. Elder principally served as president and chief executive officer of BillyVonElds, LLC, a season-long and daily fantasy sports company, where he managed all financial, legal, and operational aspects of the business from April 2019 to September 2020. From 2011 to February 2019, Mr. Elder served as a corporate and securities associate for Dechert LLP, an international law firm, where Mr. Elder&#8217;s practice focused primarily on counseling public companies on capital markets transactions, mergers and acquisitions, and corporate governance matters. Prior to joining Dechert LLP, Mr. Elder served as an analyst for Creative Financial Group. He received his J.D. from the University of Pennsylvania Law School, an M.S. in finance from Villanova University, and a B.A. in economics from Tufts University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Kelly Blackburn, M.H.A.,</i></b> has served as Executive Vice President, Clinical Development of the Company since April 2025 and previously served as Senior Vice President, Clinical Development, from August 2023 to April 2025. Ms. Blackburn also previously served as Senior Vice President, Clinical Development of EIP from May 2018 to August 2023. Prior to joining EIP, Ms. Blackburn served as Vice President, Clinical Affairs of aTyr Pharma, Inc. (NASDAQ: LIFE) from July 2013 to July 2016. Ms. Blackburn served as a clinical development consultant from September 2012 to July 2013 to a number of companies, including Agios Pharmaceuticals, Promedior Inc. and aTyr Pharma, Inc. Prior to this, Ms. Blackburn was the Vice President, Clinical Development Operations at Vertex Pharmaceuticals (NASDAQ: VRTX), a global biotechnology company, from September 2006 to September 2012 overseeing programs for Incivek and Kalydeco, as well as their early development programs. From September 2002 to August 2006, Ms. Blackburn was Director of Clinical and Safety Operations for Millennium Pharmaceuticals where she was responsible for the VELCADE program which was successfully approved during her tenure. Ms. Blackburn holds a B.S. in biochemistry from University of New Hampshire, an M.H.A. from Quinnipiac College and a M.Ed. from Cambridge College.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Mark De Rosch, Ph.D., FRAPS,</i></b> has been appointed as the Company&#8217;s Executive Vice President, Regulatory and Government Affairs and Program Management, effective May 1, 2025. Dr. De Rosch currently serves as our Senior Vice President, Regulatory and Government Affairs and Program Management, a position he has held since November 2024, and previously served as a consultant to the Company from July 2024 to September 2024. Prior to joining the Company, Dr. De Rosch consulted on drug development and global regulatory strategies since May 2023. Previously, Dr. De Rosch was Chief Operating Officer at Aura Biosciences (&#8220;Aura&#8221;) from March 2021 to May 2023, overseeing regulatory affairs, chemistry, manufacturing and controls (&#8220;CMC&#8221;) / technical operations, program and portfolio management, medical device innovation, and information technology. While at Aura, Dr. De Rosch contributed to Aura becoming a public company and growing from approximately 20 employees to approximately 65 employees to support Phase 3 readiness. Prior to joining Aura, Dr. De Rosch was Chief Regulatory Officer at Epizyme, Inc. (&#8220;Epizyme&#8221;) where he assisted Epizyme in receiving accelerated approval in the U.S. for its first drug, TAZVERIK&#174;, in two oncology indications. Prior to Epizyme, he was Senior Vice President of Regulatory, Quality, and Medical Writing at Nightstar Therapeutics, Inc., a gene therapy company specializing in treatment of inherited retinal disease, which was acquired by Biogen in 2019. Prior organizations also include Akebia Therapeutics, Voisin Consulting Life Sciences, Inspiration Biopharmaceuticals, Vertex Pharmaceuticals, Berlex Laboratories, Diatide, and Mallinckrodt. At Vertex Pharmaceuticals, Dr. De Rosch led the regulatory strategy and marketing approvals in the U.S. and European Union for Kalydeco&#174;, the first drug to treat the underlying cause of cystic fibrosis. Dr. De Rosch has a B.S. in Chemistry/Biochemistry from the University of Wisconsin-Parkside, and an M.S. and Ph.D. in Inorganic Chemistry from the University of California, San Diego. Dr. De Rosch was designated as a Fellow of the Regulatory Affairs Professional Society (FRAPS) in 2017.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">17</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXECUTIVE COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary Compensation Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The table below provides summary compensation information concerning compensation awarded for service during the years ended December 31, 2024, and2023, to the individuals that served as our &#8220;NEOs&#8221; &#8211; all individuals that served as our principal executive officer and our two most highly compensated executive officers other than the principal executive officer, as calculated in accordance with Rule 402 of Regulation S-K &#8211; during the year ended December 31, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="border-collapse: collapse; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); width: 31.9%; vertical-align: middle;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name and Principal Position (1)</b></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 8.1%; vertical-align: middle;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Year</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Salary (2)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Awards (3)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Non-Equity </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Incentive Plan </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Compensation </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(4)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>All Other </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Compensation </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(5)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Total</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">John Alam, M.D.</p>
			</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2024</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">538,535</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">228,549</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">269,268</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,036,352</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>President &amp; Chief Executive Officer</i></p>
			</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">472,399</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">134,900</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">207,856</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">815,155</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Robert J. Cobuzzi, Jr., Ph.D.</p>
			</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2024</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">465,750</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">103,008</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">232,875</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">813,233</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Chief Operating Officer</i></p>
			</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">375,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">316,524</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">703,124</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">William Elder</p>
			</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2024</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">406,475</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">103,008</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">142,266</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">651,749</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><i>Chief Financial Officer, General Counsel &amp; Corporate Secretary</i></p>
			</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">2023</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">292,782</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">60,800</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">114,771</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">468,353</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">On August 16, 2023, in connection with the completion of the Merger, the Company&#8217;s executive officers were reconstituted. At the Effective Time of the Merger, (i) Dr. Alam, the President &amp; Chief Executive Officer of EIP, was appointed as the Company&#8217;s President &amp; Chief Executive Officer, (ii) Dr. Cobuzzi, the President &amp; Chief Executive Officer of Diffusion, was appointed as the Company&#8217;s Chief Operating Officer, and (iii) Mr. Elder, the General Counsel &amp; Corporate Secretary of Diffusion, continued as the Company&#8217;s General Counsel &amp; Corporate Secretary. Mr. Elder was subsequently appointed as the Company&#8217;s Chief Financial Officer in June 2024. The amounts set forth in the table for the year ended December 31, 2023 include (A) with respect to Dr. Alam, (x) compensation from EIP for service from January 1, 2023 through the completion of the Merger and (y) compensation from the Company for service from the completion of the Merger through December 31, 2023 and (B) with respect to Dr. Cobuzzi and Mr. Elder, (x) compensation from Diffusion from January 1, 2023 through the completion of the Merger and (y) compensation from the Company for service from the completion of the Merger through December 31, 2023.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Represents base salary as described below under &#8220;&#8212;<i>Employment Agreements</i>.&#8221;&#160;&#160;From June 2023 to August 2023, Dr. Cobuzzi voluntarily waived his base salary in order to preserve cash resources in advance of the Merger closing.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The amounts shown in this column reflect the grant date fair value of option awards granted for service during the applicable year, calculated in accordance with the provisions of ASC Topic 718 and determined without regard to forfeitures. Amounts shown for 2023 include awards with the following grant date fair values: (i) with respect to Dr. Alam, $134,900 granted in September 2023; (ii) with respect to Dr. Cobuzzi, (x) $60,800 granted in September 2023 and (y) $255,724 granted in January 2024 for service during 2023 in lieu of a cash incentive bonus as described below in Footnote 4, and (iii) with respect to Mr. Elder, $60,800 granted in September 2023. The amounts shown for 2024 for each NEO include an award with the identified grant date fair value granted in January 2024. The assumptions used in the Black-Scholes model to determine the grant date fair values of awards granted during the fiscal years ended December 31, 2024, and 2023 are disclosed in Note 12 to the audited consolidated financial statements included in our Annual Report. Assumptions used during the fiscal year ending December 31, 2025, will be disclosed in our Annual Report on Form 10-K for the year ending December 31, 2025.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Represents the annual cash incentive bonuses for service during the applicable year by our NEOs as described further below under &#8220;&#8212;<i>Cash Bonus Compensation</i>&#8221;. For the year ended December 31, 2023, in lieu of an annual cash bonus, Dr. Cobuzzi was awarded an increased option award of substantially similar economic value on the grant date as further described above in Footnote 3.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 36pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">5)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The amounts reported in this column represent 401(k) Plan matching contributions by the Company. Our NEOs also participate in the Company&#8217;s health, dental, vision and life insurance plans, as well as the Company&#8217;s health savings account, on the same terms available generally to salaries employees.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Employment Agreements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>John Alam, M.D., President &amp; Chief Executive Officer</i>. Effective February 1, 2024, we entered into an amended and restated employment agreement with Dr. Alam pursuant to which he serves as our President and Chief Executive Officer. Dr. Alam&#8217;s annual base salary for the year ended December 31, 2024, was $538,534.86 and his target annual bonus was 50 percent of his base salary. Pursuant to the employment agreement, the Board may increase (but not decrease) Dr. Alam&#8217;s base salary at its discretion. In addition, the employment agreement contains certain severance and change of control provisions as described in more detail under the heading &#8220;&#8212;<i>Post-Termination Severance and Change in Control Arrangements</i>,&#8221; non-competition and non-solicitation provisions (each applicable during employment and for 24 months thereafter), and confidentiality and non-disparagement provisions (each applicable during employment and at all times thereafter). The employment agreement has an indefinite term.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Robert J. Cobuzzi, Jr., Ph.D., Chief Operating Officer</i>. Effective February 1, 2024, we entered into an amended and restated employment agreement with Dr. Cobuzzi pursuant to which he serves as our Chief Operating Officer. Dr. Cobuzzi&#8217;s annual base salary for the year ended December 31, 2024, was $465,750.00. Pursuant to the employment agreement, the Board may increase (but not decrease) Dr. Cobuzzi&#8217;s base salary at its discretion. The employment agreement also provides Dr. Cobuzzi the opportunity to earn a target annual bonus of 50 percent of his base salary. In addition, the employment agreement contains certain severance and change of control provisions as described in more detail under the heading &#8220;&#8212;<i>Post-Termination Severance and Change in Control Arrangements</i>,&#8221; non-competition and non-solicitation provisions (each applicable during employment and for 24 months thereafter), and confidentiality and non-disparagement provisions (each applicable during employment and at all times thereafter). The employment agreement has an indefinite term. On April 14, 2025, the Board approved the terms the Separation Agreement with Dr. Cobuzzi, pursuant to which his employment with the Company will conclude effective July 1, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>William R. Elder, Chief Financial Officer, General Counsel &amp; Corporate Secretary.</i>&#160;Effective June 1, 2024, we entered into an amended and restated employment agreement with Mr. Elder, pursuant to which he serves as our Chief Financial Officer, General Counsel &amp; Corporate Secretary. Mr. Elder&#8217;s annual base salary for the year ended December 31, 2024 was $429,000 following his appointment as Chief Financial Officer on June 1, 2024 and $374,760 from January 1, 2024 to May 31, 2024, and his target annual bonus was 35 percent of his base salary. Pursuant to the employment agreement, the Board may increase (but not decrease) Mr. Elder&#8217;s base salary at its discretion. In addition, the employment agreement contains certain severance and change of control provisions as described in more detail under the heading &#8220;&#8212;<i>Post-Termination Severance and Change in Control Arrangements</i>,&#8221; non-competition and non-solicitation provisions (each applicable during employment and for 24 months thereafter), and confidentiality and non-disparagement provisions (each applicable during employment and at all times thereafter). The employment agreement has an indefinite term.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cash Bonus Compensation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Each of our executive officers has a target annual cash bonus amount based on a percentage of the executive&#8217;s annual base salary in the applicable year, as described above under &#8220;&#8212;<i>Employment Agreements</i>.&#8221; The actual amount of cash bonuses is determined annually by the Compensation Committee. The Compensation Committee determines whether bonuses are earned and the amounts of the bonus payout by considering a number of factors, the principal factor being based upon performance goals developed by the Compensation Committee at the beginning of each year. Important factors that may be considered by the Compensation Committee when developing these performance goals each year or otherwise in determining the amount of executive cash bonus compensation include, among other things, clinical trial progress, business development activities, status of public filings, capital raising transactions, and stock price performance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Long-Term Equity Incentive Compensation and Other Compensatory Arrangements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Compensation Committee administers the 2015 Equity Plan in which our NEOs participate, the cash bonus payments made to our NEOs provided for in the employment agreements described under the heading &#8220;&#8212;<i>Employment Agreements</i>,&#8221; and any other compensation-related matters with respect to our NEOs as they otherwise determine in their discretion. The option grants made for service during 2023 to the NEOs vest and become exercisable in equal monthly installments over a 36-month period until fully vested, subject to the executive&#8217;s continued employment through the applicable vesting date. The Compensation Committee believes time-based vesting of these awards aligns with the 2015 Equity Plan&#8217;s purpose of attracting and retaining qualified individuals to perform services for the Company and aligning the interests of such individuals with the interests of our stockholders.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:AwardTmgMnpiDiscTextBlock" id="c7" escape="true">
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Policies and Practices Related to the Grant of Certain Equity Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Our equity awards, which have consisted exclusively of stock options during the fiscal years ended December 31, 2024, 2023 and 2022, are granted in connection with our yearly compensation cycle, regularly scheduled meetings of the Compensation Committee and, as applicable, the Company&#8217;s compensation policies and procedures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:AwardTmgMethodTextBlock" id="c9">Typically, our practice is to <span style="-sec-ix-hidden:c10">make</span> annual award grants to our existing employees in January or February of each fiscal year and to our non-employee directors at the time of our Annual Meeting of Stockholders. In addition, with respect to newly-hired employees, our typical practice is to make award grants on the seventh day of applicable month (or, if the seventh day of the month is not a business day, on the immediately preceding business day). Our <span style="-sec-ix-hidden:c11">policy</span> is to not grant stock options or similar awards in anticipation of the release of material non-public information and to <span style="-sec-ix-hidden:c12">not</span> time the release of material non-public information based on any equity award grant date, but some awards may be granted close in time to the release of material non-public information to the extent those awards are being granted, for example, upon hiring of new employees or in connection with annual grants being made as part of our director compensation policy, as described further below under &#8220;&#8212;<i>Director Compensation</i>&#8221;.</ix:nonNumeric></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">During the year ended December 31, 2024, we did not time the disclosure of material non-public information for the purpose of affecting the value of executive compensation, and none of our named executive officers were awarded options with an effective grant date during any period beginning four business days before the filing or furnishing of a Form 10-Q, Form 10-K, or Form 8-K that disclosed material non-public information, and ending one business day after the filing or furnishing of such reports.</p>
</ix:nonNumeric>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div>&#160;</div>

<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">19</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Outstanding Equity Awards at Fiscal Year End</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Option Awards</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The table below provides information regarding outstanding stock option awards held by each of our NEOs as of December 31, 2024. Unless otherwise indicated, each grant was awarded under our 2015 Equity Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="border-collapse: collapse; margin-right: 10%; width: 90%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; margin-left: 36pt;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 33.8%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Securities </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Underlying </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Unexercised </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Options </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercisable</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Number of </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Securities </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Underlying </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Unexercised </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Options </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Unexercisable</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Exercise </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Price</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>($/share)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Expiration </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Date</b></p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">John Alam, M.D.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11,041*</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">13,803</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.33</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">9/15/2033</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,736</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5,920</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.33</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">9/15/2033</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">11,833</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">23,667</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.24</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1/26/2034</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Robert J. Cobuzzi, Jr., Ph.D.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,582</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">38.25</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1/7/2030</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">818</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">75.00</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">6/17/2030</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">6,334</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">59.25</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">9/8/2030</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">716</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">83.25</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">3/1/2031</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">716**</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">83.25</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">3/1/2031</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">10,192</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">18.00</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1/27/2032</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7,111</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8,889</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.33</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">9/15/2033</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">18,573</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">37,148</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.24</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1/26/2034</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">William R. Elder</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">934</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">61.50</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">9/22/2030</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">1,169</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">83.25</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">3/1/2031</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">278**</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">83.25</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">3/1/2031</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,076</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">18.00</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1/27/2032</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7,111</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8,889</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5.33</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">9/15/2033</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5,333</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">10,667</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">9.24</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: right; margin: 0pt;">1/26/2034</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">* Granted pursuant to the 2018 Equity Plan, which was assumed by the Company in accordance with and pursuant to the terms of the Merger Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">** Pursuant to the terms of the corresponding award agreements, two-thirds of the underlying shares originally granted were automatically forfeited on October 1, 2021, due to non-achievement of certain specified performance metrics.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">All of the option grants to Drs. Alam and Cobuzzi and Mr. Elder described in the table above subject to future vesting vest and become exercisable in equal monthly installments over a 36-month period until fully vested, subject to the executive&#8217;s continued employment through the applicable vesting date. In connection with the conclusion of Dr. Cobuzzi&#8217;s employment, the Company and Dr. Cobuzzi intend to enter the Separation Agreement, which provides that, among other things, notwithstanding any terms of the 2015 Equity Plan or any stock option award agreements to the contrary, all Company stock options previously granted to Dr. Cobuzzi will remain exercisable and continue to vest in accordance with their respective vesting schedules through September 30, 2026.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>401(k) Retirement Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We maintain our 401(k) Plan pursuant to which all eligible employees are entitled to make pre-tax and after-tax contributions of their compensation. In addition, the Company makes discretionary matching contributions at a rate of 100% for contributions up to 3% of the participant&#8217;s eligible compensation and 50% for any additional contributions up to 5% of the participant&#8217;s eligible compensation. The matching contributions received by our NEOs in the years ended December 31, 2024, and 2023, if any, are reported in the &#8220;All Other Compensation&#8221; column of the Summary Compensation Table above. Prior to the completion of the Merger, Dr. Alam was an employee of EIP and not eligible to participate in the 401(k) Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Post-Termination Severance and Change in Control Arrangements</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As described under the heading &#8220;&#8212;<i>Employment Agreements</i>,&#8221; we have entered into employment agreements with each of our executive officers that provide for certain severance and change of control benefits, subject to the execution and non-revocation of a release of claims by the executive or the executive&#8217;s estate (as applicable).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Under the employment agreements with each of Drs. Alam and Cobuzzi, in the event that the executive&#8217;s employment is terminated by us other than for &#8220;cause,&#8221; death or &#8220;disability,&#8221; or is terminated by the executive for &#8220;good reason&#8221; (as such terms are defined in the applicable employment agreement), the executive will be entitled to any unpaid bonus earned in the year prior to the termination, a pro-rata portion of the bonus earned during the year of termination, continuation of base salary for 12 months, plus 12 months of COBRA premium reimbursement, provided that if such termination occurs within 60 days before or within 24 months following a &#8220;change of control&#8221; (as defined in the applicable employment agreement), then the executive will be entitled to receive the same severance benefits as described above, except that he will receive (a) a payment equal to two times the sum of his base salary and the higher of his target annual bonus opportunity and the bonus payment he received for the year immediately preceding the year in which the termination occurred instead of 12 months of base salary continuation, and (b) a payment equal to 36 times the monthly COBRA premium for him and his eligible dependents instead of 12 months of COBRA reimbursements (the payments in clauses (a) and (b) are paid in a lump sum in some cases and partly in a lump sum and partly in installments over 12 months in other cases). In addition, if the executive&#8217;s employment is terminated by us without cause or by the executive for good reason, in either case, upon or within 24 months following a change of control, then the executive will be entitled to full vesting of all equity awards received by him from us (with any equity awards that are subject to the satisfaction of performance goals deemed earned at not less than target performance, and with any equity award that is in the form of a stock option or stock appreciation right to remain outstanding and exercisable for 24 months following the termination date (but in no event beyond the expiration date of the applicable option or stock appreciation right)).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">In connection with the conclusion of Dr. Cobuzzi&#8217;s employment, the Company and Dr. Cobuzzi intend to enter into the Separation Agreement, which will provide, among other things, that Dr. Cobuzzi shall be eligible to receive: (i) a lump-sum payment of $479,723, subject to lawful deductions, equal to twelve months gross base salary, (ii) a lump-sum payment of $119,602, subject to lawful deductions, equal to Dr. Cobuzzi&#8217;s pro-rated target annual bonus for the year ending December 31, 2025, and (iii) a lump-sum payment, subject to lawful deductions, equal to the aggregate premium for 12 months of COBRA continuation coverage for Dr. Cobuzzi and his eligible dependents. Additionally, notwithstanding any terms of the 2015 Equity Plan or any stock option award agreements to the contrary, all Company stock options previously granted to Dr. Cobuzzi will remain exercisable and continue to vest in accordance with their respective vesting schedules through September 30, 2026. The Separation Agreement also includes a standard release and waiver by Dr. Cobuzzi and other customary provisions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Under the employment agreement with Mr. Elder, in the event that the executive&#8217;s employment is terminated by us other than for &#8220;cause&#8221;, death or &#8220;disability&#8221; or upon the executive&#8217;s resignation for &#8220;good reason&#8221; (as such terms are defined in the applicable employment agreement), the executive will be entitled to any unpaid bonus earned in the year prior to the termination, a pro-rata portion of the bonus earned during the year of termination, continuation of base salary for 9 months, plus 12 months of COBRA premium reimbursement, provided that if such termination occurs within 60 days before or within 24 months following a &#8220;change of control&#8221; (as defined in the applicable employment agreement), then the executive will be entitled to receive the same severance benefits as described above, except that the executive will receive (a) a payment equal to 1.5 times the sum of their base salary and the higher of their target annual bonus opportunity and the bonus payment received for the year immediately preceding the year in which the termination occurred instead of 9 months of base salary continuation and (b) a payment equal to 18 times the monthly COBRA premium for the executive and the executive&#8217;s eligible dependents instead of 12 months of COBRA reimbursements (the payments in clauses (a) and (b) are paid in a lump sum in some cases and in installments over 9 or 12 months in other cases). In addition, if the executive&#8217;s employment is terminated by the Company without cause or by the executive for good reason, in either case, upon or within 24 months following a change of control, then the executive will be entitled to full vesting of all equity awards received by the executive from us (with any equity awards that are subject to the satisfaction of performance goals deemed earned at not less than target performance, and with any equity award that is in the form of a stock option or stock appreciation right to remain outstanding and exercisable for 24 months following the termination date (but in no event beyond the expiration date of the applicable option or stock appreciation right)).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Under the employment agreements for each of our current NEOs, in the event that the executive&#8217;s employment is terminated due to the executive&#8217;s &#8220;death&#8221; or &#8220;disability&#8221;, the executive (or the executive&#8217;s estate) will be entitled to any unpaid bonus earned in the year prior to the termination, a pro-rata portion of the bonus earned during the year of termination, 12 months of COBRA premium reimbursement and accelerated vesting of the greater of the portion of the unvested equity award that would have become vested within 12 months after the termination date had no termination occurred and the portion of the unvested equity award that is subject to accelerated vesting (if any) upon such termination under the applicable equity plan or award agreement (with performance goals deemed earned at not less than target performance, and with any equity award that is in the form of a stock option or stock appreciation right to remain outstanding and exercisable for 12 months following the termination date or, if longer, such period as provided under the applicable equity plan or award agreement (but in no event beyond the expiration date of the applicable option or stock appreciation right)).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Further, under the terms of the stock option agreements with our NEOs that were granted under our 2015 Equity Plan, upon a completion of a &#8220;change of control&#8221; (as defined in the 2015 Equity Plan), options held by our NEOs will become immediately vested and remain exercisable through their expiration date regardless of whether the holder remains in the employment or service of the Company after the change of control. Alternatively, in connection with a change of control, the Compensation Committee may, in its sole discretion, cash out the options.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">For the avoidance of doubt, the Merger is not considered a &#8220;change of control&#8221; under any of the executive&#8217;s employment agreements or stock option agreements.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">21</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL NO. 3</b><br/>
<b>ADVISORY VOTE ON EXECUTIVE COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Introduction</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board is providing our stockholders with an advisory vote on executive compensation pursuant to the Dodd-Frank Act and Section&#160;14A of the Exchange Act. This advisory vote, commonly known as a &#8220;say-on-pay&#8221; vote, is a routine, non-binding vote on the compensation paid to our named executive officers as described in this Proxy Statement under the heading &#8220;<i>Executive Compensation</i>&#8221;, including the Summary Compensation Table and the other related tables and narrative disclosure therein. Once every six years, our stockholders will also have the opportunity to vote on the frequency of future advisory votes on executive compensation. Currently, our Board provides our stockholders with an advisory say-on-pay vote on an annual basis, and the next such say-on-pay frequency vote will be at the Company&#8217;s 2027 Annual Meeting of Stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In general, our executive compensation program during the year ended December 31, 2024 was designed to, among other things: attract and retain executives who are important to the success of the Company and the creation of value for our stockholders; create stockholder value by aligning executives&#8217; interests with stockholders&#8217; interests; motivate and reward our executives for the achievement of Company and individual performance objectives, the achievement of stockholder value creation in both the short and long term; executives&#8217; contributions to the general success of our Company; and, more generally, to support a &#8220;pay-for-performance&#8221; philosophy and culture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Please read the &#8220;<i>Executive Compensation</i>&#8221; section of this Proxy Statement. That section of this Proxy Statement, which includes compensation tables and related narrative discussion, describes the compensation programs and policies for our named executive officers and the executive compensation decisions made by the Compensation Committee and the Board in 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We are requesting stockholder approval of the compensation of our named executive officers as disclosed in this Proxy Statement. This &#8220;say-on-pay&#8221; vote gives our stockholders the opportunity to express their views on our executive compensation. The vote is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the Company&#8217;s compensation philosophy, policies and practices described in this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As this is an advisory vote, the outcome of the vote is not binding on the Company with respect to future executive compensation decisions, including those relating to our named executive officers.&#160;However, the Compensation Committee and the Board will take into account the outcome of the vote when considering future executive compensation decisions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Proposed Resolution</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board unanimously recommends that our stockholders vote in favor of the say-on-pay vote as set forth in the following advisory resolution at the Annual Meeting:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">RESOLVED, that the stockholders of CervoMed Inc. hereby approve, on an advisory basis, the compensation paid to the Company&#8217;s named executive officers during the year ended December 31, 2024, as described in this Proxy Statement pursuant to the compensation disclosure rules&#160;of the SEC, including the &#8220;<i>Executive Compensation</i>&#8221; section, the Summary Compensation Table and the other related tables and narrative disclosure.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The affirmative vote of a majority of shares present in person or represented by proxy at the meeting and entitled to vote is required to approve, on an advisory basis, this resolution.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Recommendation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>THE BOARD UNANIMOUSLY RECOMMENDS A VOTE </b><b><span style="text-decoration: underline; ">FOR</span></b><b> APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS, AS DESCRIBED IN THIS PROXY STATEMENT.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">22</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DIRECTOR COMPENSATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Overview of Non-Employee Director Compensation Program</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As described in more detail under the heading &#8220;<i>Corporate Governance</i>&#8212;<i>Compensation Committee</i>&#8212;<i>Responsibilities</i>,&#8221; the Board has delegated to the Compensation Committee the responsibility to establish and lead a process for the determination of compensation payable to our non-employee directors. The Compensation Committee makes recommendations regarding compensation payable to our non-employee directors to the entire Board, which then makes final decisions regarding such compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The principal elements of our director compensation program for 2024 included:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">cash compensation in the form of annual cash retainers; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">long-term equity-based incentive compensation, in the form of stock options.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Cash Compensation</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The cash compensation paid to the non-employee members of the Board for the term ending at the Annual Meeting consisted of the following cash retainers, pro-rated for any director serving a partial year term as further described under the heading, &#8220;&#8212;<i>Summary Director Compensation Table</i>.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="border-collapse: collapse; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 85%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Description</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Annual<br/>
			Cash Retainer</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Board Member</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">40,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Chair of the Board</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">25,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit Committee Chair</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">15,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Compensation Committee Chair</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">10,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Nominating and Corporate Governance Committee Chair</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Audit Committee Member (other than Chair)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">7,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Compensation Committee Member (other than Chair)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Nominating and Corporate Governance Committee Member (other than Chair)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">4,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The annual cash retainers are paid in regular installments in accordance with the Company&#8217;s standard payroll practices. The Compensation Committee has also reserved the right to make a portion of such payments in the form of equity rather than cash under certain conditions. During the fiscal year ended December 31, 2024, all retainers were paid in cash.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Long-Term Equity-Based Incentive Compensation</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In addition to cash compensation, our non-employee directors receive long-term equity-based incentive compensation in the form of options to purchase shares of our common stock. Upon a non-employee director&#8217;s initial appointment to the Board, the director receives a stock option award exercisable for a number of shares equal to 0.176% of the Company&#8217;s total shares outstanding on the grant date vesting in 36 equal monthly installments following his or her appointment to the Board. Each non-employee director also receives, on an annual basis, a stock option award exercisable for a number of shares equal to 0.088% of the Company&#8217;s total shares outstanding on the grant date (or such lesser amount as the Board may determine) vesting in 12 equal monthly installments following the grant date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">All option awards granted to our non-employee directors have a ten-year term and an exercise price equal to the fair market value of our common stock on the grant date.&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">23</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary Director Compensation Table</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The table below provides summary information concerning the compensation of each individual who served as a non-employee director of the Company during the year ended December&#160;31, 2024. Joshua S. Boger, Ph.D., our current Board Chair, was appointed to the Board and as Board Chair effective February 7, 2024. From January 1, 2024, to February 7, 2024, Dr. Gr&#233;goire served as our Board Chair</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our employee directors &#8211; Dr. Alam, our President and Chief Executive Officer, and Dr. Cobuzzi, our Chief Operating Officer &#8211; do not receive additional compensation for their service on the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="border-collapse: collapse; width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Name</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Fees Earned </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>or Paid in Cash </b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Option Awards</b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>(1)</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>All </b></p>

			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Other Compensation</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;"><b>Total</b></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 1%;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Joshua S. Boger, Ph.D.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">58,429</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">169,776</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">228,205</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Sylvie Gr&#233;goire, PharmD.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">42,537</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">72,416</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">114,953</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Jane H. Hollingsworth, J.D.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">60,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">72,416</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">132,916</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Jeff Poulton</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">60,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">72,416</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">132,416</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Marwan Sabbagh, M.D.</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">44,000</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">72,416</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">116,416</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 40%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Frank Zavrl</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">61,500</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">72,416</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">--</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td>
			<td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">133,916</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:3.3%;">&#160;</td>
			<td style="vertical-align:top;width:auto;">&#160;</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The amounts shown in this column reflect the grant date fair value of option awards granted in June 2024 to each of the identified directors and, with respect to Dr. Boger, in February 2024 in connection with his appointment to the Board, in each case, calculated in accordance with the provisions of ASC Topic 718 and determined without regard to forfeitures. See the assumptions used in the Black-Scholes Model in Note 12 to the audited financial statements included in our Annual Report. As of December 31, 2024, the aggregate number of shares subject to options awarded to each of our non-employee directors during the year was, (i) with respect to Dr. Boger, 15,750, of which 6,409 were vested as of December 31, 2024, and (ii) with respect to all other non-employee directors, 5,750, of which 3,354 were vested as of December 31, 2024.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">24</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Based on information available to us and filings with the SEC, the following table sets forth certain information regarding the beneficial ownership (as defined by Rule 13d-3 under the Exchange Act) of our outstanding common stock as of the Record Date for (i) each person or group of affiliated persons known by us to be the beneficial owner of more than 5% of our common stock, if any, (ii) each of our current directors and nominees for director; (iii) each of our current executive officers (as defined in Item&#160;402(a)(3) of Regulation S-K), as well as Dr. De Rosch, who has been appointed as our Executive Vice President, Regulatory and Government Affairs and Program Management, effective May 1, 2025.; and (iv) all of our current directors, nominees for director, and such executive officers as a group.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Beneficial ownership and percentage ownership are determined in accordance with the rules of the SEC and include voting or investment power with respect to shares of stock. This information does not necessarily indicate beneficial ownership for any other purpose. Under these rules, shares of common stock issuable under stock options or warrants that are exercisable or convertible within 60 days of the Record Date are deemed outstanding for the purpose of computing the beneficial ownership percentage of the holder thereof, but are not deemed outstanding for the purpose of computing the beneficial ownership percentage of any other person. Ownership is based upon information provided by each respective director and officer and public documents filed with the SEC, including Forms&#160;3 and 4, Schedules 13D and 13G and certain other documents, which information may not be accurate as of the Record Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Unless otherwise indicated and subject to applicable community property laws, to our knowledge, each stockholder named in the following table possesses sole voting and investment power over their shares of common stock, except for those jointly owned with that person&#8217;s spouse, if any. Unless otherwise indicated below, the address of each person listed on the table is 20 Park Plaza, Suite 424, Boston, Massachusetts 02116, c/o CervoMed Inc.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Name and Address of Beneficial Owner</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number</b>&#160;<b>of Shares (1)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Percentage of</b><br/>
			<b>Total Voting</b><br/>
			<b>Power</b>&#160;<b>(2)</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Current Directors and/or Director Nominees</i></b></p>
			</td>
			<td style="vertical-align:top;width:9.8%;">&#160;</td>
			<td style="vertical-align:top;width:7.6%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">John Alam, M.D., <i>President, Chief Executive Officer &amp; Director</i>&#160;(3)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,515,227</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">17.3%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Joshua S. Boger, Ph.D., <i>Chair of the Board</i>&#160;(4)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,067,462</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">12.3%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Robert J. Cobuzzi, Ph.D., <i>Chief Operating Officer &amp; Director</i>&#160;(5)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">60,081</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">0.7%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sylvie Gr&#233;goire, PharmD., <i>Director</i>&#160;(6)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1,515,227</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">17.3%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jane H. Hollingsworth, J.D., <i>Director</i>&#160;(7)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">12,421</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">0.1%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Jeff Poulton, <i>Director</i>&#160;(8)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">40,487</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">0.5%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Marwan Sabbagh, M.D., <i>Director</i>&#160;(9)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">13,732</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">0.2%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Frank Zavrl, <i>Director</i>&#160;(10)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">377,052</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">4.3%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">&#160;</td>
			<td style="vertical-align:top;width:9.8%;">&#160;</td>
			<td style="vertical-align:top;width:7.6%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Executive Officers (other than Drs. Alam &amp; Cobuzzi)</i></b></p>
			</td>
			<td style="vertical-align:top;width:9.8%;">&#160;</td>
			<td style="vertical-align:top;width:7.6%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Kelly Blackburn, M.H.A., <i>Exec. Vice President, Clinical Development</i>&#160;(11)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">58,883</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">0.7%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark De Rosch, Ph.D., FRAPS, <i>Exec. Vice President, Prog. Mgmt. &amp; Reg.</i>&#160;(12)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9,222</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">0.1%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">William Elder, <i>Chief Financial Officer &amp; General Counsel </i>(13)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">27,612</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">0.3%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">&#160;</td>
			<td style="vertical-align:top;width:9.8%;">&#160;</td>
			<td style="vertical-align:top;width:7.6%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>All Directors, Director Nominees, and Executive Officers as a Group (11 persons) (14)</b></p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3,182,179</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">35.4%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">&#160;</td>
			<td style="vertical-align:top;width:9.8%;">&#160;</td>
			<td style="vertical-align:top;width:7.6%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Other 5% Stockholders:</i></b></p>
			</td>
			<td style="vertical-align:top;width:9.8%;">&#160;</td>
			<td style="vertical-align:top;width:7.6%;">&#160;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">RA Capital Management, L.P. (15)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">916,063</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9.9%</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:28.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Armistice Capital Master Fund L.P. (16)</p>
			</td>
			<td style="vertical-align:top;width:9.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">734,363</p>
			</td>
			<td style="vertical-align:top;width:7.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">7.8%</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;">* Indicates less than 1.0%</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Includes shares of common stock held as of April 24, 2025, the Record Date, plus shares of common stock that may be acquired upon exercise of options, warrants and other rights exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Based on 8,702,719 shares of common stock issued and outstanding as of the Record Date. The percentage ownership and voting power for each person (or all directors and executive officers as a group) is calculated by assuming (i) the exercise or conversion of all options, warrants and convertible securities exercisable or convertible within 60 days of the Record Date held by such person and (ii) the non-exercise and non-conversion of all outstanding warrants, options and convertible securities held by all other persons (including our other directors and executive officers).</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 1,461,578 shares of common stock held jointly by Dr. Alam and Dr. Gr&#233;goire, his spouse, (b) 44,137 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date held by Dr. Alam and (c) 9,512 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date held by Dr. Gr&#233;goire. Dr. Alam disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">25</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 216,817 shares of common stock held directly by Dr. Boger, (b) 644,703 shares of common stock held by the Boger Trust, (c) 195,748 shares of common stock held by The Amy S. Boger 2021 Trust (&#8220;ASB 2021 Trust&#8221;), and (d) 10,194 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date. Dr. Boger is the sole trustee of the Boger Trust and the ASB 2021 Trust and may be deemed to be the beneficial owner of such securities. Dr. Boger disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">5)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 1,078 shares of common stock held directly by Dr. Cobuzzi and (b) 59,003 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">6)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 1,461,578 shares of common stock held jointly by Dr. Gr&#233;goire and Dr. Alam, her spouse, (b) 9,512 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date held by Dr. Gr&#233;goire, and (c) 44,137 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date held by Dr. Alam. Dr. Gr&#233;goire disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">7)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 462 shares of common stock held directly by Ms. Hollingsworth, (b) 437 shares of common stock held jointly by Ms. Hollingsworth with her spouse, and (c) 11,522 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date. Ms. Hollingsworth disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">8)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 16,444 shares of common stock held directly by Mr. Poulton and (b) 24,043 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">9)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of 13,732 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">10)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 28,345 shares of common stock held by Mr. Zavrl through an individual retirement account, (b) 153,130 shares of common stock held by The FEZ Delaware Dynasty Trust (&#8220;FEZ Trust&#8221;), (c) 171,534 shares of common stock held by the Paula Zavrl Delaware Dynasty Trust (&#8220;PZ Trust&#8221;), and (d) 24,043 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date. Mr. Zavrl is the trust investment manager of the FEZ Trust and the PZ Trust and may be deemed to be the beneficial owner of such securities. Mr. Zavrl disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">11)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 13,674 shares of common stock held directly by Ms. Blackburn and (b) 45,209 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">12)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of 9,222 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">13)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Consists of (a) 1,267 shares of common stock held directly by Mr. Elder and (b) 26,345 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">14)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Includes 276,962 shares of common stock issuable upon the exercise of options exercisable within 60 days of the Record Date.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">15)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Shares beneficially owned are based solely on the Schedule 13G/A filed with the SEC by RA Capital Management, L.P. (&#8220;RA Capital&#8221;) on February 14, 2025. RA Capital Healthcare Fund, L.P. (the &#8220;RA Capital Fund&#8221;) directly holds warrants (the &#8220;Warrants&#8221;) exercisable for up to 1,266,143 shares of common stock. The Warrants contain a provision (the &#8220;Beneficial Ownership Blocker&#8221;) which precludes exercise of the Warrants to the extent that, following exercise, the holder, together with its affiliates and other attribution parties, would own more than 4.99% or 9.99% (at the holder&#8217;s election) of the common stock outstanding. RA Capital Healthcare Fund GP, LLC is the general partner of the RA Capital Fund. The general partner of RA Capital is RA Capital Management GP, LLC, of which Peter Kolchinsky and Rajeev Shah are the controlling persons. RA Capital serves as investment adviser for the RA Capital Fund and may be deemed a beneficial owner, for purposes of Section 13(d) of the Act, of any securities of the Company held by the RA Capital Fund. The RA Capital Fund has delegated to RA Capital the sole power to vote and the sole power to dispose of all securities held in the RA Capital Fund's portfolio, including the shares of the Company&#8217;s common stock. Because the RA Capital Fund has divested voting and investment power over the reported securities it holds and may not revoke that delegation on less than 61 days' notice, the RA Capital Fund disclaims beneficial ownership of the securities it holds for purposes of Section 13(d) of the Act. As managers of RA Capital, Dr. Kolchinsky and Mr. Shah may be deemed beneficial owners, for purposes of Section 13(d) of the Act, of any securities of the Company beneficially owned by RA Capital. RA Capital, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of the securities reported other than for the purpose of determining their obligations under Section 13(d) of the Act, and the filing of the Schedule 13G/A shall not be deemed an admission that either RA Capital, Dr. Kolchinsky, or Mr. Shah is the beneficial owner of such securities for any other purpose. The securities reported as beneficially owned by the RA Capital Fund consists of an aggregate of 1,266,143 shares of common stock that may be acquired upon the exercise of Warrants, as limited by the Beneficial Ownership Blocker. The RA Capital Fund is currently prohibited from exercising the Warrants to the extent that such exercise would result in its beneficial ownership of more than 9.99% of the shares of common stock outstanding. The address of the RA Capital Fund is 200 Berkeley Street, 18<sup style="vertical-align:top;line-height:120%;">th</sup>&#160;Floor, Boston, MA 02116.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">16)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Shares beneficially owned by Armistice Capital Master Fund L.P. (&#8220;Armistice&#8221;) are based solely on the Closing 8-K. Armistice directly holds Warrants exercisable for up to 734,363 shares of common stock. The Warrants contain the Beneficial Ownership Blocker, which precludes exercise of the Warrants to the extent that, following exercise, the holder, together with its affiliates and other attribution parties, would own more than 4.99% or 9.99% (at the holder&#8217;s election) of the common stock outstanding. The address of Armistice is 510 Madison Avenue, 7th Floor, New York, NY 10022.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">26</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;text-indent:-36pt;"><b>Delinquent Section 16(a) Reports</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Section&#160;16(a)&#160;of the Exchange Act requires our directors and executive officers and all persons who beneficially own more than 10 percent of the outstanding shares of our common stock to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock. Directors, executive officers and greater than 10 percent beneficial owners also are required to furnish us with copies of all Section&#160;16(a)&#160;forms they file.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">To our knowledge, based on a review of the copies of such reports and amendments to such reports furnished to us with respect to the year ended December&#160;31, 2024, and based on written representations by our directors and executive officers, all required Section&#160;16 reports under the Exchange Act, for our directors, executive officers and beneficial owners of greater than 10 percent of our common stock were filed on a timely basis during the year ended December&#160;31, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">27</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:PvpTableTextBlock" id="c13" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PAY VERSUS PERFORMANCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The following tables and related disclosures provide information about (i) &#8220;compensation actually paid&#8221; to certain executive officers of the Company during the last three fiscal years ended December 31, 2024, 2023, and 2022, (ii) certain financial performance measures, and (iii) the relationship of the compensation actually paid to those financial performance measures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This disclosure has been prepared in accordance with Item 402(v) of Regulation S-K and does not necessarily reflect value actually realized by the executives or how our Compensation Committee evaluated compensation decisions in light of Company or individual performance. For discussion of how the Company&#8217;s executive compensation program is designed to support the Company&#8217;s business strategy, align the interests of our executives with our stockholders, and embody our Company&#8217;s overall compensation philosophy, please refer to the &#8220;Executive Compensation&#8221; section of this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Year</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Summary</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Table Total</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">for PEO(s)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(1)(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Actually</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Paid to PEO(s)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;(1)(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Summary</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Table Total</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">for Non-PEO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">NEOs (1)(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Actually</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Paid to Non-</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO NEOs</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(1)(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.9%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Value</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Initial</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Fixed</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$100</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Investment</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Based</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">On</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Total</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Shareholder</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Return</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(3)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.1%; border-right: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Net</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Income</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Loss)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(in</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">millions)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(4)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c15" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,424,613</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c16" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,302,245</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c17" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">400,727</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c18" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">318,800</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c19" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">32.65</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c20" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="6" format="ixt:num-dot-decimal" decimals="-5" sign="-">5.80</ix:nonFraction>)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c21" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,518,279</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c22" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,366,539</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c23" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">467,047</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c24" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">457,134</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c25" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">32.82</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c26" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="6" format="ixt:num-dot-decimal" decimals="-4" sign="-">2.17</ix:nonFraction>)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2024</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c27" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">1,036,352</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c28" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">953,313</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c29" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">732,491</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c30" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" format="ixt:num-dot-decimal" decimals="0">797,375</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c31" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:TotalShareholderRtnAmt" scale="0" format="ixt:num-dot-decimal" decimals="INF">10.06</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c32" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="us-gaap:NetIncomeLoss" scale="6" format="ixt:num-dot-decimal" decimals="-4" sign="-">16.29</ix:nonFraction>)</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">On August 16, 2023, in connection with the completion of the Merger, the Company&#8217;s executive officers were reconstituted. At the Effective Time of the Merger, (i) Dr. Alam, the President &amp; Chief Executive Officer of EIP, was appointed as the Company&#8217;s President &amp; Chief Executive Officer, (ii) Dr. Cobuzzi, the President &amp; Chief Executive Officer of Diffusion, was appointed as the Company&#8217;s Chief Operating Officer, and (iii) Mr. Elder, the General Counsel &amp; Corporate Secretary of Diffusion, continued as the Company&#8217;s General Counsel &amp; Corporate Secretary. Mr. Elder was subsequently appointed as the Company&#8217;s Chief Financial Officer in June 2024. Accordingly, (x) the amounts set forth in the table with respect to PEO compensation include, (i) with respect to the years ended December 31, 2023 and 2022, compensation paid to Drs. Alam and Dr. Cobuzzi, and (ii) with respect to the year ended December 31, 2024, compensation paid to Dr. Alam and (y) the amounts set forth in the table with respect to non-PEO NEO compensation include, (i) with respect to the years ended December 31, 2023 and 2022, compensation paid to Mr. Elder and Kelly Blackburn, the Company&#8217;s Executive Vice President, Clinical Development, and (ii) with respect to the year ended December 31, 2024, compensation paid to Dr. Cobuzzi and Mr. Elder. For additional information regarding the compensation paid to Ms. Blackburn with respect to the years ended December 31, 2023, and 2022, please refer to our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 29, 2024.</p>
			</td>
		</tr>

</tbody></table>
</ix:nonNumeric>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:AdjToPeoCompFnTextBlock" id="c33" escape="true">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The table below shows the adjustments made to the compensation totals presented in the Summary Compensation Table for the NEOs in order to calculate &#8220;compensation actually paid&#8221;&#160;in accordance with Item 402(v) of Regulation S-K. Equity values are calculated in accordance with ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of the grant, except as follows:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the expected remaining term of vested shares as of each applicable vesting date was estimated using the simplified method based upon the award&#8217;s original contractual term and the vesting term of such shares;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">b.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the risk-free interest rate for the expected term was estimated based upon the five-year interest rate as reported by the U.S. Federal Reserve Bank of St. Louis on the applicable measurement date; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">c.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the expected volatility of the price of the shares underlying the option awards for the award&#8217;s expected term was estimated based on upon the historical daily average volatility of the Company&#8217;s current comparable public company peer group during the 5.75 years preceding the applicable measurement date.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<ix:exclude><div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">28</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div></ix:exclude>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:72%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 15.5%; border-right: 1px solid black;">&#160;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 16.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; ">2022</span></b></p>
			</td>
			<td colspan="2" style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 15.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; ">2023</span></b></p>
			</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 16.4%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; ">2024</span></b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 15.5%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Non-PEO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">NEOs</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Non-PEO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">NEOs</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Non-PEO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">NEOs</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary Compensation Table Total</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c35" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" decimals="0">1,424,613</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c36" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" decimals="0">400,727</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c37" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" decimals="0">1,518,279</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c38" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" decimals="0">467,047</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c39" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" decimals="0">1,036,352</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c40" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" decimals="0">732,491</ix:nonFraction></b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less, value of Stock Awards reported in Summary Compensation Table</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c41" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-1">166,640</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c42" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">33,322</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c43" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">451,424</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c44" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-2">60,800</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c45" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">228,549</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c46" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">103,008</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c47" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">30,611</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c48" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">6,122</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c49" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">268,769</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c50" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">41,752</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c51" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">24,448</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c52" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">24,696</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plus (less), year over year change in fair value of outstanding and unvested equity awards granted in prior years</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c53" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0" sign="-">5,761</ix:nonFraction>)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c54" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0" sign="-">33,258</ix:nonFraction>)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c55" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">296</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c56" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">154</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c57" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0" sign="-">90,772</ix:nonFraction>)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c58" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0" sign="-">40,685</ix:nonFraction>)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plus, fair value as of vesting date of equity awards granted and vested in the year</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c59" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">24,721</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c60" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">4,941</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c61" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">32,961</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c62" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">10,239</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c63" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">133,708</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c64" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">135,062</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plus (less), year over year change in fair value of equity awards granted in prior years that vested in the year</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c65" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0" sign="-">5,299</ix:nonFraction>)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c66" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-1" sign="-">26,410</ix:nonFraction>)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c67" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0" sign="-">2,342</ix:nonFraction>)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(<ix:nonFraction id="c68" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0" sign="-">1,258</ix:nonFraction>)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c69" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">77,626</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c70" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="0">48,819</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less, prior year-end fair value for any equity awards forfeited in the year</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c71" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c72" contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c73" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c74" contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c75" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$<ix:nonFraction id="c76" contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember" unitRef="USD" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" decimals="-3">0</ix:nonFraction></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Compensation Actually Paid ($)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c77" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" decimals="0">1,302,245</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c78" contextRef="d_2022-01-01_2022-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" decimals="-2">318,800</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c79" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" decimals="0">1,366,539</ix:nonFraction> </b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c80" contextRef="d_2023-01-01_2023-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" decimals="0">457,134</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c81" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" decimals="0">953,313</ix:nonFraction></b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$<ix:nonFraction id="c82" contextRef="d_2024-01-01_2024-12-31" unitRef="USD" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" decimals="0">797,375</ix:nonFraction></b></p>
			</td>
		</tr>

</tbody></table>
</div>
</ix:nonNumeric>

<div>&#160;</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The cumulative TSR amount reported for the year ended December 31, 2022, represents the difference between the Nasdaq-reported price per share of the common stock of Diffusion Pharmaceuticals Inc. at the beginning of the measurement period (i.e., December 31, 2021) and the end of the measurement period (December 30, 2022), as adjusted for the Company&#8217;s 1-for-50 reverse stock split in April 2022. During the year ended December 31, 2022, Dr. Alam and Ms. Blackburn were executive officers of EIP, which during such time was a private company with no public trading market for its common stock. Accordingly, the amounts reported may not be reflective of the TSR to EIP security holders during the applicable period.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;">The cumulative TSR amount reported for the year ended December 31, 2023, represents the difference between (x) the Nasdaq-reported price per share of the common stock of Diffusion Pharmaceuticals Inc. at the beginning of the measurement period (i.e., December 31, 2021) and (y) the Nasdaq-reported price per share of the common stock of the Company at the end of the measurement period (i.e. December 29, 2023), as adjusted for Diffusion&#8217;s 1-for-50 reverse stock split in April 2022, Diffusion&#8217;s 2-for-3 reverse stock split in August 2023 and the Merger. From January 1, 2023, to August 16, 2023, Dr. Alam and Ms. Blackburn were executive officers of EIP, which during such time was a private company with no public trading market for its common stock. Accordingly, the amounts reported may not be reflective of the TSR to EIP security holders during the applicable period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">29</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">The cumulative TSR amount reported for the year ended December 31, 2024, represents the difference between (x) the Nasdaq-reported price per share of the common stock of Diffusion Pharmaceuticals Inc. at the beginning of the measurement period (i.e., December 31, 2021) and (y) the Nasdaq-reported price per share of the common stock of the Company at the end of the measurement period (i.e., December 31, 2024), as adjusted for Diffusion&#8217;s 1-for-50 reverse stock split in April 2022, Diffusion&#8217;s 2-for-3 reverse stock split in August 2023 and the Merger. From January 1, 2023, to August 16, 2023, Dr. Alam and Ms. Blackburn were executive officers of EIP, which during such time was a private company with no public trading market for its common stock. Accordingly, the amounts reported may not be reflective of the TSR to EIP security holders during the applicable period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">For accounting purposes, the Merger is treated as a reverse recapitalization under U.S. generally accepted accounting principles and EIP is considered the accounting acquirer. Accordingly, EIP&#8217;s historical results of operations are deemed the Company&#8217;s historical results of operations for all periods prior to the Merger and, for all periods following the Merger, the results of operations of the combined company will be included in the Company&#8217;s financial statements. Following the completion of the Merger, the business conducted by the Company became primarily the business conducted by EIP. The dollar amounts reported are the net income of the Company as reflected in the Annual Report (or, with respect to net income for the year ended December 31, 2022, which is amount reported in the Company&#8217;s Annual Report for the year then-ended filed with the SEC on March 29, 2024) and may not be reflective of the net income of EIP or Diffusion during the applicable periods.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="c83" escape="true">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Relationship of Compensation Actually Paid and Performance Measures</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;"><img alt="capvtsr.jpg" src="capvtsr.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</ix:nonNumeric>

<div>&#160;</div>

<ix:nonNumeric contextRef="d_2024-01-01_2024-12-31" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="c85" escape="true">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;"><img alt="capvni.jpg" src="capvni.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
</ix:nonNumeric>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">30</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>&#160;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EQUITY COMPENSATION PLAN INFORMATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The following table provides certain aggregate information with respect to our equity compensation plans in effect as of December 31, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: bottom; width: 25.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plan category</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-top: 1px solid black;">&#160;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Number of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">securities to be</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">issued upon</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">exercise of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">outstanding</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">options,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">warrants and</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">rights</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-top: 1px solid black;">&#160;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Weighted-</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">exercise price of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">outstanding</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">options,</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">warrants and</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">rights</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-top: 1px solid black;">&#160;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Number of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">securities</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">remaining</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">available for</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">future issuance</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">under</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">equity</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">plans</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(excluding</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">securities</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">reflected in first</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">column)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Equity compensation plans approved by security holders (1)</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">367,932</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">20.85</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">23,843</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.9%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Equity compensation plans not approved by security holders (3)</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">236,872</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17.46</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">0</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: auto; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">636,804</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">$</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">19.52</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.5%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.5%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:5.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">23,843</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.9%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Includes securities issued and issuable pursuant to the 2015 Equity Plan but excludes 32,000 shares granted to a non-executive employee on October 15, 2024, the continued holding of which was contingent upon the annual automatic increase in the share pool under the 2015 Equity Plan described in Footnote 2 below occurring and being sufficient to cover all shares of Common Stock underlying such award (and if such automatic increase was not so sufficient, the award would terminate immediately on January 2, 2025 with no compensation or other payment due).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The 2015 Equity Plan provides for increases to the number of shares reserved for issuance thereunder each January 1 equal to 4.0% of the total shares of the Company&#8217;s common stock outstanding as of the immediately preceding December 31, unless a lesser amount is stipulated by the Compensation Committee. As of December 31, 2024, there were 23,843 shares available for future issuance under the 2015 Equity Plan. On January 1, 2025, the number of shares available for future issuance under the 2015 Equity Plan increased by 348,109 shares.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Includes (i) 165,160 securities issued pursuant to the 2018 Equity Plan and (ii) 71,712 securities issued pursuant to inducement awards material to new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Additional information regarding the 2018 Equity Plan is included immediately below.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary Description of the Company</b>&#8217;<b>s Non-Stockholder Approved Equity Compensation Plans</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>2018 Employee, Director and Consultant Equity Incentive Plan</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">On March 28, 2018, EIP adopted the 2018 Equity Plan, which was assumed by the Company upon completion of the Merger pursuant to and in accordance with the terms of the Merger Agreement. Under the 2018 Equity Plan, the Company may issue incentive stock options, non-qualified stock options, stock grants, and other stock-based awards to employees, directors, and consultants, as specified in the 2018 Equity Plan and subject to applicable SEC and Nasdaq rules and regulations. The Board has the authority to determine to whom options or stock will be granted, the number of shares, the term, and the exercise price. Options granted under the 2018 Equity Plan have a term of up to ten years and, with respect to grants made prior to the completion of the Merger, generally vest over a four-year period with 25% of the options vesting after one-year of service and the remainder vesting monthly thereafter; awards granted under the 2018 Equity Plan following the completion of the Merger vest in equal monthly installments over 36 months from the grant date. As of December 31, 2024, there were no shares available for issuance under the 2018 Equity Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">31</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PROPOSAL NO. 4</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>APPROVAL OF CERVOMED INC. 2025 EQUITY INCENTIVE PLAN</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Introduction</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">On April 14, 2025, the Board, upon recommendation of the Compensation Committee, unanimously approved the CervoMed Inc. 2025 Equity Incentive Plan (referred to in this section as the &#8220;2025 Plan&#8221;), subject to approval by our stockholders at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The 2025 Plan provides for the grant of incentive and non-statutory stock options, stock appreciation rights, restricted stock, RSUs, performance awards, stock bonuses and other stock-based awards.&#160; The Board and Compensation Committee believe the 2025 Plan provides a means to attract and retain qualified individuals to perform services for our Company, by providing incentive compensation for such individuals that is linked to the growth and profitability of our Company and increases in stockholder value, and aligning the interests of such individuals with the interests of our stockholders through opportunities for equity participation in our Company.&#160; Historically, we have granted equity-based awards outside any stockholder approved plan, or through our 2015 Equity Plan and 2018 Equity Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In the following discussion, we refer to both incentive stock options and non-statutory stock options as &#8220;options,&#8221; and to options, stock appreciation rights, restricted stock awards, RSUs, performance awards and stock bonuses as &#8220;incentive awards.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Reasons Why You Should Vote in Favor of the Approval of the 2025 Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board recommends a vote for the approval of the 2025 Plan because the Board believes the 2025 Plan is in the best interests of our Company and stockholders for the following reasons:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Aligns Director, Executive Officer, Employee and Stockholder Interests</i>.&#160;&#160;We currently provide long-term incentives in the form of stock option grants to our directors and employees, including our executive officers.&#160;&#160;We believe that our equity-based compensation programs help align the interests of our directors, executive officers and other employees with the interests of our stockholders.&#160;&#160;We believe that our long-term equity-based incentives help promote long-term retention of our employees and encourage significant ownership of our common stock.&#160;&#160;If the 2025 Plan is approved, we will be able to align the interests of our directors, executive officers and other employees with the interests of our stockholders through equity participation in our Company.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Attracts and Retains Talent</i>.&#160;&#160;Talented, motivated and effective directors, executives and employees are essential to executing our business strategies.&#160;&#160;We believe equity-based compensation is an important component of total compensation at our Company because such compensation enables us to effectively recruit executives and other employees while encouraging them to act and think like owners of our Company.&#160;&#160;Equity-based compensation is especially important for smaller public companies, such as us, when our equity-based compensation arrangements can assist us in competing for talent against other companies that may offer better and more lucrative cash and other compensation packages.&#160;&#160;If the 2025 Plan is approved, we believe we will be better able to offer competitive compensation packages to both retain our best performers and attract new talent.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Supports our Compensation Philosophy</i>.&#160;&#160;We believe that equity-based compensation, by its very nature, is performance-based compensation.&#160;&#160;To align the interests of our executive officers with the interests of our stockholders, we intend that a significant part of the total compensation to be paid to our executive officers will be performance-based.&#160;&#160;We intend to use equity-based incentive compensation to help reinforce desired financial and other business results for our executives and to motivate them to make decisions to produce those results.&#160;&#160;Therefore, approval of the 2025 Plan is important to support our pay-for-performance philosophy.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Balances Appropriately our Need to Attract and Retain Talent with Stockholder Interests Regarding Dilution</i>.&#160;&#160;We recognize the dilutive impact of our equity-based compensation programs on our stockholders and we intend to strive to balance this concern with competitive compensation practices and the need to attract and retain talent.&#160;&#160;As described in more detail below under the heading &#8220;&#8212;<i>Background for Shares Authorized for Issuance under the 2025 Plan</i>,&#8221;&#160;we believe the 2025 Plan is not excessively dilutive to our stockholders.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Protects Stockholder Interests and Embraces Sound Equity-Based Compensation Practices</i>.&#160;&#160;As described in more detail below under the heading &#8220;&#8212;<i>Summary of Sound Governance Features of the 2025 Plan</i>,&#8221;&#160;the 2025 Plan includes a number of features that are consistent with the interests of our stockholders and sound corporate governance practices.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary of Sound Governance Features of the 2025 Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Board and Compensation Committee believe that the 2025 Plan contains several features that are consistent with the interests of our stockholders and sound corporate governance practices, including the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>No Automatic Share Replenishment or </i>&#8220;<i>Evergreen</i>&#8221;<i>&#160;Provision</i>.&#160;&#160;The number of shares of our common stock authorized for issuance under the 2025 Plan is fixed and will not adjust based upon the number of outstanding shares of our common stock.&#160;&#160;We currently expect that the number of shares of our common stock authorized for issuance under the 2025 Plan will last up to approximately three years, at which time we expect to ask our stockholders to approve an additional share authorization or a new plan to replace the 2025 Plan.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">32</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Not Excessively Dilutive to our Stockholders</i>.&#160;&#160;As described in more detail below under the heading &#8220;&#8212;<i>Background for Shares Authorized for Issuance Under the 2025 Plan</i>,&#8221;&#160;we believe that the number of shares authorized for issuance under the 2025 Plan is appropriate and not excessively dilutive to our stockholders.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Limit on Number of Incentive Awards in One Year</i>.&#160;&#160;No participant may be granted incentive awards covering more than 400,000 shares of common stock during any one calendar year.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Limit on Non-Employee Director Awards</i>.&#160;&#160;The maximum aggregate grant date fair value (determined in accordance with ASC 718) of incentive awards to be granted and other cash compensation paid to any non-employee director in any calendar year may not exceed $750,000 increased to $1,000,000 in the year in which such non-employee director initially joins the Board.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>No Repricing of Stock Options or Stock Appreciation Rights</i>.&#160;&#160;The 2025 Plan prohibits the repricing of outstanding &#8220;underwater&#8221;&#160;stock options or stock appreciation rights without stockholder approval, except for any adjustments required in connection with certain corporate transactions.&#160;&#160;Repricing is broadly defined to include amendments or modifications to the terms of an outstanding stock option or stock appreciation right to lower the exercise or grant price or cancelling an outstanding stock option or stock appreciation right in exchange for cash, other incentive awards or other stock options or stock appreciation rights having a lower exercise price.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>No Discounted Stock Options or Stock Appreciation Rights</i>.&#160;&#160;The 2025 Plan prohibits granting stock options and stock appreciation rights with exercise prices lower than the fair market value of a share of our common stock on the grant date, except in connection with the assumption of awards in certain mergers, consolidations, acquisitions of property or stock, reorganizations or other similar transactions.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>No Reload Stock Options or Stock Appreciation Rights</i>.&#160;&#160;Reload stock options and stock appreciation rights are not authorized under the 2025 Plan. Reload stock options and reload stock appreciation rights are incentive awards that automatically provide for an additional grant of the same type of incentive awards upon the exercise of the incentive award.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Stock Options, Stock Appreciation Rights and Unvested Performance Awards are Not Entitled to Dividend Equivalent Rights</i>.&#160;&#160;Stock option, stock appreciation right and unvested performance award holders have no rights as stockholders with respect to the shares underlying their awards until their stock options, stock appreciation rights or unvested performance awards are exercised or vested and shares are issued.&#160;&#160;As a result, stock options and stock appreciation rights and unvested performance awards, the vesting of which is based on the achievement of performance goals, under the 2025 Plan have no dividend equivalent rights associated with them.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>No Liberal Change in Control Definition</i>.&#160;&#160;The change in control definition in the 2025 Plan is not a &#8220;liberal&#8221;&#160;definition and, for example, would not be activated merely upon stockholder approval of a transaction or, necessarily, upon the consummation of such a transaction. A change in control must actually occur in order for the change in control provisions in the 2025 Plan to be triggered and, in such an event, the Board and the Compensation Committee have the discretion to determine whether outstanding awards continue on substantially similar terms or are terminated in exchange for payment of an amount equal to the consideration payable in such transaction.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>No Tax Gross-Ups</i>.&#160;&#160;The 2025 Plan does not provide for any tax gross-ups.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Material Amendments Require Stockholder Approval</i>.&#160;&#160;The 2025 Plan requires stockholder approval of material revisions to the 2025 Plan.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Administration by Independent Committee</i>.&#160;&#160;The 2025 Plan will be administered by the Compensation Committee.&#160;&#160;All members of the committee administering the 2025 Plan will be &#8220;non-employee directors&#8221;&#160;within the meaning of Rule&#160;16b-3 under the Exchange Act and &#8220;independent directors&#8221;&#160;under the Listing Rules&#160;of Nasdaq (or other applicable exchange or market on which our common stock may be traded or quoted) and any applicable rules&#160;and regulations of the SEC.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><i>Awards Subject to Forfeiture/Clawback</i>.&#160;&#160;The 2025 Plan contains a forfeiture or &#8220;clawback&#8221;&#160;provision, which, provides that the Company may recover from a participant any compensation received from any incentive award (whether or not settled) or cause a participant to forfeit any incentive award (whether or not vested) in the event that the Company&#8217;s Clawback Policy as then in effect is triggered.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Background for Shares Authorized for Issuance Under the 2025 Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If the 2025 Plan is approved, the maximum aggregate number of shares of our common stock authorized for issuance pursuant to awards under the 2025 Plan, subject to adjustment, will be 800,000 shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">33</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In setting the number of shares of common stock authorized for issuance under the 2025 Plan, we considered a number of factors, which are discussed further below, including:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Total outstanding equity awards, shares to be authorized for issuance under the 2025 Plan and how long the shares proposed to be authorized for issuance under the 2025 Plan are expected to last;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Historical equity award granting practices, including our three-year average burn rate, and our anticipated equity award granting practices; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Potential dilution.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Total Outstanding Equity Awards and Shares Available under the 2025 Plan</i>.&#160; While the use of long-term incentives, in the form of equity awards, is an important part of our compensation program, we are mindful of our responsibility to our stockholders to exercise judgment in the granting of equity awards. In setting the number of shares authorized for issuance under the 2025 Plan, we considered total outstanding equity awards, shares to be available under the 2025 Plan and how long the shares available under the 2025 Plan are expected to last.&#160; Under the heading &#8220;&#8212;<i>Securities Authorized for Issuance under Equity Compensation Plans</i>&#8221; on page 41, as required by SEC rules, we provide information about shares of our common stock that may be issued under outstanding equity compensation arrangements as of December&#160;31, 2024.&#160; To facilitate the approval of the 2025 Plan, set forth below is certain additional information as of the Record Date, April 24, 2025.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As of the Record Date, we had 8,702,719 shares of common stock issued and outstanding.&#160; The market value of one share of our common stock on the Record Date, as determined by reference to the closing price of our common stock, as reported on the Nasdaq Capital Market, was $8.80.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As of the Record Date:</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">67,345 shares of our common stock were available for future grants under the 2015 Equity Plan.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">909,419 shares of our common stock were issuable upon the exercise of outstanding stock options (vested and unvested) with a weighted average exercise price of $13.23 per share. These stock options consist of non-plan options granted outside any formal plan, as well awards granted under our 2015 Equity Plan and 2018 Equity Plan.</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">No shares underlying full value awards (such as restricted stock, RSUs and performance share awards) were outstanding.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">If the 2025 Plan is approved by our stockholders, we intend to grant any future stock options and other equity awards under the 2025 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Historical and Anticipated Equity Award Granting Practices</i>.&#160; In setting the number of shares authorized for issuance under the 2025 Plan, we considered the historical number of equity awards granted in the past two full fiscal years and our anticipated equity award granting practices.&#160; The following table sets forth information regarding equity awards granted and the annual burn rate for each of the last two fiscal years.&#160; The amounts in the following table are not necessarily indicative of awards that might be awarded under the 2025 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="border-collapse: collapse; margin-right: 15%; width: 85%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;">

		<tbody><tr class="finHeading" style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2024</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">2023</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 61.7%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Stock options granted</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">310,996</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 2.3%;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">(1)</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">198,600</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Full-value awards or shares granted or earned</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">0</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Basic common shares outstanding as of fiscal year end</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">8,702,719</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">5,674,520</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&#160;</td>
		</tr>
		<tr style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;">Burn rate</p>
			</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3.57</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td>
			<td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&#160;</td>
			<td style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">3.50</td>
			<td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">%</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">Includes 32,000 shares granted to a non-executive employee on October 15, 2024, the continued holding of which was contingent upon the annual automatic increase in the share pool under the 2015 Equity Plan occurring and being sufficient to cover all shares of Common Stock underlying such award (and if such automatic increase was not so sufficient, the award would terminate immediately on January 2, 2025 with no compensation or other payment due).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We also considered our two-year average burn rate (2023 to 2024) of approximately 3.54 percent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Potential Dilution</i>.&#160; In setting the number of shares authorized for issuance under the 2025 Plan, we also considered the potential dilution that would result by approval of the 2025 Plan, including the policies of certain institutional investors and major proxy advisory firms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Potential dilution is calculated as shown below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;"><i>Potential dilution =</i>&#160;<i>Total shares available under the 2025 Plan plus shares subject to outstanding awards (</i>&#8220;<i>Total Award Shares</i>&#8221;<i>) divided by total number of outstanding shares plus Total Award Shares</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">As of the Record Date, our potential dilution was 10.1 percent. If the 2025 Plan is approved, our potential dilution will be 16.4 percent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">34</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary of the 2025 Plan</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">A summary description of the material features of the 2025 Plan is outlined below.&#160; The summary is qualified in its entirety by reference to the full text of the 2025 Plan.&#160; A copy of the 2025 Plan is attached to this proxy statement as Appendix A.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Purpose</i>. The purpose of the 2025 Plan is to advance the interests of our Company and stockholders by enabling us to attract and retain qualified individuals to perform services for us, by providing incentive compensation for such individuals that is linked to the growth and profitability of our Company and increases in stockholder value, and aligning the interests of such individuals with the interests of our stockholders through opportunities for equity participation in our Company.&#160; Providing stock incentive awards under the 2025 Plan will be an important element in our overall success.&#160; In general, the Board believes that equity-based incentives align the interests of our management and employees with those of our stockholders.&#160; In addition, providing incentive awards under the 2025 Plan is an important strategy for attracting and retaining the type of high-quality executives, employees and advisors the Board believes is necessary for the achievement of our goals.&#160; Given the intense competition for such personnel, the Board believes that its ability to offer competitive compensation packages, including those with equity-based incentive components, such as stock options, is particularly important in attracting and retaining qualified candidates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Eligibility</i>.&#160; All employees (including officers and directors who also are employees), non-employee directors, consultants, advisors and independent contractors of the Company, or any subsidiary, will be eligible to receive incentive awards under the 2025 Plan.&#160; As of the Record Date, 21 employees and non-employee directors would have been eligible to receive awards under the 2025 Plan.&#160; We have not granted any incentive awards under the 2025 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Shares Available for Issuance</i>.&#160; The maximum number of shares of our common stock available for issuance under the 2025 Plan will be 800,000.&#160; The number of shares available for issuance under the 2025 Plan is subject to increase to the extent that we issue shares or incentive awards under the 2025 Plan in connection with certain merger and acquisition transactions, or assume any plan in a merger or acquisition transaction.&#160; However, any available shares in an assumed plan may only be utilized to the extent permitted under the Listing Rules&#160;of Nasdaq (or other applicable exchange or market on which our common stock may be traded or quoted).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Share Counting.</i>&#160;&#160;Shares of our common stock that are issued under the 2025 Plan or that potentially are issuable pursuant to outstanding incentive awards reduce the number of shares remaining available.&#160; All shares so subtracted from the amount available under the 2025 Plan with respect to an incentive award that lapses, expires, is forfeited or for any reason is terminated, unexercised or unvested and any shares of our common stock that are subject to an incentive award that is settled or paid in cash or any other form other than shares of our common stock will automatically again become available for issuance under the 2025 Plan.&#160; However, any shares not issued due to the exercise of an option by a &#8220;net exercise&#8221; or the tender or attestation as to ownership of previously acquired shares (as described below), as well as shares covered by a stock appreciation right, to the extent exercised, and shares withheld by us to satisfy any tax withholding obligations will not again become available for issuance under the 2025 Plan.&#160; Any shares of our common stock repurchased us on the open market using the proceeds from the exercise of an award under the 2025 Plan will not increase the number of shares available for future grants of awards under the 2025 Plan.&#160; Any shares of our common stock that are subject to an incentive award under the 2025 Plan that terminates by expiration, forfeiture, cancellation, or otherwise without the issuance of shares or are settled in cash in lieu of shares, or are exchanged to the extent permitted under the 2025 Plan, prior to the issuance of shares, will be available again for grant under the 2025 Plan. &#160;The shares of our common stock available for issuance under the 2025 Plan may be authorized and unissued shares or treasury shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Grant Limits</i>.&#160; Under the terms of the 2025 Plan, no participant may be granted incentive awards covering more than 400,000 shares of common stock in any one calendar year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">All of the share limitations in the 2025 Plan may be adjusted to reflect changes in our corporate structure or shares, as described below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Adjustments</i>.&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, divestiture or extraordinary dividend (including a spin-off) or any other similar change in our corporate structure or shares, we must adjust:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the number and kind of securities available for issuance under the 2025 Plan; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">in order to prevent dilution or enlargement of the rights of participants, the number, kind and, where applicable, the exercise price of securities subject to outstanding incentive awards.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Administration</i>.&#160; The 2025 Plan will be administered by the Board or by a committee of the Board.&#160; Any such committee will consist of at least two members of the Board, all of whom are &#8220;non-employee directors&#8221; within the meaning of Rule&#160;16b-3 under the Exchange Act, and who are &#8220;independent directors&#8221; within the meaning of the Listing Rules&#160;of Nasdaq (or other applicable exchange or market on which our common stock may be traded or quoted).&#160; We expect the Compensation Committee of the Board to administer the 2025 Plan.&#160; The Board or the committee administering the 2025 Plan is referred to as the &#8220;committee.&#8221;&#160; The committee may delegate its duties, power and authority under the 2025 Plan to any of our officers to the extent consistent with applicable corporate law, except with respect to participants subject to Section&#160;16 of the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">35</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The committee has the authority to determine all provisions of incentive awards consistent with terms of the 2025 Plan, including, the eligible recipients who will be granted one or more incentive awards under the 2025 Plan, the nature and extent of the incentive awards to be made to each participant, the time or times when incentive awards will be granted, the duration of each incentive award, and the restrictions and other conditions to which the payment or vesting of incentive awards may be subject.&#160; The committee may amend or modify the terms of outstanding incentive awards (except for any prohibited &#8220;re-pricing&#8221; of options, discussed below) so long as the amended or modified terms are permitted under the 2025 Plan and any participant whose rights under a previously granted incentive award are adversely affected by such amendment or modification has consented to the amendment or modification.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The committee, in its sole discretion, may amend the terms of the 2025 Plan or incentive awards with respect to participants resident outside of the U.S. or employed by a non-U.S. subsidiary in order to comply with local legal requirements, to otherwise protect our or subsidiary&#8217;s interests, or to meet objectives of the 2025 Plan, and may, where appropriate, establish one or more sub-plans for the purposes of qualifying for preferred tax treatment under foreign tax laws.&#160; This authority does not, however, permit the committee to take any action:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">to reserve shares or grant incentive awards in excess of the limitations provided in the 2025 Plan;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">to effect any re-pricing of options, as discussed below;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">to grant options or stock appreciation rights having an exercise price less than 100 percent of the &#8220;fair market value&#8221;&#160;(as defined below) of one share of our common stock on the date of grant; or</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">for which stockholder approval would then be required pursuant to Section&#160;422 of the Code or the Listing Rules&#160;of Nasdaq (or other applicable exchange or market on which our common stock may be traded or quoted).</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Except in connection with certain specified changes in our corporate structure or shares, the committee may not, without prior approval of our stockholders, seek to effect any re-pricing of any previously granted, &#8220;underwater&#8221; option or stock appreciation right by:</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">amending or modifying the terms of the underwater option or stock appreciation right to lower the exercise price;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">canceling the underwater option or stock appreciation right in exchange for cash, replacement options or stock appreciation rights having a lower exercise price or other incentive awards; or</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">repurchasing the underwater options and stock appreciation rights and granting new incentive awards under the 2025 Plan.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">For purposes of the 2025 Plan, an option or stock appreciation right is deemed to be &#8220;underwater&#8221; at any time when the fair market value of our common stock is less than the exercise price.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Types of Awards</i>.&#160; Stock options (including both incentive stock options and non-statutory stock options), stock appreciation rights, RSUs, performance awards or units, stock bonuses and other stock-based awards may be granted under the 2025 Plan. Incentive awards may be granted either alone or in addition to or in tandem with any other type of incentive award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Options</i>.&#160; Stock options entitle the holder to purchase a specified number of shares of our common stock at a specified price, which is called the exercise price, subject to the terms and conditions of the award agreement.&#160; The 2025 Plan permits the grant of both incentive stock options and non-statutory stock options. Each stock option granted under the 2025 Plan must be evidenced by an award agreement or statement that specifies the exercise price, the term, the number of shares underlying the stock option, the vesting and any other conditions.&#160; The exercise price to be paid by a participant at the time an option is exercised may not be less than 100 percent of the fair market value of one share of our common stock on the date of grant (or 110 percent of the fair market value of one share of our common stock on the date of grant of an incentive stock option if the participant owns, directly or indirectly, more than 10 percent of the total combined voting power of all classes of stock of the Company).&#160; However, in the event options are granted as a result of our assumption or substitution of options in a merger or acquisition, the exercise price will be the price determined by the committee pursuant to the conversion terms applicable to the transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">36</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">The total purchase price of the shares to be purchased upon exercise of an option will be paid (1)&#160;in cash, (2)&#160;by using a broker-assisted cashless exercise procedure pursuant to which the optionee, upon exercise of an option, irrevocably instructs a broker or dealer to sell a sufficient number of shares of our common stock or loan a sufficient amount of money to pay all or a portion of the exercise price of the option; or (3)&#160;by using a cashless exercise procedure pursuant to which the optionee surrenders to us shares of our common stock either underlying the option or that are otherwise held by the optionee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Options may be exercised in whole or in installments, as determined by the committee, and the committee may impose conditions or restrictions to the exercisability of an option, including that the participant remain continuously employed by us for a certain period or that performance objectives are satisfied.&#160; An option may not become exercisable, nor remain exercisable after 10 years from its date of grant (five years from its date of grant in the case of an incentive stock option if the participant owns, directly or indirectly, more than 10 percent of the total combined voting power of all classes of stock of our Company).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Stock Appreciation Rights</i>.&#160; A stock appreciation right is the right to receive a payment from us, in the form of shares of our common stock, cash or a combination of both, equal to the difference between the fair market value of one or more shares of our common stock and a specified exercise price of such shares.&#160; Stock appreciation rights will be subject to such terms and conditions, if any, consistent with the other provisions of the 2025 Plan, as may be determined by the committee.&#160; The committee will have the sole discretion to determine the form in which payment of the economic value of stock appreciation rights will be made to a participant (i.e., cash, our common stock or any combination thereof) or to consent to or disapprove the election by a participant of the form of such payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Restricted Stock Awards and Restricted Stock Units</i>.&#160; A restricted stock award or a RSU award is an award of our common stock that vests at such times and in such installments as may be determined by the committee and, until it vests, is subject to restrictions on transferability and/or the possibility of forfeiture.&#160; The committee may impose such restrictions or conditions to the vesting of restricted stock awards and RSUs as it deems appropriate, including that the participant remain continuously employed by us for a certain period or that the participant or us (or any subsidiary, division or other subunit of our Company) satisfy specified performance objectives.&#160; To enforce the restrictions, the committee may place a legend on the stock certificates referring to such restrictions and may take other steps to enforce the restrictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Any dividends (other than regular quarterly cash dividends) or distributions paid with respect to shares of our common stock subject to the unvested portion of a restricted stock award will be subject to the same restrictions as the shares to which such dividends or distributions relate.&#160; Additionally, unless the 2025 Plan provides otherwise, a participant will have all voting, liquidation and other rights with respect to shares of our common stock issued to the participant as a restricted stock award upon the participant becoming the holder of record of such shares as if the participant were a holder of record of shares of our unrestricted common stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Performance Awards or Units</i>.&#160; A participant may be granted one or more performance awards or units under the 2025 Plan, and such performance awards or units will be subject to such terms and conditions, if any, consistent with the other provisions of the 2025 Plan, as may be determined by the committee in its sole discretion, including, but not limited to, the achievement of one or more specified performance objectives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Stock Bonuses</i>.&#160; A participant may be granted one or more stock bonuses under the 2025 Plan, and such stock bonuses will be subject to such terms and conditions, if any, consistent with the other provisions of the 2025 Plan, as may be determined by the committee in its sole discretion, including, but not limited to, the achievement of one or more specified performance objectives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Other Stock-Based Awards.</i>&#160;&#160;Subject to such terms and conditions, consistent with the other provisions of the 2025 Plan, the committee may grant other stock-based awards not otherwise described by the terms of the 2025 Plan (including the grant or offer for sale of unrestricted shares of common stock) in such amounts and subject to such terms and conditions as the committee will determine.&#160; Such incentive awards may involve the transfer of actual shares of common stock to participants or payment in cash or otherwise of amounts based on the value of shares of common stock, and may include incentive awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the U.S<i>.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">37</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Change in Control</i>.&#160; In the event of a Corporate Transaction (as defined in the 2025 Plan), the Board, the Compensation Committee, or the Successor Board (as defined in the 2025 Plan), may, as to outstanding options issued under the 2025 Plan, take any of the following actions (i) make appropriate provision for the continuation of such options by substituting on an equitable basis for the shares then subject to such options either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (ii) upon written notice to the participants, provide that such options must be exercised (either (A) to the extent then exercisable or, (B) at the discretion of the Board or the Compensation Committee, any such options being made partially or fully exercisable for purposes of this clause within a specified number of days of the date of such notice, at the end of which period such Options which have not been exercised shall terminate; or (iii) terminate such options in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock into which such option would have been exercisable (either (A) to the extent then exercisable or, (B) at the discretion of the Board or the Compensation Committee, any such options being made partially or fully exercisable for purposes of this clause) less the aggregate exercise price thereof. With respect to outstanding incentive awards other than options, the Board or the Compensation Committee or the Successor Board, shall make appropriate provision for the continuation of such incentive awards on the same terms and conditions by substituting on an equitable basis for the shares then subject to such incentive awards either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity. In lieu of the foregoing, in connection with any Corporate Transaction, the Board or the Compensation Committee may provide that, each outstanding incentive award shall be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock comprising such incentive award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Notwithstanding the foregoing, however, no incentive award that provides for a deferral of compensation within the meaning of Section&#160;409A of the Code will be cashed out upon the occurrence of a change in control unless payment was specified in the incentive award agreement at the time of grant and the event or circumstances constituting the change in control also constitute a &#8220;change in the ownership&#8221; of our Company, a &#8220;change in the effective control&#8221; of our Company or a &#8220;change in the ownership of a substantial portion of the assets&#8221; of our Company, in each case as determined under Section&#160;409A of the Code. In taking any of the actions described above, the Board or the Compensation Committee will not be obligated by the 2025 Plan to treat all incentive awards held by a participant, or all incentive awards of the same type, identically.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Effect of Termination of Employment or Other Services</i>.&#160; If a participant ceases to be employed by, or perform other services for, us, all incentive awards held by the participant will be treated as set forth below unless provided otherwise in the agreement evidencing the incentive award or modified by the committee in its discretion as set forth below.&#160; Upon termination due to death, disability or retirement, all outstanding, exercisable options and stock appreciation rights then held by the participant will remain exercisable for a period of one year thereafter (but in no event after the expiration date of any such option or stock appreciation rights), all unvested restricted stock awards, all outstanding stock unit awards or RSUs, performance awards or units and stock bonuses then held by the participant will be terminated and forfeited; provided, however, that with respect to any such incentive awards the vesting of which is based on the achievement of specified performance objectives, if a participant&#8217;s employment or other service with the Company or any subsidiary, as the case may be, is terminated by reason of death or disability prior to the end of the performance period of such incentive award, but after the conclusion of a portion of the performance period (but in no event less than one year), the committee may, in its sole discretion, cause shares of common stock to be delivered or payment made with respect to the participant&#8217;s incentive award, but only if otherwise earned for the entire performance period and only with respect to the portion of the applicable performance period completed at the date of such event, with proration based on full fiscal years only and no shares to be delivered for partial fiscal years.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Upon termination for a reason, other than death, disability or retirement, which is not also for &#8220;cause&#8221; (as defined in the 2025 Plan), all outstanding options and stock appreciation rights then held by the participant will, to the extent exercisable as of such termination, remain exercisable in full for a period of three months after such termination (but in no event after the expiration date of any such option or stock appreciation right).&#160; Also, upon such termination all options and stock appreciation rights that are not exercisable; all unvested restricted stock awards; and all outstanding stock unit awards or RSUs, performance awards, stock bonuses and other stock-based awards then held by the participant will be terminated and forfeited.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">If a participant is determined by the committee, acting in its sole discretion, to have committed any action which would constitute &#8220;cause&#8221; or &#8220;adverse action&#8221; (both as defined in the 2025 Plan), regardless of whether such action or the committee&#8217;s determination occurs before or after the termination of the participant&#8217;s employment, all rights of the participant under the 2025 Plan and any outstanding award agreements shall terminate and be forfeited.&#160; Additionally, the committee acting in its sole discretion will have the authority to rescind the exercise, vesting, settlement or issuance of, or payment in respect of, any incentive awards of the participant that were exercised, vested, settled or issued, or as to which such payment was made, and to require the participant to pay to us, within 10 days of receipt from us of notice of such rescission, any amount received or the amount of any gain realized as a result of such rescinded exercise, vesting, settlement, issuance or payment (including any dividends paid or other distributions made with respect to any shares of common stock subject to any incentive award).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">38</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The committee at any time (including on or after the date of grant or following termination), in connection with a participant&#8217;s termination, may cause options or stock appreciation rights held by the participant to terminate, become or continue to become exercisable and/or remain exercisable, and restricted stock awards, RSUs, performance awards, stock bonuses or other stock-based awards then held by such participant to terminate, vest, settle or become free of restrictions and conditions to payment, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Dividend Equivalent Rights</i>.&#160; Any participant selected by the committee may be granted dividend equivalents based on the dividends declared on shares of our common stock that are subject to any incentive award, to be credited as of dividend payment dates, during the period between the grant date of the incentive award and the date the incentive award is exercised, vests, is settled or expires, as determined by the committee.&#160; However, dividends or dividend equivalents will be paid out with respect to any incentive award only to the extent that the shares of common stock subject to the incentive award vest.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Term; Termination; Amendments</i>.&#160; Unless terminated earlier, the 2025 Plan will terminate at midnight on the day before the 10<sup style="vertical-align:top;line-height:120%;">th</sup> anniversary of the earlier of the date of the 2025 Plan&#8217;s adoption by the Board and the date of its approval by the stockholders.&#160; The Board may suspend or terminate the 2025 Plan or any portion of the 2025 Plan at any time. In addition to the committee&#8217;s authority to amend the 2025 Plan with respect to participants resident outside of the U.S. or employed by a non-U.S. subsidiary, the Board may amend the 2025 Plan from time to time in order that incentive awards under the 2025 Plan will conform to any change in applicable laws or regulations or in any other respect that the Board may deem to be in our best interests; provided, however, that no amendments to the 2025 Plan will be effective without stockholder approval, if it is required under Section&#160;422 of the Code or the Listing Rules&#160;of Nasdaq (or other applicable exchange or market on which our common stock may be traded or quoted).&#160; Termination, suspension or amendment of the 2025 Plan will not adversely affect the rights of a participant under a previously granted incentive award without the consent of the affected participant, except for adjustments in the event of changes in our capitalization or a &#8220;change in control&#8221; of our Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Transferability</i>.&#160; In general, no right or interest in any incentive award may be assigned or transferred by a participant, except by will or the laws of descent and distribution, or subjected to any lien or otherwise encumbered.&#160; However, a participant is entitled to designate a beneficiary to receive an incentive award on such participant&#8217;s death, and in the event of such participant&#8217;s death, payment of any amounts due under the 2025 Plan, will be made to, and exercise of any options or stock appreciation rights may be made by, such beneficiary.&#160; Additionally, upon a participant&#8217;s request, the committee may permit a participant to transfer all or a portion of an incentive award, other than for value, to certain of the participant&#8217;s family members or related family trusts, foundations or partnerships.&#160; Permitted transferees of non-statutory options will remain subject to all the terms and conditions of the incentive award applicable to the participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Material U.S. Federal Income Tax Consequences</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>The discussion below is a summary of the U.S. federal income tax consequences that may result in connection with participant</i>&#8217;<i>s participation in the 2025 Plan and is based on current statutes, regulations and interpretations, all of which are subject to change, possibly with retroactive effect.</i>&#160;<i> The description does not include foreign, state or local income tax consequences.</i>&#160;<i> In addition, the description is not intended to address specific tax consequences applicable to an insider (directors, executive officers or greater than 10 percent stockholders of our Company).</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Incentive Stock Options</i>.&#160; In general, an eligible employee will not recognize federal taxable income upon the grant or the exercise of an incentive stock option, and we will not be entitled to an income tax deduction upon the grant or the exercise of an incentive stock option.&#160; For purposes of the alternative minimum tax, however, the eligible employee will be required to treat an amount equal to the difference between the fair market value of the common stock on the date of exercise over the exercise price as an item of adjustment in computing the eligible employee&#8217;s alternative minimum taxable income.&#160; If the eligible employee does not dispose of the common stock received pursuant to the exercise of the incentive stock option within two years after the date of the grant of the incentive stock option or within one year after the date of exercise of the incentive stock option, a subsequent disposition of the common stock generally will result in long-term capital gain or loss to such individual with respect to the difference between the amount realized on the disposition and the exercise price of the option.&#160; We will not be entitled to any income tax deduction as a result of such disposition.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">39</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">If the eligible employee disposes of the common stock acquired upon exercise of the incentive stock option within two years after the date of the grant of the incentive stock option or within one year after the date of exercise of the incentive stock options, then in the year of such disposition, generally the eligible employee will recognize ordinary income, and we will be entitled to an income tax deduction in an amount equal to the lesser of: (1)&#160;the excess of the fair market value of the common stock on the date of exercise over the exercise price; or (2)&#160;the amount realized upon disposition over the exercise price.&#160; Any gain in excess of such amount recognized by the eligible employee as ordinary income will be taxed to the eligible employee as short-term or long-term capital gain (depending on the period of time the eligible employee held the common stock).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Non-Statutory Stock Options</i>.&#160; An eligible employee, non-employee director or consultant will not recognize any federal taxable income upon the grant of a non-statutory stock option, and we will not be entitled to an income tax deduction at the time of such grant.&#160; Upon the exercise of a non-statutory stock option, generally the eligible employee, non-employee director or consultant will recognize ordinary income and we will be entitled to take an income tax deduction in an amount equal to the excess of the fair market value of the common stock on the date of exercise over the exercise price.&#160; Upon a subsequent sale of the common stock by the eligible employee, non-employee director or consultant, he or she will recognize short-term or long-term capital gain or loss (depending on the period of time the eligible employee held the common stock).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><i>Stock Appreciation Rights</i>.&#160; An eligible employee, non-employee director or consultant will not recognize any federal taxable income upon the grant of a stock appreciation right, and we will not be entitled to an income tax deduction at the time of such grant. An eligible employee, non-employee director or consultant will recognize ordinary income for federal income tax purposes upon the exercise of a stock appreciation right under the 2025 Plan for cash, common stock or a combination of cash and common stock, and the amount of income that the eligible employee, non-employee director or consultant will recognize will depend on the amount of cash, if any, and the fair market value of the common stock, if any, that he or she receives as a result of such exercise.&#160; We generally will be entitled to a federal income tax deduction in an amount equal to the ordinary income recognized by the eligible employee, non-employee director or consultant in the same taxable year in which the eligible employee, non-employee director or consultant recognizes such income.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Restricted Stock Awards</i>.&#160; An eligible employee, non-employee director or consultant is not subject to any federal income tax when an award of restricted stock is made, nor are we entitled to an income tax deduction at such time, unless the restrictions on the common stock do not present a &#8220;substantial risk of forfeiture&#8221; or the stock is &#8220;transferable,&#8221; each within the meaning of Section&#160;83 of the Code.&#160; In the year that the restricted stock is either no longer subject to a substantial risk of forfeiture or is transferable, generally the eligible employee, non-employee director or consultant will recognize ordinary income in an amount equal to the excess, if any, of the fair market value of the shares of common stock transferred to the eligible employee, non-employee director or consultant, generally determined on the date the restricted stock is no longer subject to a substantial risk of forfeiture, or is transferable, whichever comes first, over the amount, if any, paid for such shares and we will be entitled to a federal income tax deduction in an amount equal to the ordinary income recognized by the eligible employee, non-employee director or consultant in the same taxable year in which the eligible employee, non-employee director or consultant recognizes such income.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Restricted Stock Unit Awards, Performance Awards and Stock Bonuses</i>.&#160; Neither the participant nor our Company incurs any federal income tax consequences as a result of the grant of a RSU award, performance award or stock bonus award.&#160; Upon payment of a RSU award, performance award or stock bonus in cash, the participant will include the amount paid as ordinary income in the year the payment was received; if payment is made in stock, the participant will include as ordinary income in the year of receipt an amount equal to the fair market value of the shares received.&#160; Generally, in each case, we will receive a corresponding tax deduction, when the amount is included by the participant as ordinary income, or reported as taxable income of the participant by us, pursuant to applicable information reporting requirements.&#160; At the time of a subsequent sale or disposition of any shares of our common stock issued in connection with a RSU award, performance award or stock bonus award, any gain or loss will be treated as long-term or short-term capital gain or loss, depending on the holding period from the date the shares were received.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"><i>Excise Tax on Parachute Payments</i>.&#160; Parachute payments are payments to employees or independent contractors who also are officers, stockholders or highly compensated individuals that are contingent upon a change in ownership or control of our Company.&#160; In certain circumstances the grant, vesting, acceleration or exercise of options or other incentive awards could be treated as contingent on a change in ownership or control for purposes of determining the amount of a parachute payment.&#160; In general, the amount of a parachute payment would be the cash or the fair market value of the property received (or to be received) less the amount paid for such property.&#160; All or a portion of that parachute payment may be considered an excess parachute payment.&#160; If an individual were found to have received an excess parachute payment, he or she would be subject to a special 20 percent excise tax on the amount of the excess parachute payments, and we would not be allowed to claim any deduction with respect to such payments.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Under the terms of the 2025 Plan, unless otherwise provided in a separate agreement between a participant and us, if, with respect to a participant, the acceleration of the vesting of an incentive award or the payment of cash in exchange for all or part of an award, together with any other payments that such participant has the right to receive from us, would constitute a &#8220;parachute payment,&#8221; then the payments to such participant will be reduced to the largest amount as will result in no portion of such payments being subject to the excise tax imposed by Section&#160;4999 of the Code.&#160; Such reduction, however, will only be made if the aggregate amount of the payments after such reduction exceeds the difference between the amount of such payments absent such reduction minus the aggregate amount of the excise tax imposed under Section&#160;4999 of the Code attributable to any such excess parachute payments.&#160; If such provisions are applicable and if an employee will be subject to a 20 percent excise tax on any &#8220;excess parachute payment&#8221; pursuant to Section&#160;4999 of the Code, we will be denied a deduction with respect to such excess parachute payment pursuant to Section&#160;280G of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">40</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>New Plan Benefits to Named Executive Officers and Others</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">No incentive awards have been granted under the 2025 Plan.&#160; If the 2025 Plan is approved, awards will be granted at the discretion of the committee.&#160; Accordingly, future benefits under the 2025 Plan are not determinable at this time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Securities Authorized for Issuance Under Equity Compensation Plans</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">A table and notes providing information about shares of our common stock that may be issued under all of our equity compensation plans as of December&#160;31, 2024, is included on page 31 of this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Vote Required</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">The affirmative vote of a majority of shares present in person or represented by proxy at the meeting and entitled to vote is required for the adoption of our 2025 Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Board Recommendation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT OUR STOCKHOLDERS VOTE </b><b><span style="text-decoration: underline; ">FOR</span></b><b> APPROVAL OF THE CERVOMED INC. 2025 EQUITY INCENTIVE PLAN.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">41</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our Audit Committee is charged with the responsibility of reviewing and approving or ratifying all related person transactions in accordance with the Listing Rules of the Nasdaq Capital Market and other applicable law, rules and regulations and any related policies and procedures adopted by or on behalf of the Company and then in effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Since January 1, 2023, there have been no transactions to which we have been a party in which (i) the amount involved in the transaction is the lesser of $120,000 or one percent of the average of our total assets at year end for the last two completed fiscal years and (ii) any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock had or will have a direct or indirect material interest, except as set forth below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Executive and Director Compensation</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The employment agreements and other compensation arrangements between the Company, on the one hand, and each of our executive officers and directors, on the other hand, are described above under the headings, &#8220;<i>Executive Compensation</i>&#8221; and &#8220;<i>Director Compensation.</i>&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Indemnification Agreements</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Our certificate of incorporation, as amended, states that we will indemnify our directors and executive officers to the fullest extent permitted by Delaware law. In addition, we have entered into customary indemnification agreements with each of our executive officers and directors who serve as officers and directors of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Pre-Funded Warrant Amendment and Exercise</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In connection with the closing of the Merger, the Company issued a pre-funded warrant to the Boger Trust to purchase an aggregate of 495,995 shares of common stock for a purchase price of $0.001 per share. Joshua S. Boger, Ph.D., the Chair of the Board, is the sole trustee of the Boger Trust. On February 26, 2024, the Company and the Boger Trust entered into an amendment to the pre-funded warrant pursuant to which the parties eliminated a limitation restricting any exercise that would otherwise result in the holder&#8217;s beneficial ownership exceeding 9.99% of the Company&#8217;s outstanding common stock. Also on February 26, 2024, following the effectiveness of the foregoing amendment, the Boger Trust exercised the pre-funded warrant in full pursuant to the cashless exercise provision in Section 2(c) thereof, including the withholding of shares in lieu of a cash payment of the exercise price, and received 495,959 shares of common stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>2023 EIP Share Issuance</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">On July 10, 2023, EIP sold and issued (x) 472,303 shares of EIP Common Stock to Dr. Boger for a total purchase price of $694,286; and (y) 78,717 shares of EIP Common Stock to Frank Zavrl, a member of our Board, for a total purchase price of $115,714. At the Effective Time, each outstanding share of EIP capital stock &#8211; including such shares purchased by Dr. Boger and Mr. Zavrl &#8211; was converted into the right to receive 0.1151 shares of Company common stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Lock-Up Agreements and Waiver</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In connection with the closing of the Merger, the Company entered into lock-up agreements with certain individuals, including each executive officer and director of EIP and Diffusion, pursuant to which each such individual accepted certain restrictions on transfers of the shares of the Company for a period of time following the Effective Time. On November 9, 2023, the Company entered into waivers to the lock-up agreements by and between the Company, on the one hand, and each of Dr. Alam, our President and Chief Executive Officer and member of our Board, and Dr. Gr&#233;goire, a member of our Board, on the other hand, pursuant to which the Company agreed to waive certain restrictions in the lock-up agreements to permit the gifting of an aggregate of 22,500 shares of common stock to certain friends and families, provided that each such transferee entered into a lock-up agreement with substantially similar restrictions for the remainder of the lock-up period applicable to Dr. Alam and Dr. Gr&#233;goire.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In connection with the 2024 Private Placement, the Company entered into lock-up agreements with each of the Company&#8217;s executive officers and directors pursuant to which each such individual accepted certain restrictions on transfers of the shares of the Company for a period of time following the closing of the 2024 Private Placement. The 2024 Private Placement lock-up agreements expired on June 20, 2024.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">42</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Convertible Note Amendments</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In December 2020, EIP issued the 2020 Notes to predominantly related party investors for aggregate proceeds of $5,078,500. In December 2021, the Company issued the 2021 Notes to predominantly related party investors for aggregate proceeds of $6,000,000. Among the Company&#8217;s current directors and executive officers: Dr. Alam purchased $500,000 of the 2020 Notes; Dr. Gr&#233;goire purchased $500,000 of the 2020 Notes; Dr. Boger and his affiliates purchased an aggregate of $500,000 of the 2020 Notes and $5,000,000 of the 2021 Notes; Mr. Zavrl and his affiliates purchased an aggregate of $350,000 of the 2020 Notes and $1,000,000 of the 2021 Notes; Ms. Blackburn, our Senior Vice President, Clinical Development, purchased an aggregate of $150,000 of the 2020 Notes; and Mr. Poulton, a member of our Board, purchased $100,000 of the 2020 Notes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In June 2023, EIP and the holders of the EIP Convertible Notes amended the terms and conditions of the EIP Convertible Notes to, among other things, establish a fixed conversion price of $1.47 per share of EIP Common Stock with respect to the Merger. In addition, the 2021 Notes were amended to provide that, to the extent the conversion of such notes in the Merger were to result in the holder beneficially owning more than 9.99% of the outstanding voting stock of the Company, such holder would be granted pre-funded warrants in lieu of common stock for the conversion of any principal and accrued but unpaid interest in excess of 9.99%.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In connection with the closing of the Merger, all outstanding EIP Convertible Notes converted into shares of EIP Common Stock at the fixed conversion price of $1.47 per share of EIP Common Stock, which shares of EIP Common Stock were subsequently converted into the right to receive 0.1151 shares of our common stock (or pre-funded warrants in lieu thereof) upon closing of the Merger.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: center; font-size: 10pt; font-family: Times New Roman;">43</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>OTHER MATTERS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Stockholder Proposals for 2026 Annual Meeting and Director Nominations</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Under the rules&#160;of the SEC, stockholders wishing to have a proposal included in the Company&#8217;s Proxy Statement for the Annual Meeting of Stockholders to be held in 2026 must submit the proposal so that the Corporate Secretary of the Company receives it no later than 120 days prior to the one-year anniversary of the date of this Proxy Statement, or December 30, 2025. The SEC rules&#160;set forth standards as to what stockholder proposals are required to be included in a proxy statement. Under our Bylaws, certain procedures must be followed for a stockholder to nominate persons as directors or to introduce a proposal at an annual meeting of stockholders. Subject to certain exceptions described in our Bylaws, a stockholder wishing to make a nomination for election to the Board or to have a proposal presented at an annual meeting of stockholders must submit written notice of such nomination or proposal so that the Corporate Secretary of the Company receives it no later than the date which is 90 days prior to the one year anniversary of this Proxy Statement, or January 29, 2026, and no earlier than the date which is 120 days prior to the one year anniversary of this Proxy Statement, or December 30, 2025. Our Bylaws also set forth certain informational requirements for stockholders&#8217; nominations of directors and proposals.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Annual Report</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b>We have sent or made available electronically to each of our stockholders a copy of our Annual Report (without exhibits) for the year ended December</b>&#160;<b>31, 2024. The exhibits to our Form</b>&#160;<b>10-K are available by accessing the SEC</b>&#8217;<b>s EDGAR filing database at</b>&#160;<b><span style="text-decoration: underline; ">www.sec.gov</span></b><b>. We will furnish a copy of any exhibit to our Form</b>&#160;<b>10-K upon receipt from any such person of a written request for such exhibits upon the payment of our reasonable expenses in furnishing the exhibits. This request should be sent via e-mail to proxy@cervomed.com or via mail to Computershare, P.O. Box 43001, Providence, Rhode Island 02940-3001, Attn: CervoMed Inc. </b>&#8211;<b> Legal Proxy.</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Householding of Annual Meeting Materials</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Some banks, brokers and other nominee record holders may be participating in the practice of &#8220;householding&#8221; proxy statements and annual reports. This means that only one copy of our Proxy Statement or Annual Report to stockholders may have been sent to multiple stockholders in each household. We will deliver promptly a separate copy of either document to any stockholder upon request via e-mail to proxy@cervomed.com or via mail to Computershare, P.O. Box 43001, Providence, Rhode Island 02940-3001, Attn: CervoMed Inc. &#8211; Legal Proxy. Any stockholder who wants to receive separate copies of our Proxy Statement or Annual Report to stockholders in the future, or any stockholder who is receiving multiple copies and would like to receive only one copy per household, should contact the stockholder&#8217;s bank, broker, or other nominee record holder, or the stockholder may contact us at the provided address and phone number.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Cost and Method of Solicitation</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">In addition to solicitation by mail, our directors, officers, employees, and agents may solicit proxies from our stockholders by personal interview, telephone, telegram, e-mail or other electronic means. Arrangements will also be made with brokerage firms and other custodians, nominees and fiduciaries who are record holders of our common stock for the forwarding of solicitation materials to the beneficial owners of our common stock. We will reimburse these brokers, custodians, nominees, and fiduciaries for the reasonable out-of-pocket expenses they incur in connection with the forwarding of solicitation materials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Your vote is important. Whether or not you plan to attend the Annual Meeting, please exercise your right to vote as soon as possible by completing, signing, dating, and returning your proxy card or by using Internet or telephone voting as described on the proxy card or Notice Regarding the Availability of Proxy Materials. You may still join the Annual Meeting and vote online, even if you have already voted by proxy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align:middle;width:27.8%;">&#160;</td>
			<td style="vertical-align:middle;width:18.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By Order of the Board of Directors</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">/s/ John Alam, M.D.</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span><span style="text-decoration: underline; ">&#160;</span></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">John Alam, M.D.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i>President and Chief Executive Officer</i></p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">April 29, 2025<br/>
Boston, Massachusetts</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">44</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="text-align: center;"><img alt="image1.jpg" src="image1.jpg"/></div>

<div>&#160;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<div style="text-align: center;"><img alt="image2.jpg" src="image2.jpg"/></div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%;">&#160;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">&#160;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>APPENDIX A</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CERVOMED 2025 EQUITY INCENTIVE PLAN</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#160;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>CERVOMED INC.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b>2025 EQUITY INCENTIVE PLAN</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Purpose of Plan</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">The purpose of the CervoMed Inc. 2025 Equity Incentive Plan (the &#8220;Plan&#8221;) is to advance the interests of CervoMed Inc. (the &#8220;Company&#8221;) and its stockholders by enabling the Company and its Subsidiaries to attract and retain qualified individuals to perform services for the Company and its Subsidiaries, providing incentive compensation for such individuals that is linked to the growth and profitability of the Company and increases in stockholder value, and aligning the interests of such individuals with the interests of its stockholders through opportunities for equity participation in the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Definitions</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">The following terms will have the meanings set forth below, unless the context clearly otherwise requires.&#160; Terms defined elsewhere in the Plan will have the same meaning throughout the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.1&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Adverse Action</span>&#8221; means any action by a Participant that the Committee, in its sole discretion, determines to be injurious, detrimental, prejudicial or adverse to the interests of the Company or any Subsidiary, including:&#160; (a) disclosing confidential information of the Company or any Subsidiary to any person not authorized by the Company or Subsidiary to receive it, (b) engaging, directly or indirectly, in any commercial activity that in the judgment of the Committee competes with the business of the Company or any Subsidiary or (c) interfering with the relationships of the Company or any Subsidiary and their respective employees, independent contractors, customers, prospective customers and vendors.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.2&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Board</span>&#8221; means the Board of Directors of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.3&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Cause</span>&#8221; means &#8220;cause&#8221; as defined in any employment or other agreement or policy applicable to the Participant, or if no such agreement or policy exists, will mean (a) dishonesty, fraud, misrepresentation, embezzlement or deliberate injury or attempted injury, in each case related to the Company or any Subsidiary, (b) any unlawful or criminal activity of a serious nature, (c) any intentional and deliberate breach of a duty or duties that, individually or in the aggregate, are material in relation to the Participant&#8217;s overall duties, or (d) any material breach by a Participant of any employment, service, consulting, confidentiality, assignment of inventions, non-compete or non-solicitation agreement or similar agreement entered into with the Company or any Subsidiary or any material written policy of the Company or any Subsidiary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.5&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Change in Control</span>&#8221; means an event described in Section 15.1 of the Plan; provided, however, that if any payment or benefit payable hereunder upon or following a Change in Control would be required to comply with the limitations of Section 409A(a)(2)(A)(v) of the Code in order to avoid an additional tax under Section 409A of the Code, such payment or benefit shall be made only if such Change in Control constitutes a change in ownership or control of the Company, or a change in ownership of the Company&#8217;s assets in accordance with Section 409A of the Code.</p>

<div>&#160;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.6&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Code</span>&#8221; means the Internal Revenue Code of 1986, as amended.&#160; Any reference to a section of the Code in the Plan will be deemed to include a reference to any applicable rules and regulations thereunder and any successor or amended section of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.7&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Committee</span>&#8221; means the group of individuals administering the Plan, as provided in Section 3 of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.8&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Common Stock</span>&#8221; means the common stock of the Company, par value $0.001 per share, or the number and kind of shares of stock or other securities into which such Common Stock may be changed in accordance with Section 4.3 of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.9&#160;&#160;&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Company</span>&#8221; means CervoMed Inc., a Delaware corporation, and any successor thereto as provided in Section 21.7 of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.10&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Consultant</span>&#8221; means a person engaged to provide consulting or advisory services (other than as an Employee or a Director) to the Company or any Subsidiary that:&#160; (a) are not in connection with the offer and sale of the Company&#8217;s securities in a capital raising transaction and (b) do not directly or indirectly promote or maintain a market for the Company&#8217;s securities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.11&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Director</span>&#8221; means a member of the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.12&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Disability</span>&#8221; means the disability of the Participant such as would entitle the Participant to receive disability income benefits pursuant to the long-term disability plan of the Company or Subsidiary then covering the Participant or, if no such plan exists or is applicable to the Participant, the permanent and total disability of the Participant within the meaning of Section 22(e)(3) of the Code; provided, however, that if distribution of an Incentive Award subject to Section 409A of the Code is triggered by an Eligible Recipient&#8217;s Disability, such term will mean that the Eligible Recipient is disabled as defined by Section 409A of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.13&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Effective Date</span>&#8221; means June 23, 2025 or such later date as the Plan is initially approved by the Company&#8217;s stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.14&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Eligible Recipients</span>&#8221; means (a) for the purposes of granting Incentive Stock Options, all Employees and (b) for the purposes of granting Non-Statutory Stock Options and other Incentive Awards, means all Employees, Directors and Consultants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.15&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Employee</span>&#8221; means any individual performing services for the Company or a Subsidiary and designated as an employee of the Company or a Subsidiary on the payroll records thereof.&#160; An Employee will not include any individual during any period he or she is classified or treated by the Company or Subsidiary as an independent contractor, a consultant, or any employee of an employment, consulting or temporary agency or any other entity other than the Company or Subsidiary, without regard to whether such individual is subsequently determined to have been, or is subsequently retroactively reclassified as a common-law employee of the Company or Subsidiary during such period.&#160; An individual will not cease to be an Employee in the case of:&#160; (a) any leave of absence approved by the Company, or (b) transfers between locations of the Company or between the Company or any Subsidiaries.&#160; For purposes of Incentive Stock Options, no such leave may exceed three (3) months, unless reemployment upon expiration of such leave is guaranteed by statute or contract.&#160; If reemployment upon expiration of a leave of absence approved by the Company or a Subsidiary, as applicable, is not so guaranteed, then six &#160;(6) months following the commencement of such leave, any Incentive Stock Option held by a Participant will cease to be treated as an Incentive Stock Option and will be treated for tax purposes as a Non-Statutory Stock Option.&#160; Neither service as a Director nor payment of a Director&#8217;s fee by the Company will be sufficient to constitute &#8220;employment&#8221; by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.16&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Exchange Act</span>&#8221; means the Securities Exchange Act of 1934, as amended.&#160; Any reference to a section of the Exchange Act in the Plan will be deemed to include a reference to any applicable rules and regulations thereunder and any successor or amended section of the Exchange Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.17&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Fair Market Value</span>&#8221; means, with respect to the Common Stock, as of any date:&#160; (a) the closing sale price of the Common Stock as of such date at the end of the regular trading session, as reported by The NASDAQ Stock Market, The New York Stock Exchange, NYSE MKT LLC or any national securities exchange on which the Common Stock is then listed (or, if no shares were traded on such date, as of the next preceding date on which there was such a trade); or (b) if the Common Stock is not so listed, admitted to unlisted trading privileges, or reported on any national securities exchange, the closing sale price as of such date at the end of the regular trading session, as reported by OTC Bulletin Board or the OTC Markets Group Inc. or other comparable service (or, if no shares were traded or quoted on such date, as of the next preceding date on which there was such a trade or quote); or (c) if the Common Stock is not so listed or reported, such price as the Committee determines in good faith, in the exercise of its reasonable discretion, and consistent with the definition of &#8220;fair market value&#8221; under Section 409A of the Code and in conformity with generally accepted accounting principles in the United States.&#160; If determined by the Committee, such determination will be final, conclusive and binding for all purposes and on all persons, including the Company, the stockholders of the Company, the Participants and their respective heirs and other successors-in-interest.&#160; No member of the Committee will be liable for any determination regarding the fair market value of the Common Stock that is made in good faith.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.18&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Full Value Award</span>&#8221; means an Incentive Award other than in the form of an Option or Stock Appreciation Right, and which is settled by the issuance of shares of Common Stock.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.19&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Grant Date</span>&#8221; means the date an Incentive Award is granted to a Participant pursuant to the Plan and as determined pursuant to Section 5 of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.20&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Incentive Award</span>&#8221; means an Option, Stock Appreciation Right, Restricted Stock Award, Restricted Stock Unit, Performance Award, Stock Bonus or Other Stock-Based Award granted to an Eligible Recipient pursuant to the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.21&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Incentive Award Agreement</span>&#8221; means either:&#160; (a) a written or electronic (as provided in Section 21.10) agreement entered into by the Company and a Participant setting forth the terms and provisions applicable to an Incentive Award granted under the Plan, including any amendment or modification thereof, or (b) a written or electronic (as provided in Section 21.10) statement issued by the Company to a Participant describing the terms and provisions of such an Incentive Award, including any amendment or modification thereof.&#160; The Committee may provide for the use of electronic, internet or other non-paper Incentive Award Agreements, and the use of electronic, internet or other non-paper means for the acceptance thereof and actions thereunder by a Participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.22&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Incentive Stock Option</span>&#8221; means a right to purchase shares of Common Stock granted to an Employee pursuant to Section 6 of the Plan that is designated as and intended to meet the requirements of an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.23&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Non-Statutory Stock Option</span>&#8221; means a right to purchase shares of Common Stock granted to an Eligible Recipient pursuant to Section 6 of the Plan that is not intended to meet the requirements of or does not qualify as an Incentive Stock Option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.24&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Option</span>&#8221; means an Incentive Stock Option or a Non-Statutory Stock Option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.25&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Other Stock-Based Award</span>&#8221; means an equity-based or equity-related Incentive Award not otherwise described by the terms of the Plan, granted pursuant to Section 11 of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.26&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Participant</span>&#8221; means an Eligible Recipient who receives one or more Incentive Awards under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.27&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Performance Award</span>&#8221; means a right granted to an Eligible Recipient pursuant to Section 9 of the Plan to receive an amount of cash, a number of shares of Common Stock, or a combination of both, contingent upon and the value of which at the time it is payable is determined as a function of the extent of the achievement of specified performance objectives during a specified period.&#160; A Performance Award is also commonly referred to as a &#8220;performance unit&#8221; or &#8220;performance share.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.28&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Previously Acquired Shares</span>&#8221; means shares of Common Stock that are already owned by the Participant or, with respect to any Incentive Award, that are to be issued to the Participant upon the grant, exercise, vesting or settlement of such Incentive Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.29&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Restricted Stock Award</span>&#8221; means an award of shares of Common Stock granted to an Eligible Recipient pursuant to Section 8 of the Plan that is subject to restrictions on transferability and a risk of forfeiture.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.30&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Restricted Stock Unit</span>&#8221; means an award denominated in shares of Common Stock granted to an Eligible Recipient pursuant to Section 8 of the Plan to receive an amount of cash, a number of shares of Common Stock, or a combination of both, contingent upon the achievement of specified performance objectives or that the Participant remain in the continuous employment or service with the Company for a certain period or other conditions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.31&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Retirement</span>&#8221; means unless otherwise defined in the Incentive Award Agreement or in a written employment, services or other agreement between the Participant and the Company or a Subsidiary, means &#8220;Retirement&#8221; as defined from time to time for purposes of the Plan by the Committee or by the Company&#8217;s chief human resources officer or other person performing that function or, if not so defined, means voluntary termination of employment or service by the Participant on or after the date the Participant reaches age fifty-five (55) with the present intention to leave the Company&#8217;s industry or to leave the general workforce and completion of at least ten (10) years of continuous service with the Company or a Subsidiary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.32&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Securities Act</span>&#8221; means the Securities Act of 1933, as amended.&#160; Any reference to a section of the Securities Act in the Plan will be deemed to include a reference to any applicable rules and regulations thereunder and any successor or amended section of the Securities Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.33&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Stock Appreciation Right</span>&#8221; means a right granted to an Eligible Recipient pursuant to Section 7 of the Plan to receive a payment from the Company, in the form of shares of Common Stock, cash or a combination of both, equal to the difference between the Fair Market Value of one or more shares of Common Stock and a specified exercise price of such shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.34&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Stock Bonus</span>&#8221; means an award of shares of Common Stock granted to an Eligible Recipient pursuant to Section 10 of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.35&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Subsidiary</span>&#8221; means any entity that is directly or indirectly controlled by the Company or any entity in which the Company has a significant equity interest, as determined by the Committee, provided the Company has a &#8220;controlling interest&#8221; in the Subsidiary as defined in Treas. Reg. Sec. 1.409A-1(b)(5)(iii)(E)(1).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">2.36&#160;&#160;&#160;&#160; &#8220;<span style="text-decoration: underline; ">Tax Date</span>&#8221; means the date any withholding tax obligation arises under the Code for a Participant with respect to an Incentive Award.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Plan Administration</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">3.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">The Committee</span>.&#160;&#160;The Plan will be administered by the Board or by a committee of the Board.&#160;&#160;So long as the Company has a class of its equity securities registered under Section 12 of the Exchange Act, any committee administering the Plan will consist solely of two or more members of the Board who are &#8220;non-employee directors&#8221;&#160;within the meaning of Rule 16b-3 under the Exchange Act and who are &#8220;independent directors&#8221;&#160;as required by the Listing Rules of The NASDAQ Stock Market (or other applicable exchange or market on which the Company&#8217;s Common Stock may be traded or quoted).&#160;&#160;Such a committee, if established, will act by majority approval of the members (but may also take action by the written consent of all of the members of such committee), and a majority of the members of such a committee will constitute a quorum.&#160;&#160;As used in the Plan, &#8220;Committee&#8221;&#160;will refer to the Board or to such a committee, if established.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">3.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Authority of the Committee</span>.&#160;&#160;In accordance with and subject to the provisions of the Plan, the Committee will have the authority to determine all provisions of Incentive Awards as the Committee may deem necessary or desirable and as consistent with the terms of the Plan, including the following:&#160;&#160;(a) the Eligible Recipients to be selected as Participants; (b) the nature and extent of the Incentive Awards to be made to each Participant (including the number of shares of Common Stock to be subject to each Incentive Award, any exercise price, the manner in which Incentive Awards will vest or become exercisable and whether Incentive Awards will be granted in tandem with other Incentive Awards) and the form of Incentive Award Agreement; (c) the time or times when Incentive Awards will be granted; (d) the duration of each Incentive Award; and (e) the restrictions and other conditions to which the payment or vesting of Incentive Awards may be subject.&#160;&#160;In addition, the Committee will have the authority to:&#160;&#160;(i) interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in the Plan and any instrument or agreement relating to, or Incentive Award granted under, the Plan; (ii) establish, amend, suspend or waive any rules and regulations and appoint such agents as the Committee may deem appropriate for the proper administration of the Plan; and (iii) make any other determination and take any other action that the Committee may deem necessary or desirable for the administration of the Plan.&#160;&#160;In addition, the Committee will have the authority under the Plan in its sole discretion to pay the economic value of any Incentive Award in the form of cash, Common Stock or any combination of both.&#160;&#160;The Committee may exercise its duties, power and authority under the Plan in its sole discretion without the consent of any Participant or other party, unless the Plan specifically provides otherwise.&#160;&#160;The Committee will not be obligated to treat Participants or Eligible Recipients uniformly, and determinations made under the Plan may be made by the Committee selectively among Participants or Eligible Recipients, whether or not such Participants and Eligible Recipients are similarly situated.&#160;&#160;Each determination, interpretation or other action made or taken by the Committee pursuant to the provisions of the Plan will be final, conclusive and binding for all purposes and on all persons, and no member of the Committee will be liable for any action or determination made in good faith with respect to the Plan or any Incentive Award granted under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">3.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Delegation</span>.&#160;&#160;Except to the extent prohibited by applicable law or the applicable rules and regulations of any securities exchange or inter-dealer quotation system on which the securities of the Company are listed or traded, the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities and powers to any person or persons selected by it.&#160;&#160;Any such allocation or delegation may be revoked by the Committee at any time.&#160;&#160;Without limiting the generality of the foregoing and to the extent consistent with the applicable corporate law of the Company&#8217;s jurisdiction of incorporation, the Committee may, by resolution, authorize one or more Directors or one or more officers of the Company to do one or both of the following on the same basis as can the Committee:&#160;&#160;(a) designate Eligible Recipients to be recipients of Incentive Awards pursuant to the Plan; and (b) determine the size of any such Incentive Awards; provided, however, that (x) the Committee will not delegate such responsibilities to any such Director(s) or officer(s) for any Incentive Awards granted to an Eligible Recipient who is subject to the reporting and liability provisions of Section 16 under the Exchange Act; (y) the resolution providing such authorization will set forth the type of Incentive Awards and total number of each type of Incentive Awards such Director(s) or officer(s) may grant; and (z) such Director(s) or officer(s) will report periodically to the Committee regarding the nature and scope of the Incentive Awards granted pursuant to the authority delegated.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">3.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">No Re-Pricing</span>.&#160;&#160;Notwithstanding any other provision of the Plan other than Section 4.3, the Committee may not, without prior approval of the Company&#8217;s stockholders, seek to effect any re-pricing of any previously granted, &#8220;underwater&#8221;&#160;Option or Stock Appreciation Right by:&#160;&#160;(a) amending or modifying the terms of the Option or Stock Appreciation Right to lower the exercise price; (b) canceling the underwater Option or Stock Appreciation Right in exchange for (i) cash; (ii) replacement Options or Stock Appreciation Rights having a lower exercise price; or (iii) other Incentive Awards; or (c) repurchasing the underwater Options or Stock Appreciation Rights and granting new Incentive Awards under the Plan.&#160;&#160;For purposes of this Section 3.4, Options and Stock Appreciation Rights will be deemed to be &#8220;underwater&#8221;&#160;at any time when the Fair Market Value of the Common Stock is less than the exercise price of the Option or Stock Appreciation Right.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">3.5&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Participants Based Outside the United States</span>.&#160;&#160;In addition to the authority of the Committee under Section 3.2 of the Plan and notwithstanding any other provision of the Plan, the Committee may, in its sole discretion, amend the terms of the Plan or Incentive Awards with respect to Participants resident outside of the United States or employed by a non-U.S. Subsidiary in order to comply with local legal requirements, to otherwise protect the Company&#8217;s or Subsidiary&#8217;s interests, or to meet objectives of the Plan, and may, where appropriate, establish one or more sub-plans (including the adoption of any required rules and regulations) for the purposes of qualifying for preferred tax treatment under foreign tax laws.&#160;&#160;The Committee will have no authority, however, to take action pursuant to this Section 3.5 of the Plan:&#160;&#160;(a) to reserve shares or grant Incentive Awards in excess of the limitations provided in Section 4.1 of the Plan; (b) to effect any re-pricing in violation of Section 3.4 of the Plan; (c) to grant Options or Stock Appreciation Rights having an exercise price less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date in violation of Section 6.3 or 7.3 of the Plan, as the case may be; or (d) for which stockholder approval would then be required pursuant to Section 422 of the Code or the Listing Rules of The NASDAQ Stock Market (or other applicable exchange or market on which the Company&#8217;s Common Stock may be traded or quoted).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Shares Available for Issuance</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">4.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Maximum Number of Shares Available</span>.&#160;&#160;Certain Restrictions on Awards.&#160;&#160;Subject to adjustment as provided in Section 4.3 of the Plan, the maximum number of shares of Common Stock that will be available for issuance under the Plan will be the sum of:</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">(a)&#160;&#160;&#160;&#160; 800,000 (the &#8220;<span style="text-decoration: underline; ">Base Amount</span>&#8221;);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">(b)&#160;&#160;&#160;&#160; the number of shares issued or Incentive Awards granted under the Plan in connection with the settlement, assumption or substitution of outstanding awards or obligations to grant future awards as a condition of the Company and/or any Subsidiary(ies) acquiring, merging or consolidating with another entity; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-indent: 27pt; text-align: justify;">(c)&#160;&#160;&#160;&#160; the number of shares that are unallocated and available for grant under a stock plan assumed by the Company or any Subsidiary(ies) in connection with the merger, consolidation, or acquisition of another entity by the Company and/or any of its Subsidiaries, based on the applicable exchange ratio and other transaction terms, but only to the extent that such shares may be utilized by the Company or its Subsidiaries following the transaction pursuant to the rules and regulations of The NASDAQ Stock Market (or other applicable exchange or market on which the Company&#8217;s Common Stock may be traded or quoted).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">The shares available for issuance under the Plan may, at the election of the Committee, be either treasury shares or shares authorized but unissued, and, if treasury shares are used, all references in the Plan to the issuance of shares will, for corporate law purposes, be deemed to mean the transfer of shares from treasury.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">Notwithstanding any other provisions of the Plan to the contrary, (i) no more than 800,000 shares of Common Stock may be issued pursuant to the exercise of Incentive Stock Options granted under the Plan; and (ii) no Participant may be granted Incentive Awards covering more than 400,000 shares of Common Stock during any one calendar year.&#160; All of the foregoing share limits are subject, in each case, to adjustment as provided in Section 4.3 of the Plan.&#160; Incentive Stock Options issued as a result of the Company&#8217;s assumption or substitution of like awards issued by any acquired, merged or consolidated entity pursuant to applicable provisions of the Code will not count towards the limit in clause (i). Incentive Awards issued as a result of the Company&#8217;s assumption or substitution of like awards issued by any acquired, merged or consolidated entity will not count towards the limit in clause (ii).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">The maximum aggregate grant date fair value (determined in accordance with ASC 718) of Incentive Awards to be granted and other cash compensation paid to any non-employee director in any calendar year may not exceed $750,000, increased to $1,000,000 in the year in which such non-employee director initially joins the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">4.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Accounting for Incentive Awards</span>.&#160;&#160;Shares of Common Stock that are issued under the Plan or that are subject to outstanding Incentive Awards will be applied to reduce the maximum number of shares of Common Stock remaining available for issuance under the Plan.&#160;&#160;All shares so subtracted from the amount available under the Plan with respect to an Incentive Award that lapses, expires, is forfeited (including issued shares forfeited under a Restricted Stock Award) or for any reason is terminated unexercised or unvested or is settled or paid in cash or any form other than shares of Common Stock will automatically again become available for issuance under the Plan.&#160;&#160;Any shares of Common Stock withheld to satisfy tax withholding obligations on Incentive Awards issued under the Plan, any shares of Common Stock withheld to pay the exercise price of Incentive Awards under the Plan and any shares of Common Stock not issued or delivered as a result of the &#8220;net exercise&#8221;&#160;of an outstanding Option pursuant to Section 6.5 of the Plan or settlement of a Stock Appreciation Right in shares of Common Stock pursuant to Section 7.7 of the Plan will be counted against the shares of Common Stock authorized for issuance under the Plan and will not be available again for grant under the Plan.&#160;&#160;Any shares of Common Stock repurchased by the Company on the open market using the proceeds from the exercise of an Incentive Award will not increase the number of shares available for future grant of Incentive Awards.&#160;&#160;Any shares of Common Stock related to Incentive Awards under the Plan that terminate by expiration, forfeiture, cancellation or otherwise without the issuance of shares of Common Stock, or are settled in cash in lieu of shares, or are exchanged with the Committee&#8217;s permission, prior to the issuance of shares, for Incentive Awards not involving shares, will be available again for grant under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">4.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Adjustments to Shares and Incentive Awards</span>.&#160;&#160;</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160; In the event of any reorganization, merger, consolidation, recapitalization, liquidation, reclassification, stock dividend, stock split, combination of shares, rights offering, divestiture or extraordinary dividend (including a spin-off) or any other similar change in the corporate structure or shares of the Company, the Committee (or, if the Company is not the surviving corporation in any such transaction, the board of directors of the surviving corporation) will make appropriate adjustment (which determination will be conclusive) as to the number and kind of securities or other property (including cash) available for issuance or payment under the Plan, including the sub-limits set forth in Section 4.1 of the Plan and, in order to prevent dilution or enlargement of the rights of Participants, (a) the number and kind of securities or other property (including cash) subject to outstanding Incentive Awards, and (b) the exercise price of outstanding Incentive Awards.&#160;&#160;The determination of the Committee as to the foregoing adjustments, if any, will be final, conclusive and binding on Participants under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; Notwithstanding anything else in the Plan to the contrary, without affecting the number of shares of Common Stock reserved or available under the Plan, including the sub-limits in Section 4.1 of the Plan, the Committee may authorize the issuance or assumption of benefits under the Plan in connection with any merger, consolidation, acquisition of property or stock or reorganization upon such terms and conditions as it may deem appropriate, subject to compliance with the rules under Sections 422, 424 and 409A of the Code, as and where applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Participation</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">Participants in the Plan will be those Eligible Recipients who, in the judgment of the Committee, have contributed, are contributing or are expected to contribute to the achievement of objectives of the Company or its Subsidiaries.&#160; Eligible Recipients may be granted from time to time one or more Incentive Awards, singly or in combination or in tandem with other Incentive Awards, as may be determined by the Committee in its sole discretion.&#160; Incentive Awards will be deemed to be granted as of the date specified in the grant resolution of the Committee, which date will be the Grant Date of any related Incentive Award Agreement with the Participant.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">6.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Options</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">6.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Grant</span>.&#160;&#160;An Eligible Recipient may be granted one or more Options under the Plan, and such Options will be subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion.&#160;&#160;The Committee may designate whether an Option is to be considered an Incentive Stock Option or a Non-Statutory Stock Option.&#160;&#160;An Option will be an Incentive Stock Option only if the Eligible Recipient receiving the Option is an Employee of the Company or a Subsidiary in accordance with Section 422 of the Code.&#160;&#160;To the extent that any Incentive Stock Option (or portion thereof) granted under the Plan ceases for any reason to qualify as an &#8220;incentive stock option&#8221;&#160;for purposes of Section 422 of the Code, such Incentive Stock Option (or portion thereof) will continue to be outstanding for purposes of the Plan but will thereafter be deemed to be a Non-Statutory Stock Option.&#160;&#160;Options may be granted to an Eligible Recipient for services provided to a Subsidiary only if, with respect to such Eligible Recipient, the underlying shares of Common Stock constitute &#8220;service recipient stock&#8221;&#160;within the meaning of Treas. Reg. Section 1.409A-1(b)(5)(iii).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">6.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Incentive Award Agreement</span>. Each Option grant will be evidenced by an Incentive Award Agreement that will specify the exercise price of the Option, the maximum duration of the Option, the number of shares of Common Stock to which the Option pertains, the conditions upon which an Option will become vested and exercisable, and such other provisions as the Committee will determine which are not inconsistent with the terms of the Plan. The Incentive Award Agreement also will specify whether the Option is intended to be an Incentive Stock Option or a Non-Statutory Stock Options.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">6.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Exercise Price</span>. The per share price to be paid by a Participant upon exercise of an Option granted pursuant to this Section 6 will be determined by the Committee in its sole discretion at the time of the Option grant; provided, however, that such price will not be less than 100% of the Fair Market Value of one share of Common Stock on the date of grant (or 110% of the Fair Market Value of one share of Common Stock on the date of grant of an Incentive Stock Option if, at the time the Incentive Stock Option is granted, the Participant owns, directly or indirectly, more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary corporation of the Company). Notwithstanding the foregoing, to the extent that Options are granted under the Plan as a result of the Company&#8217;s assumption or substitution of Options issued by any acquired, merged or consolidated entity, the exercise price for such Options will be the price determined by the Committee pursuant to the conversion terms applicable to the transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">6.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Exercisability and Duration</span>. An Option will become exercisable at such times and in such installments and upon such terms and conditions as may be determined by the Committee in its sole discretion at the time of grant, including (a) the achievement of one or more specified performance objectives; and/or that (b) the Participant remain in the continuous employment or service with the Company or a Subsidiary for a certain period; provided, however, that no Option may be exercised after ten (10) years from the Grant Date (five years from the Grant Date in the case of an Incentive Stock Option if, at the time the Incentive Stock Option is granted, the Participant owns, directly or indirectly, more than 10% of the total combined voting power of all classes of stock of the Company or any parent or subsidiary corporation of the Company).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">6.5&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Payment of Exercise Price</span>.</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160; The total purchase price of the shares of Common Stock to be purchased upon exercise of an Option must be paid entirely in cash (including check, bank draft or money order); provided, however, that the Committee, in its sole discretion and upon terms and conditions established by the Committee, may allow such payments to be made, in whole or in part, (i) in accordance with a cashless exercise program established with a securities brokerage firm, and approved by the Committee; (ii) by tender, either by actual delivery or attestation as to ownership, of Previously Acquired Shares that are acceptable to the Committee; (iii) by a &#8220;net exercise&#8221;&#160;of the Option (as further described in paragraph (b), below); (iv) by a combination of such methods; or (v) by any other method approved or accepted by the Committee in its sole discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; In the case of a &#8220;net exercise&#8221;&#160;of an Option, the Company will not require a payment of the exercise price of the Option from the Participant but will reduce the number of shares of Common Stock issued upon the exercise by the largest number of whole shares that has a Fair Market Value on the exercise date that does not exceed the aggregate exercise price for the shares exercised under this method. Shares of Common Stock will no longer be outstanding under an Option (and will therefore not thereafter be exercisable) following the exercise of such Option to the extent of (i) shares used to pay the exercise price of an Option under the &#8220;net exercise,&#8221;&#160;(ii) shares actually delivered to the Participant as a result of such exercise and (iii) any shares withheld for purposes of tax withholding pursuant to Section 14.1 of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(c)&#160;&#160;&#160;&#160; For purposes of such payment, Previously Acquired Shares tendered or covered by an attestation will be valued at their Fair Market Value on the exercise date of the Option.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">6.6&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Manner of Exercise</span>.&#160;&#160;An Option (or any part or installment thereof) shall be exercised by giving written notice to the Company or its designee (in a form acceptable to the Committee, which may include electronic notice), together with provision for payment of the total exercise price for the shares of Common Stock to be purchased in accordance with Section 6.5 of the Plan, and upon compliance with any other condition(s) set forth in the Incentive Award Agreement.&#160;&#160;Such notice shall be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to the Committee), shall state the number of shares of Common Stock with respect to which the Option is being exercised and shall contain any representation required by the Plan or the Incentive Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">7.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Stock Appreciation Rights</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">7.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Grant</span>.&#160;&#160;An Eligible Recipient may be granted one or more Stock Appreciation Rights under the Plan, and such Stock Appreciation Rights will be subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion.&#160;&#160;The Committee will have the sole discretion to determine the form in which payment of the economic value of Stock Appreciation Rights will be made to a Participant (i.e., cash, shares of Common Stock or any combination thereof) or to consent to or disapprove the election by a Participant of the form of such payment.&#160;&#160;Stock Appreciation Rights may be granted to an Eligible Recipient for services provided to a Subsidiary only if, with respect to such Eligible Recipient, the underlying shares of Common Stock constitute &#8220;service recipient stock&#8221;&#160;within the meaning of Treas. Reg. Section 1.409A-1(b)(5)(iii).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">7.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Incentive Award Agreement</span>.&#160;&#160;Each Stock Appreciation Right will be evidenced by an Incentive Award Agreement that will specify the exercise price of the Stock Appreciation Right, the term of the Stock Appreciation Right, and such other provisions as the Committee will determine which are not inconsistent with the terms of the Plan.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 27pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">7.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Exercise Price</span>.&#160;&#160;The exercise price of a Stock Appreciation Right will be determined by the Committee, in its sole discretion, at the Grant Date; provided, however, that such price may not be less than 100% of the Fair Market Value of one share of Common Stock on the Grant Date.&#160;&#160;Notwithstanding the foregoing, to the extent that Stock Appreciation Rights are granted under the Plan as a result of the Company&#8217;s assumption or substitution of stock appreciation rights issued by any acquired, merged or consolidated entity, the exercise price for such Stock Appreciation Rights will be the price determined by the Committee pursuant to the conversion terms applicable to the transaction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">7.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Exercisability and Duration</span>.&#160;&#160;A Stock Appreciation Right will become exercisable at such times and in such installments as may be determined by the Committee in its sole discretion at the time of grant; provided, however, that no Stock Appreciation Right may be exercisable after ten (10) years from its Grant Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">7.5&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Manner of Exercise</span>. A Stock Appreciation Right will be exercised by giving notice in the same manner as for Options, as set forth in Section 6. 6 of the Plan, subject to any other terms and conditions consistent with the other provisions of the Plan as may be determined by the Committee in its sole discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">7.6&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Settlement</span>. Upon the exercise of a Stock Appreciation Right, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying:</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160; The excess of the Fair Market Value of a share of Common Stock on the date of exercise over the per share exercise price; by</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; The number of shares of Common Stock with respect to which the Stock Appreciation Right is exercised.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">7.7&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Form of Payment</span>. Payment if any, with respect to a Stock Appreciation Right settled in accordance with Section 7.6 of the Plan will be made in accordance with the terms of the applicable Incentive Award Agreement, in cash, shares of Common Stock or a combination thereof, as the Committee determines in its sole discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; margin: 0pt;">&#160;</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">8.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Restricted Stock Awards and Restricted Stock Units</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">8.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Grant</span>. An Eligible Recipient may be granted one or more Restricted Stock Awards or Restricted Stock Units under the Plan, and such awards will be subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion. Restricted Stock Units will be similar to Restricted Stock Awards except that no shares of Common Stock are actually awarded to the Participant on the Grant Date of the Restricted Stock Units. Restricted Stock Units will be denominated in shares of Common Stock but paid in cash, shares of Common Stock or a combination of cash and shares of Common Stock as the Committee, in its sole discretion, will determine, and as provided in the Incentive Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">8.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Incentive Award Agreement</span>. Each Restricted Stock Award or Restricted Stock Unit will be evidenced by an Incentive Award Agreement that will specify the type of Incentive Award, the period(s) of restriction, the number of shares of restricted Common Stock, or the number of Restricted Stock Units granted, and such other provisions as the Committee will determine which are not inconsistent with the terms of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">8.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Vesting Requirements and Restrictions</span>. The Committee will impose such restrictions or conditions, not inconsistent with the provisions of the Plan, to the vesting of such Restricted Stock Awards or Restricted Stock Units as it deems appropriate, including (a) the achievement of one or more specified performance objectives; or that (b) the Participant remain in the continuous employment or service with the Company or a Subsidiary for a certain period. If any vesting requirements of a Restricted Stock Award or Restricted Stock Unit are not satisfied, the Restricted Stock Award or Restricted Stock Unit will be forfeited and the shares of Common Stock subject to the Restricted Stock Award will be returned to the Company and no shares of Common Stock or other consideration will be issued with respect to the forfeited Restricted Stock Unit. If the Participant paid any purchase price with respect to such forfeited shares, unless otherwise provided by the Committee in the Incentive Award Agreement evidencing the Restricted Stock Award, the Company will refund to the Participant the lesser of (4) such purchase price and (y) the Fair Market Value of such shares on the date of forfeiture. Notwithstanding the foregoing, Restricted Stock Awards may in the sole discretion of the Committee be granted without any restrictions or conditions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">8.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Rights as a Shareholder</span>.&#160;&#160;Except as provided in Sections 8.1, 8.5 and 8.6 of the Plan, upon a Participant becoming the holder of record of shares of Common Stock issued under a Restricted Stock Award pursuant to this Section 8, the Participant will have all voting, dividend, liquidation and other rights with respect to such shares (other than the right to sell or transfer such shares) as if such Participant were a holder of record of shares of unrestricted Common Stock.&#160;&#160;A Participant will have no voting, dividend, liquidation and other rights with respect to any shares of Common Stock underlying any Restricted Stock Units granted hereunder unless and until the shares of Common Stock are issued under the terms thereof and the Participant becomes the holder of record of such shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">8.5&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Dividends and Distributions</span>.&#160;&#160;</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160; Dividends or distributions paid with respect to shares of Common Stock subject to the unvested portion of a Restricted Stock Award will be subject to the same restrictions as the shares to which such dividends or distributions relate.&#160;&#160;The Committee will determine in its sole discretion whether any interest will be paid on such dividends or distributions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; Unless the Committee determines otherwise in its sole discretion (either in the Incentive Award Agreement evidencing the Restricted Stock Unit at the time of grant or at any time after the grant of the Restricted Sock Unit), any Restricted Stock Unit shall carry with it a right to &#8220;dividend equivalents&#8221;&#160;(as defined in Section 12 of the Plan).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">8.6&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Enforcement of Restrictions</span>.&#160;&#160;To enforce the restrictions referred to in this Section 8, the Committee may place a legend on the stock certificates or book-entry notation representing Restricted Stock Awards referring to such restrictions and may require the Participant, until the restrictions have lapsed, to keep any stock certificates, together with duly endorsed stock powers, in the custody of the Company or its transfer agent, or to maintain evidence of stock ownership, together with duly endorsed stock powers, in a certificateless book-entry stock account with the Company&#8217;s transfer agent.&#160;&#160;Alternatively, Restricted Stock Awards may be held in non-certificated form pursuant to such terms and conditions as the Company may establish with its registrar and transfer agent or any third-party administrator designated by the Company to hold Restricted Stock Awards on behalf of Participants.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">8.7&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Lapse of Restrictions; Settlement</span>.&#160;&#160;Except as otherwise provided in this Section 8, shares of Common Stock underlying a Restricted Stock Award will become freely transferable by the Participant after all conditions and restrictions applicable to such shares have been satisfied or lapse (including satisfaction of any applicable tax withholding obligations).&#160;&#160;Upon the vesting of a Restricted Stock Unit, the Restricted Stock Unit will be settled, subject to the terms and conditions of the applicable Incentive Award Agreement, (a) in cash, based upon the Fair Market Value of the vested underlying shares of Common Stock, (b) in shares of Common Stock or (c) a combination thereof, as provided in the Incentive Award Agreement, except to the extent that a Participant has properly elected to defer income that may be attributable to a Restricted Stock Unit under a Company deferred compensation plan or arrangement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">8.8&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Section 83(b) Election for Restricted Stock Award</span>. If a Participant makes an election pursuant to Section 83(b) of the Code with respect to a Restricted Stock Award, the Participant must file, within thirty (30) days following the Grant Date of the Restricted Stock Award, a copy of such election with the Company and with the Internal Revenue Service, in accordance with the regulations under Section 83 of the Code. The Committee may provide in the Incentive Award Agreement that the Restricted Stock Award is conditioned upon the Participant&#8217;s making or refraining from making an election with respect to the award under Section 83(b) of the Code.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">9.</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><span style="text-decoration: underline; ">Performance Awards</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">9.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Grant</span>. An Eligible Recipient may be granted one or more Performance Awards under the Plan, and such awards will be subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion, including the achievement of one or more specified performance objectives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">9.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Incentive Award Agreement</span>. Each Performance Award will be evidenced by an Incentive Award Agreement that will specify the amount of cash, shares of Common Stock or combination of both to be received by the Participant upon payout of the Performance Award, any performance objectives upon which the Performance Award is subject, any performance period during which any such performance objectives must be achieved and such other provisions as the Committee will determine which are not inconsistent with the terms of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">9.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Vesting</span>. The Committee may impose such restrictions or conditions, not inconsistent the vesting of such Performance Awards as it deems appropriate, including the achievement of one or more specified performance objectives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">9.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Form and Timing of Performance Award Payment</span>. Subject to the terms of the Plan, after the applicable performance period has ended, the holder of Performance Awards will be entitled to receive payment on the value and number of Performance Awards earned by the Participant over the performance period, to be determined as a function of the extent to which the corresponding performance objectives have been achieved. Payment of earned Performance Awards will be as determined by the Committee and as evidenced in the Incentive Award Agreement. Subject to the terms of the Plan, the Committee, in its sole discretion, may pay earned Performance Awards in the form of cash or in shares of Common Stock (or in a combination thereof) equal to the value of the earned Performance Awards at the close of the applicable performance period. Payment of any Performance Award will be made as soon as practicable after the Committee has determined the extent to which the applicable performance objectives have been achieved and not later than the March 15<sup style="vertical-align:top;line-height:120%;">th</sup>&#160;immediately following the end of the performance period, or earlier than the January 1<sup style="vertical-align:top;line-height:120%;">st</sup>&#160;preceding such March 15, except to the extent that a Participant has properly elected to defer payment that may be attributable to a Performance Award under a Company deferred compensation plan or arrangement. The determination of the Committee with respect to the form of payment of Performance Awards will be set forth in the Incentive Award Agreement pertaining to the grant of the award. Any shares of Common Stock issued in payment of earned Performance Awards may be granted subject to any restrictions deemed appropriate by the Committee, including that the Participant remain in the continuous employment or service with the Company with the provisions of the Plan, to or a Subsidiary for a certain period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">10.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Stock Bonuses</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">An Eligible Recipient may be granted one or more Stock Bonuses under the Plan, and such Stock Bonuses will be subject to such terms and conditions, if any, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion, including the achievement of one or more specified performance objectives.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">11.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Other Stock-Based Awards</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">11.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Other Stock-Based Awards</span>.&#160;&#160;Subject to such terms and conditions, consistent with the other provisions of the Plan, as may be determined by the Committee in its sole discretion, the Committee may grant Other Stock-Based Awards not otherwise described by the terms of the Plan (including the grant or offer for sale of unrestricted shares of Common Stock) in such amounts and subject to such terms and conditions as the Committee will determine.&#160;&#160;Such Incentive Awards may involve the transfer of actual shares of Common Stock to Participants or payment in cash or otherwise of amounts based on the value of shares of Common Stock, and may include Incentive Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">11.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Value of Other Stock-Based Awards</span>. Each Other Stock-Based Award will be expressed in terms of shares of Common Stock or units based on shares of Common Stock, as determined by the Committee.&#160;&#160;The Committee may establish performance objectives in its sole discretion for any Other Stock-Based Award.&#160;&#160;If the Committee exercises its discretion to establish performance objectives for any such Incentive Awards, the number or value of Other Stock-Based Awards that will be paid out to the Participant will depend on the extent to which the specified performance objectives are met.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">11.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Payment of Other Stock-Based Awards</span>.&#160;&#160;Payment, if any, with respect to an Other Stock-Based Award will be made in accordance with the terms of the Incentive Award and in cash or shares of Common Stock, as the Committee determines, except to the extent that a Participant has properly elected to defer payment that may be attributable to an Other Stock-Based Award under a Company deferred compensation plan or arrangement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">12.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Dividend Equivalents</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">Any Participant selected by the Committee may be granted dividend equivalents based on the dividends declared on shares of Common Stock that are subject to any Incentive Award, to be credited as of dividend payment dates, during the period between the Grant Date of the Incentive Award and the date the Incentive Award is exercised, vests, is settled or expires, as determined by the Committee.&#160; Such dividend equivalents will be converted to cash or additional shares of Common Stock by such formula and at such time and subject to such limitations as may be determined by the Committee.&#160; Notwithstanding the foregoing, dividends or dividend equivalents will be paid out with respect to any Incentive Award only to the extent that the shares of Common Stock subject to the Incentive Award vest.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">13.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Effect of Termination of Employment or Other Service</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">13.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Termination Due to Death, Disability or Retirement</span>.&#160;&#160;Unless otherwise expressly provided by the Committee in its sole discretion in an Incentive Award Agreement, and subject to Sections 13.3, 13.4, 13.5 and 13.6 of the Plan, in the event a Participant&#8217;s employment or other service with the Company and all Subsidiaries is terminated by reason of death, Disability or Retirement:</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160; All outstanding Options and Stock Appreciation Rights then held by the Participant will, to the extent exercisable as of such termination, remain exercisable in full for a period of one year after such termination (but in no event after the expiration date of any such Option or Stock Appreciation Right).&#160;&#160;Options and Stock Appreciation Rights not exercisable as of such termination will be forfeited and terminate.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; All Restricted Stock Awards then held by the Participant that have not vested as of such termination will be terminated and forfeited; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(c)&#160;&#160;&#160;&#160; All outstanding but unpaid Restricted Stock Units, Performance Awards, Stock Bonuses and Other Stock-Based Awards then held by the Participant will be terminated and forfeited; provided, however, that with respect to any such Incentive Awards the vesting of which is based on the achievement of specified performance objectives, if a Participant&#8217;s employment or other service with the Company or any Subsidiary, as the case may be, is terminated by reason of death or Disability prior to the end of the performance period of such Incentive Award, but after the conclusion of a portion of the performance period (but in no event less than one year), the Committee may, in its sole discretion, cause shares of Common Stock to be delivered or payment made with respect to the Participant&#8217;s Incentive Award, but only if otherwise earned for the entire performance period and only with respect to the portion of the applicable performance period completed at the date of such event, with proration based on full fiscal years only and no shares to be delivered for partial fiscal years.&#160;&#160;The Committee will consider the provisions of Sections 13.6 and 13.7 of the Plan and will have the discretion to consider any other fact or circumstance in making its decision as to whether to deliver such shares of Common Stock or other payment, including whether the Participant again becomes employed.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">13.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Termination for Reasons Other than Death, Disability or Retirement</span>.&#160;&#160;Unless otherwise expressly provided by the Committee in its sole discretion in an Incentive Award Agreement, and subject to Sections 13.3, 13.4, 13.5 and 13.6 of the Plan, in the event a Participant&#8217;s employment or other service with the Company and all Subsidiaries is terminated for any reason other than death, Disability or Retirement, or a Participant is in the employment or service with a Subsidiary and the Subsidiary ceases to be a Subsidiary of the Company (unless the Participant continues in the employment or service with the Company or another Subsidiary):</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160; All outstanding Options and Stock Appreciation Rights then held by the Participant will, to the extent exercisable as of such termination, remain exercisable in full for a period of three months after such termination (but in no event after the expiration date of any such Option or Stock Appreciation Right).&#160;&#160;Options and Stock Appreciation Rights not exercisable as of such termination will be forfeited and terminate;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; All Restricted Stock Awards then held by the Participant that have not vested as of such termination will be terminated and forfeited; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(c)&#160;&#160;&#160;&#160; All outstanding but unpaid Restricted Stock Unit, Performance Awards, Stock Bonuses and Other Stock-Based Awards then held by the Participant will be terminated and forfeited.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">13.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Modification of Rights Upon Termination</span>.&#160;&#160;Notwithstanding the other provisions of this Section 13, upon a Participant&#8217;s termination of employment or other service with the Company and all Subsidiaries, the Committee may, in its sole discretion (which may be exercised at any time on or after the Grant Date, including following such termination), except as provided below, cause Options or Stock Appreciation Rights (or any part thereof) then held by such Participant to terminate, become or continue to become exercisable and/or remain exercisable following such termination of employment or service, and Restricted Stock Awards, Restricted Stock Units, Performance Awards, Stock Bonuses or Other Stock-Based Awards then held by such Participant to terminate, vest, settle or become free of restrictions and conditions to payment, as the case may be, following such termination of employment or service, in each case in the manner determined by the Committee; provided, however, that no Option or Stock Appreciation Right may remain exercisable beyond its expiration date and any such action adversely affecting any outstanding Incentive Award will not be effective without the consent of the affected Participant (subject to the right of the Committee to take whatever action it deems appropriate under Sections 4.3, 13.5, 13.6 and 15 of the Plan).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">13.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Determination of Termination of Employment or Other Service</span>.&#160;&#160;Unless otherwise expressly provided by the Committee in its sole discretion in an Incentive Award Agreement:</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160; The change in a Participant&#8217;s status from that of an Employee to that of a Consultant will, for purposes of the Plan, be deemed to result in a termination of such Participant&#8217;s employment with the Company and its Subsidiaries, unless the Committee otherwise determines in its sole discretion.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; The change in a Participant&#8217;s status from that of a Consultant to that of an Employee will not, for purposes of the Plan, be deemed to result in a termination of such Participant&#8217;s service as a Consultant, and such Participant will thereafter be deemed to be an Employee, in which event such Participant will be governed by the provisions of the Plan relating to termination of employment or service (subject to paragraph (a) above).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(c)&#160;&#160;&#160;&#160; Unless the Committee otherwise determines in its sole discretion, a Participant&#8217;s employment or other service will, for purposes of the Plan, be deemed to have terminated on the date recorded on the personnel or other records of the Company or the Subsidiary for which the Participant provides employment or other service, as determined by the Committee in its sole discretion based upon such records.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(d)&#160;&#160;&#160;&#160; Notwithstanding the foregoing, if payment of an Incentive Award that is subject to Section 409A of the Code is triggered by a termination of a Participant&#8217;s employment or other service, such termination must also constitute a &#8220;separation from service&#8221;&#160;within the meaning of Section 409A of the Code, and any change in employment status that constitutes a &#8220;separation from service&#8221;&#160;under Section 409A of the Code will be treated as a termination of employment or service, as the case may be.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">13.5&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Effect of Actions Constituting Cause or Adverse Action</span>.&#160;&#160;Notwithstanding anything in the Plan to the contrary and in addition to the other rights of the Committee under this Section 13, if a Participant is determined by the Committee, acting in its sole discretion, to have taken any action that would constitute Cause or an Adverse Action during or after the termination of employment or other service with the Company or a Subsidiary, irrespective of whether such action or the Committee&#8217;s determination occurs before or after termination of such Participant&#8217;s employment or other service with the Company or any Subsidiary and irrespective of whether or not the Participant was terminated as a result of such Cause or Adverse Action, (a) all rights of the Participant under the Plan and any Incentive Award Agreements evidencing an Incentive Award then held by the Participant will terminate and be forfeited without notice of any kind, and (b) the Committee in its sole discretion will have the authority to rescind the exercise, vesting, settlement or issuance of, or payment in respect of, any Incentive Awards of the Participant that were exercised, vested, settled or issued, or as to which such payment was made, and to require the Participant to pay to the Company, within ten (10) days of receipt from the Company of notice of such rescission, any amount received or the amount of any gain realized as a result of such rescinded exercise, vesting, settlement, issuance or payment (including any dividends paid or other distributions made with respect to any shares of Common Stock subject to any Incentive Award).&#160;&#160;The Company may defer the exercise of any Option or Stock Appreciation Right for a period of up to six (6) months after receipt of the Participant&#8217;s written notice of exercise or the issuance of share certificates upon the vesting of any Incentive Award for a period of up to six (6) months after the date of such vesting in order for the Committee to make any determination as to the existence of Cause or an Adverse Action.&#160;&#160;The Company will be entitled to withhold and deduct from future wages of the Participant (or from other amounts that may be due and owing to the Participant from the Company or a Subsidiary) or make other arrangements for the collection of all amounts necessary to satisfy such payment obligations.&#160;&#160;Unless otherwise provided by the Committee in an applicable Incentive Award Agreement, this Section 13.5 will not apply to any Participant following a Change in Control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">13.6&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Clawback/Forfeiture of Incentive Awards.</span>&#160;&#160;Notwithstanding anything to the contrary contained in this Plan, the Company may recover from a Participant any compensation received from any Incentive Award (whether or not settled) or cause a Participant to forfeit any Incentive Award (whether or not vested) in the event that the Company&#8217;s Clawback Policy as then in effect is triggered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">14.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Payment of Withholding Taxes</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">14.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">General Rules</span>.&#160;&#160;The Company is entitled to (a) withhold and deduct from future wages of the Participant (or from other amounts that may be due and owing to the Participant from the Company or a Subsidiary), or make other arrangements for the collection of, an amount the Company reasonably determines to be the minimum statutory amount necessary to satisfy any and all federal, foreign, state and local withholding and employment-related tax requirements attributable to an Incentive Award; (b) withhold cash paid or payable or shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with an Incentive Award; or (c) require the Participant promptly to remit the amount of such withholding to the Company before taking any action, including issuing any shares of Common Stock or paying any cash amounts, with respect to an Incentive Award.&#160;&#160;Shares of Common Stock issued or otherwise issuable to the Participant in connection with an Incentive Award that gives rise to the tax withholding obligation that are withheld for purposes of satisfying the Participant&#8217;s withholding or employment-related tax obligation, will be valued at their Fair Market Value on the Tax Date.&#160;&#160;When withholding for taxes is effected under the Plan, it will be withheld only up to the minimum required tax withholding rates or such other rate that will not trigger a negative accounting impact on the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">14.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Special Rules</span>.&#160;&#160;The Committee may, in its sole discretion and upon terms and conditions established by the Committee, permit or require a Participant to satisfy, in whole or in part, any withholding or employment-related tax obligation described in Section 14.1 of the Plan by withholding shares of Common Stock underlying an Incentive Award, by electing to tender, or by attestation as to ownership of, Previously Acquired Shares, in accordance with a sell-to-cover &#160;program established with a securities brokerage firm and approved by the Committee, or a combination of such methods.&#160;&#160;For purposes of satisfying a Participant&#8217;s withholding or employment-related tax obligation, shares of Common Stock withheld by the Company or Previously Acquired Shares tendered or covered by an attestation will be valued at their Fair Market Value on the Tax Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">15.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Change in Control</span>.</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">15.1&#160;&#160;&#160;&#160; A &#8220;<span style="text-decoration: underline; ">Change in Control</span>&#8221;&#160;will mean the occurrence of any one or more of the following:&#160;&#160;(i) the accumulation (if over time, in any consecutive twelve (12) month period), whether directly, indirectly, beneficially or of record, by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act) of 50.1% or more of the shares of the outstanding Common Stock of the Company, whether by merger, consolidation, sale or other transfer of shares of Common Stock (other than a merger or consolidation where the stockholders of the Company prior to the merger or consolidation are the holders of a majority of the voting securities of the entity that survives such merger or consolidation or the parent of such entity), (ii) a sale of all or substantially all of the assets of the Company or (iii) during any period of twelve (12) consecutive months, the individuals who, at the beginning of such period, constitute the Board, and any new director whose election by the Board or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the 12-month period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board; provided, however, that the following acquisitions shall not constitute a Change in Control for the purposes of this Plan:&#160;&#160;(A) any acquisitions of Common Stock or securities convertible, exercisable or exchangeable into Common Stock directly from the Company or (B) any acquisition of Common Stock or securities convertible, exercisable or exchangeable into Common Stock by any employee benefit plan (or related trust) sponsored by or maintained by the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">15.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Corporate Transactions</span>.&#160;&#160;In the event of a merger, consolidation, or sale of all or substantially all of the Company&#8217;s assets or the acquisition of all of the outstanding voting stock of the Company (or similar transaction) in a single transaction or a series of related transactions by a single entity other than a transaction in which the Company is the surviving corporation (a &#8220;<b>Corporate Transaction</b>&#8221;), the Board or the Committee, or the board of directors of any entity assuming the obligations of the Company hereunder (the &#8220;<b>Successor Board</b>&#8221;), may, as to outstanding Options, take any of the following actions (i) make appropriate provision for the continuation of such Options by substituting on an equitable basis for the shares then subject to such Options either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (ii) upon written notice to the Participants, provide that such Options must be exercised (either (A) to the extent then exercisable or, (B) at the discretion of the Board or the Committee, any such Options being made partially or fully exercisable for purposes of this clause), within a specified number of days of the date of such notice, at the end of which period such Options which have not been exercised shall terminate; or (iii) terminate such Options in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock into which such Option would have been exercisable (either (A) to the extent then exercisable or, (B) at the discretion of the Board or the Committee, any such Options being made partially or fully exercisable for purposes of this clause) <span style="text-decoration: underline; ">less</span>&#160;the aggregate exercise price thereof.&#160;&#160;For purposes of determining the payments to be made pursuant to subclause (iii) above, in the case of a Corporate Transaction the consideration for which, in whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined in good faith by the Board.&#160;&#160;For the avoidance of doubt, if the per share exercise price of an Option or portion thereof is equal to or greater than the Fair Market Value of one share of Common Stock, such Option may be cancelled with no payment due hereunder or otherwise in respect thereof. Where a Corporate Transaction involves a tender offer that is reasonably expected to be followed by a merger (as determined by the Board or the Committee), the Corporate Transaction will be deemed to have occurred upon consummation of the tender offer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 27pt;">With respect to outstanding Incentive Awards other than Options, the Board or the Committee or the Successor Board, shall make appropriate provision for the continuation of such Incentive Awards on the same terms and conditions by substituting on an equitable basis for the shares then subject to such Incentive Awards either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity.&#160; In lieu of the foregoing, in connection with any Corporate Transaction, the Board or the Committee may provide that, each outstanding Incentive Award shall be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock comprising such Incentive Award (to the extent such Incentive Award no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of the Board or the Committee, all forfeiture and repurchase rights being waived).&#160; For purposes of determining such payments, in the case of a Corporate Transaction the consideration for which, in whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined in good faith by the Board.&#160; For the avoidance of doubt, if the purchase or base price of an Incentive Award or portion thereof is equal to or greater than the Fair Market Value of one share of Common Stock, such Incentive Award may be cancelled with no payment due hereunder or otherwise in respect thereof.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">In taking any of the actions permitted under this Section 15.2, the Board or the Committee shall not be obligated by the Plan to treat all Incentive Awards held by a Participant, or all Incentive Awards of the same type, identically.</p>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">15.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Limitation on Change in Control Payments</span>.&#160;&#160;Notwithstanding anything in Section 15.2 of the Plan to the contrary, if, with respect to a Participant, the acceleration of the vesting of an Incentive Award or the payment of cash in exchange for all or part of an Incentive Award as provided in Section 15.2 of the Plan (which acceleration or payment could be deemed a &#8220;payment&#8221;&#160;within the meaning of Section 280G(b)(2) of the Code), together with any other &#8220;payments&#8221;&#160;that such Participant has the right to receive from the Company or any corporation that is a member of an &#8220;affiliated group&#8221;&#160;(as defined in Section 1504(a) of the Code without regard to Section 1504(b) of the Code) of which the Company is a member, would constitute a &#8220;parachute payment&#8221;&#160;(as defined in Section 280G(b)(2) of the Code), then the &#8220;payments&#8221;&#160;to such Participant pursuant to Section 15.2 of the Plan will be reduced (or acceleration of vesting eliminated) to the largest amount as will result in no portion of such &#8220;payments&#8221;&#160;being subject to the excise tax imposed by Section 4999 of the Code; provided, that such reduction will be made only if the aggregate amount of the payments after such reduction exceeds the difference between (a) the amount of such payments absent such reduction minus (b) the aggregate amount of the excise tax imposed under Section 4999 of the Code attributable to any such excess parachute payments; and provided further that such payments will be reduced (or acceleration of vesting eliminated) in the following order:&#160;&#160;(i) options with an exercise price above fair market value that have a positive value for purposes of Section 280G of the Code, (ii) pro rata among Incentive Awards that constitute deferred compensation under Section 409A of the Code, and (iii) finally, among the Incentive Awards that are not subject to Section 409A of the Code.&#160;&#160;Notwithstanding the foregoing sentence, if a Participant is subject to a separate agreement with the Company or an Affiliate or Subsidiary that expressly addresses the potential application of Section 280G or 4999 of the Code, then this Section 15.3 will not apply and any &#8220;payments&#8221;&#160;to a Participant pursuant to Section 15.2 of the Plan will be treated as &#8220;payments&#8221;&#160;arising under such separate agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">16.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Rights of Eligible Recipients and Participants; Transferability</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">16.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Employment or Service</span>.&#160;&#160;Nothing in the Plan or an Incentive Award Agreement will interfere with or limit in any way the right of the Company or any Subsidiary to terminate the employment or service of any Eligible Recipient or Participant at any time, nor confer upon any Eligible Recipient or Participant any right to continue in the employment or other service with the Company or any Subsidiary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">16.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">No Rights to Awards</span>.&#160;&#160;No Participant or Eligible Individual will have any claim to be granted any Incentive Award under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">16.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Rights as a Stockholder</span>.&#160;&#160;As a holder of Incentive Awards (other than Restricted Stock Awards), a Participant will have no rights as a stockholder unless and until such Incentive Awards are exercised for, settled or paid in the form of, shares of Common Stock and the Participant becomes the holder of record of such shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">16.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Restrictions on Transfer</span>.&#160;&#160;</p>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(a)&#160;&#160;&#160;&#160; Except pursuant to testamentary will or the laws of descent and distribution or as otherwise expressly permitted by subsections (b) and (c) below, no right or interest of any Participant in an Incentive Award prior to the exercise (in the case of Options or Stock Appreciation Rights) or vesting, settlement or issuance (in the case of other Incentive Awards) of such Incentive Award will be assignable or transferable, or subjected to any lien, during the lifetime of the Participant, either voluntarily or involuntarily, directly or indirectly, by operation of law or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(b)&#160;&#160;&#160;&#160; A Participant will be entitled to designate a beneficiary to receive an Incentive Award upon such Participant&#8217;s death, and in the event of such Participant&#8217;s death, payment of any amounts due under the Plan will be made to, and exercise of any Options or Stock Appreciation Rights (to the extent permitted pursuant to Section 13 of the Plan) may be made by, such beneficiary.&#160;&#160;If a deceased Participant has failed to designate a beneficiary, or if a beneficiary designated by the Participant fails to survive the Participant, payment of any amounts due under the Plan will be made to, and exercise of any Options or Stock Appreciation Rights (to the extent permitted pursuant to Section 13 of the Plan) may be made by, the Participant&#8217;s legal representatives, heirs and legatees.&#160;&#160;If a deceased Participant has designated a beneficiary and such beneficiary survives the Participant but dies before complete payment of all amounts due under the Plan or exercise of all exercisable Options or Stock Appreciation Rights, then such payments will be made to, and the exercise of such Options or Stock Appreciation Rights may be made by, the legal representatives, heirs and legatees of the beneficiary.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt 0pt 0pt 27pt; text-align: justify; text-indent: 27pt;">(c)&#160;&#160;&#160;&#160; Upon a Participant&#8217;s request, the Committee may, in its sole discretion, permit a transfer of all or a portion of an Incentive Award, other than for value, to such Participant&#8217;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, any person sharing such Participant&#8217;s household (other than a tenant or employee), a trust in which any of the foregoing have more than fifty percent of the beneficial interests, a foundation in which any of the foregoing (or the Participant) control the management of assets, and any other entity in which these persons (or the Participant) own more than 50% of the voting interests.&#160;&#160;Any permitted transferee will remain subject to all the terms and conditions applicable to the Participant prior to the transfer.&#160;&#160;A permitted transfer may be conditioned upon such requirements as the Committee may, in its sole discretion, determine, including, execution and/or delivery of appropriate acknowledgements, opinion of counsel, or other documents by the transferee.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">16.5&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Non-Exclusivity of the Plan</span>.&#160;&#160;Nothing contained in the Plan is intended to modify or rescind any previously approved compensation plans or programs of the Company or create any limitations on the power or authority of the Board to adopt such additional or other compensation arrangements as the Board may deem necessary or desirable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-22</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">17.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Securities Law and Other Restrictions</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">Notwithstanding any other provision of the Plan or any Incentive Award Agreement entered into pursuant to the Plan, the obligation of the Company to issue any shares of Common Stock under the Plan or settle Incentive Awards in shares of Common Stock or other consideration will be subject to all applicable law, rules and regulations, and to such approvals by governmental agencies as may be required.&#160; Notwithstanding the generality of the foregoing and notwithstanding any other provision of the Plan or any Incentive Award Agreement entered into pursuant to the Plan, the Company will not be required to issue any shares of Common Stock under the Plan, and a Participant may not sell, assign, transfer or otherwise dispose of shares of Common Stock issued pursuant to Incentive Awards granted under the Plan, unless (a) there is in effect with respect to such shares a registration statement under the Securities Act and any applicable securities laws of a state or foreign jurisdiction or an exemption from such registration under the Securities Act and applicable state or foreign securities laws, and (b) there has been obtained any other consent, approval or permit from any other U.S. or foreign regulatory body which the Committee, in its sole discretion, deems necessary or advisable.&#160; The Company will be under no obligation to register for sale under the Securities Act any of the shares of Common Stock to be offered or sold under the Plan.&#160; The Company may condition such issuance, sale or transfer upon the receipt of any representations or agreements from the parties involved, and the placement of any legends on certificates representing shares of Common Stock, as may be deemed necessary or advisable by the Company in order to comply with such securities law or other restrictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">18.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Deferred Compensation; Compliance with Section 409A</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">It is intended that all Incentive Awards issued under the Plan be administered in a manner that will comply with the requirements of Section 409A of the Code, or the requirements of an exception to Section 409A of the Code and the Incentive Award Agreements and the Plan will be construed and administered in a manner that is consistent with and give effect to such intent.&#160; The Committee is authorized to adopt rules or regulations deemed necessary or appropriate to qualify for an exception from or to comply with the requirements of Section 409A of the Code (including any transition or grandfather rules relating thereto).&#160; Notwithstanding anything in this Section 18 or Section 19 to the contrary, with respect to any Incentive Award subject to Section 409A of the Code, no amendment to or payment under such Incentive Award will be made except and only to the extent permitted under Section 409A of the Code.&#160; If any amount is payable with respect to an Incentive Award that is subject to Section 409A of the Code as a result of the Participant&#8217;s &#8220;separation from service&#8221; at such time the Participant is a &#8220;specified employee&#8221; within the meaning of Section 409A of the Code, then no payment will be made, except as permitted under Section 409A of the Code, prior to the first business day after the earlier of (i) the date that is six months after the Participant&#8217;s separation from service or (ii) the Participant&#8217;s death.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-23</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">19.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Amendment, Modification and Termination</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">19.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Generally</span>.&#160;&#160;Subject to other subsections of this Section 19 and Section 3.4 of the Plan, the Board at any time may suspend or terminate the Plan (or any portion thereof) or terminate any outstanding Incentive Award and the Committee, at any time and from time to time, may amend the Plan or amend or modify the terms of an outstanding Incentive Award and Incentive Award Agreement.&#160;&#160;The Committee&#8217;s power and authority to amend or modify the terms of an outstanding Incentive Award and Incentive Award Agreement includes the authority to modify the number of shares of Common Stock or other terms and conditions of an Incentive Award, extend the term of an Incentive Award, accelerate the exercisability or vesting or otherwise terminate any restrictions relating to an Incentive Award, accept the surrender of any outstanding Incentive Award or, to the extent not previously exercised, settled or vested, authorize the grant of new Incentive Awards in substitution for surrendered Incentive Awards; provided, however that the amended or modified terms are permitted by the Plan as then in effect and that any Participant whose rights under a previously granted Incentive Award are adversely affected by such amended or modified terms has consented to such amendment or modification.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">19.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Adjustment of Performance-Based Awards</span>.&#160;&#160;The Committee may amend or modify the vesting criteria (including any performance objectives or performance periods) of any outstanding Incentive Awards based in whole or in part on the financial performance of the Company (or any Subsidiary or division, business unit or other sub-unit thereof) in recognition of unusual or nonrecurring events (including the events described in Section 4.3(a) of the Plan) affecting the Company or the financial statements of the Company or of changes in applicable law, regulations or accounting principles, whenever the Committee determines that such adjustments are appropriate in order to prevent unintended dilution or enlargement of the benefits or potential benefits intended to be made available under the Plan.&#160;&#160;The determination of the Committee as to the foregoing adjustments, if any, will be final, conclusive and binding on Participants under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">19.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Stockholder Approval</span>.&#160;&#160;No amendments to the Plan will be effective without approval of the Company&#8217;s stockholders if stockholder approval of the amendment is then required pursuant to Section 422 of the Code, the rules of the primary stock exchange or stock market on which the Common Stock is then traded, applicable U.S. state corporate laws or regulations, applicable U.S. federal laws or regulations, or the applicable laws of any foreign country or jurisdiction where Incentive Awards are, or will be, granted under the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">19.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Incentive Awards Previously Granted</span>.&#160;&#160;Notwithstanding any other provision of the Plan to the contrary, no termination, suspension or amendment of the Plan may adversely affect the rights of a Participant under a previously granted Incentive Award without the consent of the affected Participant; provided, however, that this sentence will not impair the right of the Committee to take whatever action it deems appropriate under Sections 3.2, 4.3, 13, 15, 18 or 19.5 of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">19.5&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Amendments to Conform to Law</span>.&#160;&#160;Notwithstanding any other provision of the Plan to the contrary, the Committee may amend the Plan or an Incentive Award Agreement, to take effect retroactively or otherwise, as deemed necessary or advisable for the purpose of conforming the Plan or an Incentive Award Agreement to any present or future law relating to plans of this or similar nature, and to the administrative regulations and rulings promulgated thereunder.&#160;&#160;By accepting an Incentive Award under the Plan, a Participant agrees to any amendment made pursuant to this Section 19.5 to any Incentive Award granted under the Plan without further consideration or action.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-24</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">20.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Effective Date and Duration of the Plan</span>.&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 27pt;">The Plan will be effective as of the Effective Date and will terminate at midnight on the day before the date which is ten years from the earlier of the date of its adoption by the Board and the date of its approval by the shareholders and may be terminated prior to such time by Board action.&#160; No Incentive Award will be granted after termination of the Plan but Incentive Awards outstanding upon termination of the Plan will remain outstanding in accordance with their applicable terms and conditions and the terms and conditions of the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">21.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Miscellaneous</span>.&#160;&#160;&#160;</p>
			</td>
		</tr>

</tbody></table>

<p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.1&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Usage</span>.&#160;&#160;In the Plan, except where otherwise indicated by clear contrary intention, (a) any masculine term used in the Plan also will include the feminine, (b) the plural will include the singular, and the singular will include the plural, (c) &#8220;including&#8221;&#160;(and with correlative meaning &#8220;include&#8221;) means including without limiting the generality of any description preceding such term, and (d) &#8220;or&#8221;&#160;is used in the inclusive sense of &#8220;and/or&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.2&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Unfunded Plan</span>.&#160;&#160;Participants will have no right, title or interest whatsoever in or to any investments that the Company or its Subsidiaries may make to aid it in meeting its obligations under the Plan.&#160;&#160;Nothing contained in the Plan, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Participant, beneficiary, legal representative, or any other individual.&#160;&#160;To the extent that any individual acquires a right to receive payments from the Company or any Subsidiary under the Plan, such right will be no greater than the right of an unsecured general creditor of the Company or the Subsidiary, as the case may be.&#160;&#160;All payments to be made hereunder will be paid from the general funds of the Company or the Subsidiary, as the case may be, and no special or separate fund will be established, and no segregation of assets will be made to assure payment of such amounts except as expressly set forth in the Plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.3&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Relationship to Other Benefits</span>.&#160;&#160;No payment under the Plan will be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare, or benefit plan of the Company or any Subsidiary unless provided otherwise in such plan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.4&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Fractional Shares</span>.&#160;&#160;No fractional shares of Common Stock will be issued or delivered under the Plan or any Incentive Award.&#160;&#160;The Committee will determine whether cash, other Incentive Awards or other property will be issued or paid in lieu of fractional shares of Common Stock or whether such fractional shares of Common Stock or any rights thereto will be forfeited or otherwise eliminated by rounding up or down.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.5&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">No Representations or Warranties Regarding Tax Effect</span>.&#160;&#160;Notwithstanding any provision of the Plan to the contrary, the Company, its Subsidiaries, the Board and the Committee neither represent nor warrant the tax treatment under any federal, state, provincial, local, foreign or other laws of any Incentive Award granted or amounts paid to any Participant under this Plan, including when and to what extent such Incentive Award or amounts may be subject to tax, penalties and interest.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-25</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000"/>
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#160;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.6&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Governing Law; Venue</span>.&#160;&#160;Except to the extent expressly provided in the Plan, the validity, construction, interpretation, administration and effect of the Plan and any rules, regulations and actions relating to the Plan will be governed by and construed exclusively in accordance with the laws of the State of Delaware, notwithstanding the conflicts of laws principles of any jurisdictions.&#160;&#160;Unless otherwise provided in an Incentive Award Agreement, recipients of an Incentive Award under the Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts of the State of Delaware (including the Court of Chancery) to resolve any and all issues that may arise out of or relate to the Plan or any related Incentive Award Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.7&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Waiver of Jury Trial</span>. By accepting or being deemed to have accepted an Incentive Award under the Plan, each Participant waives (or will be deemed to have waived), to the maximum extent permitted under applicable law, any right to a trial by jury in any action, proceeding or counterclaim concerning any rights under the Plan or any Incentive Award, or under any amendment, waiver, consent, instrument, document or other agreement delivered or which in the future may be delivered in connection therewith, and agrees (or will be deemed to have agreed) that any such action, proceedings or counterclaim will be tried before a court and not before a jury.&#160;&#160;By accepting or being deemed to have accepted an Incentive Award under the Plan, each Participant certifies that no officer, representative, or attorney of the Company has represented, expressly or otherwise, that the Company would not, in the event of any action, proceeding or counterclaim, seek to enforce the foregoing waivers.&#160;&#160;Notwithstanding anything to the contrary in the Plan, nothing herein is to be construed as limiting the ability of the Company and a Participant to agree to submit any dispute arising under the terms of the Plan or any ward to binding arbitration or as limiting the ability of the Company to require any individual to agree to submit such disputes to binding arbitration as a condition of receiving an Incentive Award hereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.8&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Successors</span>.&#160;&#160;All obligations of the Company under the Plan with respect to Incentive Awards granted hereunder will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation or otherwise, of all or substantially all of the business or assets of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.9 &#160;&#160;&#160; <span style="text-decoration: underline; ">Construction</span>.&#160;&#160;Wherever possible, each provision of the Plan and any Incentive Award Agreement evidencing an Incentive Award granted under the Plan will be interpreted so that it is valid under the applicable law.&#160;&#160;If any provision of the Plan or any Incentive Award Agreement evidencing an Incentive Award granted under the Plan is to any extent invalid under the applicable law, that provision will still be effective to the extent it remains valid.&#160;&#160;The remainder of the Plan and the Incentive Award Agreement also will continue to be valid, and the entire Plan and Incentive Award Agreement will continue to be valid in other jurisdictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">21.10&#160;&#160;&#160;&#160; <span style="text-decoration: underline; ">Delivery and Execution of Electronic Documents</span>.&#160;&#160;To the extent permitted by applicable law, the Company may:&#160;&#160;(a) deliver by email or other electronic means (including posting on a Web site maintained by the Company or by a third party under contract with the Company) all documents relating to the Plan or any Incentive Award hereunder (including prospectuses required by the Securities and Exchange Commission) and all other documents that the Company is required to deliver to its security holders (including annual reports and proxy statements), and (b) permit Participants to use electronic, internet or other non-paper means to execute applicable Plan documents (including Incentive Award Agreements) and take other actions under the Plan in a manner prescribed by the Committee.</p>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: justify; text-indent: 27pt;">&#160;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">A-26</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>crvo-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 08:13PM UTC 2025-04-29--><xsd:schema xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:crvo="http://www.diffusionpharma.com/20241231" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.diffusionpharma.com/20241231">
  <xsd:import namespace="http://xbrl.sec.gov/dei-sub/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd"/>
  <xsd:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"/>
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xsd:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xsd:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd"/>
  <xsd:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd"/>
  <xsd:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd"/>
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crvo-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crvo-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crvo-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="statement-document-and-entity-information" roleURI="http://www.diffusionpharma.com/20241231/role/statement-document-and-entity-information">
        <link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>crvo-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 08:13PM UTC 2025-04-29--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsOnly" xlink:type="simple"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember" xlink:label="ecd_AllAdjToCompMember" xlink:type="locator"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>crvo-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 08:13PM UTC 2025-04-29--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>crvo-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome XBRL - 08:13PM UTC 2025-04-29--><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>capvni.jpg
<TEXT>
begin 644 capvni.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M<RJ\$K$KL/EY4C+)GV(SC-7/"NE^9X%.EWD-Q;AY+E"KJT;JK3.5(SST((-
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M+\3:KX?E:31+W4K&VEFD22Y#L-XP5(X_OD!0/0<]@" =$^H6<=T+:2[@6<D
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ML:"1XE.YU4G 8J.0N>_3K7*S:MH&J>)K.XT^_M[B\TN.9+2T@==T\C)@J/\
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MC?D/\*-C?\]&_(?X4 /IDT9FA:,2/'N_B0X(HV-_ST;\A_A1L;_GHWY#_"@
MABCMX(X85"1QJ%11T  P!3Z9L;_GHWY#_"C8W_/1OR'^% #Z*9L;_GHWY#_"
MC8W_ #T;\A_A0 ^BF;&_YZ-^0_PHV-_ST;\A_A0 ^BF;&_YZ-^0_PHV-_P ]
M&_(?X4 /HIFQO^>C?D/\*-C?\]&_(?X4 /HIFQO^>C?D/\*-C?\ /1OR'^%
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M('BR(B0J(ZX?!+D'*I72:=:?8-+M;3?O^SPI%NQC=M4#./PH L4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJPHHHKV3Q HHHH U_"1V^-=$)SQJ$!X&?^6BU]1_:4_NR_\ ?IO\*^7?"/\
MR.VA_P#81M__ $8M?4]?-9U_$AZ'U.1_PY^I%]I3^[+_ -^F_P */M*?W9?^
M_3?X5+17@GOD7VE/[LO_ 'Z;_"C[2G]V7_OTW^%2T4 1?:4_NR_]^F_PH^TI
M_=E_[]-_A4M% $7VE/[LO_?IO\*/M*?W9?\ OTW^%2T4 1?:4_NR_P#?IO\
M"C[2G]V7_OTW^%2T4 1?:4_NR_\ ?IO\*/M*?W9?^_3?X5+10!%]I3^[+_WZ
M;_"C[2G]V7_OTW^%2T4 ?*_BT[O&NMD9YU"<\C'_ "T:LBMCQ=_R.VN?]A&X
M_P#1C5CU]_2_AQ]$?G=7^)+U84445H9A1110!]%_"R=4^&FE*1)D>=TC8C_7
M/W KK_M*?W9?^_3?X5RGPI_Y)EI7_;;_ -'/785\)BO]XGZO\S[_  G^[T_1
M?D1?:4_NR_\ ?IO\*/M*?W9?^_3?X5+17.=)%]I3^[+_ -^F_P */M*?W9?^
M_3?X5+10!%]I3^[+_P!^F_PH^TI_=E_[]-_A4M% $7VE/[LO_?IO\*K:C;V&
MKZ;/I^IVINK2X0QRPRP,5=3V/%7J* /%[G3_ !%\&+J;4?"<-QK?@?>&N-#(
ME:XTU""6DA9LY7<2Q!]>1UD'IWAWQ=HGBS1TU3P[>F^LW9D$B0N,,IP005!!
M]B.A!Z$5M5Y5XB^&^L>%M8G\4_!QK;3[Z6-4O-!:-4L[X+C;A<J(V'/((SDX
M*Y;< >H?:4_NR_\ ?IO\*/M*?W9?^_3?X5R_P_\ B/H_Q$TVYGTN.XM;JR<1
MWEE=)MD@8YQG'4$JV#['('2NMH B^TI_=E_[]-_A1]I3^[+_ -^F_P *EK%\
M2>*],\*6\$^KM*J3N43RTW<@9JH0E.7+%79,YQA'FD[(U?M*?W9?^_3?X4?:
M4_NR_P#?IO\ "N(_X7'X3_Y[77_@.:/^%Q^$_P#GM=?^ YKI^IXG^1_<<WUW
M#?SK[SM_M*?W9?\ OTW^%'VE/[LO_?IO\*XC_A<?A/\ Y[77_@.:/^%Q^$_^
M>UU_X#FCZGB?Y']P?7<-_.OO.W^TI_=E_P"_3?X4?:4_NR_]^F_PKB/^%Q^$
M_P#GM=?^ YK3T#XB:#XDU1=/TR2=IV0N \148'7FIEA:\5S2@[>A4<7AY-1C
M--OS.D^TI_=E_P"_3?X4?:4_NR_]^F_PJ6BN8Z2+[2G]V7_OTW^%'VE/[LO_
M 'Z;_"I:* (OM*?W9?\ OTW^%'VE/[LO_?IO\*EHH B^TI_=E_[]-_A1]I3^
M[+_WZ;_"I:* (OM*?W9?^_3?X4?:4_NR_P#?IO\ "I:* &HXD7*A@/\ :4C^
M=<SX^UG6-!T*"]T6*,H+J-;R=XO-^SPDX+^6&4L,X!P20"2 <5U%9FN^'=.\
M26:6NJQ2/&CAU,4[Q-]-R$$@]QT- '/^(/&%Y86,]_8RV$5G#+(@END8HQB0
MLZEPPVER-JG!QM)PVX*-+5-4U5;Z)=.>TMX5CA,R7-NTCLT[F-,$.H4(PW,"
M#N' *]:O/X>T^6X$DT;2(EPMS' 6(B250 &V#@X*JPW9PP##!YJ.3PSITMY#
M=DW?VB%G>-S>2L S$MRK,5<*22BL"$_A H NZ==M>V0ED14D#O&ZJV0&1RAP
M<#C*FK50VEJMG;+"C,^"S,[XRS,2S$XP.22> !Z 5-0 4444 %%%% !1110
M4444 %%%% !1110 4444 <?\5O\ DF6J_P#;'_T<E?.%?1_Q6_Y)EJO_ &Q_
M]')7SA7U63?[N_7]$?)9U_O$?3]6%%%%>R>(%%%% &QX1_Y';0_^PC;_ /HQ
M:^IZ^6/"/_([:'_V$;?_ -&+7U/7S6=?Q(>A]3D?\.?J%%%%>">^%%%% !11
M10 4444 %%%% !1110 4444 ?+'B[_D=M<_["-Q_Z,:L>MCQ=_R.VN?]A&X_
M]&-6/7W]+^''T1^=U?XDO5A1116AF%%%% 'T?\*?^29:5_VV_P#1SUV%<?\
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MAS^[!7TRFF-&D61D4N@(5B.5!ZX/X"G4 %%%% !1110 4444 %%%% !1110
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M/_1C5CU]_2_AQ]$?G=7^)+U84445H9A1110!]%_"QIA\--*V1QE?WV"7(/\
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MU]3U\UG7\2'H?4Y'_#GZA1117@GOA1110 4444 %%%% !1110 4444 %%%%
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M_OT?_BJEHH BVW'_ #UB_P"_1_\ BJ-MQ_SUB_[]'_XJI:* (MMQ_P ]8O\
MOT?_ (JC;<?\]8O^_1_^*J6B@"+;<?\ /6+_ +]'_P"*HVW'_/6+_OT?_BJE
MHH ^5_%N?^$UUO<03_:$^2!C_EHU9%;'B[_D=M<_["-Q_P"C&K'K[^E_#CZ(
M_.ZO\27JPHHHK0S"BBB@#5L_^/1/Q_G4]06?_'HGX_SJ>OS+&_[U5_Q/\SSI
M_$PHHHKD)"BBB@#V+X1"4^$KKRW11]N?AD)_Y9Q^XKO-MQ_SUB_[]'_XJN'^
M#_\ R*%U_P!?S_\ HN.N]KT:?P(_2LK_ -RI^A%MN/\ GK%_WZ/_ ,51MN/^
M>L7_ 'Z/_P 54M%:'HD6VX_YZQ?]^C_\51MN/^>L7_?H_P#Q52T4 1;;C_GK
M%_WZ/_Q5&VX_YZQ?]^C_ /%5+10!%MN/^>L7_?H__%5Y=\<1*-%TOS'1A]H?
M&U"/X?J:]6KRSXZ?\@32O^OA_P#T&N_+O]ZA_70\_,O]TG_74\3HHHK[0^'"
MBBB@ JS8_P#'T/H:K59L?^/H?0UQ9A_NE3T9%3X6:=%%%?FAYX4444 %=/\
M#C<?B!INP@-^]P2,C_5/7,5U/PV_Y*%IO_;7_P!%/5P^)'7@?][I?XE^:/==
MMQ_SUB_[]'_XJC;<?\]8O^_1_P#BJEHKTC]0(MMQ_P ]8O\ OT?_ (JC;<?\
M]8O^_1_^*J6B@!J!PO[QE8^JKC^IK/\ $%A+JFA7-E#%:S&="C1W0.QP>V1G
M![@X/3I6E10!P[>$]77P==>'&G%W+<PQ'^T9I3C<BQ(58'+Y(3(/S9YW$'&[
M0M?#FI6WCFZUXW<#17",AA4%2RE8@JMU'R%)"&ZMYF" %S7444 <:?"E^CO
MCPM;MY$$)W$>3#'.TI8GJ7(95  P-F<\XKLJ** "BBB@ HHHH **JZEJ-MI.
MGR7EZY6*/&=JEF8DX  ')))  JO_ ,)#I@>!9;GR3/#YR-*C(NW&X@L1M#
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M:26"*%@1'C"%B&X7J=[9[<\ 5>HH YF7P>@E"6UTXMY'C$RRX;9#'(TBQ1
M!06;EFW':,>A7IJ** "BBB@ HHHH **** "BBH+Z\CT_3[B\N QBMXFE?8N3
MA1DX'X4 3T5AVOBFWGL;*Y>UG070#, 4<0J6"J[$-RI)&"N>N>@)&Y0 4444
M %%%% ''_%;_ ))EJO\ VQ_]')7SA7T?\5O^29:K_P!L?_1R5\X5]5DW^[OU
M_1'R6=?[Q'T_5A1117LGB!1110!)!_Q\1_[P_G6Q6/!_Q\1_[P_G6Q7QW$7\
M6'H<E?=!1117S!SA1110 5]1U\N5]1UUX?J?6\-_\O?^W?U"BBBNH^N"BBB@
M HHHH **** /ECQ=_P CMKG_ &$;C_T8U8];'B[_ )';7/\ L(W'_HQJQZ^_
MI?PX^B/SNK_$EZL****T,PHHHH U;/\ X]$_'^=3U!9_\>B?C_.IZ_,L;_O5
M7_$_S/.G\3"BBBN0D**** /9O@__ ,BA=?\ 7\__ *+CKO:X+X/_ /(H77_7
M\_\ Z+CKO:]&G\"/TK*_]RI^@4445H>B%%%% !1110 5Y9\=/^0)I7_7P_\
MZ#7J=>6?'3_D":5_U\/_ .@UWY=_O4/ZZ'GYE_ND_P"NIXG1117VA\.%%%%
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M$L>\O[;>] #OLEO_ ,^\7_? H^R6_P#SPB_[X%<M:6'EQQ V,Y ,9B,D.?+
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
:4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>capvtsr.jpg
<TEXT>
begin 644 capvtsr.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M0X R2K$;6_ G]*TJY/Q%%INL^*;'2I+]8+Y+6>2!H9 )H)-T15@/7 ;CN U
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M61@9^3CVH [VBLSPVEU%X;LDOE=9ECQB3[P4$[=W?.W&<\YZUI-N_A('U&:
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MH<5O+!%HNGI#-CS8UM4"R8.1N&,'';-6;'2[#2XVCTRQMK-'.YEMX5C#'U(
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M]3@ 9]A3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_OZ?_B: ):*BW7'_ #RB_P"_I_\ B:-UQ_SRB_[^G_XF@"6BHMUQ_P \HO\
MOZ?_ (FC=<?\\HO^_I_^)H EHJ+=<?\ /*+_ +^G_P")HW7'_/*+_OZ?_B:
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MQ_SRB_[^G_XF@"6BHMUQ_P \HO\ OZ?_ (FC=<?\\HO^_I_^)H EHJ+=<?\
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M'_/*+_OZ?_B:-UQ_SRB_[^G_ .)H EHJ+=<?\\HO^_I_^)HW7'_/*+_OZ?\
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M_P#B:-UQ_P \HO\ OZ?_ (F@"6BHMUQ_SRB_[^G_ .)HW7'_ #RB_P"_I_\
MB: ):*BW7'_/*+_OZ?\ XFC=<?\ /*+_ +^G_P")H EHJ+=<?\\HO^_I_P#B
M:-UQ_P \HO\ OZ?_ (F@#E/BM_R3+5?^V/\ Z.2OG"OHOXIM,?AIJN^.,+^Y
MR0Y)_P!<GM7SI7U63?[N_7]$?)9U_O$?3]6%%%%>R>(%%%% !7TW\/?^2>Z-
M_P!>X_F:^9*^E_A^TX^'^C[8XR/LXP3(1W/M7B9S_!CZ_H>[DG\:7I^IRWB/
MX9ZEH.L77BOX1W,&D:J\*BZT<PI]CU((P.W' B8@$;AC.>J%F<[_ ,//B/8>
M/;&=%M;C3-7L=JWVFW:A)(F*@EE&<E,D@$@'CD#BNMW7'_/*+_OZ?_B:\_\
MB-\*H?'=]9:U;W4FE:_I:?Z#>02@J&#!TW@H20K9(P1C<>M?+GU9Z+17F/A#
MXI:E)K4_ASXE:;9>&-?18WMTEN-D-ZK8'[ISN5FW'&T,3S@9*MCTG=<?\\HO
M^_I_^)H EHJ+=<?\\HO^_I_^)HW7'_/*+_OZ?_B: ):*BW7'_/*+_OZ?_B:-
MUQ_SRB_[^G_XF@"6BHMUQ_SRB_[^G_XFC=<?\\HO^_I_^)H EHJ+=<?\\HO^
M_I_^)HW7'_/*+_OZ?_B: ):*BW7'_/*+_OZ?_B:-UQ_SRB_[^G_XF@"6BHMU
MQ_SRB_[^G_XFC=<?\\HO^_I_^)H EHJ+=<?\\HO^_I_^)HW7'_/*+_OZ?_B:
M ):*BW7'_/*+_OZ?_B:-UQ_SRB_[^G_XF@"6BHMUQ_SRB_[^G_XFC=<?\\HO
M^_I_^)H EHJ+=<?\\HO^_I_^)HW7'_/*+_OZ?_B: ):*BW7'_/*+_OZ?_B:-
MUQ_SRB_[^G_XF@"6BHMUQ_SRB_[^G_XFC=<?\\HO^_I_^)H EHJ+=<?\\HO^
M_I_^)HW7'_/*+_OZ?_B: ):*BW7'_/*+_OZ?_B:-UQ_SRB_[^G_XF@"6BHU:
M<L-T<8'<B0G^E24 %%><WT[6_P 0-<M)M5EG%]IWF1!=2-M%;;"%\F0KEH<D
MY$J 'YV!!(7-3PSJ-U<'33JVHWL-]9I!#;VLE^S+.#<213.3P+D;$X=@V%57
MX+%B >HT5Y[XGU:6";4-1T?4YFO50Q11Q7)>-+7[/O,ZPY*$A\D2;2>-N2.*
MZ?PHX.D21PSR75I#<21VMS+.T[31@\$R,26P2RY)_AH VZ*** "BBB@!J1I&
MI6-50$EB%&.2<D_B233J** &1P10M(T,21M*^^0JH!=L 9/J< #/L*?110 4
M444 %%%% !1110!X1\</^1VL_P#L')_Z,DKS>O2/CA_R.UG_ -@Y/_1DE>;U
M]O@?]VAZ'PN8?[U/U"BBBNPX0HHHH [#X4_\E-TK_MM_Z)>OH^OG#X4_\E-T
MK_MM_P"B7KZ/KY7.?]X7I^K/K<E_W>7K^B"BBBO&/;"BBB@ HHHH **** "B
MBB@ HHHH **** ./^*W_ "3+5?\ MC_Z.2OG"OH_XK?\DRU7_MC_ .CDKYPK
MZK)O]W?K^B/DLZ_WB/I^K"BBBO9/$"BBB@ KZ;^'O_)/=&_Z]Q_,U\R5]-_#
MW_DGNC?]>X_F:\3.?X,?7]#W<D_C2]/U.DHHHKY<^K,/QCX0TGQQX9N=$UV
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M1OC:7/C6T\Q54_V>G"MG_EI)["O.:^WP/^[0]#X7,/\ >I^H4445V'"%%%%
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M[OU_1'R6=?[Q'T_5A1117LGB!1110 5]-_#W_DGNC?\ 7N/YFOF2OIOX>_\
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M -L?_1R5\X5]5DW^[OU_1'R6=?[Q'T_5A1117LGB!1110 5]-_#W_DGNC?\
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MXR&V_+GKCCI3K6PL[%[A[*T@MVN93-.T480RR$ %VQ]YL <GGBK%% !1110
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M ./AO]W^HJI5O3_^/AO]W^HKS\S_ -SJ>AG4^!FC1117YN< 4444 %:GA?\
MY&_1_P#K^@_]&"LNM3PQQXNT?O\ Z=#_ .C!51W1K0_BQ]5^9]'T4S>W_/-O
MS'^-&]O^>;?F/\:],_5A]%,WM_SS;\Q_C1O;_GFWYC_&@!]%-#$G[C#W./\
M&G4 5&U2P35DTM[VW74)(C.EJ90)&C!P7"]2,\9IC:WI26UM</J=FL%W,(+>
M4W"A9I22 B'.&8D$ #G@USNJZ3=R?$&UN[;3OM-C-;E+_P"T1QO$RA' V;FR
MK_,%/!!5CTY-5?#?AVZL/#_A^";3;VQO-.FDV"&Y18H8VFRRNBR;7!CX PVW
MM@\T =E)?V<-]!937<$=W<*S0P-(!)*%QN*KU(&1G'3(IUM=VU[$9;.XBN(U
M=HR\3A@&5BK+D=PP(([$$5RFJ:1JM[XDN+FRMGM7GCA2*_9T/D"/SP00&SSY
MG& ?OG.,5-X$T6]T:SN%N[-;"-TMD2V$BOAH[=(V?*DCG8 .^$!.,XH ZNBB
MB@ ILD:2Q-'*BNC@JRL,A@>H(IU% %*+1M,ABMHHM/M52T8M;J(5Q"3U*\?*
M?I2-HFE/!/ ^F6;17,GFSQFW0K*^<[F&.3GN:O44 4#H>EM(TCZ?;.S3"X)>
M(-B0  .,]"  ,BIFTVQ;[3NLK<_:QBXS$O[[C'S\?-QQS5FB@!%544*@"JHP
M !@ 4M%% !1110 4444 >$?'#_D=K/\ [!R?^C)*\WKTCXX?\CM9_P#8.3_T
M9)7F]?;X'_=H>A\+F'^]3]0HHHKL.$**** .P^%/_)3=*_[;?^B7KZ/KYP^%
M/_)3=*_[;?\ HEZ^CZ^5SG_>%Z?JSZW)?]WEZ_H@HHHKQCVPHHHH **** "B
MBB@ HHHH **** "BBB@#C_BM_P DRU7_ +8_^CDKYPKZ/^*W_),M5_[8_P#H
MY*^<*^JR;_=WZ_HCY+.O]XCZ?JPHHHKV3Q HHHH *^F_A[_R3W1O^O<?S-?,
ME?3?P]_Y)[HW_7N/YFO$SG^#'U_0]W)/XTO3]3I****^7/JPHHHH **** "B
MBB@ HHHH **** "BBB@ KY8\7?\ ([:Y_P!A&X_]&-7U/7RQXN_Y';7/^PC<
M?^C&KW<E_B3]#Y_//X</4QZK7VG6NHPF.\@208(5B/F7/H>U6:*^EE%25I*Z
M/F8RE%\T79G/1WE[X>D,>L22WMD5'EW:IDQGH0_U)X.3_AT".LD:O&P=& *L
MIR"/44DD:2QM'(H9'!5E(X(/:L"6TN_#K2W.F;9--5=TMHQ)9.F60GVYY/K[
M5R^_A_.'XK_-?BO,Z_<Q/E/\'_D_P?D=#5O3_P#CX;_=_J*RM.U&VU2S%S:.
M60G!!&"IQT/OS6KI_P#Q\-_N_P!16&8R4L#.47=6."M&4$XR5F:-%%%?G)YP
M4444 %:GA?\ Y&_1_P#K^@_]&"LNM3PO_P C?H__ %_0?^C!51W1K0_BQ]5^
M9]'T445Z9^K!1110 4444 %%%% !1110 4444 %%%4M82631;Q+>\6QE:%@E
MR_2(X^]^% %VBO.HM?>#1]%AB?4E5=042R*DMPL@WD%!*H.X<YP?F/ ]15@7
M9?4;.VEU2Y%G>B.74'^UN/)E*RML#@YB!95&T$8V 8&XY .]HKC]0U&2:'3Q
M+>R1,FGO<;8YC&9+E53:C$$9^\QV'AL\@XJD-5OV67?<3#[5<"._;S6'V%?M
M'EA5P?W>8_XA@\;\]Z .]HK,\-W-Q=^&[*:\+-*T>"[C!D ) <^[ !OQK1=R
M@&V-G_W2./S- #J*B\Y_^?:7\U_QH\Y_^?:7\U_QH EHJ+SG_P"?:7\U_P :
M/.?_ )]I?S7_ !H \-^.'_([6?\ V#D_]&25YO7HWQM8MXUM"R,G_$O3AL?\
M])/0UYS7V^!_W:'H?"YA_O4_4****[#A"BBB@#L/A3_R4W2O^VW_ *)>OH^O
MF_X6,5^)>E$*6/[[@8R?W+^M?1?G/_S[2_FO^-?*YS_O"]/U9];DO^[R]?T1
M+147G/\ \^TOYK_C1YS_ //M+^:_XUXQ[9+147G/_P ^TOYK_C1YS_\ /M+^
M:_XT 2T5%YS_ //M+^:_XT><_P#S[2_FO^- $M%1><__ #[2_FO^-'G/_P ^
MTOYK_C0!+147G/\ \^TOYK_C1YS_ //M+^:_XT 2T5%YS_\ /M+^:_XT><__
M #[2_FO^- $M%1><_P#S[2_FO^-'G/\ \^TOYK_C0!RGQ6_Y)EJO_;'_ -')
M7SA7T7\4Y6;X::J#!(H_<\DK@?OD]#7SI7U63?[N_7]$?)9U_O$?3]6%%%%>
MR>(%%%% !7L/A;XHV>C>%K#3Y=.GD>WB"%U< 'FO'JU[;_CUC^E?/9_-QH1:
M[_HRXXNMA7S4G9L]A_X7)8?] JY_[^+1_P +DL/^@5<_]_%KR.BOCO;3+_MS
M'?S?@CUS_A<EA_T"KG_OXM'_  N2P_Z!5S_W\6O(Z*/;3#^W,=_-^"/7/^%R
M6'_0*N?^_BUM>%?'UKXJU22RM[*:W:.$S%G8$$!E&./]ZO":[OX1,5\6W15&
M?_07X7'_ #TC]35PJS<DF=N!S;%UL3"G.6C?9'M%%1><_P#S[2_FO^-'G/\
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MK+K4\+_\C?H__7]!_P"C!51W1K0_BQ]5^9]'T445Z9^K!1110 4444 %%%%
M!1110 4444 %%%4]6:=='NC9W,-I<>4WE3S_ '$;'!/MF@"Y17(Z?JEY<>'K
M&:*_F2[2<+<QS[&4*KCSBS;1\JH20P(ZKW.*2/6+^36-+LSJ#".^BCDF<)'F
M%BLI"+\N!DICYLGY".O- '7T5S-UJU[Y%DRS^2SZ7+>$*B_O9%"';R#Q\Q)
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M]IW65N?M8Q<9B7]]QCY^/FXXYJS10 BJJ*%0!548  P *6BB@ HHHH ****
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M/VBXNH8X"J I!%(^T.F1]X @$,#\Q!Y!P0#MJ*S?#]_+J>@6MW<;?-=2'*C
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MT65XFC2HN-25G?\ 1'S6:X6M6KJ5.-U;]6>>T5Z%_P *5\4?\]-/_P"_[?\
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M"LY89PO7!KV,JK4Z,Y.H[:'BYM0J5H15-7U/+J*]"_X4KXH_YZ:?_P!_V_\
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M_C1YS_\ /M+^:_XUZ!^C$M%1><__ #[2_FO^-'G/_P ^TOYK_C0!+14:RN6
M,$BCU)7C]:DH **YWQW%<3^$YXK2X:&5G3Y4N&@>8!@3&LBD,I(!Y'\LUS^B
MZLNHWFB:Q:ZAJ)-W<1V:6UQ<Y$L)M#*=\:GRRX;+>8HR=N-VTX(!Z%17FFOZ
MA=)XD: ZI>6@U&Z^R74*7# 0P+-;(KIS^Z9A-C<FT_OP<Y52.Y\/Y&C)'YLD
MRPRRPH\LAD=D21D7+G)8X4?,22>I)- &E1110 4444 %%%% !5--(TY'N&6Q
MMP;G'G?NQA\>H^O/UJY10 V.-(HUCB141 %55& H'0 4ZBB@ HHHH **** "
MBBB@ HHHH *J:G?G3;%KD6ES=[<DQVRJ6P 23R0.@]?89)JW535+2>^L'MK>
MX6W\SY9&,>_*?Q*.1C(XSV[<\T 4U\26LL\\=M#<7 B7Y7B0$3/A247G.X!U
MSD #G)^5L(OB:T(L6-O=+'>2>49#%\L$FXJ$<YZ[E*_+D ]2 03';>'Y;.XD
MF@NX@?,DFB5H#M21P W1AE>&P.,;NIQ4J:1=!;%'NK9DM&WE?LI&]O[WW^N"
M?7DY[4 :]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M &*/$\#+<+'87SW$$BI]E\M5DD#*75U#,!@JK'!(;@@@'BI(_$,,V6AM+N2)
MH//MY512+E?E^X,[@<NH^8+USTYI%TB\$[7'VNV\\S^<'^RMR=C( 1YG("D
M8QTSW-,L=#N;&".W%Y!-;PVJVT*2VN2  -Q8AOF+8Y& .!@#G(!IV5TM]917
M*(\8E4-LD&&7V..,CV)'H34]4])TY-)TN&RB;<D6=N%P "2< =@,X ] *N4
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MW:) !Q*>5 Y&2"2<UI/A_<3:'_9DNK0M&8MI<69W!]C1AA^\X&USD=SW&<4
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M%8E)F1E \OS#(1@;5/*D]<8S5RT\/SQWEK/>WRW)T]'CL0(-FP,-N9/F.]L
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
5HH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X0 B17AI9@  34T *@    @  0$2  ,
M   !  $       #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R
M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M            ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ***.E !17/?$GQ!JWASP%K&HZ'8PZKJ=E:2SVMG)+Y*W4BJ2L>_
M!V[B,9P<9KA_V*_VG1^U]^S5X<^( TB30)=;242V$DPF^SR12O$X#@#<-R'!
MP#ZBM/92]G[3H=L,OKRPDL=&/[N,E!NZTE)-K3?51EKY,]9HKY-^*_\ P49\
M0>"=+^.>KZ%X(TSQ+HGP2NK:SNI$UDP7%_(8HY;H!#$53R5D_O-NVD8!KZ-^
M''Q"7XB?#S1O$4<#V=MK6GP:DB2D;H8Y8ED )'!(#<D<5=3#5*:YI+3_ (%S
MJQV18[!T(XC$0M&3LM4W?EC.S2=U[LXO5=?)G2T5\<>(?^"HVM:)^Q]=_&F#
MP%INI>&(/$[Z5'%;:]^]ETU;IK47^3"%!:11B+)^5@2W6OJ35?'<.A>$KO6K
MV>&TL;&SDOII)?E6.)4WDL>P Y_"BIAJD+<RW=OF5F'#^/P48RQ%.UYR@K.+
M]^'+S1T>ZYX_?H='17Q_??\ !2[Q-H/[//PC^)6H?#JU.@_$_6[73)EL]<$L
MND0W;[;6?YHE$I;#%E&-O')SQ]$?&_XQ0? WX/\ BKQAJ)MS9^%]+N=2E$DG
MEQN(HV8+NP<9("YP<%OS<\-4BTFMW9>J#&9!CL-.%.M#6<I0C9J5Y1?+)7BV
MKI]][IK1H[BBOEW4/V]_$WA.\^ HU_P+96MI\;YDLS-9ZQYYT2XEC$T"$-$O
MG!HVR6&W:588. 3ZA^U9^T='^RW^SQXK\>7=O!?#P[:>=!:2S?9Q>3,ZI'#O
MP=I=F"@X/7I2EAJBE&-OBT7WV"KP_CX5:%!PO*LVH6<7=J;ANFU\2:U]=K,]
M2HKYUU3]LWQ)X+_:<^%GPZ\1^#+6UC^*&DW%U#JECJGVE+"]MXC+-;%&B0L@
M79B3(SO^[P:ZO]L#]IZ7]F'X/-XDMM.LM8U*[U.QT;3=.N+S[(M]=7=PD*+Y
MNU]NT,SGY3PC4/#U%*,6M]OR%+(,<JM"CR7E65X6<7S+FE#=-KXHM.^UM3U^
MBO!_A/\ M>:QXP_;$\9_!_7O"<>CWWA?1K;7;;4[;4!<V^H6\S!/NE%9&#EE
MYSG83QQG4_:!_:@O/A#\6OACX.TK2M-UG5?B3JEQ:)'=7YM#9VMO T\UR (W
M,FU0 $^7)8#<,T?5JG/R6UM?Y$RR/&QQ$<*X>]*'M%K&W)R<_->]K<NKZK:U
MSV2BO#/V<_VO-0^-?QZ^*OP_U3PRF@ZE\,+VWA:XCOUNH=3AN$=X95&U6C)1
M0Q4YQN'-:/Q-_:6O_"O[5/@3X8:/IVEZA=^*M-O=8U">YO6@;2[2W,:AUC",
M96=W(5<J/D;)XH>'J*?(UK:_RW"KD>-IXEX6</?4/:/5-<G)[3FNG:W+K^&Y
M[%17A?['W[7>I_M+WOC_ $W5_"C>%=9^'?B2;PY?0"\%W%.R*&25'"K@,K X
M([BK>O?M2:C_ ,-?I\*-#T;2]1FM/"[>(]4OI]2:%K$M*T5O (A&V[S' )8L
M-JY."< DL/-2<&M4.MD6.I8FIA:D+3IQYI:JRC9.][VU35M=;I+4]IHKPW]B
M+]KZZ_:[^$EWXCO?#A\*ZAI6LWNA7^G?:Q=B&XMG"MMD"KN'/H.A[8)YOXH?
MMQ>(O#?Q(^+?A_PMX2TGQ.OPC\-VVNW\LFL_9)+B>9))?L@3RF52L,3.6+?Q
M(,<\-86HYNG;5;_A_F:_ZMYC]=JY>Z=JE+XKRBDO>C'63=M92BM^O8^EJ*\Z
M_9U^.R_M%? GPCXXL[*338?%>FP:DEK(PD: .,E-PQNQSSCT->&^+O\ @H_X
M@L?@%\7_ (BZ#X*TK7="^%NOW&DP[-:*2:Q!:NJW=P!Y)$90,"J9;=AN1QDA
MA:DFXI;.S];V)PW#V/KXF>$IP]^$U"5VE:<I<B5VTM976C>S>R/K>BN6^'WQ
M$7Q_\.-#\11I]CM]=TZWU-$F(+0)-$LH#8XRH;!/3@UPG['?[3>H?M4?"ZX\
M7R:3INE:1<ZI>V>D&VOS=F^MK>X>$7#?NU";RA8(-WRD'-9^RE9OMH</U#$>
MRJ5G'W:;49>3=[+U?++[F>R44#D45F<84444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %!Z44'D4 9/B)R-"OMNT;;>3&>@.PU\9_\ !$N]_P"$;^ ?C'P<1J0B
M\&^)'99;LA5EAN[6"Z1HQV3YV; P/FSW-?9_B<!/#U_QG_1Y"<?[AK\^OV<_
M&#?L\?$OXP1+<7V_7OA!X?\ %UI),A>QAN8K%K+:B]7W-Y'3KR#SBO3P?OX>
MK3ZNS7WV_4^VX;A+%9-C\OW<O932[RA/E7G\-274R/@QHS?$G]FG]K[[==W$
MI\:ZU#>R31P!"@O;2!LQH>-H61=N>H S7N/[%GQBN+7_ ()1:%KSFYM=0\,^
M'+S3<Z@K2R?:K1Y;9-PZL"\:C:><$*<&N,^%_A1O /A']I;11(]RVC:IX;LT
M9UVLXCTK35!;MN.,G& ,XK/_ &?KE?#WPV^*_P *5GU.(V_QP&CI<7<6^2>V
MOKR"\80K_"!%YIW8Q@%^>M>A6Y9QE'M*+^2BD_S1];F=58_"5Z+]Z,:M"HEI
M\/LHPETZIP7_ &ZM#CM+^$(\3?\ !#.Y\&;[KS#KM[IL;B-6N&:+6YMF% QN
M9D' [MCK7OL/Q2D\=_\ !)W2==1[FUN_%/@NSTR(72>?,\US%':$8!^9V+$C
MWP:P_P!FU1>?L3^'8GW*+KXJW,;%1G&[Q/.*X_\ 8IU@VW[)?@#X>O<ZC!-X
M8^)>IZ&ZWJ"2YNK?39KJ\!Q_RS3"VX)(X!P -RFE6]YOO&=_EK_D98ZM/&4Z
M]2H[NEB_:>7OJ7.]NKA X7]H?PM_;'_!"?X3I;R7:2Z+:V6IP&U&96>UM;N9
M=O<',?4<CKVKZ#_;]\:1^.O^";%_-:S7-BOQ"T:UA6.2,2W"17, GDC&.-_E
M*_S=!M)Z"N9^"7@^/X@_\$U?V>M!EEEABUN!-/>2( R1K+I>HQEESP6&[(^G
MI7GGPX\93?$;_@FK\+-(::[MWT3P;XE>]@ND+W<[:58W-ADG/R(9)L'ODHO'
M-7[-.:?2-1_BW_DSMQU>5>LJJU^KXVK-?]Q')_A[&^M]QO\ P4*1K3]BK]FS
MQ2'U,2^!X=*\2%+ ?OI5M[>T\Q,_PCRY'RV1C')QFO5/^"RM_P#VC^PSJ&EP
M2F!]>F2Y:#R@\KP6T;794=0H#11*Q/9B.]9WQS\"'XH_L.?#70%>[CDU;X7:
ME$AMEW3!QHD+*$'.264#\:X#XX_$T_&__@GKX?U-)9U>U^"MWJ]Q;R_O+@S3
M"SM%DDDY'S;+@@=69"3]TBIH>].E?[,VOO;,LHJ\];+:S^*AB)W?E*?-!+I?
MFC+IU.K_ ."F<H\"_M"_LU^-"FHRIX2UJ(R161 +Q75S96SACP0OSCO@YVG.
M16W_ ,%?=1>\\)?#30XIF/E^,-/UJXA6$NQ6WOK6%23_  1[KD9/<XIO_!6+
MP;/XM^!.MBWFOHKO1_A]>ZS UHNZ8R6E]IEPH '/)CY(Y Y'(KG/VU/'*_&+
MP1;:];RR);:;H_@R=;1E#-$^IZ[:38ED!P2([6+Y0<89CSD5&'Y9NC-_9YE^
M.GYG-E%5SHY7BE_RXE5AZ)R4H_\ DU21H^.[EO!7_!;O0-55=1E7Q7X>D\,O
MY0Q;1.EJ;N,R^I.V7 /3&1SFMC]I2\?7?^"J?P$B^T%H?#BWD1A6/(62[L+U
MV+OZ[;6+"^CL3UKG?V]&/@O]HS0?'F[4F_X1#XC^%/,AL>&FBN[>XM)!(>@3
M$B]< Y(ZD5N>-9W\0?MX?#_6?M*S1R_$O4-(C58B@1;/PW*F 3]X^;),&8Y'
MR@#I3C./N3[0M\_^&8E6E.GA<:GJL)4I7\U&6G;X)\O?SN9_P*F;P'_P69^(
MK,NIO;_$'09EVXQ:13:>MCS_ +3^7-[D;QT!K<U/53XG_P""T.B7"S&>+2O!
MFHZ/$HBPD+JMK<2 M_$^;E,XQ@%?6N;^,T;>#/VY_A;XMVZI(&^*FI^&9$ML
MB()?:-9A6D/3:'A0X/7!P"0*WOAG=)K_ .W=X UV.Y^TQ>(Y/'EPCHFR-X(9
M]+M(MGJI2V4[NY)/3%$DI/VCZTVOFD_\D:SJ.<H8UO6>#J4WZPA4BE_X+A%?
MTS*_83OV\%_\%(?VB_#J#4I(O%$@\20O+_Q[(\5]<VDBJ!U./+.[K\I!Z+6S
M\!K\^)?^"OWQ)U$S>? W@\:9!B/:B):7L*$<\LWFO*"W3*@=JYW0C'\/O^"E
M?PXUR3^TVA\82^-O#,JIA;6#R;YKV.20\<D"4;3ST('#&MC]C"XDU3]LW2=:
MFF^T3>)_AO?:VSB+RE;[5XAFE7:O9-K+CU&#WHKI>]47VH17S6GZ&&;592]I
MCWJZN&A%O3[+Y/Q]@F8W_!(:23PGX]^.WA18]2E!\00>)H)9@! 4ODE)6(9Y
M DA<9XS@=2#5'X/7">)OC'^V=JPN?M,'B+08I8Y1'Y:&*./4[1"N>H*6ZMN[
MDGM4?[.?B:/X/?MG6.KS2ZA'8^+_ (27=[-+,=EE:MIFISL25_B81RY/4@,>
M@:M#X,:=+I</QLBN9));E_@YX?N+AY(O+9I9K;59GRG\.&D(V]@ *T;7/4J1
M^TH_^E1_R.[%U'[?&XYM_OJ-!Z]7&K14_P#R>FSJ_P#@E%X@C\&?L%3V%W+J
M$0^&.JZUHL]SJ@P2EM,\BN5!RJ"-TXP,8. !BO+OV<? TFO?\$J_CIHEX\XN
M-8\2ZM%<2^4L<H>Z^RM(0I&!AI2 I_N@5L>!-9E^'.L_M:^#8[C4(I=9U72;
MZQFND\R,_P!M6L5N8X8QR3O$@!P<D#/(-=O\,;7^S/V:_P!H>!=S+;?$[5$4
M,>H$]EC\Q^I-1.?+.<_YI1?XW_4RQE65#$8O%TG_ !*V'K+R;Y:B?_E3_@%[
M]B[XN26'_!*31-<8W5E?>&/#-YI@.H RN]S:-+;#<O)(:1%PIYY XQ6[_P $
M@]"_X1/]A'P[I/[W=IFJZQ:$RILD;R]2N4#,.Q(&3]:\A_9_N3X<\ ?%KX5_
M:]3A>/XW'1X[B[BWO-;WUU!>D1)_#B+SFW8"XR_/->[?\$P&\_\ 94\P@ MX
MJ\1'W_Y#-YUY/-<^,25.HUUDG\F>1Q6_9T,=&&D*M>-1>DHS<?N4Y6]=CZ*'
M2BBBO%/S)!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "B@G%5-5U:'1K.>YN9HK:UMXS)+-*ZI'&H&2
MS,2 H ')/% %NBN<\!?%#0_B:ES+H&LZ7K=M:2&&::PG6>)'P/EWJ2I/7H3T
M/I71T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 445YE^UA^UUX!_8E^#FI?$#
MXF^)+7PKX/TJ6""XOYH)9V\R:18XT2*)6DD8LPX120 S'A20 >FT5S?PM^*_
MA_XT^#M/\2>%-;TGQ+X<U:+S['4],NH[FUNTZ91T)!P<@CJ",'FNDH ****
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M6=4N<^196&NVMS<SX&Y@L:2%CA02< \<T =[17 >(?VH_AOX.\07.E:S\1/
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M#^TU_P &]?P6\6:4=?\ @SIJ_ ;XIZ1,E_H'B/PQ--;Q6]S$"422V#^48V;
M<JH; Z]0=G_@CC_P4!\9?M&+X^^#_P :%T^T^._P2U(:5XA:U=-FN0G 2_14
M5456;Y6" +RC8&\"ON2==R#DK@@Y]*_,S3H](M?^#J&0:+]IBO[GX-N?$:Q
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M\%6_VK/@!X1^)'A3_AF(>&_&NF1:MIPO(;B&X$,HRN] 2%;U&37P!_P<P?\
M!-KXA_L2_MD:U\<M+\1^(M>\"?&FYO(9M0E>:6ZT26:+RYM+N93D&"2)F6'Y
MAF-63:/+RW[.?\&ZG[4G@[]H/_@D[\*]-\)ZNE_J?PZT:V\,>(;1XC'+I]["
M@RC ]5=2K(PR&5NQ!  ,O]C,?\%'O^&E?#(^.[?L_#X4E[C^W?\ A'!.=3(^
MS2^2(=W'^O\ )W9_@W5Y;_P<F_\ !:^7_@G/\'8/AQ\-=6%M\9_'EIYHNXXA
M*/#>F$LC77)PEPY!6+AL8=R!A,_4O_!7;_@J9X8_X)7?LH:AXWU;^SM8\57Y
M:R\+>');GRI==O<J#C +"&$-YDK]E4*#N= ?YG_ &E^)/B1X>^(?[<WQOM9?
M%\$'B2.V\-66J3_Z+XO\3/('2&2,L9/[.L8@9'C7AQ%# "%9R@!^I?\ P:T_
M\$4K/X4^#;#]I?XN:/;MXN\1K]J\!Z?J:NLVA6I+J^H/&^ 9YU*F)L'9'AP<
MR?+^WEG=116ZA60H6PA0[@?R]_YU^ /['G_!OM\4O^"Q'@6']H/]J_XU^-]-
MUCQY;K?:'I6GQ1"XM[)@OE2,KCR;:-UY2VBB&U2C$@L5KAOC/\'/VEO^#4CX
MMZ#XV\%?$(_$_P#9\\7ZP+.]TN^1XX9& +^1<PG>+6X:/>4N(#\YB^9<?NR
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** (KH,4 4<D_E[U^9WB7]MR3]MC]H;XH:/I]]<VOA+X4>)G\)K:P7.Z#4
M2BAI=0D*#;(#/^Z1&)"K%P5=LG])_%%L]]H%W;QR+%+<0O%&[9"JS*0"<=L_
MYS7XR?\ !!O0_#?[,WQG\;_#3XEM!IWC"^U!KE([B["6L-W'<&T\F96.YY96
M0,C_ '699.I() /H"W_8!US]M;4/"EW(_P#9/A&UU"6ZU;4KB-8WU.(,B/';
M1QGGSMC$EL",C<"Q 4_HGX"\$:9\-/!>E^']%M$L-(T:V2SLK969Q!"BA57+
M$DX ZDDFK]EID&G*JPHL2HH140;54#H .@K ^)GQ5TOX66=C/J=RD9U.\BTZ
MQMU!:XO[F0G9%"@Y=L!F('158]!0-R;.BNX3/%M&TG/\72OR+O[CQ=_P;P_M
M<?$#6AX2UGQ7^R+\6=2;Q#<W'A_3P\OP\U&66*,B4EMQAVEO7*A-N&!!_7D=
M*K:GHUKK5I/;7D$5U:W,9BF@F0/%*I!!#*>""#T/% CYI\-_\%I_V3_%7AK^
MUK/X_P#PS-DL<<CF;6(X)8@XRN^-\.IQG((!&#G%?,_QG_X*K>._^"BWQGT[
MX2_L4W.HBWT[5X/^$P^+3:?!<:%HEF"3)#;K<(R7$CIRI&,D #()8?7OB?\
MX);?LX^,O%-OK>I?!'X97&IVT@E28:!;QY8# W*JA6'LP(SSUKUOP)\+/#7P
MMT)=*\,:!HWAS2E?S19:78Q6=N'[MLC51N.!SUXH _-S_@XPO[?X9? W]F:Z
M\0ZTLMMH/Q=T";4M8OO+A#+$=TMS+M4(F0K.VW:HYP,#%?3L7_!;7]D;++_P
MT5\)B0QR/[?AXY^M>^_$3X*>$/B_H:Z9XN\,Z!XJTU"66UUC3X;Z%6(P6"RJ
MP!QQD5S$?[$WP:A9F3X2_#-'<89AX7L03SG_ )Y>IS0!P/Q+_:N^&_[67[!O
MQ?\ $'PS\:>'_'.B6GA?6K*:]T>[6YABG73Y6,99?XMI!Q[BO%/^#??PKI7Q
M-_X(;_"K0M3L8+S1=9T74-.OK8L#'<0R7-Q'(I*GNI9>#D9K[,\)? GP7\/_
M  YJ&CZ!X5\.Z%I.K.TE]9:=IL-M;7C,@1S)&BA&W* IR.0,&M?P1X%T7X:>
M%K30_#NDZ9H6BZ>ACM;#3[6.UMK9<D[4C0!5&23P.] 'Y2?LC>/=4_X(4?MX
MO^S_ ./=3*?LW?%^]EN_A5K5Q<2W,6@7C2HG]F2RL,J7+KD?=#M&P.'?'ZVQ
M$,O QMXY'2N?\=?!_P *?%&RM[;Q-X;T'Q';6<XNK>+5=/AO8X)ATE19%8*X
M[,.:W;"PBTVRCMX5V0Q*$1<YVJ!@#\A0!^('_!03XQ:__P $</V\/CWIGAJ.
M^U71?VP/"<M[X7TVTC DLO%,D@LL+G Y:65_E//F1CJ!G]1/^"6O[)4?[$/[
M _PU^&TEK9V^KZ)I$3ZVUNF!<:C*/,N9&.22QD8@G)Z #@"O6O&/P5\(?$74
M=(O/$7AG0?$%WH$OGZ9/J5A%=2:?)Q\\3.I*-PIRN#E5/4"NFC3RUQDGG/-
M'Y^_\%@?V._BA!\5?AS^U!\ X)]3^*_PC1M.U'P]$%;_ (2K0Y)-T]LF[CS
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M$Q/ KHAA*LTG&.Y[.%X>S'$TX5J-)N,MGIW:ZOJTTOYFFHW>A]-45\X^%_\
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M\*02"R!L;AD6+Q+O>G_2;L_Q+>>9[.#@\'=>CNO9RE**TM\$I2_Q[;I'R?\
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M4%^'7CF\\2Q*^N:+9Z#876JKJFJZ<]M8ZQ96TABGN+*4G_2$5UQE<$[D(!#
MG,L_^"DO@6]\#2:J-"\?PZO%J%KI4?A>?P^\?B&\DN(C-"T5KNR\;PAG#AMH
M"/D@@BMGB,2W;V??\=STJF?YY.4Z4\%H[IK6UJLE.:O?[<DG?[#=M#YOL/@3
M\0?@AX'CU9_A]XJUVZ^(_@7Q!H']F:5 DUQX>O=1U6>^MTO<N%2-8[D*\BDJ
MK0N#P5K6^$?[.?COP!J'AKX27?A76Y8]&^)%IXWF\6QP)_84UE%8(K1B1FWF
M8RH8O+VYR=WW0#7T%XO_ ."CGPY\'>"/"^OPCQ-KEKXHT^76%BTK1Y+NYTBS
MA94GN;Z,$-;I$Y\MP>0ZN,$J<:UK^V]X&UGXX6W@6S?7)WEO%T^'7HM/+>'W
MO6MQ<+9B\!VF<PG<%&1G SNP*AXK%.'O4_/[C!YWGGLIR6#W4I-M2TY6TGJ_
ML7M;[76]KGB_[%'PP\86?Q,^%&E:UX.\0^'K;X'>%-5\.ZIJ6HP)'9:W<7,T
M"1/9.')EC,=L9"Q P)%!^;(KPN3]C/Q4/'GCZ]\5^"_B+XJ\2I=^(IWBMM,T
MZ+1]=BU#S$MA]O %S< B2W/E,<0-;E_E"#/W1\#OVS_!OQ\\?W_AS1+;Q#9W
M$5O+>6%YJ&FM:V>OV\,_D2SV,K'$\:2  D8X96 P0:]=E>"' :2-67&5W#()
MX ]L\8J)9A6A4;E&S:V^;?YMG%B>,LSP6,FZU!4Y22T=TXISE-Z[^]*<KI.Z
M;M?0_/[]G+]G[Q1\(/C?\(KKQQ\/]5U[6M O?$&E^(_%"6 OUU._NVLY;36&
MF<[_ "2B2+YGWHF0J0,\_H7;S#RLC!^G.:XR_P#B[H6A?%;0/!%Y<LNN>);.
M[O+*W1-P,5MY7FEFZ+CSD [MN]J[-HA$H(Z@=37'B:TJKCS*SM^%SYGB/.\5
MFDZ6)Q<.5\KM;9ISG*Z71<TI)6T222V+(Z44#D45R'@!2-]T_2EI&^Z: /AS
M]M+X7>,M3^(_Q2TG0_!_B'Q''\<?">D^'=/U+3HT>QT*XMYYTE>^9F!BC$5R
M)0P!#")E^]BN2^*G[.GCGQGJ/B7X26OA37(8M9^(]WXW@\5RP :$EE-8.JQF
M7=O\\2MY9C"=1G[O)^G/C3^VGX-^ GQ!LO#NM1>(KFXN88;J^NM-TQ[NST"V
MFG$$4U[(#^XB>0D G/"EL!034.I?MR^![#XZ/X(N9=8@GMKMK"36WTYAH*WH
MMS<-9F]W;/.$0+%<8S\N=W%>Q0Q6(45:%[;>=DE<_2<!GN<T\-2]EA>9*',G
M9Z\L8P4M_LQC%6Z_%K<^3M3^!7Q%^./@<ZI%X!\4>'KSX<^!O#_AS^R]7MXH
M[GQ%>Z;JL%_<)9$.5>,QVVQ)&*JS3+CH<;6F:-XX\-?M,:I^T!_PK#X@7>C^
M);[5;.#PW#8Q_P#"0VT4FG65O#<RVY?:D;RV;#&XLHD1B,9KZ#\'_P#!1;X<
M^+O WB3Q \7BG1+/PQIT.KF+5](>UNM8LIG*6]Q9QD[ITED78F,,79 0-PS4
MU3_@I!X%L/!]MJG]C>/GU5M2NM-D\,1>'I)=?M);:$33F6U#96-(F5]^2I#K
M@DD Z+$XB\H^R[K[UJ=4<RSB,Y06 WO!KWM%."<H[]5[W-O%=>A\V3_LQ_$7
MX.?""]\ )X-U_P 0W_Q-^&N@^%(M2TN%9+'P_?6TTXG^VLS I&J70<. 0WE,
MHR<5J:)^S/X[\5PZ/\+#X7UC25\ ZCXNOI_$U[;!=$U5-3MKR*T6TD#%W<M?
M NI7*"&0$DD"OI/QC_P4&^'W@R_T% ^O:Q9:]IEKJ\FIZ7IKW-AH]E<R+'!<
M7LH(^SH[D@9R1ABP 4D6O#G[<?@3Q7\6]0\)0'6K,V#7VS6[JQ,>BZC)9JIN
MXK:Z)VRO%NRPP/N.03M-#QN+MSN'G^"7Y%8CB+/JU.56KA+M\TW*TM9<J@W:
M]ERPLDO^WM3Y,/PK^(GCGQ+\/?B ?AMXVTJ/X'Z/X;TB_P!&N[*(:AX@ELKM
MGNVT\!\31HA#!B5$F?E!(Q7IR_"SQ9\2/V0/BYX7'A7Q'H_B#XU7_B/Q'I-M
M?683^R(W,(@M[U@Q6&>4("BY/4Y(*FO2="_X*4_#K7O!VK:LMAXUM38Q6<ME
MIUWHDD6I>(H;R4Q6LUA"6W3I(ZD C!'5@HYKO?!O[37A7QS\#KWQ_#<W>D:!
MI$=TVJ1ZO ;6ZTI[8L+B&>(Y*2(5.5/)RN,Y!.=2O7:CS0MRM6?SO^9R9CG>
M<4HP<\'[-0G#E^+1Z34=W>\GS=_L['RKXE\(>-OBUXUUCXQQ?#KQOI$&AZWX
M0O$\,7]I&FN:C#I8NC>/!$'(.#>X0,P+_9W('*YY5/A7\1/ _B/X@_$#_A6O
MC75(_CAHWB/2+#1K.SC.H>'Y;RZ1K0Z@I<"&-T!9F!81X^8 G%?4.@_\%"_
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MG']GSQ7XAL/@7X?\<S>(O$6O:[K>O)IES8ZA?275O<1//L;RX22(VC4>8#&
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M7RUX]_8^^,;>,KQ_AW\>%^'?A%BIL=!7PI;Z@+$;!O\ W\K[WW2!GY)QN '
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M-G>V>F74%A-+#>78+6]JZQL5DE ZHIPQ]E-?-#_L=_M,N,-^U8Q&>_@.R_\
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MW[YSS40KQ;M8P698=<SY-'>RTT;=V]KWMY'5PSJQ(VL"O;'2I/-'HU?(8_9
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MG_A!V7_Q='_#'W[3?_1ULG_A!V7_ ,71]5I?\_H_=+_(/]7<O_Z&='_P&O\
M_*3Z[><(N<,:8UZJ#+!P,9Y%?(S_ +('[32C)_:MD '_ %(=E_\ %UL?#;]E
MO]H3PQ\2M$U37OVDCXET&SN5EO\ 2CX-M+;^THAUA\Q6)CS_ 'AFE+#4E&ZJ
MI_*7^1G6R' 0IRG',:,FE>RC7N_)7HI7?F_4^IZ*1>@I:XSY<**** "BBB@
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M_MKPI\2)/$GCR<Z7+HOA[3[K5+V4^)9)'$\5_P#;=D41:V-PLUNKK&HC1]@
M4G]?5TJ*([$4+&W5 %"GG.<8ZT/HUOYA81(CDD@A0""1@D'&<D=^]9TLPC"]
MHWO;?R,,-QS3P\ZKAADU+V22DT_=I144I7A[U[:N*ANT?!/_  3:TGP79?MG
MW^H6^MZ[?ZYK_P .M%OK"35M0NC<ZG+NN4U-WC9RC21S)$KJ1^Z9B!@NV?T&
MJG:Z?%'.D@1=Z@@' XR<GG'<U<KCQ6(=:?.^UCYOB#.GFF+^M.+C[L8V;O\
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MO!G/L#BO)OA7^SAJ.K?\$TY/BRFHZ>FCZ+\+/%/AN2Q*O]JDGGU2642 XV[
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MY4?-&1\XZ$=":]N_8/\ V.-<_93V_P!JZIH^HH/!?A_PUBQ$@"S:=]K\UU#
M?(_VA=O<;2"*YL5#"^_.G*_-LNBU/(S^APYRXO%X&O&4JB]R"BTHOVJU6WV(
MW_[?/IL=**!R**\D_,@QFC ]*** "BBB@ HHHH **** "BBB@ HHHH ****
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M!T.<,IR#@X//L>*G0[A3::W!23V%HHHI#"BBB@ HHHH **** "BBB@ HHHH
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M! KWZODS_@ISHVC:IXA^$-SXPT+5/$/P]TOQ'<S>([:VTRYU&+8VGW"P-+#
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M=/M=/3UL?,O[0\LVH?$WP]%-)MCTFUT"6S3D-NN-4"W)'J5$%N-PY42$'B0
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M3FDDFGM>S]]WWUW3WZ_(]E R!2XQ0O045QGBABC&*** # ]*,444 &*,444
M&**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M  R^&:Q1P^=OTFZNM3W=<QX\V-O,X'13G(P<\5ZV#IT7!<T4WYRM^"_S/O\
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MIJ[.2][>VUUKLT?1H.110.E%<1X84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% '-:A\7_#.F?$6U\(7.LV,'B>_L)-4M
M=+DD"W-U;1N$DEC4_?5&90VW.W<I. 02_P *_%KPWXXU36[+1]8L=3NO#5__
M &7JL=M()/[/N_+20V\A'"R!)$)7.1N&<&OFO_@L=X9D\%_L>:Q\8_#<]KH_
MQ'^!:R>+O#&KRVHN##(B>7<VTBY5F@N;=GBDC#*#\A.=@KY=_:^>;]C*?3/A
MM'\<?$OPHTCPI\(]4^(-GKMK=06%Y\0?&27(\V2]FF1Q>L[$2/:#+/YXSD!<
M 'ZI?;4SR&!QG[O3_.:1[]%'1FQR<8X]?RK\HO@=_P %$/$OC'1?!>@^(/B:
M]G\4M8_:0TW2=4\.M?B#48-)GLH[B2Q^RL3(EIEF^4C QM)W BNR_P""@7Q1
M^)'AG]J_XM:AX:^+7C/PG8?#FW^'*Z3HMA/ =,\_6M:N=/NI[B&1#YW[DY6)
MF",ZHQ#; * /TJ_M&$1[P>!W'IZT-J,2C)R/J,=\=_>OR*^(?[2WB[PS\.=2
M^%EQ\8O&D6JZ7\3/&.DZ5KVL>.+;PW(^F:4+$[K[5OLTDTKP->Y2TBC#W"YR
MZK$*L_!G]JKXU>/O!'[/_AF3QUXEO]3_ &JO"GAB\L-<2YC271IM-E+^(IH,
M?<-QIRP$@-'M=V:/=*S4 ?K<UW&!C[Q)P!Z\^]0:GX@L]%TRZOKV>*SLK&)I
M[FXG=8XK>-069W8D!5 !))X !K\]_P!MG]H7XE?";]K?Q-\(-'U?Q-$?CQ)X
M5_X0B]MKT"7P^#>_9->^S,5S%LLX5G78LGER2/*^%;%?/'C_ /:*\4?%JW\3
M6UU\;/%^M^)_B/\ \+.\.>,?AZES$D'A/2]*L-2_L^>&T">;8N?LU@#,^1.-
M08'.]< '[#^'O&6F>+=$L-3TRZBO]-U6VCO+*Z@(>&[AD4.CHP^\I5E8$=0:
MO-J,:#)#8R!GC'/?/2OQ#_9K_:$^*LGQ1^'_ (<^'_QGL+?0_ -CX(LM+M_$
M?Q#@BM]=L[ZU@GU!/[-^R2-J;-)<W%G#)%,GV9K".,@&-R?JW_@K)\?M6\#?
M'V[T"Z^-&N_!;P_X<^%6J>./#T^F7D&GGQ)XBM[G9%:2R3*RW2(FPFS3!D\[
M)R,8 /T-.I0KN+ J%4L21_",\_3K7(_"[]H_P)\;F(\(>*=&\2'^S;36,6%P
MLV;.[\S[-."."DODR[3W\L^E?F%\!_C!\7/%]YX)^*FO?%OXCVVI:M\?X/ >
MI>$)KB*/0HM/N[!&GM#:LAD5DF9BA9]T?"@ #->;?L>>/O'7C[QQ^S#\(-%^
M*GC;P-X/\1^"O#"7,'AW48[:81R:)XCN9_)+(P1I'M(,OC</+5E(910!^VHU
M&(J2#E1P2.BGT/O2_P!H1^8%(8,>V.E?B;XX_:W^.>O?##X5^"[+XQR:1?Z3
MHGC"^C\8:YXWM_"K^(-0TSQ+<Z7:?:IFM)X]0^SP6\;RV:*AE\YF9B *^MOV
MZ?C)KBZS^SYX5\:_&JY^"?AGQEX4UC6_$OBKP[>QZ2D^L6EC9R6]O%=W"$)
MQFNYQ"0&E6V4'A64@'WVNI1,3@D@#.<5B>"?BSX;^)7]K_V!JUEJYT#5)M%U
M(6T@?[#>P[?-MY/21-RY';(KX5_X)=_%;XA_M9_'BP\0^//'?C))]&^%?@OQ
M)<>'K25;#2;G4-1AU>.YEGMO+W?O!'#*%#*H9%;& !7@FB:_K4G[1_Q%\/\
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MXBBLO$ES80ZF+.2"2+7&$-JMN;$")FD9F$A9\#S_ ,*?$GQ1\*_V<_AY\/?
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M&T!"[CN"@@ CI7:W'@OX^Z&T_P#:_CSXT^7'")DDT73/#>J"3[VY=OEQN&&
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+Q1\&/#'C>RU*VUKPQX=UFVUN*&#48K[3H+A+^.%BT*3!U(E6-F9E#9"EB0
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MZYX<U5/%N@^&O$WQ9\0Z&NK^%#)'<^'XXG\U)!Y:.X4^6(\(I^\.W-._;O\
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M&_A9IW@CQG9&Q@CG^)&OIXBL[DW<,<;DW4<4227!N7VY#,H8E<  _9[X7_\
M!2GX2_$[]HSXF_#W3_%>CPW_ ,*[.TN]7O;G4;2&RG69'=V@D\S]ZL(51,_"
MQLZHV&S7N/A[QUHWB_0+;5=(U73]6TN\B$]O>65RD]O/&1D,DB$JP(YR"1BO
MQO\ VF/^":RW'[3/[1VDVWP)^($'AK4AX.\1> M<\"^&]+GM]/&EVGE7:1QW
M#"*8F9@TE@<-="-CDD+GVSX.?#;XN0?\$GO$GP@/POD^'/Q,^+UEXI31KSPM
MX;71].LR8";:\U>*.0QZ9=WJ@)Y2%D#L!\G( !^A%I^T5X OOA]=>+8?&_A"
M7PG8RM!<ZVFM6S:=;R*0I1YP_EJV6 P6SDCUHU_]HGP#X4BMWU7QMX1TM+NS
M74(&O-9MH!/;,RJLZ%G&Z,LR@.,J2P&<FOR&UO\ 9#\0Z_\ !7P-XCT;]E/Q
M;X?\'>$/&O@^_P#'OA*1 VH?$R*PTK[+=7":$3]GB%M<,A!#9N@AD.=M>5ZS
M_P $P/C/+X#UZ+5?A'KMU;7OP?\ B(?"VBMID5Z?"DFH:R+G2M)5DW)'="(M
M(D<9S'YA (.X4 ?L+^V+_P % ?!/[*7[._B;QZ)(_&__  B^IVFC7&CZ!J%M
M-?M?7%Q% EJ%+X$X,N[RV(;:IXKRCPU_P6,\,>*OB%IJ6WPZ^(;_  SUWQ>_
M@/2OB*D%NVCWVKH_EE!$)?M2VYE62-;@Q>6S1\$@U\"W/_!//XIW/QYG\)Z=
M\)/$6A>$_&7C7X3ZI=Z[;Z2L5GI*Z1H;R:A<-$FT-_I9,4C94B1B3N)Y^G/V
M#-0^.7[&GP?\'?LWV'P0\0ZQJ?A+QE?VM_XRO=D/A>3PW/>7%U_:5O=!\_:B
MEP@6V".58,#T. #N_@I_P7%TSXSZ1\/M6F^#WQ#\/>&_BY?7NB^"]7NK_3)H
M=>U6V$^+'9%<-+ 96MY4665%C#!=S!3FNN^'7_!7WP'\4O"/[/6J:1H?B!G_
M &@I=3^Q6MP\-NWAZ'3(Y'U&XNY'81F.W,3!MC,6^\@9037Q'^P3_P $_OBA
M^S_X6_9 \:>,?"7Q0\4:)H/B?6H?$G@/5I&FA\ WT]S=KI_B"VM5P41%8^:"
M9 !=&15!P1?_ &)_^"<'Q-U']M;X@^ ?%N@>)O#GPI^$^D>.-*^'6MW^F?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^17?#AJ^AOV<_P!D?]FWP7^S;<?$9M=T_P 9>&C\-Q_PDFF&!&U>9VD5S?\
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M?X'U[X=_$?3?#VL:2/#FFW=S]NL=<62;[4UO<W+"6<S2&2:.=FW2B=&W;FH
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MK+Y4PC;KL;!P??!KYVLO^"//@6PLXK>+XB?'1(($$<4:^-YT6-0,  !0, 8
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M?&P\$W=Q\.]0UZ]\1>)-8OXM'L[^35$U2[:[A<W5K;2M9V@G> C8KO@1JP*
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M=K)YD;2V\SP3)N_O)+&Z-Z,I':NBH ",T8HHH ,4444 %%%% !1110 4444
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MGG'//7^0_*G44 ,-O&T@<HA8'(..0<$?R)_.AK>-Y"Y1"Q7825&2OI]*?10
MPV\9=&V)NC&%.T94>WI2"SA&,11C#;Q\HX;U^OO4E% ")&L2X50H] ,"EHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M (A^'=_HNI^-[?7)-4FTRZ?Q6-!%K+#)HL=VS&*WA@,I,02,A\L7V<@Q2_\
M!*_X_>(_"NK6NL?$?X;K>V?PVTWX<:$^EZ?J%HMY96.JP7134"'+F.^M86M[
MA82-@F<+N!S0!]A?LA_MK>%?VR]-\5-H&E^*?#^J^"-6_L37='\1:;]AU#3;
MDPQSJCH&=>8Y4/#$C)! (Q7L&*^6_P#@FI^PYJW[%%S\3DOV\!6]CXVUJRU3
M3M,\(:5+IFFZ-%#IEM:&!879B?GA8^9N)DSN8*Q*CZDH ,"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTD\TKF26::61FDFED=F9Y)&9V)))- FS\ROV<_VR_%-__P %'_@[;^$?B/\
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M=:OS!I^IR%C+/#;F?R8_,9MSHJ!'(4D$J,>L?$+]E_P1\5/C)X&\?Z]HYO\
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M3XV^'O@+X2?Q!XHU)--T=+RRTXS""2<K<7ES%:VR%8PS?//-&@.,#=DD $T
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MC*O(LDUM&L!)MOE39*2/-W'"@ %@#[IBN5F8@=1P1QQ4E?&/[.'@+7OV=/\
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M'WP5\:ZD^J>*/@'XFD\-17<D@EFO-#EC6ZTB=WZNWV.2.)GV@EH&SE@QJ/\
M8^U73OV??VV?B=^SGI-E=VGA*QT2S^(/AF"2X\Z+3(KVXFBOK.'))2!;E!)&
MG"I]HD50%50-7X#6\2_\%9/VB NT'_A"O!6[&"?]9K>,]^U 'U)UIEPSI;N8
MU#.%)4$XR<<"GTV1/,C9<LNX$9!P1]* /Q8_8H_:H^.'Q@_:.TN^O/VC;BP^
M/<'C>33O%WP/\;P)H_AZ+0_M#QN-+S&&N9XX?)DCDB8ERV6!!W/],_ O_@IM
MX<^#_P"S1K.L+)\7OBKXA\1?&;6/ 7AS0-9N;%]:U/4%N=IM+5@Z0QV4*J[(
M9&!1!\V.HX[Q+_P3=_:C^+WQ4^'_ (&\=>*/ 'B3X5_"[X@0^,]+^)%Y--+X
M]O;.&[^TQ::^4VQMAA"\H8!TA4$8(K@_BE^Q?XD_9!^!_@O6/%/BSX4^'O'O
MAW]I+5OB5X1TSQ#XF_LS1_$T%Y)*XLGO#$?(N?L[NR@J5#( 2P.*!H^@8O\
M@NSX>\P6(^#WQ1/B+_A9O_"JAH!^PC4?[6^P_:\D>?Y?E#[F[?\ [8RG-?0O
M["O[<FB_MH^%?%7V?PWXC\%>*? .OS^&?$_AW6TC-UI%_$ VPRQ,\4RM&RNK
MQL1AN<=_S3_89_9P\?\ [:7QMU;XE:./!\^E^&/VJY?'&K7^FZB\VE7UI#I
MM9QIT[)_I7ES.$W80.59A@$ ??G[ '[)_BW]FGXT_M*Z]XF_LO[#\5?B3+XK
MT+['<>=(;-K6")1,-HV/NC/RY;CO0#.7M/\ @L/X-G^!D?Q"'A'Q4NGS?%T?
M!_[(9H#,;\WWV/[63OQY ?G&=^.U8'A'_@N)X5\2>.;2'4/A?\1= \$3_$6[
M^%UQXTO&LO['M=9BFDABC;;-YQBE=0!($PK.%/S9%>$:S_P2H_:(TGP_-\+]
M(M?AGJGP\L_C]:_%^W\1S:W/;ZI<VK:@EY/9FS\DHDL1+_-YI#A0  3D><?L
M3_LR?$_]MSX;ZMX/TVS\(6'PDTC]J#7?&VM>(7U20:S;MI^J/.ME%:>2T<AE
MD\K$GF *A8%<C- VE8^K?^"^O[2'Q*^ _P"SOX*LOA[;^,M.D\7^.-)T74M=
M\-ZC:V5[!!)<(/L,<DK"1)KO)1)54HAC.]E4G/0ZG_P5U\%?!C7)M"U7PUX]
MO/!_P[GTSPU\0/'<\UM=6'@O5KF-%2TU"19/-GE5WB6XGMT>*-YU+-@FNY_X
M*P?LC^+/VP/@OX"T3P<=*^W>'?B3X>\57@U"Z^SQ_8[*Z\V?8P5LR%>BGJ3U
M%?./[1/_  2:^)?Q#\2?&_X>>'[_ ,+/\)?VD_&MAXVU_P 37EV\6N>%7@>%
M[BTM[-8S'="0VL(BE:1-@D?>KX% DD>]_"+_ (*?V'QP_:J\4_"3PO\ "_XB
MZE?^!_%]QX8U_7/(C&A:1#';><+V6X+;0LA!CC@ ,A89(4%6,'[3'_!7OP!^
MS'\<]7\(ZKX>\8:IIW@AM*3QSXFTR"!])\$G4W$=BMRSRK(QD8KNV(?+1E=N
M#BM;]@']D_Q=^S9\8?VE==\2KI9T[XJ_$>;Q3H*V5V97^QM:PPCS@5'ER%HR
M2N2.1S7SQ^U9_P $C?%/Q!_;Q\;?$G2/ 7P/^)FE?%C^PA/=>/XIII? [V C
MANF@M$0+=I<6JX4"2.2.55;=M4+0(UE_X*)3?LN?MM_MD7OCO7/%/B'PEX0U
M#P/HWA#PQ:.L\DFH:I9/MM+&)BJB2XFPS$L -K,>!7JD/_!8;X=VO[,/B;XA
MZIHGB_1=;\&>*8O NJ>")[>"77AX@E>..+3HECE,<K2-*"CA]C+N?E1SX9^U
M_P#\$>_'W[3WQ0_::U82^#TL/B'XB\#^)_"=KJ-Q)):ZK)H=M)%<V5^BINBA
MF$C("A8\JW !%7];_P""4'C+QW^PWJ7AS3?!OP5^#_C6U^)&G?$30- \-I,=
M'8:=-&;>TU*\"!IY7C1U,\44>/W8VX5B0"+]K_\ X*D_$RVU+X VWA+X7_$;
MPCJ7B#XMGPCXL\.ZD+*"]OS:Q>>MA;73R_9Y8;G<&,\3F,K#)&SJ3@^L+_P6
M4\(W/QB^)7A:3P+X^M]*^#OB"\TKQKXKGAC'A_P]9VMFUR]]/<*QR'P8TMU#
M2LV,JH*D\;^TI^S-^U%^TMIWP=\<ZUH_PM?QI\+/BO\ \)I:>$[76Y[>WAT=
M;:6".TDU P.)KA6?>95@12K8VY4FM;P5_P $S/$GB7X<?MK>#?&FJV&B:+^T
MCXLU"^T>^TUA>36=E<V45NLLD3*H$H=,E,G@?>'8 Z_X0_\ !6GPS\2;;7K;
M7/ OC;X>^(+/P;-\0_#VCZ^+9+CQ;H$<;.;NU:*5TC?Y0K0S,DD?F(6&#D>>
M^$/^"U?A_P".W@?1K*^^'7Q:^&%C\6? .L>)_!7B"Y%D9-66QL'GNEMS'+(8
M;B*,-)&\ZJC[48'#KNQOAI_P3>^,7CCQ7/XJ^(R>"M!USP)\&;WX.^%=/T'4
MI;VV\1&>+:VI74DD2&V5BD.V *Y7<Y9VP <.#_@E+\6(/@_^R+H(7PH;SX+_
M  W\5^%?$V=381_;-1T(V5MY!\O][&;C!=CMVKS@]* .\^%__!571/A9^RC\
M";+0] ^+?QO\;>/_  $WC&VT^5[*3Q"^DVT:M/J%_*TB0;_F"!8R3*^%49P#
M]'?&[]M7PG\!/V+[_P".FOP:]8>%=/T6+6S875@UIJC^<$$%J8)2K)</)(D8
M1R,,XSP*^-OA]_P3<^//[+GA/]F_QKX!B\":]\3/A-\*+GX9:WHNKZM)::?O
MG\N2*]MKA86\PPSH"\;J!)'PI1OF'TE^WE^R)XW_ &U_^":?B7X5:IK?A^'X
MB:UHMH\NJ6T,EKI=QJUM+#<#".9'BMI9H=IY+JKY'(X /GGX+_\ !1_Q+#_P
M4C^-.L_%&T\=?"KX>>!?@MIWBJZ\(^)+B"1=+E^U2-+>((9'B9WB*)D.#O5D
M8!E-<W^W;_P6#E^+O_!.CXROX#M/B-\&/BCX3L/#GB.Q@U/R;75+K1=2U2VC
MM[^!HI) $EC+(Z'#QE]K ,>-_4/^";OQM_:N^-/QX\2_%FR\#> +;XO?!>V^
M'EK#X=UJ75GTV]BF=VD?S((]\99BWRCA,+RP+'SS5?\ @C;\4M:_8<^*/@'3
M_A?^SSX#\4:YH>@>'=-NO#=S<?:/$3V6I0W5Y>W=X\:^7#.($=+8QNRNIS)\
MU 'N&L?\%(]"_9J_;Q^*VC>(+WXJ^)--E\3^"_"%X+NXLG\.^$+C5+"5[>XL
MXE(N/+FE4+."'82;2 $YKT+QQ_P5]\ ^ $^,ES>:)XGN+#X0>*=.\#BXM5B=
M_%>NW@7&GV$;.KF2-Y%5V?8G5E+!37F'QY_X);^./C3XG_;8:?\ X1>*P^/&
ME^&1X,FGOI1Y.H:39[5DNE1-T:K<I$5(+[E'(QD5SEY_P1S\9^,O^"1^F?"K
M69O!8^+;>./^%FZY$\L\WA_6M4;4'NI;25MOF"WDA?R&,07! /3<2 >EZO\
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MW7[3;0(FC'PKX6T37?$4=G;&2&X\16\-M=B&)E,K,A$MFY622-"^YB(E";F
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MJ+*=RQ:$2"39R<?,.#Q@^V<=JN44 ?,'QV_Y2R?L\?\ 8D^-/_1FB5]">/\
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MD,T]TTA!:6YM)C)>C=EY ]RH):05];?#WQYI'Q1\#Z3XDT#4['6="UVUCO\
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M>;2-0N$M8=3:57+W-K#(8T90S,-R;0<';X7^UY\>=0_;P^"7[%_BGX=Z%/\
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M;<X P'ST+4 ?M2.E%16,+6]E#&V-R(JG'J!4M !1110 4444 %%%% !1110
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M'@G/5T4 <AIGP-\):*FFQV?A7PU:IHS/)IX@TR",6#.XD8P@)^[+.JL2N"6
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M8LKQKC3DJ,K5':'NOWO\.FOR/DK_ (B8OVM_^C6K3_P1Z[_\11_Q$Q?M;_\
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M=TV[*Z:NKO1)ZMZ6/DW_ (B8OVM_^C6K3_P1Z[_\10/^#F']K@CC]EFT(_[
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MA^'/^"%_C;0_A]\-_!?@3XC>,M#M+R*P\!/)(?$%DT%IF=]PW?;YK7S@RI@
MG 89Y\P_:O\ ^"<W[0'[=&B?'7XM^+O FF>%OB!XE\/6'@[P3X&LM:MYIH[.
M*]MYYKFYNF<0,2B,%&Y3D-D*  ?O7X@_!#QYXJ_X)YV_@CPGXAN_ /Q*@\%Z
M?I^FZK:WQMWTG4;>VA^4S('_ '1DC,;LH.0Q ZT ?G#^R5X=_9?_ &BOB%\
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M5/C[>:MXEDM=,D\27J6.F^!M-F8F**60,97MPN-S%L*V]QM#;#EV/P'^-_\
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M_$?A&3POI46B:=8ZPMUK]O=:E=R-JECM;,,;!F\IQ)@Y^7C(SBOK+HJXZ
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MU=HR#U/M&J_L$WZ?LEZ3\.K'Q#9W-_<^*8/$WB>[NXF2'62;CS[Q!&N=J,0
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MXE_^!5C_ /':#_P=,_"@G)^%OQ+)]?M5C_\ ':_2K_AS!^RC_P!&_P#PO_\
M!)%_A1_PY@_91_Z-_P#A?_X)(O\ "@.6)^:O_$4Q\*,_\DL^)?\ X%6/_P =
MH_XBF/A1_P!$L^)?_@58_P#QVOTJ_P"','[*/_1O_P +_P#P21?X4?\ #F#]
ME'_HW_X7_P#@DB_PH#EB?FK_ ,13'PH_Z)9\2_\ P*L?_CM!_P"#IGX4'_FE
MOQ+_ / JQ_\ CM?I5_PY@_91_P"C?_A?_P""2+_"C_AS!^RC_P!&_P#PO_\
M!)%_A0'+$_-7_B*8^%'_ $2SXE\_]/5C_P#':#_P=,_"@_\ -+?B7_X%6/\
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M  21?X4!RQ/S5_XBF/A1_P!$L^)?_@58_P#QVC_B*9^%'_1+/B7_ .!5C_\
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M@C_DEGQ+_P# JQ_^.U^E/_#F']E'_H@'PO\ _!)%_A2_\.8?V41_S;_\+_\
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M*?\ AS#^RCG_ )(!\+__  21?X4O_#F']E'_ *-_^%__ ()(O\*!<L3\U?\
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M9^%'_1+?B7_X%6/_ ,=H_P"(IGX4?]$M^)?_ (%6/_QVOTJ_X<P?LH_]&_\
MPO\ _!)%_A1_PYA_91S_ ,D ^%__ ()(O\* Y8GYJ_\ $4S\*/\ HEOQ+_\
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M'^IZ=J,1@N[2\DTVXM[F,]8WC=RK ^^?I7Z9_P##F']E$?\ - /A?_X)(O\
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M]N#_ ,.-8_\ Q%?M/_PY@_91_P"C?_A?_P""2+_"C_AS!^RC_P!&_P#PO_\
M!)%_A0+G1^+'_#Z#X4_]#'^W!_X<:Q_^(H_X?0?"G_H8_P!N#_PXMC_\17[3
M_P##F#]E'_HW_P"%_P#X)(O\*/\ AS!^RC_T;_\ "_\ \$D7^% ^='XL_P##
MZ'X4\_\ %1_MP<_]5&L?_B*0?\%H/A2/^9C_ &X/_#C6/_Q%?M/_ ,.8/V4?
M^C?_ (7_ /@DB_PH_P"','[*/_1O_P +_P#P21?X4!SH_%G_ (?0_"G_ *&/
M]N#_ ,.-8_\ Q%)_P^@^%)_YF/\ ;@_\.-8__$5^T_\ PY@_91_Z-_\ A?\
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M\13/PH_Z);\2_P#P*L?_ ([7Z5?\.8/V4?\ HW_X7_\ @DB_PH_X<P?LH_\
M1O\ \+__  21?X4!RQ/S5_XBF?A1_P!$M^)?_@58_P#QVC_B*9^%'_1+?B7_
M .!5C_\ ':_2K_AS!^RC_P!&_P#PO_\ !)%_A1_PY@_91_Z-_P#A?_X)(O\
M"@.6)^:\7_!TQ\*"_P#R2WXF;L';B\L 2?09DK]<?V)/CM8_M/?LE?#[XAZ9
M8W6F:?XRT6#5;:TN=OG6Z2KN"MM)7/T->:2?\$7/V4)4*M^S]\+R#V_L2+_"
MOH'X:?#30/@WX!TGPKX5TBQT'PYH-LMGIVG6<8CM[.%1A8T4<!0.@H"R6QN4
M444 %%%% !1110 4444 %%&:,T %%&<T4 %%&<T4 %%%% !11FB@ HHSFB@
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M/P!LKCQG_:]S\$=>UC7Y9!I MX=5?48+^)K:"(2$6=O ;[]U&"X6.%$&,;@
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M77C[X>ZAXAU30DU#1DF@U1M1TV.RM8+O]^@8V[HSB8$<7$_RC(% 'M7_  4
M_;Q\3?L=^,?#.D^'/AS;?$1]5T#7/%>JB37TTJ6RT[2!:/<F /$Z3S%+D%8V
M:,-L.6%<W\*/^"F^K_'C]J/6_ 7A/PGX,ETC3K"TO+*]UCQS'IVMZLUWH4&K
MVPATLV[LT?\ I,44DBR$1XD;#;"M=#^WS^P;XJ_;#\5>%-6T#XC6?P[N-*\.
MZUX4U@MH"ZM)>V&KK:)=+;L\J+#,$ML)(RR ;\E#6/\  S_@FC>_L]_MA7GQ
M$T/Q%X1N?"EY#I]JNDZGX-CNO$%BEGHMOI,2V^L&<-$A2VCD=5APQ:0?Q$T
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M*XBAW)OVNWF\,/ND8^]Q7M8TY <[I"<YY;.*7["F5Y;Y:I5*/6G_ .3,/KN
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MFVIOV(WF\L?N@8Y;BD'[:W_%(C6?^%2_&P#[;]B^P_\ "+9O<>7YGG>6)?\
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M'.=Q!ZC/6E^Q)N!Y)'2FJE'K3_\ )F*.,P"T>&OO]N7^70\1/[:O_%(G6?\
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M3O$.AZY;ZOH.KVR7EGJ-FD<UM<PNNY'5U!!##D'^M?GO^V]\-_%7Q<_X*[^
M_#?A#Q-IO@^_UOX*^(--N]2O='_M.,V<MV(IXUC\V$"5E<%7+X!7[IS7E?Q
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M'=3?;U.HZ=<WL:?:X+.2>1E:>/Y(69OF3!V@'[Y-\3/$"3-$;]O-4X*?9U+
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M/*5U5[B*/,-S_P M$G:8AEC09*XS0!^\:^/O$K;#]L<"0C:?LZD'/0\"N/\
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M^U,GQ&\1PHK->. W3,"#/Z=?:AOB-XB1 [7SJA.-QMEP.<9^[TSQ^(K\OO\
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M._C;=>'="TU+G0=,\*IXCN]3GCN8)1(]S<6XM%C:'8)$:UE$BO(KHV%V9#8
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MWP\\+^')-6NM9NC:+=+9Q);Z/=W$]ZSQ2RQR011QL\T,B03%)8PT;^6V&)%
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MJD9"<1ACNKV&VC:*/#')S4E% !1110 4444 %%%% !1110 4449YH **,T4
M%%%% !1110 449HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110!%=C?&JX!WL!WX_*OR^_9O_;_ /B1X9\
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M_P""R7CGXB>+?"/@[1_@1;6_Q&\9W=G<:=I.K>-(8+/^Q;W2[O4[2^>ZBMY
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MX7UCQ-K-[;R>'_@YX;U+3+]]=GCFL;A_MNZY4^9B65BD8+.KERJ@[@2#]5_
MW7-6\2_!KPKJ.OPFU\07VD6D^JP&+RC;W;0H9HRG.PK(6!7^$C':@#JJ***
M"BBB@ HHHH **** /CK_ (+;_M"_$;]G/]EOP?>_"[Q4G@WQ1XH^(N@>%O[4
M;3H+\007UP89"8IE96QD-V/RX##-<W%^P9^V9M.?VY=V#U_X5-I0_P#:GK47
M_!P-_P FQ_"+_LMO@S_TXBONN'[I_P!X_P Z /S*_;;^#W[9?['G[(GQ'^*8
M_;-_MX^ = NM;&G'X7Z3;B],,9;R_,W-LSCKM-??O[+GBN_\>_LT_#W7M5G-
MUJFN>&M.U&\G*JIFGFM8Y)'(4!02[,<  <\ "O%_^"VW_*(S]HO_ +$/4_\
MT0U>K_L6?\F<?";_ +$S1_\ TAAH ],K\_OV]_B%\>/B+_P5.^'GP/\ A/\
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M8BZ^V7$[A2PA6:1LRE/EB$CL-^T,Q&3@ ]-FF$$98@D#L!DFE1Q(N1TKPO\
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M'_&MNQ\6/XB>/[!90Z;ITUQ8I:!N1(C31CC;NN"Q[F@#[&^WQXY+ ^F#G_\
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M*\1;25V#Y<$C&*B\-?"+P[X&TR*QT'P[H6BV-O<_:X;?3[&&UBAF*[#*JHH
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M/ECS]XG)/.*_2HG%% 'PA_PM7_@HS_T2+]ES_P +#5/_ (S1^PE^S)^T4_\
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M;:ZU;1ZQ8K:R7EA<A_(N44.Q5&,<B[9-KY0G: 5)]-H **** "BBB@ HHHH
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M2?!1\?ZMK_BG3?"MCHXU1=-,]Q?2-'&?.9'4?.%'( ^;DC%>2']O']L@$_\
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MCQC.#Q7WU7P=_P $?QO_ &FOVW5/0_&ZY''7']GVIH N_P##>/[9/_1CI_\
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MO!+%)M8!EW(ZG! (S@@&OOZH+73H;(GR8TB!_A10H_(5/0!\ _\ !QGXHLO
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/)=.QY=\_2?P&^%$WPIU#QVAM=.LM.USQ(VIZ9!9J$2*W-E9PX*@ *WF0R'
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MB^%WQL\'^/)_%WQL\8:MX%U)=8TBV\4>.KO5;&"[165)C%)QN4,<8(]#D9!
M/M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBC- !111F@ HHHSS0 449HH **,Y
MHH **** "BC- .10 444$@=Z "BBC- !111F@ HHHH **,T9H ***,XH ***
M,CU% !1110 449S10 4444 %%%% !7B'Q5_X*(_"OX-?'N+X9:UJ?B*3QG)%
M93-9:;X6U34X[=+R1XK=I9K:WDBB#M&_+NH 1B2 ":]OKY+M_P!COQ%KW_!4
MCQO\4;_7?'GACPLNA>&8]*CT37([;3O$L]J^IFY@O[8!GE2,30;=VP?OGP3S
M@ ^JY-5@B+;G4;!ECN'R^F>>,]O6I;:ZCO(1)$P=&Z,.A^E?CU\1?^"5WQQ\
M;^.?',=UX*^WVVL:Z6\6ZT_BX7,7Q<L;CQ/I]]99M9'7R5TO3(KB!A*$)&4B
MWA@:_6OX8^ =#^%?@33/#?AG3+/1O#VB0+9Z=86D?EP6<"#"QHO90* -N>=;
M= S9P3C\3TK@OV?OVHO _P"U)X6U;6O NL_VWINAZU>>'KV86LT'DWUH_ESQ
M8D52=K?Q %3U!(J;]IR[\467[/'C9_!.FW&K^,3HMVFB6<,L,3S7C0LL.&F(
MB&'*GYSMXY]*_+7QI^Q5\4/^"=G[#/QN\.^)/$>BZGX*U?PQX3O9=8T:*?1;
M)Y;*ZALM1TJ<K+/<QF\L4BB-V-L*+O>01?,: /U\CU.&1@OF*"S;0-PR3Z#G
MWK$^'GQ6T;XI>'1JNC27<EFUS<6@^TVDMG)YD$[V\G[N94?;YD;!6QM<8*E@
M03^(W[.?[(_CG]J/2O#WC/X7_#2%/".B_%&[UG1M3LO$R7TN@VR:_I<TD$,]
MS*JR6YLDN/WUHK2.T+P&3RD57]D^)_\ P2K^)_Q"\*^(GU/P&]]K>D^"?%2>
M$"=:B LM<NO&-]J&GS*%F"K(MG-'+&[\1%MH*OD4 ?J?\4?C7X7^"_A"?7O$
M^KVVDZ3;W5O8O/)E@)[B9((8MJ@MN>61$ QU8=N:@^-7QX\+?L\?"'Q%X\\8
M:F-(\*^%+&34M5O?)><6L$8RS;(PSN>#\J DGH#7Y-^(?^"47Q*\1V/[05A>
M_ ^WUC3M<U?3=?TQM9\3VES?^+)X/$@OKBWCG25(YHGT\S+')?0PSPF8V_F/
M$=P^VOV[/V=?'O[1O[.7PP^''P^TBR\#V=YKNCWFM-J,,-_8^%['3D^UQVTU
MLDR-./M$%M"JV\@R5R6$>20#WK2?VH?!&N>)? ^CVVL%]1^(^BS^(?#T/V:4
M?;[&%;9I9L[<)@7=O\KE6)D  )!QL_%/XR>&?@G\.]<\6>*M7M=%\.^&[-K_
M %*]G)*6D"C)<A<D^P ))( !)%?EE\3_ /@GE\<+?X(?"CPG=_"V/XFR_"O0
M_'/A*.XM=6LM)0?:KBS?0=5M(Y)P0(O+0A))/,C^S2.69UC,F-XX_P""37QB
M\;>,/CWIU]\/K#Q#=>-O =[:KXNUSQ##<'Q!K?DZ:;8VKK(LWDO/:S2"&]@/
MV21089BKG !^L_CGXN:)\.O"0UO4YKO[ 9K6#-I9S7DNZYF2"$^5"KOM+R)E
MMN%!+,0H)&[)JT$9/SAL<_*03C.,X';(/Y&OQEMO^"8_QBU+]HRU\4^$O@2_
MPH\-W.HVYFTBT\16#H+*+6/#]W LS+<O))+##:WH,8;R(C'L@3#EG^D_V(_^
M">7B;]G?]J_P1X]E\(2Z/J&HR?$-O&NI#51/)=+>ZY'<:)&Z>:P:+[,)71(Q
MMB9WW!7<Y /T0ZT4#I1F@ HHS1F@ HHS1D4 %%&:,\T %%&:,T %%%&0* "B
MC.:,T %%&:,\T %%%&: "BC.:* "BC- .: "BC(HS0 449HS0 4444 %%&:,
MXH **,T9H **** "BBB@ K(\=>.=,^&W@_5M?UFX-GI.AV<VH7MQL9Q#!%&T
MDCX4$G:BL< $G' -:]><_M6^$=0\??LW?$?0M'MVO=7USPKJ>GV5J2JK=3S6
MDL<2;FPHR[*.3@9YXH R?V8?VX?AY^V%H]_J'@2[\0WEAIT,%Q)<:EX;U'1X
MI8I@QCDB:\@B$RD(3NC+  J3C<,^J-JL"S"+S$\UL83<-QSWQGI7Y\?$/_@G
M=X]T/_@F/X/\"Z=?>/\ XGZC:7OA_6?%_@KQ'XM7?K=A:P1K?:!;70"1Q0NR
MC$;N(F,14L%:F_\ !+?_ ()U^)_@I\>[KQI\7?"-A-KFA^$M'L/!^I3:BNJ3
M>&$^T:PT^E0S%MY^S6EU96S2%=KB,;68#- 'Z(UP'[0W[4'@C]E7PQI.L^.]
M:&B:=K>M6?AZRE-O+/YU]=R>7!%B-6(W-QN("CJ2!S7?CI7P[_P5F_8<^*'[
M?OC[PKX8\)ZAH?ACPKH/AG7;FXU?6K,7]K=:G>0+96\"0QS1SQR1PO<OYQS&
MHE&%=P H!]N/?Q1LP9U&WJ20!U _F1^=8'CCXMZ'\.AI)U6>Z3^V]6@T2U^S
MV<UW_I4V[8K^4K>6ORG=(^U%XW,,BOQE_P""@7B37]6_:6^'&D_$G2Y-1^*6
MLZ%\/UTRRNO$,MM>>$+V+6XO[7$%K;@P7_VTK&\AMF<1+:[I?+VQAN@\.?\
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M(&C0:=X;>U@DUC4M M[1M/N;F.[^T"&.)EOK^80R1&8J#\ROY:CPV;_@F?\
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M$,1@ZR*P/F9 C"_-7>^+]"TCX@W5CI6M6$]U!:W,.M6S%)$BBFM)XI8G:08
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M[3>B^!+'P%=^)?&+7]OI7AA"T]WIMS<PW*Q.55[4?92)94D.Q3!RKG:-IXH
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MQJR);VZ00QQ+I<@1U<Q8QF1VED<ELMOD<C&]R0#S#3OVQ_B1JOA3PE:1:3X
MC\5^-K#2M<MI&FO'TVRM+ZQU"X\M@/WDDL<FGL-RE%=90<(0<ZWAG]N'5-/E
MT#4O%MCX<T[P[K6E:?XBGO[624+I5AJ4-VUFDCR';O6:U\IWP%=KF+:JX->H
M_ S]F3P3\%_!NA^'=*T?3&?PO]GECNO+03FXCMC;)<,!PKM$T@P %'FOM&"<
MVM1^#?PY\.^#-=CE\/\ AU?#FJ3-JNK"2)'MIG0^897SP I3< ,*I#$8YH \
MK^$?[97BGQY\4M*\/ZGX0EL!=3Q:5?\ EZ==JMA=2Z:NI!C=-_HY5(G2!H Q
ME$N7'R#%=Q^T!\>-6^%^LPV.BV>FW<ECH.H>+-3-\7'FV-BT*S00A",3N9UV
MNV47:<JV1C4N/A%X%^-TUMXB6V$>I:G86KK?6A>QU#[&62>.-ONR1;EPC<*^
MUF3('%=;XT^&OACQ]<Z>->T[3]3GTJ87UI]I 9X70_?'L"1D?=/&1P* /%/V
M;?VG/%/Q9O-'E\06/AZULO%&@:AXATU+%ITDL8[2]BMO+G>1F#&19XY,JJB,
MHZ_O 0U<EX2_;6\<^-]4TKPWI^D^&(M<U^[T[['J=W8WL&E+9WMOJ4H>.-G$
MUR8VTY@LRF.*X61639SCZ6T'X8>%/#:Z?<:;I6EV@L[62RLY(44".">5)9(U
M/]V2548CN0*P_!W[,?PV\ ZNFH:)X5T+3[\W2SQW$,8\T2Q"X"!6)) C$]R%
M0<()'  &10!Y+XE_:R\16_P&\$^)-/TS2'UGQ(]U)-8"UN[^6;[+O\Q;>&$A
M]KLG,LCA(%<,^_OR_C_]KSQOX]L_"GBCP5I]C:Z'#K,,$ND3RROJ.J2MX<FU
M<V^8R8VC,<D:!!@^;$K[]HVGV_Q-\*OAEXRO=)^'FL:#HMV+>UGU6RTHPMLA
MBCDC65@1@ %[E R$_.)>0RYK<M_V<_A]:>*]%U2/PMH,>K^&[:*TTN9;=1)8
M1)$\,:QC^'$321@XSL++G&10!\_^(OVR_%/BGXC,O@/3M&U;1KZVN$T6]=IK
MU[V.W:Q:ZGBM$GB2[*O<R($1TE'V><KNV^7(I_;T\0O\,-0\61:/X<N=.L1>
M:(L<,\X:;5;?2)=4\S<P&VU*Q^4T17S8W+ L=I!]SUS]E7X:>)?#]IHMUX3T
M,V-E%+%:00Q^0UJC3)+((F0ADS(J%BI!/0\$@V8/V=/A[(K>5X:T)E72Y-!8
M+"NW[&04>W('&,$J3][!()Y- 'E'@K]I;QO#XXL_!7BS3/"W_";:IJ]M-9KI
M;7 LI-#FADG>X E;S#)&L$T+-]SS6BX"E@.;TC]J/Q9\.H/$S:NVAZK87FO^
M)X="GN)IR^G_ &&_D5$N2 =T95U2..)0P*1IEC)E/7?!?AWPM\1?C?\ \)E9
MWQU*71[&]\,6,26 BATYH+M8[Q#+C<\ADC55!( 02[<AV-;]K^S=\/;/4_$,
MT7A;0DN?%XE.KXA7.H[Y"\K..Y9WRS#!)"$DE5P ?._P_P#VY?'7B_Q;>6%]
MX?TK2]+T+68?#FHW5S:7-H]]<S1PR(Y4S-+I;NMU"8;>ZB8RDA!*C.E=%^S!
M^T]XJ^)OB'PM9:YINBZ=I/B?1?MFFE&N)YK@I;Q,YCO&DD2Y<,666%UBFB*,
M290-[>C:-^QQ\(_ACK,>N:9X,T#2M0LM]VUT@(:1EC5&N)LMB:145 ))-S+A
M<$<&O-_A':? [XQ:V]IX$T/6=)N[G2K+4);NPTF\TR*&Q.R2"/SF18X//CB4
MD(5DEB);.&R0"+]I7QU\0/#WQXU.S\/:]9VUDUKX-2QLY1,D2W%SK\]O.TK*
MQ!CDA4HZJH9E51N&":JW'[>7B3P_XALM%N/#<>IZAI-U-!K;Z;IMV]O=JNJW
M.EAH9 6CL\O;O.3=2,I!$88EBZ_0^J_"+PCXF\56_B&\TG3KW5I(;:&&\?YF
M=+>?[7;@<X/ES9D3CY3DCO5>X^#/@:Z\1:=-+HNBOJ6FWMQJ=H"B^9%<SL99
MI0O=F=C(<@C> XPP! !YKXV_:1U[PIKGC/5X;'03X.\!7-WI^HVL\[1:KJ$T
M.F#4#+;-GRCD,D8A*%V^=]ZJFT\/\0/VT/'O@7[9IJ:3X-NM9T*VO-3U"4O<
MBSGM(],;4HXH%W;A,RCR6=VVCB4*1^YKV[XI^#/A]X&U0_$3Q#IFF1:GI4/V
M9=2GB,CHKG8/E&0SX8J&*E@K,,A2:LV?[.'P]TWPZ-.3PQH<>G(MZHA,0\M5
MNT*7*\]G0E".FT!1A0  #P^Y_:[\>VNOZOITNE>#'?PGIVK:SKC*]SMN8+*+
M2[D0VF3D.8M1,9DDR-\"ML"R;$S/#/\ P4#\3^/]+C;0?"<<']O7UE!H\VLV
M%Y:6]M'+JUOISK-*>+E_WS3J]M^[&PQL0<.WKLW[,7@'XA_%'1O%U[HEL+FR
MBNA!8W-H(O-N'>TS<.K?.9%2QA7!X9 NX'"X[ ?!?P+I%YK&MC0=&CN+Z\BU
M74+H0@F2XMG#QRG'0I(F_C'SAF(W$D@'A7AK]K?QY?\ CR"SU/3?"<>AV&N/
MX<O[V))_+N;N.]EM"3*)G-@7*HT44\<@FWA!,K.N/,_$O[<?CGQ%X^TJ _8K
M2TTWPCK?BRZ2SMKVPM-=MFT^=K6.%WD$K"*:W8B["JDH=7B"\@?0_P ,/"7P
M<^+?Q A\4:%I.AWVN11PZQ'="VDA:07J-=13[6 65V$C298,T9?JI  VM+_8
MN^$FFW37EMX(\/"?9/ T_E[F,<D<T,L18GF/9/.GEGY5#L !0!Y+XV_;4\6Z
M5JFBVVD:1X;GB\8>)CX2T8W4T_F64]M>QVMU/=%3\R.'=HU0 C:@<GS"8^XL
M_P!H+7U^![ZI=VFD2^)AXI?P8IB\R.P>\_M,Z<MR49FD6$OB0QAV8#@/GYJ]
M%G^!7@A?$,VL2>']'&HSR6DCW+1#>7MY%>W;)Z,KI&01R3&F<[5Q=F^&?A>_
M\.ZOH+Z9ITNFZI+--J%GM!262X<RRNZ]FD=BQ/!R<CGF@#YY_9U^(OB_XG_%
MSXZ:EJFJK!<>&8(/#VEV*3W)TVTNK>*X6XN%A,NTB2>/>" LBQ_(6.,UYA\,
M/VSOB1\#/@9_PF/B^32_&^E-?:;I,D<:7)U,W,WANQO#)&<L%B\W>3$$=W:9
MG# X0_:7A+X5>%? 5E-_8VE:=IL%]##;3- H47*(OEQ*Q_BPK%03DG<>2365
MX;_9P^'W@[PS8^'--\,Z+:Z9I\OVRUL1$'2-UMOL>_:V<_Z.WDG.1L.WI0!G
M_LQ_%74OBUX3O[G6--GT[4]'U&73)S)83Z>MX52.03QV]QF:%&$@&R4YW(Q!
M92K'TVN'^#$7A#P[H]WH7A*/3[+3O#EX=,EM[8%5AN#%%/L+-_K'*31MNR2=
MW))!QMZU\0--T+QEI&A3WD,>I:V)39VY!+3B)-[X(X7"\\XSVH W:*** "N=
M^(/Q<\*_"6U@N/%7B30/#-O=,8X)M6U"&RCF8 L55I64,0H)('.!FNBK\]?^
M"Z/PWT#XP?&/]C/PKXJT;3O$/AO7_C'#::CIM_ LUO>0MIUWE'4\%3CD=Z /
MK[_AM#X._P#15_AI_P"%/8__ !VE'[9WP>;.WXK?#5BO)QXGL>!Z_P"MKR;_
M (<D_LC#_FW7X3?^""'_  KY(_X+D_\ !+']G']GG_@F5\1/%_@CX*?#OPMX
MHTF;2#9:IIVD1P75J9-5M(WV.HR-T;,I]F- 'ZM*P=0000>01WI:@TO_ )!M
MO_UR7^0J?K0!P_C?]HGX<?#GQ#_9_B7QOX+T#5H(Q-]FU36;6TN8T<D!MDCA
M@K%6 .,'::R_^&T?@[_T5?X:?^%/8_\ QVOA?QG^R+\,/VN?^#@_XEZ/\3O
M?ACQWIFE_!O0[VTMM9L4NX[>8ZC<)YBA@<-M)''8FOI#_AR3^R-_T;K\)_\
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M_:=_;=P0<?&^Z'_E.M:5_P#@CY\374C_ (;?_:D&>XO]/S_Z3U[9_P $^O\
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MS;S+J/E:Q;:9J,43*^$V/<1JDK[0V6;;A,-IVW_!07P2?B59^&KA/L>OF?\
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M+[Z72M*\$ZO/XCEN'@T_3%U&W5Y/+#M-'.[$"TN(D7<\$@W8DCV[@Q8,TO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBCW-Y9S$!%:\.>'/$-AX^^"!\0:S\1M2L5;PUXBO;C4[V[F,>J7.G:S#.LI
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M10 4444 %%%% !1110 4444 %%%% !1@9SWHHH **** "BBB@ HHHH ****
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M.4 ?<$ERL8'\1)P *>CAUR*_+O\ ;&'[7'_!/32OAOXSUK]J6W^)&CZW\1-
M\+7VA3?#O3=-CNH+Z[6*0F:-F<83/"X.2.1CG]0;5/+BVY8[3C).2?K0!)11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#QKXK\4#49Y/#T&G1G0K7_A&X;/_ $VX.HM+')>K*9"_E1^49T C(,:S;F8
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MXTJ\\E_+E\BXUQX9-C8.UMCG!P<'!Q07&*9^[?\ Q%A_LJ_\\OBE_P"$S_\
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M/QM^(G[,/[/'B+XC^!-.^'FIZ;X&TFZU?7+/Q&;U)[J.,(4CM6M\('.6SYI
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M5/B+]HCP_P"#["VUO0=1CM)M#U47*65N)-12W0?:"L8G'D.)&DB^59/D(&&
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M\B/_ )YI^5'D1_\ /-/RH ]]_P"$DT__ )_;3_OZO^-'_"2:?_S^VG_?U?\
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MZ=\/K[Q%\!-6\2VMG:3^(919>(K'6!(1>F46^ZV:!W!-OM9I%Z.IZ3_L7_\
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M@OP+I/CNWO)-*UY;H6-[<V$X^S%62:WF>"52&8'Y9(W7(&#MX)% 'Y$>$O\
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MUI[IX1M/!L%QIVN7NKWFM"&5G:]=IF$5I PV;+.*,>6=WS=J\6\-_P#!*_\
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MD\TNK26@MVF#+<VAA<B(D.RJS L@P<,.".1D$&@#\U?BE^P'\>?BE^WOX?\
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MDM6NY[J,RF==]JVRZB4LNR[F1;F4'$F[8&/TQ]A09QN!/?-'V%#C)8D=\\T
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M.N6*>,+R[F\&:GJPM)M8>RLTUA;>QT^[CBNIA!^_.ZZE5;>UB29T 8./)8L
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MEAN-9\,MI-Y:N;2U\V*Y-Q;274,0B>>>X50KM,GEP1%61E)(!]3^)/[7&K>
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M_HW7X3?^""'_  I/^')/[(W_ $;K\)__  00_P"% 'JG_#8GP7_Z*E\,/O\
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M^R-_T;K\)O\ P00_X4 >L?\ #:/P=_Z*Q\-/_"GL?_CM'_#:/P=_Z*Q\-/\
MPI['_P".UY/_ ,.2?V1O^C=?A-_X((?\*/\ AR3^R-_T;K\)O_!!#_A0!ZQ_
MPVC\'?\ HK'PT_\ "GL?_CM'_#:/P=_Z*Q\-/_"GL?\ X[7D_P#PY)_9&_Z-
MU^$W_@@A_P */^')/[(W_1NOPF_\$$/^% 'K'_#:/P=_Z*Q\-/\ PI['_P".
MT?\ #:/P=_Z*Q\-/_"GL?_CM>3_\.2?V1O\ HW7X3?\ @@A_PH_X<D_LC?\
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M>>*\J_X<D_LC?]&Z_";_ ,$$/^%'_#DG]D;_ *-U^$W_ (((?\* /5V_;/\
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MGOZU(?VR?@T2A/Q4^&1,9RG_ !4UC\IP1D?O>."?SKRK_AR3^R-_T;K\)O\
MP00_X4?\.2?V1O\ HW7X3?\ @@A_PH ]6/[9OP<+9/Q6^&>?7_A)['_X[33^
MV/\ !DRAS\4_AB7 P&_X2:QSC.>OF^O->5_\.2?V1O\ HW7X3?\ @@A_PH_X
M<D_LC?\ 1NOPF_\ !!#_ (4 >JC]LOX-!B1\5?AD">2?^$FL>?\ R+2-^V1\
M&6*D_%3X8DH-JY\36/RCT'[WVKRO_AR3^R-_T;K\)O\ P00_X4?\.2?V1O\
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M"EW#W_*OA/\ XA^OAC_T5W]J+_PZ>H4?\0_7PQ_Z*[^U%_X=/4* /NS</?\
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M0@D1A'J7BK4(&^PKD@*Z65GOFX)Q+=1$_=&/M""!;:,(@PHH ?1110 4444
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %>8_MI?\FB_%/_ +$[6/\
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M   T_P#^2*^\** /@_\ X? _$W_HR']J/_P T_\ ^2*/^'P/Q-_Z,A_:C_\
M #3_ /Y(K[PHH ^#_P#A\#\3?^C(?VH__ #3_P#Y(H_X? _$W_HR']J/_P
M-/\ _DBOO"B@#X/_ .'P/Q-_Z,A_:C_\ -/_ /DBC_A\#\3?^C(?VH__   T
M_P#^2*^\** /@Y_^"P'Q,; /[$'[4;#/(^P:?_\ )%5O^"4D/C_Q[^VO^U!\
M7_&7PJ\<_"C1_B1)X;BTBP\4PPQ7LALK&6"8E8G8%=Q4AAQ\^,Y4U]]5'+:K
M*^[)#8QD=J )*_-7]H7QM\2_V1O^"T/C?XIZ/\ ?BS\6O"?BCX8Z5X;M[OPG
M902);W45Y<32*S2N@.%V<#)!8=J_2JB@#X/'_!8'XFX'_&$/[4?_ ( :?_\
M)%'_  ^!^)O_ $9#^U'_ . &G_\ R17WA10!\'_\/@?B;_T9#^U'_P" &G__
M "11_P /@?B;_P!&0_M1_P#@!I__ ,D5]X44 ?!__#X'XF_]&0_M1_\ @!I_
M_P D4?\ #X'XF_\ 1D/[4?\ X :?_P#)%?>%% 'P?_P^!^)O_1D/[4?_ ( :
M?_\ )%'_  ^!^)O_ $9#^U'_ . &G_\ R17WA10!\'_\/@?B;_T9#^U'_P"
M&G__ "11_P /@?B;_P!&0_M1_P#@!I__ ,D5]X44 ?!__#X'XF_]&0_M1_\
M@!I__P D4?\ #X'XF_\ 1D/[4?\ X :?_P#)%?>%% 'P?_P^!^)O_1D/[4?_
M ( :?_\ )%'_  ^!^)O_ $9#^U'_ . &G_\ R17WA10!\'_\/@?B;_T9#^U'
M_P" &G__ "11_P /@?B;_P!&0_M1_P#@!I__ ,D5]X44 ?!__#X'XF_]&0_M
M1_\ @!I__P D4?\ #X'XF_\ 1D/[4?\ X :?_P#)%?>%% 'P?_P^!^)O_1D/
M[4?_ ( :?_\ )%'_  ^!^)O_ $9#^U'_ . &G_\ R17WA10!\'_\/@?B;_T9
M#^U'_P" &G__ "11_P /@?B;_P!&0_M1_P#@!I__ ,D5]X44 ?!__#X'XF_]
M&0_M1_\ @!I__P D4?\ #X'XF_\ 1D/[4?\ X :?_P#)%?>%% 'P?_P^!^)O
M_1D/[4?_ ( :?_\ )%'_  ^!^)O_ $9#^U'_ . &G_\ R17WA10!\'_\/@?B
M;_T9#^U'_P" &G__ "11_P /@?B;_P!&0_M1_P#@!I__ ,D5]X44 ?!__#X'
MXF_]&0_M1_\ @!I__P D5R?QU_X*A_%3XJ_!3QEX8M?V*/VG;2[\2:'>Z5#<
M3:=8-'"T]N\09@)RVT%P2 ,G'%?HY10!\]?\$H_A=K_P,_X)O_!'P9XLTRXT
M7Q-X;\'V%CJ-A/M,EK,D2AD;:2,@]1G@\=0:^A:BBM5@?*EA[=C4M 'Y"_\
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MSHVCW_.@#X3_ .(@7X8_]$B_:B_\-9J%'_$0+\,?^B1?M1?^&LU"ONS:/?\
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MZ9'S%DW8 +>$::39-7)*E.2BYK73SVO>W9ZI/N?3+ZO"C$'?D<<#.:5M5A5
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW%!]I2".XM[7E@4WS)/*A90#)M!4[D!"HJAR:IF.%CECI<M2,W/3II?SUO\
M/?33?3HOB!^V+X8\ 7N@RW0OY+'Q)X9OO%%E=QQX1X+:."3ROF((DE68;%ZD
MJ1UJA\$OVTM)^-GCI=!M-(N+9KJRAO8G>[B>92]I;W1$L"G?$H2Y11(_RNX9
M16I\5_V;/A_\2;G0-/UJ)H8_#M@T6G64%YY"1VT;1;CMZE5"HF>@#=B01!\+
M_A1\-]#U]+;PWKD4NN:4@O&%OJL4MX()K6"W'F!>3$R0P,NX8WJK*>:E1H^S
MV=R.7+'@](3]I9W?1.[L_NLOD:GA7]I;1/%5OX[EM;3477P3)*UPB1J[Z@J*
M^9;=5;+AFBD4=,E1Z\8$'[:.D#1/#-Y>Z=<6[^(M2DLE,%[;WEM$J! ;DSHV
MQHMTL:$C[KEP?N<[7@7]G3P)X,358]#MX+'S=-;1-5:SF6&2[7_6^9<M'AC<
M@N[B4D,//8_Q<<K#^R_\)_&WAJ2XN[^V\5P^(TGLH=3N;VUN729\&26U=%$<
M=P!!'EHAQ]E0D94DD%1O[UR:2RQSDY1FXZ>OPZ_CKWLK&(W_  4K\*7F@:%?
MV.EZE+/KFB6NN"*]N(K"*P6YO8[,0W$KMMAD5Y=S;N @!_B%=-J7[:.EP?#N
M\UV+2KM8H#I<9CO+V*SC9M0<)&6F?Y4C0DDR'@C##(-8^A_LM?![X5&SUJ36
M!;6L<=M=I<ZCK:&">.*:VDBE8OA2IEBBRW1C*PS\P W/B?\ "/P/XDU#5?$U
M_P"-;W0[:Z73;JY:VU:TAL89+9E>SN,R1MM)X"@G8ZG[IZUI4CA^:T4['96C
MD\JJ5&G/D\[W?O?#IY7U\O/3;\<_M.Z-\-OA?X?\1ZM%F+7IHK<1:=>1WRQ*
MP+/*)%(62*-06+)QT]:YK6OVW](L4UZ.VTG4KF^\.ZCJ&FO TL<?FR6NS;(&
MR0(I0_R,>FULCY:Z;6OA#X&^)GA/P]/K]S8>,-*@LY+"PEU![:>UO#<;4\X!
M46-IF V*4 X9@!DUR'BK]F?X8#0UEO\ 7[RRETN#5;:35'UB))XQ/*DMTTCL
M-C/'(@8;U/EY<$88@S35'[29SX6&6-M5HSYKN]D[+5V5F[]D^OW:^R_#+Q['
M\0/#XO5CDMYHIYK.ZMY&5GMIX9#%+&2"0=KJR[E)#  ]ZZ9>_P!:Y;X6>&='
M\,^%;6'1Y6NK28M=?:GF$SWDDI\QYV<<,9&;>2O!W< #BNI3H?K7#.U]#PZM
MO:/EV%HHHJ2 HHS10 4444 %%%% !1110 4444 %%%% 'B?_  4>^.NO_LR_
ML(?%?XA>%#IX\1^#O#=WJNG&^@,]MY\2;E\Q 067/4 BOP/7_@ZL_:P ^_\
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MQZ:;/1>&_%S_ (*":3\%KW7_ .U_AO\ %^32O#C2?:]9M?#HDTPQH,F99C*
M8L<AB *]?^&7Q#M_BC\/-%\26UAJ^EVVMVD=Y%::G:FVO(%=0RK+$22CX(RI
MY&:^;_VM;.'X_P#[5GPF^#U[&UQH.^X\<^([<QEH+RVLOW=I;S?*5*/<NKE2
M0#Y&".0:^H+65%M .NPG@C&/2BK""IPLM7KO?3H:9M1P=+ 8:4*;A5J)R?O7
M]U>ZM.C<E)M:67+O<YOXU?'OPW^S[\*->\:>*+M['0_#MJUW=NJ;Y6 Z(B#E
MW8X"J.22*V_ ?C>S^(O@C2/$&GB<6.MV4-_;B9-D@CE177<,G!PPR,U\+_\
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M=C#\>^!=)^(_A.[T77=*L-:TF^0QW-G>Q++!.I[,K @_EQP>U87P7_9_\&_
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M,N(+2*32]+ECL6+6Z- A%N2<DID?*3U.,5T&SW-&P8I\\EL/VM31<ST,#2_
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M.6.3R:Z#9[FC8*%.2V&JDU:TGH<_I/@+2]"NVGM-,TRVF9=ADAMTC<ID'9D
M'&1G'J,UC7'[/7@N\BF@D\(^&);>:Z:^:)]+MV1KAAAIBNSF0@D%S\Q]<<5W
M.P4GE#/>J52?<?MJMVU)Z^9S][X TF^L;JUGTW3[B&[F%Q+%+ CI,X"@.X(^
M9L*HR<\*OI45S\--'O?$-MK$FD:.^K6G^IO&M8S/#\NWB3&X';\O!'''3BNE
M\L>IH\L9[_3M1[2?<2JU-^9_?W'#I11THJ"!)(UF0JZJRMP01D&OES_@LW86
MT?\ P2K^/XCMHO-7P3J!79""W^J/3 Z_2OJ2HY[5+E6#J&5A@@@$'\Z /S._
MX-1].BD_X)8OY]LI?_A-=7&9(N<8@]17Z90V\=LFV-$C7.<* !3;>QBM#^ZC
M2//7:H4'\JEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "N?\=?%7P[\,SIXU_6++23JMTEE:?:)-GGRMT4?XG@9&2,BN@KPK]L
M[X#Z]\;KGPN-#CL)5LY9[6]6XN?(,<%QY6Z4?*2P3RN4'+9&#P: ._U']H[P
M-I7C=/#4WB;2_P#A('U"/2O[.CD\VXCNI(!<)$Z*"48PE9/FQA64G 89T?%'
MQE\)^"-*GO\ 6O$F@Z/8VTXM);F^U"&VBBG*AA"S.P"R%2&"G!P0:^4O"/[#
M_CKP3^TWKWC:1_#NJW>K^)+?5K/Q%:75SIU[:VOG+-?6\T!>19EGBBBM!S\J
MJF $&%A\*?L"_$+3O&.E7NJ>*XYT\0:]#XL\0SV$-K;W6CWZQ7XDC@$D4L=R
MKB^6(NR(=ML"%!D^0 ^Q]$\7:9XED9=.O[*_V1QS,;>X24*DB[HV.TG"LO*G
MHPY&16C7SG^SM^SOXW^&W[1VN^.-5U73;NW\;B[35M+BB2,:2J3!M/\ +F"Y
MN D(:(Y$>-Y)W8%?1E !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1@9HHH ,
M<4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
' 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_X0 B17AI9@  34T *@    @  0$2  ,
M   !  $       #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN;P(0  !M;G1R
M4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M            ]M8  0    #3+4A0("
M                                 !%C<')T   !4    #-D97-C   !
MA    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:
M   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV
M=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#
M "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $
M/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA
M<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M         !)S4D="($E%0S8Q.38V+3(N,0
M                                        6%E:(        /-1  $
M   !%LQ865H@                     %A96B        !OH@  ./4   .0
M6%E:(        &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M        %DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H
M='1P.B\O=W=W+FEE8RYC:
M                      !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E
M9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@
M-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                        9&5S8P         L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                         '9I97<      !.D_@ 47RX $,\4  /MS  $
M$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P         !
M                     H\    "<VEG(     !#4E0@8W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNIW$$MC)IC\2+(YVI/#< J(_,PS;UQ[]_P %*/$WB[]D[_@E?\.O WAUM!\
MZSXP\0>&OAO=7'@T306VAVU_<+#<MIAF!D3$6Y49_F7<3]X"@#[^BU:WG5C'
M*D@3[VQ@V/?C\:GCD$J9&<5\!_#K_@F#\*_^"8GQ^M/B9\./&WB/P-X:T7PA
MJ;^)_ _V]]2?QXEI%YOVS%Q*7\V#.X^0@^9T *!V#>(?"[_@X_U_Q_\ "KXA
MZQ!X-^'\VH:?\,=1^)WAJUTC6;B_73([5U1M*U@&./R[O:RREHB%*L% R"2
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M?G!1CP"*]7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,T %?
M%_\ P4M_X)?^.OVZOCY\+_&WAGXQ6_P_C^%9DO-+TVZ\*0:Y;KJ3MD7^R:18
MS(B!50.C["-RE22:^T** /@?]I7_ ((G:I^U-/X5U;Q!\:M?L?%5[X9A\%_%
M+4]+T6WMD^)>D),)FA>(';:2%PP#KO"I(Z[3G-4_C9_P1Q^)GB7]N/\ X71\
M-_C[8_#:72] M?"OAS2F\"VNLIX9TN&%8WM[5YY<(9&$C&14#[9-A)48K]!,
MT9H&G8^&_&'_  1+T3QA^V<_Q$?Q_P")(?A[JOB:V\?:_P##UXDFT_6O$ULF
MR"^,SDO'$,*[0*""Z*0RJ H],_;R_P""=5I_P4!\3?"JV\6:Y OP_P# FO2>
M(-=\+3:<+N'Q;((3'#;S.7"K N^1F4QN6++@H5R?IBC(H$?GI\?O^#?;P+XF
M\5:[=_!^^\/?!'1_&'@#6/ 7B+1](\-I+9ZHE\%:.\VK+'B:&1$()W94%1MR
M36]^T?\ \$8I_P!H-;#/Q ATHV'P-O?@SDZ+YYD-SY/_ !,<^<N-OE?ZGG.X
M_.,5]VT4 F?$WQ=_X(UZ=\<_%_AVXU_QK=)HFE?!:[^#E[:65@(KF]BN/)S?
M),SL(F7RO]7L<<_>XYR_@3_P2"\9^$OCAX5\9_$/XW3>-F\*_#2]^%]I;Z7X
M9CT%[>PG\L)<1RQS.5G54Y8@Y;:5V $'[MHS0!^8-A_P;Q:_9^$I-"E^-6G7
M6EV?PRUCX4:1&/!:6YL-+OF247,A2Y'VB]\]6DED?"RESA$/)^H_VK_^"=[_
M +3G_!-O_AGQ?%0T+;I.C:6-;^P?:0?[/DM9-Q@\Q>'^SXQYF1NSDXKZ;S0#
MF@;9^?\ \?\ _@A;9_&J_P#VBKBW\?3:0_QU_LK[$KZ?)=1^%_(O+>]O]JM.
M!,+RYMHY"/D\OHN0#GO=-_X)@>)O 7[57B+QQX$^,.L>"/!_CWQ9:>-?%OAJ
MSTF&:XU*_@@6)XX;UVW16UQLC,T3QR9P0ACSFOL.C(SUH!,^//@-_P $O?$G
M[./QXO\ 4/"GQ@U?2?A/J/BO4_&MQX)AT>$37%_?QLLUO+?ERTEB'?SA$T7F
M"101*  !PGP6_P""*.L_"CX=? OPE=_%:'6M#_9_^(TWC7P^6\.B"ZNK25+D
MM97#B<AI?-N9'$X4 +A/+XW5]_44!<^#_AK_ ,$9IOA=\ _V9_!I^(:7I_9T
M\;W'C/[6NB>6WB$RO>.;81^<?(.+K&\%_N9VC/'QE\%?@9K.J_M1?LR?#+P%
MJGQ1O/!7PO\ BEJ7B^/PMXG^&ESX>;P'IH-S/+'>:F^^.\D,DP2 1MEEF;>2
MVW;^W4T*SIM;.,YX.*0PJPQN;'INH!.Q\^_MD_L/7O[2/C;X?>/?"GBS_A _
MBC\*;NZN?#.MSV U:RC2[B\B\M[FS9XQ-%+$!RKQNC(I5AR#Y/H'_!&'2O!G
MAOX%V.D^-+S[;\*_B3-\4-?U&\L%EE\7:I<I*+L[%=4M%=Y255 RHJ*N"<L?
MMZB@1X'^WO\ L.Q_MJ_#+1;&P\3W_@3QKX+UFW\2>$_%-C;I/-HFHPD[9#$Q
M"RQNI9'C) 96Z\<_,NN_\$(]=\9_"+QE)XB^.6J>(?C-XX\:Z#XWU'QK?^'8
M3;-/HS,+&T%A'(BBV1'<;1(IR>NW"C]%LT9H'<^(?VAO^"06J?'3QEXUU"U^
M*4OAG3_CAHFFZ%\7;*#0([G_ (2J.R01":P>24G39)(3+$V/.4(X( D4.=#Q
M5_P2BUOPS\>M4\6?"+XO:S\)M)\:67A_3?%NGV6E1W]W>6^BB..T-E=ROOM9
M&MT^SREUE1T8G9NRU?9U% CX*UG_ ((G?:?BSXC\<6'CV"P\3ZI\:K/XO:;?
MC0UDGTQ8H!!-IA)EQ*DL1D4.PPGF$A,\T^?_ ((J22?LT_\ "NE^(:1J?C<?
MC"+]=%^X/M_VL:>(_.Y(^YYQ;WV=J^\LT4#NSX?^-W_!&*S^*_Q+\?P6?C^]
MT;X0_&3Q#9^*_B!X,73$GN=;U&V9'S;ZBS^9:PS-#;F6,(Y_='RVB#D53^(/
M_!%:'QWX&^.FG?\ "P9[/5_BI\3+3XHZ!J<>E*Q\):E:" VZF)I"MV@,)#!M
M@*R'@$!J^[**!'Y]ZQ_P1!UCXG/\8]6\??&";Q!XS^*6K>&/$UEK=AX;ATY?
M#>K:$'^S2QV_FR)- 2^WRI23LSEF;YQVFJ?\$N_''Q$U/X1ZSX^^-%SXP\0_
M#7XG-\1YIGT!+:RD7R)(4TRS@$K-:VZA@P9Y)FW%L8!P/M"B@:9\;?MZ?\$M
M?$7[=WB"[TG6?BFEM\+=<FTVZU+PW=^&;>_OM,FM)5=WTC4"Z-8M<!%60M'*
M3\Q& Q6O7/VV?V+-*_;6^!(\&:EJFH:%=Z7J5GKN@:Q:;7FT?4[.02VMSY;?
M),J.,-&_RNI(.#AA[;10(^$?B5_P1?O/C1^S9\;-#\5_$U=2^*7Q\O\ 2;SQ
M+XMAT$6UC'%ID\+V=M;Z>LV$C2*(H6,K2,TA9F("J/I/]K3]C_PW^VA^SIJW
MPX\8->QZ=J<4+0WUA,8+W2KR!ED@O+:0<QS12*KJ1Z$'()%>MY [T9% 'PK\
M!O\ @CGK\'QP3XB_'[XU^(_C]XDTGPS>>$- BNM,BT:RT:RO(1!=S+'$[,UU
M+$71IMP8JQSDX(S/"G_!&3QGH7[)_C/X+WGQ\U?5/ .H> KCP!X6TU_#D$,6
MC6TKLRW5X$D_TRZB4K$KIY ,:X8,3NK[]HH ^1?VV?\ @EO)^U]^PGX1^#]K
MXYN?!VN^!X]+_LKQ9::<LT\,EI;&VD98BZE!-$TBD+("-V"67(+/BE_P2UN$
MN?A?XA^$WCI/AE\0OA5X3/@33]9ET.+5K*]T5XU62&6R+Q(LHDC29)$8;7!#
M*Z$K7U[10!\!6_\ P05\)^&Y/#>F:%XLU&U\)^'?A+K7PP^P7L#3W5[)J=V;
MR74WN$E0AQ.S.8U4 Y(#*.*A\-?\$(],6Q\+Z?XE\=W7B'2[#X4ZY\-M?06!
MAN-=N-7O3>W>JB4S,8I#.\C^5AER_P!X 8K] Z,T#YF?#I_X)$>)_B'^REX^
M^$OQ-^-VM>-O#_B/P[IWAKP]'!HD&F0^'(M/;S+6\:)'83WN]8?,<&..18$!
MC'6NK_9%_P""=/CCX(?MB>(_C3\0?BU;?$CQ+XE\%67@Z:&V\,1Z+!"EK.94
ME14FDZY)*G^-W((7:B_6^:*!'PI^T)_P1CF^/7QR^)'C,_$-=*7X@^./!7C+
M['_8OGFR_P"$=21/L^_SEW_: ^=^!Y>/NM5WXZ?\$9[/X]?$KXZ^)[[QU<Z7
MJ'Q9UCPKXCT6:TTQ7E\)ZEH$12WF^=RETK,S$HZ* K$=<,/MZB@#YL^'/[*G
MQN\(:?X<DU3]H:^UW4T\9R>)/%!?PS;I9ZMIS1E1HUG$\CO8VZL(WW^9*^X/
M@A6VCZ1A0HG)Y]/3VIU% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&<4 %%%&>* "BBC-
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M)6;P)J%O($M]-G/FN;M)?-C(=Q!(X3(3YC74?M$_\$AO''QV_:9U3QI;^)?
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M^-OC?QWX'OOB,/B7H_C+Q3#I.G7-MIAL=+TR73X+6T60O(TS!_,9Y"JY8@#
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MH3"]TF&5?*,TL330G[2NT JPYKV+P7_P2>\0^%?V!?B5\(=2O/AEXKU#Q?\
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MX\\=^!K[XBQ_$G1_&/B>+2;"YM=*^P:9IDEA!:6:N6=YCO,K22;!EMN/E!8
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M#_P2N\5:1\!_V+/!_P#PDWALW?[,6N6.K:U,$F\K6([>REMG6V&-P):4$&0
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M?#'@_49_$&NZC#$FH7FOS7PFC$(63<J-YMRYC\O:B^6/,8Y P/VA_P#@F/\
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MP=[[ ?X\<@'DWP,_X+A>"/B]\4/"OAK5? 7CCP-%XFN?$^EOJVL26)LM.O\
M0%,FH02F*=F*QP@/YRKY>6"@DY(YCP-_P<,_!SQE\*?%?B,Z3J^FWFBQ:3=Z
M/HUSJVFM=>)H-5N&M[&1'6X:*U9I%)E2Z>)X$P\@ J_\./\ @B19>$/B5X5U
MS5O'+:_I>@^*_'OB&[TW^R&MCJ5OXJ@$$MGY@G)C\A ?W@!WYX"8S7'^$?\
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MT'PKHWB+6)=2>)3I\^IH\D.G2)N\QKA(T+.P!08QNW<#Q#XG_P#!#36OB_\
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M?Q/\66?Q!AL(ELWC\->)+5XFBU*V=H2\@'E;3!.7B*N1MR P^VZ* /SQN/\
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M6YN?#5CIDEO=KIML%C\J2,7,3YD<.Q!X;N?4/C5_P1N\)?&SXO>.O&%]XO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ3;W#Z1I'Q"\$7/CB'7M3U.SMK+1H8;F.W-I=GS2(KG=+'E"?E+!2=U> _\
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MVW^!6H6VG^#YOAG-::WI/A."XO=:CMH(EU#[?J+S&:!;)]Z"VAC4'!=R1]X
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M>&] M4LM-TVSC$=O90(,+&B]@!71444 %&*** "C%%% !1BBB@ I-H]!2T4
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M_9^\8S^!O@</"OAGQ]X8DTWP+HEIH,.G?#R\N=4C\<0ZO ^L/&\YMX;&X91
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MTWPSXDU#PI='4+46Q^V6,@BF"#<04W'Y3QD \#%>HO>QH><@#))/ &.I.:_
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M &!Z4444 &**** #&**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW_HT'XH?^%;X9_\ EA0!]0T5\O?\-M?&W_HT'XH?^%;X9_\ EA1_PVU\;?\
MHT'XH?\ A6^&?_EA0!]0T5\O?\-M?&W_ *-!^*'_ (5OAG_Y84?\-M?&W_HT
M'XH?^%;X9_\ EA0!]0T5\O?\-M?&W_HT'XH?^%;X9_\ EA1_PVU\;?\ HT'X
MH?\ A6^&?_EA0!]0T5\O?\-M?&W_ *-!^*'_ (5OAG_Y84?\-M?&W_HT'XH?
M^%;X9_\ EA0!]0T5\O?\-M?&W_HT'XH?^%;X9_\ EA1_PVU\;?\ HT'XH?\
MA6^&?_EA0!]0T5\O?\-M?&W_ *-!^*'_ (5OAG_Y84?\-M?&W_HT'XH?^%;X
M9_\ EA0!]0T5\O?\-M?&W_HT'XH?^%;X9_\ EA1_PVU\;?\ HT'XH?\ A6^&
M?_EA0!]0T5\O?\-M?&W_ *-!^*'_ (5OAG_Y84?\-M?&W_HT'XH?^%;X9_\
MEA0!]0T5\O?\-M?&W_HT'XH?^%;X9_\ EA1_PVU\;?\ HT'XH?\ A6^&?_EA
M0!]0T5\O?\-M?&W_ *-!^*'_ (5OAG_Y84?\-M?&W_HT'XH?^%;X9_\ EA0!
M]0T5\O?\-M?&W_HT'XH?^%;X9_\ EA1_PVU\;?\ HT'XH?\ A6^&?_EA0!]0
MT5\O?\-M?&W_ *-!^*'_ (5OAG_Y84?\-M?&W_HT'XH?^%;X9_\ EA0!]0T5
M\O?\-M?&W_HT'XH?^%;X9_\ EA1_PVU\;?\ HT'XH?\ A6^&?_EA0!]0T5\O
M?\-M?&W_ *-!^*'_ (5OAG_Y84?\-M?&W_HT'XH?^%;X9_\ EA0!]0T5\O?\
M-M?&W_HT'XH?^%;X9_\ EA1_PVU\;?\ HT'XH?\ A6^&?_EA0!]0T5\O?\-M
M?&W_ *-!^*'_ (5OAG_Y84?\-M?&W_HT'XH?^%;X9_\ EA0!]0T5\O?\-M?&
MW_HT'XH?^%;X9_\ EA1_PVU\;?\ HT'XH?\ A6^&?_EA0!]0T5\O?\-M?&W_
M *-!^*'_ (5OAG_Y84?\-M?&W_HT'XH?^%;X9_\ EA0!]0T5\O?\-M?&W_HT
M'XH?^%;X9_\ EA1_PVU\;?\ HT'XH?\ A6^&?_EA0!]0T5\O?\-M?&W_ *-!
M^*'_ (5OAG_Y84?\-M?&W_HT'XH?^%;X9_\ EA0!]0T5\O?\-M?&W_HT'XH?
M^%;X9_\ EA1_PVU\;?\ HT'XH?\ A6^&?_EA0!]0T5\O?\-M?&W_ *-!^*'_
M (5OAG_Y84?\-M?&W_HT'XH?^%;X9_\ EA0!]0T5\O?\-M?&W_HT'XH?^%;X
M9_\ EA1_PVU\;?\ HT'XH?\ A6^&?_EA0!]0T5\O?\-M?&W_ *-!^*'_ (5O
MAG_Y84?\-M?&W_HT'XH?^%;X9_\ EA0!]0T5\O?\-M?&W_HT'XH?^%;X9_\
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MP/(H ]^HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRTO(UGM[B"19(IXV4,KJRDAE(((()!!H MT444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\+'PYH3>&5MOL0T;[##_ &>MOC'D^1M\OR_]G;BD;XM^'E\=_P#"*_\ "0Z
M?%'V;[8VC"_B_M!(,X\XP;O,\O/\6W;UYKRS]H#_ (*-?"K]GWX<W7B6^\:>
M%]9M[*ZTZVEM=*UFSGN5^W74-O!*5,HVQ#SA(SG@1H[C(6@#T/2_V>O!.B-
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M]8RF^N(;F6!8XI(I6CDED\O<(D8R)NV.JNK*/2[>0RQ@GKWH ?1110 4444
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M:O/M7A?3/#O[(WPIU'<(+W6H%U7QA/!T$I@8;82X)(!$3+@8?^)NK_X(\?\
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MA^!/_*6+]H?_ +$KP7_Z,UNOIZOF'X$_\I8OVA_^Q*\%_P#HS6Z /IZBBB@
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M\N_L!?#/X#_\%K/V,_ /A?XU^%+SQ'\3_P!G"T'A+Q#I5]<W.F7.C7BJ+=Y
M+:1%DCE^Q@ ]0T+@A6!S\S?M4_\ !/&']C#]O+X6_ _7_$D^B_L7?%WQ_;>*
M[.WN2]S#9ZQ!%L71Y)2S.L<LA@5&<G<9=QR8W)^\/VL/^".VJ7W[25W\<OV;
MOB/+\!_C#JZ7 \03?8O[1T7Q69%7!NK=R41MR@EU0Y(W;=_SUYA^TQ_P2?\
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M!\;_ -H#Q4\.F)-XU^"TX\/3:I>6P0VHU&SM+UX[:7=\T<D36Y8@#YHP.=M
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M+6UU:JMUK+2R))-'--N,0D;<59]M?MLL-LS,PD4D[<_/TST^F>WK7@_[2O\
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M*IK]*O\ A\'^RMO9A\>?AZ"W7_B;KS1)_P %AOV5Y00WQY^'I##:1_:RX(H
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MU&:XOM3\:6NFR--90/-*6BCN;4B\LY8K?9NCN1*B*]P0/II?^"PO[*RNS?\
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MY3.<,C @\@'/4$ @@@5XG_P^2_99_P"B[_#C_P &BT?\/DOV6?\ HN_PX_\
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M\%?M,_\ !23]H7Q3X \3:3XN\.MX3\'V8U'39?-MS/')K)>/=TW*'4D=MPH
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M5:_\^UO_ -^Q1_95K_S[6_\ W[%3YS10!!_95K_S[6__ '[%']E6O_/M;_\
M?L5/1G- $']E6O\ S[6__?L4?V5:_P#/M;_]^Q4]&: (/[*M?^?:W_[]BC^R
MK7_GVM_^_8J?/-&: (/[*M?^?:W_ ._8H_LJU_Y]K?\ []BIZ,T 0?V5:_\
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MK7/E11Q[NNU0,U)10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU'<_$'Q#JFE>(-*NO'0\:S>'-0T*.[MI=GAL:&ENQD=E.&47 <H<,H4*" P
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MP!LKCQG_ &O<_!'7M8U^60:0+>'57U&"_B:V@B$A%G;P&^_=1@N%CA1!C&X
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M+:CH/AOXA:[9^*!,OA76=8\K[-;6T+6Z/?0H;FR\R8>7C[4NU&V2!>A\2_\
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M/XB30U>]M1:;M/A+MYH=O,R"H ^8&NWU_P#X*?WWA;]A/Q=\3[KX?PZ;XO\
M 7BR/P-KOAB^\110V-IJAU&VLI'74A&RFV'VF.83-$#LSN12#7$:+_P1O\3:
M#\*?B'X3M?B-X"MX?%.N1^(='U6'X<I'J]A<)XA37%2]NA=[M0A#KY01O+P
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MPOXUC\2Z=8QZ4VGA4\]((U>67[=\RX'E>4/O[^/*/BY_P6BO_A%H7BOQ9/\
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M-15&:1O"N([/=(R8F;S?E(V[CC.%(/>O;A9(N>6Y_2@V2$#KQ5>TH?\ /O\
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M5'\<5%Z(29V\*8AMO, _UC>;QLS\V,XP>M>W"Q09Y;G]*/L28 YX&*/:4/\
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M:_PH_P"%H_\ !7;_ )_%_P# 7PU_A0!^\7FK_>%'FK_>%?@[_P +1_X*[?\
M/XO_ ("^&O\ "C_A:/\ P5V_Y_%_\!?#7^% '[Q>:O\ >%'FK_>%?@[_ ,+1
M_P""NW_/XO\ X"^&O\*/^%H_\%=O^?Q?_ 7PU_A0!^\7FK_>%'FK_>%?@[_P
MM'_@KM_S^+_X"^&O\*/^%H_\%=O^?Q?_  %\-?X4 ?O%YJ_WA1YJ_P!X5^#O
M_"T?^"NW_/XO_@+X:_PH_P"%H_\ !7;_ )_%_P# 7PU_A0!^\7FK_>%'FK_>
M%?@[_P +1_X*[?\ /XO_ ("^&O\ "C_A:/\ P5V_Y_%_\!?#7^% '[Q>:O\
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M?Q?_  %\-?X4 ?O%YJ_WA1YJ_P!X5^#O_"T?^"NW_/XO_@+X:_PH_P"%H_\
M!7;_ )_%_P# 7PU_A0!^\7FK_>%'FK_>%?@[_P +1_X*[?\ /XO_ ("^&O\
M"C_A:/\ P5V_Y_%_\!?#7^% '[Q>:O\ >%'FK_>%?@[_ ,+1_P""NW_/XO\
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M ?O%YJ_WA1YJ_P!X5^#O_"T?^"NW_/XO_@+X:_PH_P"%H_\ !7;_ )_%_P#
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MGU-&3ZFDHH 7)]31D^II** %R?4T9/J:2B@!<GU-&3ZFDHH 7)]31D^II**
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M9IRA9%<@'RP$4*#DX'+$DFOS4_X?O?M;_P#1I[?^$]XA_P#B*/\ A^]^UO\
M]&GM_P"$]XA_^(H#ED?>_AG_ ()G_#/PE#X42S_X2/\ XHSXA7WQ.TTR:@&/
M]KW8/F;SY8W0<G$?&/[QK5\6_P#!/CX7_$/7_BY?>(]&N]?B^-L6G1^)K&\N
MR;=C8)MM7@V[6B=>&+!LEAGBOSS_ .'[W[6__1I[?^$]XA_^(H_X?O?M;_\
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M'_XB@.61^O%%?D/_ ,/WOVM_^C3V_P#">\0__$4?\/WOVM_^C3V_\)[Q#_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5R7QO^"?AS]HGX5Z_P""?%^G#6/#
M'BFQDT[5+(SR0BYMW&'3?&RNN1W4@UUM% 'EO[(_[&_P]_8:^%A\$?##P^/#
M/A<WLVHFS^VSW?[^7;YC[YG=^=J\;L#'%>I444 %%%% !1110 4444 %%%%
M#+GFWD_W3_*OQ4^+WC+7/V7O^"^/QH^/]A=7,?A'P3XB\'>$?'L?'V:'0]:T
MM8?M<@Z_N+N&U?=D!0<G.<']J+YF6V;: 2>,8)_E7R9X=_X)NKX@_:6_:I\0
M^-KS2-;\"_M':=H^E#284=;NRAM-/>TF\QV&S<Q<.A7.W;ZT ?'O[(?[:NH_
ML+?\$MOC!XL\-:#:^+_%VN?M#>(?#'A?3)YC%97^HWVKB. 32 @I%@LQ/&<
M94-N&W^T)^UE^V%\$M(UKX.?%.\^$J^+OBOX)U?5_!7BKPW97,=KITVG6XN-
M4T^YB,HE\P60F\FXC&/.DB/0$5VWP,_X(/ZGX'_X)6:K^SQK_P 1((_$$'C:
M3QIX9\7Z3;.[Z1=13Q2V<[02%0[J(R'7.W+Y!) -=)\._P#@F5\;OC%\3;[Q
MI^TE\6O"'C37]&\&ZIX/\%VWAK0WM+#0IM1M_(NM5D5R"]T\9*$+A=O0C(4
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MQ?:KH]UH_P 9#H']G:?"DGVJQ_LZR>WD\YB-AWLV5VY^4<\T ?/'_!:SX7?
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MW9F-O:QY"1Q[C@*3P6( !]"4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %&*BNYS;0[@ 3FOE?]HK_@MA^S7^R5\7M:\!_$+XCKH'BKP[Y1U&
MS.B:A<"T$L231EI(H6CYC=6X;@'F@#ZMQ1@5E^$?%UCXW\.Z=JVEW=MJ&F:M
M;1WEI=0.&CGAD4/'(I[JRD$'TK4ZT  &* ,"BC/% !1BOGO]L/\ X*>_!3]@
MS4-+L?BKX]L?"NI:W"UQ967V&XO+J>%"0TWE0H[",$%=S #.!G/%>U^ /'VC
M?%#P7IOB+P]JMAK>AZS;I>6%_93+-;W<+J&21'4D,I!R#0!LXHQ7GGC[]I_P
M7\,_C'X*^'^M:T+'Q;\15OF\/6)M9I#?"RA$UR2ZJ4CV1D-\[+G.!D\5;_9R
M_:-\'_M8?![2O'O@/5CKGA;6S,+*\-K-:F4PS/#(#',JNN)(W'S*,XR."#0!
MW&*,"O)OB;^VI\./@U\5&\&^*_%5KX?UT>&+OQDZWD$B6L&DVKA+BZDN-OE(
MJ,0"K,&YR 17H?@7QE8_$3P7I.OZ7.MUIFMV<-_9SA643P2H)(W 8!@&5@<$
M \\@'B@#6QS14-[=K9VYD8D(F2QQD* "3FO'=!_;]^%?B;]D2\^.]EXH$OPK
MT^RN]1N-;.GW(V06LKPSOY/E^<=LD;C 3)QD9!% 'M%&.:Q? GCFP^(GA;2M
M;TJX%WI6MV,.HV5QL9//@E021N P! *LIP1D9YYK:SF@ P/2C ]*^._C1_P7
MB_9<^ ?Q-\2>"_%/Q/.D^)?"5])IVJ6Q\/ZE.MK/'C>GF) 8VQD=&/6OJSP#
MX\T?XG>#=-\0^']4L=:T/6;>.\L+ZSF66WNX74,DB..&4@@@T ; &**,T4 &
M*3:,]!7 _M$_M,>#/V6?">E:SXWUDZ+8:[K5GX=L91:RW!GO[N3R[>$+&K$;
MWXW'"CN17=P2-(A)'(./K0!)1BO*/VG_ -M#X??L=Z#H>I?$'7FT:'Q+J*:1
MI<%OI]SJ5WJ-XREA!#!;1R2R-M5B<+@ 9-<[^U[_ ,%*/@[^P4GAH_%CQ<WA
M?_A+5G;2MNEWEZ;H0>7YI(@B<H%\V/[V/O"@#WG%&*^:/!G_  5O^ 7Q%^#-
MGX_T+XB6FJ^&+[Q':^$%FMM.NFG@U6Z?R[>VE@\OS8F<D$&154 @D@'-?2=O
M(9$)88P<?6@"0C-&*,UR?QG^,WA[]G_X>:MXO\7ZQI_A_P *Z#;&ZU#4KR79
M';(#C&.K,Q(55&2S$  DXH ZBXA$L17&<]1TS7(Z'\"?"'AOQK=>)M.\'>%-
M-\2WI?S]7M]*MXK^?>07WS(@=MVT9R><#.<5U]O.MS DB9VR*&&1@X(STI]
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M?VB]8^+%KHQC\?:]H<'AN^U3[3*?/L()6ECA\HMY0P[$[@H8YP3C%<E\/O\
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M"_\ P3-^"?[/GQA?QWX2\%1:9XA478LBVH75Q9Z,+M_,NOL-K)*T%EYK??\
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M=D)*;D96(QDD@&@#\U_C'^T#\:OBGIW[7?Q MOC=\1_"$_P;\ ^#/&OAS1=
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MXQC!(/I6A?\ !/SX.>&?VJ]7^-UAX"T6U^*6NV1L;W7HPXED0J$9PF[RTF9
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M=DKM5V7=UW_@J?X!\/CQ\\FB?$*Y@^'NM/X:N9K;P\\D6L:P+F*V73;!M_\
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MZ# 95X) /N6BOF'QI_P5;^'GP\^+UUX/UG1OB'IT@M-7N]-U>Z\-RV^EZ_\
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M_:'<G'E@ @L,@'@\X%<O^TA_P4B\$_LL?%;X=:7XTU30O#O@_P ?:!JNN?\
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M<>068 -ZL.] 'R]\7O\ @E%XQ^)FA:+!:^,] TN^\/\ PHT#P=97+6<EPO\
M;6D:O::I!<NF5#6CRVBHR@B3:Q(P:UOA+_P3N^)D'Q_\*_%7QYXH\$WGBY_B
M!=>-O$EEHEK<0Z=!'_PCDFAVUK9&4F1V5/*D>2;&27P!QGT?2O\ @I1X&^)/
MCSX3V'PXUCP]\1-#^)WB*^\.S:KI.IJ\>BS6NEW&H$LH4EV98578=A D#9(&
M#%\&/^"BMA\5?^"@WQF^ %QX?FTG4?A+IFFZNFKFY\V#5K>ZA220E-J^2T9E
MC&-S[@2?EQB@#P;P1_P3G_:+^#?B_P ./HFN_!+Q9X9\'ZEJ^M:%I/B1-4CA
MTS4;_5K^\>^V6X"S7"PW4<2/)GRL2E,&0M71>!/^"2%UX'_;VUWXEOIOP?UK
M0=;\4S^-4UG4M"GG\8Z7>3(NZSMIMXMT@60%TF*F1 [+M).^ND_95_X+.?#/
MXX?LL:K\7?&^L>'/A5X4A\::EX0TNYUG50L6J_9F_=3J9$C8&6/,GE[244')
M.":]U\>_ME?"_P"%'BOP?H7B?XB>#-#UGX@;?^$<M+O588Y-9#%%1H!N^=69
MT56SAF8 $DB@#YT_9'_X)R_%/X"?'OX8W>O>+_ ^J_#GX*^']=\)^%+2QLKJ
M+5Y["^EM'MY;N1V,;3QQVJQ-L #;=^<N56#XZ?\ !-WXJ>-?CC\1?%GA;Q;X
M'L(=8\8^'_B3X8CU.TNI)+;6M+M(;(V=Z$;:]C+!$S;XBLJR2#@JF&Z+P/\
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M%FH>"?A]:_#W5].\=:-<ZCIB1Q>4XU&R$3I)YRNLB^7*=DB. 60Y)]\\8?\
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METO6/&RZA8+I-I<M8Q7?E)"9A<RL/-CB;9$P21B&Q@T ?,G[$W["GQ2^%?\
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MN^78OZ P_&GP7)/K40\9>%7?PW<16>LJNKV^[2YI6\N**X&_,3N_RJK[2QP
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M@C)R1G(/&*#8H23\WS#! . ?PH _,Z7]BCXM_!OXWW/Q"\-_"+PYXVB@\?\
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MEK&E)91^(]3BCV2R[8Y +B&;^&3>#*%QGD9^_191@Y(SSGG!Y]?\^E(-/3:
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MY6H6RZLEY#:W9!8LB3Q))L8 AP/F&#7W[_9Z8(RV#QC/ I4L(T &"0O8G/\
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M8Y8;3P1@8I%L8DR H /4=C_G^E $U%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 )(XC7)Z?RKRC3/V[?@UK'Q\N_A9;?$WP7+\1;&7R)_#PU6'[>DNU
M7\KR]W,FUE.P9;!Z<&O4;]"T2E5W,K C/3/O7X+W>O\ A_\ 9]_:*.A:#<^!
M_B7\/]0_:0#?\*[URSN=!^(WA;Q'-=!GO[:6VE,L]G$N9%=QY<D<A5E"Y6@#
M]P_A]\=?"'Q7UKQ-IOAOQ#IFM:AX-U(Z-KEO:S!Y-+O0@<V\H_A<*P./0BNF
M-_&&P<C'4\87ZU^%GBCQ[XQ^ /[0'[0/Q#\'?$?Q9X7>']K/1O#=QHVG7$0T
MO4K>]%NMV;J%D)F=H@$ +;5VDA0S$U@:U_P4U^(/BSQ1\8M?\$?%SXJR^&=7
M^"_C3Q3IXUS7;"2\MM1L-16""XM[&T7&E+&,K'&6,CH-S#!!8 _?'^T(P,_,
M.-W2D&I1LN<-GIC'/^>#^5?BE^W-^T+\=/V>_AO\$=.T?XO^*(+7Q'\,+WXD
M77C#Q+XJ321?:V([%EM6\NVD^U00K)O33(8]\HN7)9MHKT#X:?MA?$RR_P""
MIGAW3/'?Q3\2:G8^//$=I8Z1H?@?6+.ZT[1(IM/CNFTC5M#NK=;RW0'S'_M)
M/F"% 67)  /UO6^C8 YQGCDCKZ?GQ31J4?RYR"1G!QD#Z5^=_P 5?B%\2?$G
M_!8_XF^'-"\<>-E\/_#3X1:?XWTCP1IMXL5AK^JK/<K'#.H4NT4K!%=$9#)\
MH)P!7Y[:)_P48^/<?[.EA>ZM\<-4TL>(]2\"ZUJNJVOB?^UM4\--?7]S%?AR
M+5+6R@EB!<Z<[R-#]E&1M8T ?T-?VE$%RS;._P W&!ZT-J"1J"V5!;;DX_.O
MQ%\,_M8?%3XEZKX/^'VB_'_QY>>$G_:=N/AWI'CBQO8)-2U_0&TQYVC:[$9B
MN2LS,JR;3M*KCE% ZC6OVM/CWH/_  4]\1^#[;XBIX<L-$\7R_#[2]*\0>(9
M;M[K3!X?\VWU(Z/':R232^85OVU&21(RP:(C! (!^R2ZC&Q PX8]B.?RI$U.
M-\8W<G'8U^'7PN_X*$?&;P)^Q;^T4;+XE>-/'?Q3\'^"[#69-6M]?T_Q/X3>
M.[O5MYM8TR[@A6:RD2'SI!8SC$*Q[]G!J_\ !']H?XQ?'']IGX.?""_^.GBB
MP\-:EXQ\::7<:IX5\7MJVHW=A;:1;7J6DVJR6<<-W+!*TB+<0QMM67@AE7:
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MV_'K5!XH^)MWXB\!+K5B)_$FLZ?KK:-=PZ<9MMAK%DBQZA CD,L[Y=6&TX
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MNJ3AI((+ (UUJ+S(W[R>7;'  %!!QD _7=-2C<G&<#J3@ 5B_$OXL^&_@WX
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M#^';S5]:U&QTC2=.B:>[O;V=+>WM8U&6>21R%10.I8@"N6\(_M,> ?'WC_\
MX171?%FB:IXC_L6V\1G3K>Y5[@:;<';!=[?^>4AX5N^:^;_^"T'B72OBK_P2
M$_:,DT77K;4;33/#&HI-+HU^DH$]L<R6DK)N')4I+&<':64XSFORY\2SZCX'
MUWXH>+/AQ\8_'-K?_#_]E'0_$ECK.EZ[!-=WUU%<SLMM-<!&W6\$C,AB7:<1
MJC'"4 ?T$-J$2OMR<]O?V%>4?M _M\_!C]E+Q'8:/\2?B5X2\$:IJEJ;VTM=
M6OTMY+B /L,J@]4# C=TS7Y:^._^"@7QWG_;L\$G_A-(=%TO3K;X<K9Z;>:V
MUI:>++?6+-GU&5=*@M99;Z669Y4$RM'':FS7)&XLOKG_  4F^'WCCXN?\%G_
M  +X1^'S^"K;7_$GP*\1:9/-XH6XDM(;.>_6*615@^8S /N7/RG!!H _4#3/
M$%EK>G6]Y9W,%W9W<2S07$,BR13(P!5E8'#!@001D&I1J*,!@-DXXQR*_*GX
M(_#7Q_\ LW_MU77P+\+_ !*\>ZIX7_9V^ >BZUHWAFQG2WL_%NK6\EQ$GVB%
M07\N9E4/%&ZE\JI8@<_./P2_;R^(7B+X.75Q+^TOXTU6._\ @S/\3?%6KR:C
M!))\/O%L.H*MKIJ+$BGR9WS:FPDW!AR%#$&@#]O/B'\>_!OPFUCPSI_B;Q'I
M>AWWC/5%T70H+R81/JMZREEMX0?O2$*2 .N*ZC^T8B <G![XX&>E?C%X%_:M
M^)'QAU[]FSQ9XZ\3:K8?$3Q;^T<VA>,? \Z[;?P$L%E.(=(BAD4E 8Q'.91\
M\AGY8[:\[^!W[=W[2WQ.\,?$ZXF^-7A?P%XB\1^%M8U>\3Q%XDDO$\&WEEX@
M^S?) MFT6B1_9S)9[9Y79B$N!@\H ?O%]OC!P6V\9R>!CUI5O490<G!.!D=>
M<5^>?_!.CXG^*/VM_P!@3XV>']-\8_%F'QEH]UJ7AZRO]>U^PU&XT/4!:>8B
MV&NV486^MUE=2+APSKDKT %?&/[%/_!0CXQ?M=_'?X"^&HOC9K5W>_%?7=#N
MM;T^WF>R_L^ST#39QK44$I!&+FZCC,J8_?$G;\I+@ _7,?\ !2#X#L^KJ/BM
MX+)T"TU&_P!1 U!3]C@T^40WLK^BP2,%<_PDXKUWPOXGL/&OANPUC2KJ&^TS
M5+>.[M+F%MT=Q#(H>.13W5E((/H17\W_ (I^(.I?$+Q'^T%=ZM>I=W%M\,/C
M+:1,(XXQ%#'KMN(T 4 8 '4Y)[DU_0'^Q8XD_8Y^$S @A_!NCGCI_P >,- '
MIE%%% !1110 4444 ([B-<FN1O?A9X/U#XAIXK/AGPU<>*[11#'K+:= VH6Z
M8*E1/M,BC#L,;A]X]B:ZV6)9DVMR*_%;PE^U9\5_V/OVG/VB_%7@^_\ "EQX
M2UK]J33/"&L:/J.F375]J']HQVT+M%.)D6!8TV%!L<L[-G: ,@'Z]R_ OPE=
MR7;S^$_"\QO]1CUBY#Z7 WVF]CQY=V^4^:=<#$ARXP,'BJ8_9I\ ++?./ /@
MC.I1SPW>-$M0;J.X8/<)(?+^996 9PV0Y&6S7Y8?MK?\%K/CG\,/C9XJL/AE
MXE^'GBS1+=?%26\5GX(U*>UTB?0K=+A[,7TLL0OKQE5Q.L,7E6_FI\SGBNV\
M1_\ !;+XIS_ +XP>/=/\/V-O"OC_ ,-_#GP+96NC2:H]E/?VMM)<WDA$L7V]
MMTS"."/R_P!XL:%B&) !^E/B7X,>&/%]AH]KJOA?PUJUOH$T=QID5]IL,\>F
M2(,)) K*1&RCA2F" .,5._PJ\/OX]_X2O_A'M!_X2K[*+'^VC8Q?VAY&<^5Y
M^WS/+S_!NQ[5\P_LM_M^>+_&'_!.OQ?\2OB19Z)X*\5_#^76;#4[O7X'T[3B
MUD[>5>7-O!)<2VJNAC,EN&>5'#J,\&OCGP=_P6R^.*^'O%=K/J?A'Q%/HGQ'
M^'OA_3]:D\%WF@C5]-\0K(T[)97$[2JN(PT$K[6=&#-&-P  /UGM_ VDV7BV
MZ\0+I&DKK]S;)93:FEHBWMQ"K%DB:7&]D#$L$+8!R>M>+?M/?\$XO 7[4?PV
MTGP]#;67@NSL?&VF^.;B;P[I]K =5O;&;S5^T#9B02'Y78Y? Z]:_.G7?VK_
M (U_M1_\%QO!_A&+QGHGA_0?AQ\1O%_AG1;.'199X9+6UT:&XE>[07"K<3M%
M*\4;D+Y)8R -DJ?/_P!AW_@I;\6/^"<W[#?P,U"=O"'BCX9^*O#OQ U&ST*/
M3IUU:UFTB2YNDEFO6E"N99W*-&L2JD:C#%CP ?M;%\$?".CZ3H]O;^#_  Q;
MV?ANZ:^TFUM]*MUCTRY8DF>W79MBE)9CN3!^9N>34\?PW\+GQX?%,.@>'?\
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M  ]\/KKPM9>#O"=IX<U R?;-(M=)MX=/NO,QYAD@"^6^_ W9!SBODG_@F?\
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MHMK#<:@)3^]1Y%0%P_&Y23O[YK\\?^"HWPGN/C3_ ,%K/A-H$/PL\'_&4_\
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M?PI\*M.EO_$OQ-^-/Q*O4NCH3:]+!!IN+@0+;"X@R9))(@\IDV11),X#;0I
M/V,\8?L[^!/%FH:AJ.L^!_!FK:AJWE"\NKW0[>ZENC'CRO-=T+/LQ\NX_+@8
MQ4^K_"3P9JVJW%U>^%/#%QJ-_<VUW<7%QIUN\\]S;?\ 'M([,I9I(@?W;$DH
M#\I%?!>K?\%4OC-\9OB;X9TKP):_#7P5-H7PPT'XC^+-/\93".RU)]2U!+66
MP344G,=H(D$S+(4E+N43'.1\G?LF>*_&;:]\%K[QAJVD^.X]5_:VUK3;.6^M
M+E;JPN((KM)[J&=;G#JX1%BBD5DB1"OS\%0#]MM*^%>BZ%HM_IFGZ)H6GZ9J
MLTUQ>V=M91Q07TDQ)F>5% 61I"3O+ E\G-5/#/P(\(^#+.^MM&\(>%-&M]4M
MX[2^BL=*@MX[Z&.,QI%*J*-\:H2JJV0%XQBOR=U__@NQ\=_"?[/T?Q-O+;P!
M<:#\7_#?C;6? >G6VDS?;_!\N@R.(4OV:?9=)-&OSE-NUP ,J3CZA_X)S?MT
M?&3XP?MCZI\-?B;?>!M6MKOX5:#\2+.70M'GT]M.EOY&1K0F2:3S44 '>0C9
M_A H ^TO"/P^T;X<>$[?1="T?1] T:T!6WT_3;5+2T@5B2RI'&%5<DD\ 9)Y
MK'\(?"3P3X(T+5-(\/\ A;PMI&F:FS?;['3-,MX+>[+#8QECC4*^5^4[@<C@
MU^=_@;_@K5\9?B+^T#I]PZ^"K/X6_$KXK:W\&_#VFKI4SZ[X<O;*UE$.J33>
M<(KB-IXRSQ!5VQD;6)/',_\ !'+Q0O[#?_!#/QY^T/<Z?H/B#Q%<:;K'B&XE
MMM.>VU'438W-VD<=]<M*QNF\[S7#@(5279ABNX@'Z:W7[.O@F^^'4/A.7P1X
M*?PS:R":WT9]%MGTZWD!)#+ 4\L,"S'(4')/J:U-*^%'A[1?&=_XBL_#N@6>
MO:M EO?ZG#81)?7\:@!8Y9@N]U4*N Q(&!QP*_-SX'_\%<?B[J?[*7CW4?B)
MJ'A7P#XATS4?#=OH/BK7_"-Y!#>)K,"/Y$>BVD]S=3W*.LP@&Y%G1H9#L&]1
MP_P$_P""S'[1'[2%IHO@[1YOAQX:\>:+'XQUO6-3\4Z+)IVG:G::)?V]K!9W
M"&Z/]FR2>;(9I2THAV( &):@#]3/ WP7\%^ -1>;P[X4\+:%=FV-H[Z9I=O:
M2&#>9#"6C53L+LS[3QN8MC-/M/@5X2L_%']NV_A+PO:ZX;J6].I1Z7 EZ9Y4
M$<DWG*H;S'0!6;.64 '(K\A/C1^UM\6_V5_VKOVV?C/X!OO ]A#X9C^'-YKN
MEZC:RZRFJM=V4,(M[6XCEB2.$">5O.VLTF(]J+N)'W?_ ,%"_P!K'XH^ _C7
M\!_A)\);OPGH'B_XQW.JW,FN>(].EU"PT^UTVP-U+$(8Y$=I9&:-0<\*'/4"
M@#Z3TGP1X<\)^$/^$=L=&\/Z?HDD;Q+I-M:Q0V9C<GS$\D *58LVX!<,2<@D
MU@Z7^S;\,_#^A7^CV/@'P-I>D:R\7VVQAT*TAMKXQMNB\V,($DVL,J6!VGI@
MU^47_!-OXGZI_P %1/\ @K[HWQ@\867A>(Z1\+=/U^'1KC2I+N/1[B'4+NR)
MT^9ILP.;J)YQ.5+/$PC* @O7F7_!2F?XGWW[=O[0#0^,]-O]+T7XP_"RWLM+
MO[&X,$+W$<LFGA)%F)MH87W^<(T/V@REL1MU /W/M?A3X<M_'X\5?\(YH \3
MBU^P_P!LK81?;_(SGRO/V^9Y?^QNV^U5/&GP@\&>++_4+O7/"WA;4Y]5MXK*
M]N-0TRWF:[ACD$L44C.I+HL@#JK9 8 @9K\R?&'_  6#^.GPY\)^+_ ]X-"\
M1?$33OCB/A3IOB#0/",MV#;"P%\\XTHW8,LQ4-$D8N ,G)/'.U_P4;_:'\4?
MM4_\&V.N^._&&B+X;\7ZQ;:5#JUA!,GE)=0ZY;V\IC,;N!'(R%@-Q*K( >01
M0!^B$WP2\#^)5ODF\*>$=134=035+P2:7;3)=7D8&RZDRA#3J-N'.7&!S@5/
MIG[/_@O13;FR\'>$[+[)9SZ?#Y&D6\?E6T[EYH%VH,12.69T'RNS$D$U^5WP
M&^+=Q_P32_:5_:MU6;X;:=\,+GP1\&]-\96?PW\+:N=4\.Z@\<MVC:A)*8X"
MMTSK%$0$SY0;+$A<=;X4_P""N_QC^'N@^(/!7Q1\6_"31?&=UX2\*>+=#\76
MWA[4KC3X4UR<PFQ_LZ!Y)[N[1L"%8RB2<ER@!H _1R#]FWP);Z!?:9#X%\%0
MZ;J<4$-Y9+HML+:[C@Q]G22,)M=8L#8&!"?PXJSJ?PA\*WWC-]<O?#?A>XUV
MYL6TR6_ETV%[V:T;(-N9BN]H3W3.T@\C%?F-^S__ ,%8OVC?VD-4^!WA'3K_
M ,">'/$?CWQEX\\*ZSJ.J^%;@-';Z''!+!<_8A<YAN KR*T)E9=X4%AAJY3]
MG;]JSXG_ +;O_!0#]A_XM^.Y_!T'A_QS?>/Y?#.D:);W$=UHUO;VK6S074KN
M5N"?)5PX5,%F!'3 !^O6@>#K#P;X<MM+T?3+'2M-LHUM[>QLX$@MX8@,"-(T
M 5$ Z # KDK#]G3X96FF7%A#X!\ Q6UW;):W%O%H5HD<L*S>>L;($^:,2_O0
M"-H<;ASS7PW^W'_P5A^*WP*_:)^--UX8L_!\GPR_9O'A:#Q3HNI6$[:MXG?6
MI@C/9W*2!(?*CD3:K(=S@Y^4UG_\$CO@A=:S_P %!OVR_B+XBN_#_B#7=$\?
MZCX=M-0?1G35+5&M[>58XKEIFV6HA$<?D!2-T>\. =@ /T*7X5^$KS3M?LSX
M<\-7%IXH<RZW;?8('BU9RNTM=+MVRL5 &7#$@ $TFH_ _P %>+? 5EX:O/"/
MA'4O"^F[!::1-IEO-86;1GY/+A*&-2G;"C;DXQ7XR?\ !-WPG;? #X(?L#_$
M?P+HR:9XZ^*OQ$UKPGXQU&V69I?$FCM+J9D2Z16Q*(A:PNLC ^48 <@;L]G_
M ,$POVR/BIJ'[6G_  ISX?K\._!?A+6_$_CKQ-KTDVC7=]<3"PUV*&1H=UU\
MLTT;;3N(C4N7"_*J$ _7"_\ @OX7U3Q7+KUSX5\,7.O7%D^F3:G+IL+W<MJP
MPUN92N\Q$<&,G:1QC%5_^%+>#].^'"^#XO"/A>/PI"?DT-=*@&F_?W@"W">6
M/WGS?=^\<]>:_)OPY_P<)?&B+X.?$/XC7_@6WF\*ZKX:O]6\%2W&B?88-)NX
M]9&FV\3RF[9M1@V30O++''%LEBEC'&&/4?MO>.?V@O%7Q+_9H\+:_P#$7X=Q
M^)M,^.;Z FK>&K>2:#5%%D;FTN-2TT7 ^SR0[9-]DTKEB8I Z[,$ _42U^"_
MAJR\+:CH,'AGPS;Z!J\DLM]ID6FPI9WS2G,C2Q!=CES]XL#N[U%>_ ;PA?K<
M_:/"7A:Y^W::FCW(DTJ!A<6*?<M7ROS0+GB(_(.PK\U/@9_P68^-7BNT\*>*
MM?M? USX3^.V@^.]5\%:=8:;-'J7@^3P]'<20K>R-,8[I9DB&[8%VO@ X)(;
M=?\ !2/]K'3OV#?@G\6[P^$KG1OBEI[:WXD\0>'O 5YK"> ;46L1MO-L4NQ-
M<133%VFG08@7.U'VJ7 /TOTGX5>%;6318['PUX<M)/"430:0(=/@C;18W7:R
M6X5<PJRC!";0P&""*;#\!_!T4?B(#P=X34>+P!KP&E6__$\X(_TKY/W_  S#
M]YNZGUKQ?_@G_P#"G2=7U+Q!\?[?Q'I/B?7OCYH^AWNI76@AET#99VGDQ-9B
M15G*OYDC%IR9.54X" #XB\,?\%F?CUX<UCPUXR\27'P_U'X?ZA\9?$WPWN-$
ML]#FBU.6RTZ*[F6X%R;@HLP$"HJB,AR<DC.T 'Z@WGP \'ZA::G;3^#?!T]M
MK<5M#J$4FD0-'?+; "W692N)5B"J(PW" #;C JSXS^#'AKXD"$^)?#/ASQ&;
M6.2"W74].ANQ!%*H66-?,4X5U&& P&  .<5^0GB__@N_^T1\+/V<[;7];3X:
M:AK?Q-^'%I\3O!TUCH]PD/AZ&36K6SDT^]1ISY^+>?Y94*MYA.1A>?5_ G_!
M5?X_:3^UIH?@SQ)J'PYU;0K;X^S_  @U/[)X?N+*XO[>33?ML5U&QNI!$T1^
M4+AB_5B.E 'VIXK_ &(M!^)/[5/@CXDZMK%WJ5G\,+&2V\)>%4M;2+2-!NY(
M_)EO%*1^:\ODX1$=_+CQN50V&'JWC7X3^'_B1#91^(O#OA_7H],N5O+)-1L(
MKM;2=?NRQB13L=>S+@^XK\7/V3/V\_C%X-^(/CGX=_"EOAMX(TLW'Q-\;7\]
M[H5WJCO/I>JA0T8:['SS?*K L$&YF51M53Z3KO\ P7=^.&NV_P (9_#7@[3;
MVZN/AMX=^(/C&SL]$-U;7XU*_6WEA6Z>[B73XTA25DD<2[IF2,C!W  _5+2/
M@?X5\/RZ.VG^%_#=B_AUIGTEX-,@B_LLS$F;[/M4>5YF3OV8WY.[.34_@SX3
M>'_AR;X^'/#V@^'/[4N6O+Y=+L8K07L[?>EE\M1O<]V;+?K7YT?LV_\ !8'X
MU_'_ /:^\4Z/I7@6&]\#7]_XL\/^'(+G3$L(['4-&@#6V_4&NC]K-Q(DRS)'
M"GV??"=S!B5],_X)*_M_?%/]J3XC^)_"WQ;OO#6B^,]%TJ'5-3\$R^$M0\/Z
M]X;EEF\LJIFEE@O; ;2$N8WWNWWD48R ?84'PI\*7'BS6=:C\->&6UOQ!;?8
M=6U%=/@-SJ$ 4*()Y0N^5  !L<D8 &.!5*#]G_P!H%IH,,7@GP59VWA69Y=%
M5='M8X]&DD;<[6PV8A9F^8F/:2>3DU^4G[&_[7GQ5\/^*_!/PT^$P^'7@A_B
MM\8?BG9ZG=ZCI%WJ44 TPPSI<HC708RG=(2N]8V;:,(H-=3^U_\ M9^*?VW_
M /@UZUCXF^,8-/MO%&OFTM[]=+C>WMY7M_$D5KN169F0.L62"Q +$=* /U&N
M_AOX<\1^-]/\23Z%H%[KVF0R0V&KR644E[91OD.D4^TNBL"V0K ')SUK.A_9
MN\!VVFQV:^!/!8LX;*72X[<:-;"-;2:3S)K<*(\"*1_G:,#:S<D$G-?F3J=Y
M\6O^"57[(G[4WQJ\)?#_ $[X.^'-5U3PW)X"^'^KWD.JVNAL&MK+4+N2*TF:
M%%NFDW@)+NRFY@" #T'QO_X*F_M#?L]?$KXI/?W_ ,-->\._LX#PLGC>SCT"
MZM;CQ1)K]SG_ (E[_:&\A;6":)$,FXRR1$L$#8 !^D-W\"O"%])>M/X2\+7)
MU'3DTBZ,NEP,;BR0Y2U?*'= .T9R@QP*DT[X,>&=(DT%K/PSX<LCX71HM&,&
MG0QG1T9=KK;;5'E!E 4A-H*\$$5^:'[//_!7KX[>(?C5X"O_ !.?A[J7PX\=
M_&K7_A%#IUIIL]KJ]HMN9'MKYI_->)BBQ[614P^[.5/2K\*?^"RG[17BW2?"
M?B2Q\*>!/&D'Q_TOQE>_#;PM:6D]EJ&AW.A._D6M].\_EW'VB-2&*;"L@4#A
MC@ _3/P_\!O!WA+6CJ6D^#_"FEZB1,#=VFDV]O.1,X>8;T0-B1AN?GYFY.:I
MZ5\ _ ?A*WTVRTWP;X.TN#2+U]4T^VM=)MH4L;IAAKF)50!)2,@R* QSC=S7
MP!\(/^"M'C_4/V4/B!J/C/XF?#7PQX]\.ZSH>@O!KOP_UO3M7\,7NH,ZO:W.
MD1M,]Y*Q1UM#;R;)PA=V3E1Y/_P32_:_\:?MM?\ !7/X9>)_B!#;0>)=$\">
M./#%QY&GOIAG2QURWCC>6T:23R)MK8>/>VUEQGK0!^L^G_#;PUHJZZ+70]"L
M_P#A*)FEU=8K&*/^V963:S7&%'G,R#:2^XE1@DBD\,_"[POX%OTO=)\.>'-&
MGM[&/3%GL["&VD2UC),=L&55(B0G*I]T9R *^(?VMO"VO:+_ ,%R/V2=1OO%
M^L:CHVNOXJ%AX?"BWTW1DM]& WA%/[ZXDDEF9I7Y"%$55"DM[1_P6B7[+_P2
M6_:$E$DD,@\"ZB?,4D,G[DY(]Q0![;J_PD\&^)_[;%[X:\+:K_PDC0MJWG:=
M;W#:H8<>2;@,I\TQX&W?D)@8QBK>D_#[POI7C&\\2V>B>';;7-4A6*[U:&RA
M6]OHTP%62<+N=5PN S'&!TQ7X]_%[X-77[/_ /P3!T#4[;X->"?@FGQ2O_ _
MA#Q#XI\(^(7NM1USP_J$\9U"2YF\B'[$& BW,S2*?M#J6[F_^V%X0L?V7=>_
M;\^#WPX@30OA5%\#;3Q5_8=H7>Q\/ZS(LENQ@ ^6V,T$<<C1?><J'QC% 'ZY
M^(OAWX7\<^(=)U;4=!\/ZYJGA^;[1IE[<V<%U<Z;(V,O;R,K-$YVKDJ1G95+
MQ!\(O GBSQ6-1U3PGX2U36V2!/M5WIEM<796!_,B&]U+D1.=R#/RMRN*_,#_
M ((\>$;>/_@H;HZ>$? \GP1L/#'P6TZ7Q;X<GOH=WCRYO7CDL]:BCMW>.9%"
M3!I)&#HTH3:"6%<-^U5^S%XM_:H_X*A?M<>'_ASX!NM3^)$6J^ I] ^(0U:W
ML$^&31VT$T]SEY5G/G11.I%O&['9AAAA0!^P2_ CP@H\1[?!_A1/^$PYUXC2
MK?\ XGG!'^E?)^_X9O\ 6;NI]:O:+\+="\.:Z-3L-!T.RU 646G&[M[*.*X-
MK&28[?>%#>4A/RIG:O8"OS<^(_\ P5=^-WPO\*_MB^.IIO!%_P"%/V?_ !1+
MX-\-Z,NC3+?WE[<FSBM;BZG,^TP0-<;V5$WRAF *[5W8/CC_ (*L_M(_#S]H
MC0OV?[K4_A9>?$NU^)6B^$=0\4Q:!=#1=2L=5TB:^B<6_P!HWQ7$3H5(5RKA
M4Z;FP ?I;K'[/7@O7M?GU;4/!7@_4M7NIEGFO[G1[>6ZED6(Q*[R,A9F6-F0
M$GA6*]"15[PK\'?#7@?5([O1?#7AW1YX;*/3(YK+3X;>5+2,DQVP9%!$*$DJ
MGW5SP!7YK?#/_@K+\>_VAO"OPA^'7A^?X<^'/BWXP\=>,/"&K^)KO2;F\T-H
M_#<)DEECM1*LD<ER7B 4NP0*Y[J!S)_X+C?'#QOX*^%OQ$GTGP?\)?A?XFT.
M.6[\3:MX:O\ 7M NM;74)K.YL;F[M)C)IUM^XWPSO$Q<RH&P,L #]1+/X%>#
M=!\-:WI5OX/\)6NC^)97GUBRCTFWCMM4DDX=[B,)LE9N[."3WS46K?L_^!/&
M'@_3-"U'P3X-U/P]HJ;=,T^XT>VGL]/P-H$,3(408)'R@<<5^:/_  4:_P""
MJ?C[PY^T9KOPV\/^)?!/B+P1KFIZC\/]<TC3_#6H-+X>=]#N9RUQJ[LD!OBX
M+"U@CD")&2\@/7@_@#_P4+^,7[)/['7[+]C9OX:\"_!M_AAH5ROC7Q#X7O\
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MTY"[ H&U<')))U=+_9C^'V@Z7=65CX"\%65E>V1TRXMK?0[6**XM"[.;=U5
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MV.B:3!H.DV]E:PP6UK:1K#!#"@2*%%&%15'"J   !P  !5JB@ HHHH ****
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MZOX66Y\:G1)/#=S>+J%S%#J>G2)*C6MU;)((+B/;-+@2HVW?D8(!'L>:,YH
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M-E-93^6T1:.6W=)%#1NZ,N[:P8@@UZX6 [BEH \B^$?[#?PP^!/Q.7Q?X/\
M"5AX=UF/PS:^#HC:22+;0:1;2-+!:)!N\I%1W8Y50QSR2*XSXN_\$H/@9\=?
MCE)\1_$W@N:[\775_I^IW5U;ZY?VD-[<V!!LYIX(IEAEDAP K.A...G%?2&>
M:* /G[Q7_P $R?@UXST?QQI][X0E\GXA^)H_&FLS0:Q>6UR^LHH1;R&:*59+
M:0(H&8608)XY.=;Q/_P3^^%'BW]DF'X%77@VQA^%,4%O:KX?L9Y;.$1PS+.G
M[R)EDW><@=FW;G;)8DDU[6"#WHS0!X;\%/\ @G9\)OV?(?%B>'?"TMQ)XYLQ
MIFNW>M:K=ZU>:C9A&06C3WDDLHMP'?\ =*P7+L<9.:XSPY_P1G_9S\)?!_4/
M MA\-;6#P_J=_8:G<$:O?/?-<6#%K)UO&F-P@@W,(U60*@=@  37U+1F@#Y]
M^%7_  3$^#'P4\5^%M9\,^#1IVH^"=6UC7-%G;5;R?[+>:M&J:A*5DE8/YJH
MHVOD+C*@$DG.^%G_  25^ ?P5^.>G?$KPI\/;+0/&.D7U[J%A<6NHW?V>PEO
M4*70AMS*8(XY S$QJ@4,Q8 $YKZ3HH \&^+7_!-CX-?'KX]:9\3O&/@:RUWQ
MKH\=O%#>37=PL$XMY&EMC-;*XAF:%W9HVD1F1L$$$#'9?";]ECP9\#/$?CO5
M/"VD?V;??$K6G\0^(I3=2R_VC>O&L32D.Q"910-J +QTSS7H^>:,T ?./[-'
M_!*CX(_LB>-['Q%X#\'3:;JND07%MI;WNMW^IQZ.EP=UQ]DBN9I([=I3P[1*
MI9>"2"0=/X,_\$T_@Y^S[\74\>>$?"!TCQ5&NJA+Q=4NY@O]IW*W5[A))&7]
MY.BMT^7&%VCBO>\C.,\T9H ^=-#_ ."4_P !=!U?QU>P_#?2I)?B/876EZV+
MB[N;A#:74KSW-O;(\A6SCEFD:5UMA&'<ASE@",^Z_P""1'P$F^%.F^#QX%==
M-TKQ"?%L%VNNZ@FKG5BI0WLFHB;[7),4)3<\I^0!?N@"OIO-&: /G/P)_P $
MJ_@3\+O&OC'Q'H7PZT^RUGQU;7UGJEP+ZYD*PWQ/VV.W5Y"MJLY8LX@"!F /
M4"K?C'_@F+\&/'?P,\$_#;4?![GPC\.K867AV*VU>\M+S3+?R6@>%;J&59S%
M)"Q21&D*R*<,#Q7T#10!SW@3X=:5\,?".E^'_#VEV&B:%HELEI86%E$L-O:0
MH-J1HB@   #\J\@\/?\ !,OX->&?^$<%GX-,0\*^,[OXB:;G5+I_(UZZW>?=
MG,AW;M[_ "',8SPHKZ SBC- 'RGHO_!%?]FSP]X!\7>%[+X86%IHOCE(8-7C
MCU6],K6\5TMY';0RF7?;VZ7*+((82B;L\?,<]G_P[7^#B_$ ^*AX/4:^?' ^
M(_VH:C=$G7A;_9OMA7S-O^J^4QXV=]N>:]YS02!WH ^;_!O_  2F^!OP]\6:
MGKND>!%M=6U:RUK3KJ==7O&\Z#6)A-J*[6E*CSI/FR!E.B%:9KG_  24^ /B
M/1OA[IM_\.[.^T[X8:=;Z-H5K/J-VT LH)5FAMKF/S-M["DR+(L=R)%#C=C-
M?26X>HI: /#-!_X)S?![PM^T'K'Q3LO ]@WCC7!=?:;NYNI[FV1[M$CO)(;6
M1VMX)+A(U662*-6D4$,2":M?LS?L"_##]CO4=6O/ASX7AT&\UI(K>YN)KZYU
M":.UB+&&S@>XD<P6L9=RD$96-"QPHKVG-&<T >!_#[_@FG\&_A;XT\.^(]#\
M'"SUKPIK.M^(M+G.J7<OV6^UE574I-K2%6$P4?*P*ICY%6I'_P"";OP?_P"&
M0%^ @\(X^$PD$AT(:E=8)%Y]MYG\SSC_ *1\_P!_VZ<5[QFB@#@_VCOV:_!O
M[5_P8U/X?>.](_MSPGK!@-Y8_:9;?S?(F2>+YXV5QB2-#P><8.02*X7XK?\
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MJ/P5^*-O\04\5Z?X2?PO;7.EWEXEU?6,MY;9>*Y,(;$3))&SAHF'SXVMCO\
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M?"G_  5-\#^,O^"=?B[]HC3M-U&ZT+P-::E+K6BV]S;3WUK=:>[QW-KYL;M
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M:$N],\07/AKXD_V;#H>F@6]O<FXU!?\ 1XIY)9%A@7<-KRN^Q,;B<='^#O\
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M\&>,_&CZ%X;/C#Q=?>'HK>6+P?HWG"!;RZ621'<,V]MD8+;(BW8X^+/VQ_\
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MR]F9/M&WR<?+OW<5Q_PX_;X\!_$G5/B<T>MZ/I7ASX8:G8:?=>)+S5;5-'U
M7=C;7D4L-QYFSR]MRB98C+@XR,9 /<L45Y?\/OVHM)\;_M#Z_P##=H);;5]+
MT.R\3:==>;'+:>(-,NF>,7-JZL21%,ACD!'&^)@6#\>H4 &*,#THHH *,"BB
M@ HQ110 8HP/2BB@ P*, 444 &.:,<444 &,48YSWHHH ,48'H*** #%%%%
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M3QZ;::!#J%S:73C>\<31W^]\C.),YP*_5S[ G!R^X=\\THL(@A78I5NH(XH
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M!!DCC']K7+QJ08YV"/&$*&1$Q-E<L/G7_@VL<O\ \%*PQW<>#-7P#U #6_%
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M?\+BUO\ OV/_ (#_ /UZ/^%Q:W_?L?\ P'_^O7*T4 =5_P +BUO^_8_^ _\
M]>C_ (7%K?\ ?L?_  '_ /KURM% '5?\+BUO^_8_^ __ ->C_A<6M_W['_P'
M_P#KURM% '5?\+BUO^_8_P#@/_\ 7H_X7%K?]^Q_\!__ *]<K10!U7_"XM;_
M +]C_P" _P#]>C_A<6M_W['_ ,!__KURM% '5?\ "XM;_OV/_@/_ /7H_P"%
MQ:W_ '['_P !_P#Z]<K10!U7_"XM;_OV/_@/_P#7H_X7%K?]^Q_\!_\ Z]<K
M10!U7_"XM;_OV/\ X#__ %Z/^%Q:W_?L?_ ?_P"O7*T4 =5_PN+6_P"_8_\
M@/\ _7H_X7%K?]^Q_P# ?_Z]<K10!U7_  N+6_[]C_X#_P#UZ/\ A<6M_P!^
MQ_\  ?\ ^O7*T4 =5_PN+6_[]C_X#_\ UZ/^%Q:W_?L?_ ?_ .O7*T4 =5_P
MN+6_[]C_ . __P!>C_A<6M_W['_P'_\ KURM% '5?\+BUO\ OV/_ (#_ /UZ
M/^%Q:W_?L?\ P'_^O7*T4 =5_P +BUO^_8_^ _\ ]>C_ (7%K?\ ?L?_  '_
M /KURM% '5?\+BUO^_8_^ __ ->C_A<6M_W['_P'_P#KURM% '5?\+BUO^_8
M_P#@/_\ 7H_X7%K?]^Q_\!__ *]<K10!U7_"XM;_ +]C_P" _P#]>C_A<6M_
MW['_ ,!__KURM% '5?\ "XM;_OV/_@/_ /7H_P"%Q:W_ '['_P !_P#Z]<K1
M0!U7_"XM;_OV/_@/_P#7H_X7%K?]^Q_\!_\ Z]<K10!U7_"XM;_OV/\ X#__
M %Z/^%Q:W_?L?_ ?_P"O7*T4 =5_PN+6_P"_8_\ @/\ _7H_X7%K?]^Q_P#
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M\!__ *]<K10!U7_"XM;_ +]C_P" _P#]>C_A<6M_W['_ ,!__KURM% '5?\
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M-=C<_'3P?::WI^G3>,?"J:EJXB%A9G5H%GO3,K/"(D+[I/,5'9-H.X(Q' -
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M,0#R0#)=^/=,M?%5MH)U?2AKMW;-=P:;)=(E[<0J0&D6'.\H#P6 P#0!X_\
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MC7G_ #Z77_?EO\*/[&O/^?2Z_P"_+?X5[]M]S1M]S0!X#_8UY_SZ77_?EO\
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M*8+>P>]B6[GDV&0H(MV\L(U9L 9VJ2> < 'E']C7G_/I=?\ ?EO\*/[&O/\
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M^(@/X9_]$E_:B_\ #5W] 'W?17PA_P 1 ?PS_P"B2_M1?^&KOZ/^(@/X9_\
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M'&+>-H LJ@%VC&#[C_Q$!_#/_HDO[47_ (:N_H_XB _AG_T27]J+_P -7?T
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?+G_!;;_E$9^T7_V(>I_^B&KU?]BS_DSCX3?]B9H__I##7E'_
M  6V_P"41G[1?_8AZG_Z(:O5_P!BS_DSCX3?]B9H_P#Z0PT >F4444 %%%%
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M^RY_X1^J?_'J /NZBOA'_A57_!1G_HKO[+G_ (1^J?\ QZC_ (55_P %&?\
MHKO[+G_A'ZI_\>H ^[J*^$?^%5?\%&?^BN_LN?\ A'ZI_P#'J/\ A57_  49
M_P"BN_LN?^$?JG_QZ@#[NHKX1_X55_P49_Z*[^RY_P"$?JG_ ,>H_P"%5?\
M!1G_ **[^RY_X1^J?_'J /NZBOA'_A57_!1G_HKO[+G_ (1^J?\ QZC_ (55
M_P %&?\ HKO[+G_A'ZI_\>H ^[J*^$?^%5?\%&?^BN_LN?\ A'ZI_P#'J/\
MA57_  49_P"BN_LN?^$?JG_QZ@#[NHKX1_X55_P49_Z*[^RY_P"$?JG_ ,>H
M_P"%5?\ !1G_ **[^RY_X1^J?_'J /NZBOA'_A57_!1G_HKO[+G_ (1^J?\
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M"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\
M"JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/
M4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3
M_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\
M"/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9
M<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]
M%=_9<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X
M*,_]%=_9<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\
M*J_X*,_]%=_9<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45
M\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!
M]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\
MX]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_
M5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_
M ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\ "JO^"C/_ $5W
M]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\ "JO^"C/_
M $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\ "JO^
M"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/4?\
M"JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3_P"/
M4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\ "/U3
M_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9<_\
M"/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!]W45\(_\*J_X*,_]%=_9
M<_\ "/U3_P"/4?\ "JO^"C/_ $5W]ES_ ,(_5/\ X]0!Z7_P6V_Y1&?M%_\
M8AZG_P"B&KU?]BS_ ),X^$W_ &)FC_\ I##7Q+^TM^QA^WW^U)\ /&'PY\4?
M%W]FC_A'?&VE3Z/J/V3PMJ<%P()D*,8W,C!6P>#M-?>_[/W@*X^%/P)\&>%;
MNX@N[GPQH5CI,L\((BG>"WCB9USSM)0D9YQ0!U]%%% !1110 4444 %%%% !
M110#F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;+PMJZZ-/#K#P/+<2&!)]R^4[#;MDQR0<CTK^2^OW]_X,^O^32/BU_V/,?\
MZ;;>@J4$E<_7\=****#,**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^"+O[*$2A5_9^^%X Z#^Q(O\*"H/E5F?R/Y'J*_?W_@S[('[(_Q;/IXXC_\
M3=;BON7_ (<P?LH_]&__  O_ /!)%_A7JO[/?[(OPS_9.T+4=+^&?@KP_P"!
MM-U>X%W>VVCVBVT5S,$""1P!RP50,^@%!4IIJQZ-11THH,PHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
4B@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVD[94[$?+7'WOC_XD_$&$66BZ9):VLXVE[=2,CI]]N/RKV'XH> K?QOX<:-
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@0 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>mini.jpg
<TEXT>
begin 644 mini.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
M   *    &@    !'<F5E;G-H;W0 _]L 0P '!04&!00'!@4&" <'" H1"PH)
M"0H5#Q ,$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ
M_]L 0P$'" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ
M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\  $0@ 6P%$ P$B  (1 0,1 ?_$
M !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40  (! P,"! ,%
M!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()
M"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$!
M 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P !
M @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:
M)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#
MA(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3
MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ^D#UI*4U
M0UC48=*TR6\N&"I&I/U]J=KNR)E)0BY,??:C;:?;&:\F6)%ZLQQ5#0_$UAK[
MR?V>6=(VQOQ@-]*\,\0>(KWQ%?/<7;,(23Y<6?E0=J[GP5>#3K&SE495AAOI
M3Q:6&IQE+J>+A\R6(K\D=CU6EJ&&59H5>-MRD9!S4U0FFKH]P****8!1110
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M\$_$K0_'$3#393'=(,R6TO#J/7W%=@IR*S:<79EIIZH6BBB@!#44T2S0M'(
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B*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CervoMed Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001053691<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PAY VERSUS PERFORMANCE</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The following tables and related disclosures provide information about (i) &#8220;compensation actually paid&#8221; to certain executive officers of the Company during the last three fiscal years ended December 31, 2024, 2023, and 2022, (ii) certain financial performance measures, and (iii) the relationship of the compensation actually paid to those financial performance measures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">This disclosure has been prepared in accordance with Item 402(v) of Regulation S-K and does not necessarily reflect value actually realized by the executives or how our Compensation Committee evaluated compensation decisions in light of Company or individual performance. For discussion of how the Company&#8217;s executive compensation program is designed to support the Company&#8217;s business strategy, align the interests of our executives with our stockholders, and embody our Company&#8217;s overall compensation philosophy, please refer to the &#8220;Executive Compensation&#8221; section of this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 4.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Year</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Summary</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Table Total</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">for PEO(s)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(1)(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Actually</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Paid to PEO(s)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#160;(1)(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Summary</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Table Total</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">for Non-PEO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">NEOs (1)(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Actually</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Paid to Non-</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO NEOs</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(1)(2)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.9%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Value</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">of</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Initial</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Fixed</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$100</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Investment</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Based</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">On</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Total</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Shareholder</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Return</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(3)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.1%; border-right: 1px solid black; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Net</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Income</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Loss)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(in</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">millions)</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(4)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2022</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,424,613</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,302,245</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$400,727</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$318,800</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$32.65</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(5.80)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2023</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,518,279</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,366,539</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$467,047</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$457,134</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$32.82</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(2.17)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2024</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$1,036,352</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$953,313</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$732,491</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$797,375</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$10.06</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;">&#160;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(16.29)</p>
			</td>
		</tr>

</tbody></table>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">On August 16, 2023, in connection with the completion of the Merger, the Company&#8217;s executive officers were reconstituted. At the Effective Time of the Merger, (i) Dr. Alam, the President &amp; Chief Executive Officer of EIP, was appointed as the Company&#8217;s President &amp; Chief Executive Officer, (ii) Dr. Cobuzzi, the President &amp; Chief Executive Officer of Diffusion, was appointed as the Company&#8217;s Chief Operating Officer, and (iii) Mr. Elder, the General Counsel &amp; Corporate Secretary of Diffusion, continued as the Company&#8217;s General Counsel &amp; Corporate Secretary. Mr. Elder was subsequently appointed as the Company&#8217;s Chief Financial Officer in June 2024. Accordingly, (x) the amounts set forth in the table with respect to PEO compensation include, (i) with respect to the years ended December 31, 2023 and 2022, compensation paid to Drs. Alam and Dr. Cobuzzi, and (ii) with respect to the year ended December 31, 2024, compensation paid to Dr. Alam and (y) the amounts set forth in the table with respect to non-PEO NEO compensation include, (i) with respect to the years ended December 31, 2023 and 2022, compensation paid to Mr. Elder and Kelly Blackburn, the Company&#8217;s Executive Vice President, Clinical Development, and (ii) with respect to the year ended December 31, 2024, compensation paid to Dr. Cobuzzi and Mr. Elder. For additional information regarding the compensation paid to Ms. Blackburn with respect to the years ended December 31, 2023, and 2022, please refer to our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 29, 2024.</p>
			</td>
		</tr>

</tbody></table>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 1,036,352<span></span>
</td>
<td class="nump">$ 1,518,279<span></span>
</td>
<td class="nump">$ 1,424,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 953,313<span></span>
</td>
<td class="nump">1,366,539<span></span>
</td>
<td class="nump">1,302,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">The table below shows the adjustments made to the compensation totals presented in the Summary Compensation Table for the NEOs in order to calculate &#8220;compensation actually paid&#8221;&#160;in accordance with Item 402(v) of Regulation S-K. Equity values are calculated in accordance with ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of the grant, except as follows:</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">a.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the expected remaining term of vested shares as of each applicable vesting date was estimated using the simplified method based upon the award&#8217;s original contractual term and the vesting term of such shares;</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">b.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the risk-free interest rate for the expected term was estimated based upon the five-year interest rate as reported by the U.S. Federal Reserve Bank of St. Louis on the applicable measurement date; and</p>
			</td>
		</tr>

</tbody></table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 54pt;">&#160;</td>
			<td style="width: 18pt;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">c.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">the expected volatility of the price of the shares underlying the option awards for the award&#8217;s expected term was estimated based on upon the historical daily average volatility of the Company&#8217;s current comparable public company peer group during the 5.75 years preceding the applicable measurement date.</p>
			</td>
		</tr>

</tbody></table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>



<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div>
<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:72%;margin-left:auto;margin-right:auto;">

		<tbody><tr>
			<td style="vertical-align: top; width: 15.5%; border-right: 1px solid black;">&#160;</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 16.8%; border-top: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; ">2022</span></b></p>
			</td>
			<td colspan="2" style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 15.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; ">2023</span></b></p>
			</td>
			<td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 16.4%; border-top: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><span style="text-decoration: underline; ">2024</span></b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 15.5%; border-right: 1px solid black;">&#160;</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Non-PEO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">NEOs</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Non-PEO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">NEOs</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PEO</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Average</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Non-PEO</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">NEOs</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Summary Compensation Table Total</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$1,424,613</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$400,727</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$1,518,279</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$467,047</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$1,036,352</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$732,491</b></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less, value of Stock Awards reported in Summary Compensation Table</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$166,640</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$33,322</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$451,424</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$60,800</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$228,549</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$103,008</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plus, year-end fair value of outstanding and unvested equity awards granted in the year</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$30,611</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$6,122</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$268,769</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$41,752</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$24,448</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$24,696</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plus (less), year over year change in fair value of outstanding and unvested equity awards granted in prior years</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(5,761)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(33,258)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$296</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$154</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(90,772)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(40,685)</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plus, fair value as of vesting date of equity awards granted and vested in the year</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$24,721</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$4,941</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$32,961</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$10,239</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$133,708</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$135,062</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plus (less), year over year change in fair value of equity awards granted in prior years that vested in the year</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(5,299)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(26,410)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(2,342)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$(1,258)</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$77,626</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$48,819</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Less, prior year-end fair value for any equity awards forfeited in the year</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">$0</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Compensation Actually Paid ($)</b></p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$1,302,245</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$318,800</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$1,366,539 </b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$457,134</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$953,313</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>$797,375</b></p>
			</td>
		</tr>

</tbody></table>
</div>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 732,491<span></span>
</td>
<td class="nump">467,047<span></span>
</td>
<td class="nump">400,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 797,375<span></span>
</td>
<td class="nump">457,134<span></span>
</td>
<td class="nump">318,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Relationship of Compensation Actually Paid and Performance Measures</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;"><img alt="capvtsr.jpg" src="capvtsr.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<div style="text-align: center;"><img alt="capvni.jpg" src="capvni.jpg"/></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>
<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 10.06<span></span>
</td>
<td class="nump">32.82<span></span>
</td>
<td class="nump">32.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">(16,290,000)<span></span>
</td>
<td class="num">(2,170,000)<span></span>
</td>
<td class="num">(5,800,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">228,549<span></span>
</td>
<td class="nump">451,424<span></span>
</td>
<td class="nump">166,640<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">24,448<span></span>
</td>
<td class="nump">268,769<span></span>
</td>
<td class="nump">30,611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(90,772)<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="num">(5,761)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">133,708<span></span>
</td>
<td class="nump">32,961<span></span>
</td>
<td class="nump">24,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">77,626<span></span>
</td>
<td class="num">(2,342)<span></span>
</td>
<td class="num">(5,299)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">103,008<span></span>
</td>
<td class="nump">60,800<span></span>
</td>
<td class="nump">33,322<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">24,696<span></span>
</td>
<td class="nump">41,752<span></span>
</td>
<td class="nump">6,122<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(40,685)<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="num">(33,258)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">135,062<span></span>
</td>
<td class="nump">10,239<span></span>
</td>
<td class="nump">4,941<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">48,819<span></span>
</td>
<td class="num">(1,258)<span></span>
</td>
<td class="num">(26,410)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text">
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Policies and Practices Related to the Grant of Certain Equity Awards</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Our equity awards, which have consisted exclusively of stock options during the fiscal years ended December 31, 2024, 2023 and 2022, are granted in connection with our yearly compensation cycle, regularly scheduled meetings of the Compensation Committee and, as applicable, the Company&#8217;s compensation policies and procedures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">Typically, our practice is to <span style="-sec-ix-hidden:c10">make</span> annual award grants to our existing employees in January or February of each fiscal year and to our non-employee directors at the time of our Annual Meeting of Stockholders. In addition, with respect to newly-hired employees, our typical practice is to make award grants on the seventh day of applicable month (or, if the seventh day of the month is not a business day, on the immediately preceding business day). Our <span style="-sec-ix-hidden:c11">policy</span> is to not grant stock options or similar awards in anticipation of the release of material non-public information and to <span style="-sec-ix-hidden:c12">not</span> time the release of material non-public information based on any equity award grant date, but some awards may be granted close in time to the release of material non-public information to the extent those awards are being granted, for example, upon hiring of new employees or in connection with annual grants being made as part of our director compensation policy, as described further below under &#8220;&#8212;<i>Director Compensation</i>&#8221;.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#160;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">During the year ended December 31, 2024, we did not time the disclosure of material non-public information for the purpose of affecting the value of executive compensation, and none of our named executive officers were awarded options with an effective grant date during any period beginning four business days before the filing or furnishing of a Form 10-Q, Form 10-K, or Form 8-K that disclosed material non-public information, and ending one business day after the filing or furnishing of such reports.</p>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">Typically, our practice is to make annual award grants to our existing employees in January or February of each fiscal year and to our non-employee directors at the time of our Annual Meeting of Stockholders. In addition, with respect to newly-hired employees, our typical practice is to make award grants on the seventh day of applicable month (or, if the seventh day of the month is not a business day, on the immediately preceding business day). Our policy is to not grant stock options or similar awards in anticipation of the release of material non-public information and to not time the release of material non-public information based on any equity award grant date, but some awards may be granted close in time to the release of material non-public information to the extent those awards are being granted, for example, upon hiring of new employees or in connection with annual grants being made as part of our director compensation policy, as described further below under &#8220;&#8212;Director Compensation&#8221;.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>39</ContextCount>
  <ElementCount>21</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="crvo20250425_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="crvo20250425_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="crvo20250425_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="crvo20250425_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>crvo-20241231.xsd</File>
    <File>crvo-20241231_def.xml</File>
    <File>crvo-20241231_lab.xml</File>
    <File>crvo-20241231_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="crvo20250425_def14a.htm">crvo20250425_def14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>capvni.jpg</File>
    <File>capvtsr.jpg</File>
    <File>image1.jpg</File>
    <File>image2.jpg</File>
    <File>logo.jpg</File>
    <File>mini.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="73">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "crvo20250425_def14a.htm": {
   "nsprefix": "crvo",
   "nsuri": "http://www.diffusionpharma.com/20241231",
   "dts": {
    "schema": {
     "local": [
      "crvo-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "crvo-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "crvo-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "crvo-20241231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "crvo20250425_def14a.htm"
     ]
    }
   },
   "keyStandard": 21,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 8,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2025": 3,
    "http://xbrl.sec.gov/ecd/2025": 3
   },
   "contextCount": 39,
   "entityCount": 1,
   "segmentCount": 8,
   "elementCount": 266,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2025": 73,
    "http://xbrl.sec.gov/dei/2025": 4,
    "http://fasb.org/us-gaap/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "d_2024-01-01_2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crvo20250425_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2024-01-01_2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crvo20250425_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "d_2024-01-01_2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crvo20250425_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2024-01-01_2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crvo20250425_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "d_2024-01-01_2024-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crvo20250425_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2024-01-01_2024-12-31",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crvo20250425_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "d_2024-01-01_2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crvo20250425_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "d_2024-01-01_2024-12-31",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crvo20250425_def14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r105",
      "r121",
      "r156"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r108",
      "r124",
      "r159"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160",
      "r164",
      "r172"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r128"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r128"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101",
      "r152"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101",
      "r152"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r105",
      "r121",
      "r156"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r102",
      "r118",
      "r153"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r112"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160",
      "r164",
      "r172"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r117"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r195"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r117"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r110",
      "r126",
      "r161"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r110",
      "r126",
      "r161"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r102",
      "r118",
      "r153"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r103",
      "r119",
      "r154"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r104",
      "r120",
      "r155"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r111",
      "r127",
      "r162"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r106",
      "r122",
      "r157"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001437749-25-013543-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-25-013543-xbrl.zip
M4$L#!!0    ( %&#G5I]O!P'($@  !1@   *    8V%P=FYI+FIP9^R[!53<
M6Y(__L6"!G?70+#@#HT$"R%H< ($@@1WIX$$#4Z 0 @0",$A!'?WX.[N[M[]
M:][,>_/FR>S,[NQ_]^SY-^=RNJ]6U:VJ^ZDKT GH H#]1$9>!H"#@P,,87\
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MUO:MG'DR73*>[\5T"A9)_[H6A")T7<D?)[>)N2P-TA?X.& V"ZYAK'S KB!
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MGB/Y:26-?<PTOPT==41=-L)P+F)-R+Y)V66\^8@8B1V)DIWG$>?N1>C2U&
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M?5Q/0R@:M@D?71J?@XY%QR&$X("&]3.#&V3P0<:O?Q2AI4?FRX'&6 V..O;
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M9/UOU;SRT6^6H"*9U,;(H>\-Y\P^?M+X&D'I_X9H4;L8"D1^/N'5^1FP+?T
MS3)[<#%[L0[#:#N6ZO]I _GO%IG5O)P+6$C,@ Z+?<L;KAYN+1[2%2% SA5N
M%(YEZV VO4F5_9? 7A.T'%+&)$+C,44QI3-O3:E+^-P%6(WG:LR.RC:L0C0C
M.04HD C:O^;Q!XN(7 4$!1?FLYW)Q!]/33TV24P1F.&;Q/%[J<6DC'SH2EU0
M\*A5,Z&>75%L29 V6"M!H-R>_+O_QT]Z8?B7H1'N32(KI, 64R'N>*M.J28_
M;I<'(YIADJ[\2[WI$!M2/!1FN,X)E_BN&2I!1*2]C;]3UNP]7'FV+W(,1Z]>
MT=!/D1GMV'G<,C]A0DCX?O V?DQC@/?(JU"Q4TY.F^@'+J)$S0H)^>GBQ\_4
M$;"V\'SE?A,E4F1X(W'D0]XQ\Q W:2C@=7=7Y]U./!0X;GYTO:!RI@"^7"2Z
M/?CI)M!W72C0C]*P[R<[R08%UN=@%7ZZ/F92 052W?ZY_#*DS6#M)V9^A73H
ML;@=M0WE<R? _D\=UQJ<-V;\,K(FFX71:@<V'W<4ABD=O>!18^*<LG#NKG4:
M.2X'A_DUZR/3PP>Q#N_L7=<*MVTOSH"'E\#UEQT#B:J0KJ8TS*Q_CH.WL"%_
MNLO490L%1&BA0#T2U1W1*3C@>?B?;C,Q--P<O(-<X/]GY/-/]7[==M>IV%T5
ML</_3'[AZZLIP5/WE/MBBY([\A\DWB8^SM[KN+Z!O\>EU-N.0H^0]@=,K%.7
M![_0V1^VH>.\S-=F^R92,5O.UZ&<+=LM'(! C\US(VS-\#5^\$GHF_ZX8:L7
M+YXG1[F8[&X/^?*(_<^)ZE_L_6_ZM/^?R&?A;K5OX8V19D@>QQ4VHD1Q+:7+
M,02_/0#..PSEVJXI9LMS[!WM,^L&5.P,'.[AE<;2O*6L0O%=.2XUP8CUAQN[
M_87.7TG,X:Q<J-2'9<CTFMY,J>)[#%+<5R/:0KK56!L$W*SP6:&%,,KR_V9)
MDD9_L0P>5/9@:I/*MCCS*'A;+O0IGS\^]OYW"1&CP8X7$@O'&DQI&'GSZ.8Z
MR:9L"O(EM;X!L*"I\JT\IKJ14ORD?J,=&4D'29N>-5];QF-+%H?HM'#\ULKG
MB-@9$0 S"F6:Q_,D)OB@,\*$NDDKZK N!_85G#0)UA9$N06[';0<I.\2RAY^
MFAO_P>NO N<<K8GJ@MW=NA(!AL=#N80(.21BIT'+^YCZ%UG-_5\WCZ3(>YD%
M+"8"&D5.$"%QT1D7#\[ZI0=YPJ7?M%DCS? [Z'3Y]G"O %KWV@4$@"N-F:@S
MO9NI>=N1CBFEJ2.'3<OY_N*)PKRLTK!WX-?Z_#8J7*LNIYW]-J>\=;-U4R4Z
M_?A-SXC;%[]Y"Q2:ZF->3,Y-3$O32K,TO*=4Q\X]T/2+IW__?#W-5*Q#DH)Y
M:5U]U-;TD?DCZXRR<'[XG@IPGYU<GP$"<MKY,IZQZAQD:+=;9U:*FZE+:P5#
M_'0IJ]!YQYG$J4877'))B[(4:H]10Q\G.X?3F8]6!$2\O79M5T1H!;^JC=C:
M5X[1)KB)CU1FQK_D?+O"08?+@A=IX,"$4)->>RU=/EH6SKSX>:3HJ<'K)+)(
MYFNN3R7UB%;R1YUZ'C;$NZ'55WS55B)E'U6.9TV.382"P!P\GG:R@)D :I1]
M% > ;"Y'W+4]/!>MK>]*=X\R;:T*E<?:=+G-_^ADIBSX@_RJE$=W[G-M]>P9
MSO-Z(U\L0>0ZSUN\U@12$QAXT&]SHGF(X7_IJU+63GQOM8* IDI@C],?;KH$
M4?6'9#8)?0KPM85'$_O+@%Q,ZP*7$,<KHRV4;:V#Z2WT=#T=$<?.H;[. M;<
MOF+!U1#Z(S@K+#V,ESE0P-A 5X<MKJK:4HN=WNVFQ@^]?C_1YQ7=*H:6=8>D
M@$ ;X+3P9F M;^8UH4L,JZNKG?@>5Q[K9P4,OT;&$;]3VLK4"YE:"2/'<"[+
M$N0/Q"Q;F-V@\3<M(*EZ/"@ )]KQJ/K@K(0M+E],OZVIPIWCG AM3[T?/Q2=
MD/Z0##/K6R_@BJ=$4(K%VQJ"KQ+>3_?MN<J6_.;3LKJR.AE/E@\V!,](TJ,$
MD(=#UW:LV?=K&7(?QY2-?\(?*W<@"XQ2H-2CB_GA+OQ-R2XCNTW*>3&O,ZT\
MX9EE:U5TC&ZYPJ>P'3\"]5W#3)<\#,.STU[ .=4\R,IZ739$U\K,[K)?!$NM
MZ2;WR?+)+*.N_$G%"&20?U*#6KYF!H[2T*%;Z<<S97\'.ZQG0=]@J(Z%K&U*
MM+UAT;*.KW=9/FNR+).>J26/? %OP$/5@TXHYCWU*H%+_.Q-N+Q-P4(\4U8*
MTTIB>6O$ @DF=P!RSI5JDR/2B*F"=D8B @$;62 ).4[TC"9CEINJIP'ZQI7H
M%?W:E 6E-K756_HJ&;)O#N@/-T=4)3(NPKW\[.T06+BY=?I4$'A;2K]D'=J&
M^.K%%@<17X^P*:N]ST)ZR,)7OKOB?-1#SLD3*]1!BE%2U:BRI:BB"):-W7L]
MQM;N5B75#M=O( D2:AL^J7.9ZG-+6DSB#W#M<.FUIX\PABL7C$7A-\NF2_%/
M'ZX5%(MG8Z<+W2TB;;+>^Q*J]?U)+I)$C6^&I<,]]UYNJ2S/:X$]Z=H$._IU
MXI O<!$>]N-),B-6T>NRM14:%7!?U9C?8(NB.[9[;U->/ZVO#E(MX0C0E]1:
MP?OB&UPO-UJ]L.)N$H;I(.2H..+DN?WIQ=%1#_83(SEC=PX-]:YC[(@,$#L6
M,;5+)_7_:^?<OYE0  "\82AK.:1HGK4X%@E7L;;U0/.*E.N:K3PVC*YEK6&Q
M2SE2+&R+D$<+E:(8MC$JKQF3:D(6-XR<F3F<JY&.VSVG/^#^<G^]/WS_Q?=]
MT&U/E3)7>(2\V38%Z,(6JBK30OCK? 'I[24J>#$'_%YBZF2V8#DZN%BF6ULG
MC_@DMKTU&4B\$UND8PK)/PJ2&@5$,;*.REKM1LBM8;0,%+I/H[*)MQHVNZ<5
MT-:O7>IN]K?Y^FO J.!EBRB:+S@[])IX:PZ,F3\_[NQ6W'2$\UB>%ZR%@V.N
M\M?1N$&NSSX[4[BV#MF/K0LY]N4B"7T@+8[8T<G>X%H24VKW.?&0AO<SM8<@
MUR 0YZQ<P/*3YWJ!K1^^,G:=B<I(?^=+X4_W/XG%A,1CEB?9QE;M$D6R;">^
MPN -]+=B#0;K9L%^.8&L\'ID_#M]8A@X"4/"O_9+*P&(V1.+E$]EWI'2(NN"
MLY>8O'=?2QV6SV,OU=6P20>"31396AY73E6Y6M_M6G)!G8A^_W"CL >^]4@9
M* Z[KZZI<I):VYC] &"_J#-<86K)VY5"R,="(&P:4C-"8-G>/I ]YC/E>?#G
ME#0MM^L,XOMW+5501DMCY4SU#H=9W]VZETN6H^ERG 6E[]<+3EA+[YJ&)$WH
MB)]A7\J<9-&OI#27,!_<Z;=IX@Z+!-!LLL!U.M=R\_U%J;%AM94P5B:<.6UD
M #)G^%B= U&*_S0?N[HF8\O\7QR:[%H0.U5='MB_9YJO'Q/5'^@A!NW](^<Y
M;M' <1:/?\B[&T_6858S1(V@DG)R[CG=(!!C!?A)5$\:7C()B2DI!Z 2H#B5
M_YP3@;9CD$GLL4YR<4&$HCG@X<T\!QD>YR7S3/@<3T<.L=]4].L\L\C4R+V)
M=CEN./>6^'JFBK+]A$ HW'XAFJB%U#+A1-TW&Y""-S,A?<\;QF.5"DM"R<@A
M=*S9-TS=]*KZW+B=;M$SMWG.E&-/0V=7>N?8M.& _7R*>46#H=X3.<:J;^QG
M/ 5R],3*UBJJY.U%M06EZ^@11+](*62.<BCZK4=M2;U 9,^A&0'9581RSJ=&
MH-,9&[Z*G7M3Y>/8E3?,:]E"GG]R@=I9O,IK;IH99*;W<%$;+\(WXF:V_+N/
M&ZPQH&%4:D:<-OUZ1/*VY"A3F&(>O(N:?VP[0,G6C)W.)K1EE]$^&V*!?^T9
M96"$=;9E!U/#L7,^U2>+4R*?5G_@R#HT4L_5FW=F/JK7/,$.#L82WU$86Y;,
M=D5LK?"TM'DQ-Z'6C2!*$Q>KTL@OUKL)VE^)*D+$Z<)]V"#VK>2';1_][26.
M J'X#(!&D7"\V-TJ&)G+^C!W&*6/ZD-T?)E TN/IB>#0]:R@8/-$2]7QJ=/6
M><<"KT0,&0&%K!$D-3QE?U^W1[%DT?N&Z-3(5EYA\ K42FQ%/IX#32$N/X ,
M5U>F)G+CR3$^!#R9;@IGEM/<%EB"WH*62:]7I+ R^]WVR_N;.=+$L>_0:,3R
M]!382&];.:TAK;<M*_ ]KC='+3BXJ_%VV03A!R" -F$<Z0J+N<X"3C$E>SPB
M]?5P.JOX[F:<'\=+ 5]MC(E:\D:WI4+#(R!*?J%R,_MN(RQX\I?+"<,A7J^7
M)I<ZW ,6FA1(Q1$;16M_%4S&HAM8L,(?D))F?<3X0J"\ZUNT_H4\Z5F])#:L
MJ9[ETGYXD%=^ W7R<6A03MA '-4%@:H9OR)-D+B3)II%J![G9#TNV#G\7Q7!
M__D/\] ?$_\ 4$L#!!0    ( %&#G5JR$K<+^4L  "5H   +    8V%P=G1S
M<BYJ<&?LO 545=O:/[P(0:4$03H4$*2[4Z1$1$(ZE) &Z683 K(E! 2D2Z13
M6KI[T]W=W6SV_C;><^\YQW/.O>_[_^[[_=\QOKL8<XRUF,]<:\[YU.]YYIP;
M/@:? ^X\E9*5 I"0D(!7B#\ /@\P23J;O@$ >7F  0" FX@Z=@ 9<7<;44@0
M!9"V-3*RLC.QM@?@DX $@'[C!MH-5'2T&V@WT=%OWL;%N'WKUFT"G#N8N$0$
M),1$!$2$I!1T]TG):<D)B1ZP/*"E?\3(Q$A"Q<K)RL!!Q\#(</T2)/2;-V_?
MNHV/@8'/0$9$QO#?ON#U .Y-)#WD4!2D!P R+A(*+A*\&: $ *0;2#\NX)<+
M"1D%]08:^LU;MS$0!*5W &0D%!1D5)0;-U!1$;4>B'H %?<&WGUV<;2[BJ_1
M']C@<WB'I=RD?ES40*#4OT?#J6_K<^OV/4(B8A+:AW3TCQBXN'EX^?@%))Y(
M2DG+R#Y55GFIJJ:NH6E@:/3&V,34S,[>P=')V<75]YV??\#[0'!XQ*?(J.C/
M,;&I:5_2OV9D9F47?RLI+2NOJ*QJ;&IN:6UK[^@<&!P:'AD=&Y^87UA<6EY9
M75O?V#\X/#H^.3T[O[@>%Q* @O3WZT_'A8L8%S(J*@HJ^O6XD)"=K@EP46_<
M9T?#$U=$?VUS]P&']TW\QV$I10VWJ#F5]@CT;?MOWZ/AFJ?=OQ[:CY']UP;F
M\W\TLG\,[-=Q30"8*$@(YJ'@ J+ A128/AGYGY5O4G5?X8 U%O%7^SIZ'7UG
M'0DOCJ=%I%I[=$=Y#$M0R7MQN6=?VYZ&7[VJE=-8\D[Y>"LYPEY2'4<;;;$"
M2XQP!VJ<JB[G1#XUJACW0*3/LX$?US<>[[$!.CIZRI;9<DB-0:;\<L/)%VNF
M3I%^8RX@LU6&)9DB+2/O+<E(.I<KW8=17962[Y?D-9E,]<Q="\^X/+\'\&WP
MD^>H=,=&!3IEK%/0"/0L]\9NDCW=8_?%Z'UF5H%^WZ6C5W@-);5\_TV@@PT^
MV\QJ+XB%F(1./=UZ)_?=#8.M6WF"75UN&/PL!;3JKP*=!(OF;B\ZY%D_'16B
MO0I+.\S4?B!Y ]S\)"K_9H-16_O=_.?H72UFSIW\4>0<ERMNC*1#B0>TJ!%$
M[5C>H^9WQDX@9D#?MWV*& \'\I*[51#ZAWQ??61BZHFG4#)I;: ZPN=Y3Y>Y
M:VP'5?MVC/:Z/V2:W9GLH+FKZ;6"4AA2\SD$^;B#S":L>]-UJ\ @2\_93:6*
M1'^=.')FOL-_J>)F2F!GQU@^"%L2< TF6'8]#<Q+$V$@\:R% U5E9;%-774&
MA_&[XX=VPQP"=H-Y>)O?]%KRI#/,"5ESA%N^F1:UV#;S+ 65#?<.5!=1HR)%
MM "NZ02K/ ()5VV!%!C39EKF<8+CF@M]D^TI><6SG/P17;A;K43T5-Y32U6S
MS8Z/NV1-CG<3=V7BM06G2_R,5)[Q-,ZZWX&].Q2C"%3D;I9]6TA(84XMDS65
M_?$6=,S3877@S)^8KLR/U>@6[: 4Z_TA(S=I$/VK>Y=7"KC^*$ZN 4T"/7G-
ML=PGE9DRQ>0/3)82-1*%N\,?4?,3WW^N,#CIA2/YK8JPS&:*2?DQ#?$M(2-R
MSVP7 F$7ZP#HXX,)DV+SBX2^01:N-H52YJ9\EG<!;YW0!<L,3(0O;G^M6MZZ
MIV9C/M'34K/E26&:)E5EHJZP(KL<CD3)+T%(?MB>C*.;F5SIOTZ\O:1!H).F
M+\@1GBN*C&47[AS\>N]YM,/)I'WUT&LP_9LHL;L]1L3Z'I5\QT2YF[<B&CV9
M(N2B=F8(AE/P)K5J.CS*,?QHEE N&^UV.J?74,JB5'P(H][<(C/3&$O$QY;-
M8$1_T=5._:!ZXN1@4&>/(OU$+N_QR@4Y>]3!]-+'7#O,NY4*4NU6Z$3H(9'F
MRD.+WQ*O'M34WIDR,1=.[%BQ',B*8(K?]RZ,MPFB^(2TANZM?@*C&]QQ+V!Z
M+C395DR:2HV7;XN3(7&N1I[M[/-DG\9.:W:Z@4RSF5T!OYB_^YGO1]_;18F3
MWOIV/NS@@J^;FMHYMX,?SY[.,%2$L=/?^+C;A&.=X'**C[3!'9WE'/I\P%J_
MI,8\C*M3DQO<:^KDW=$@2?4136:+D:*'96&?>NVQ5IO_S.M,TA@6\D"_XGMD
M$1&'_G/[I1[RD@L]C^G==>8WG1T$&04+#^]8B;U-26/@^/[IP)DL*$GW$]+0
MF-ZDF2.[KGKGP_)/1F3(G+TXZ&'MK8\6YDB;K)>[PH@B/)L*E\*"ISG;%-)=
M3K[CUU*6DEAH^@W,R!H[.5J]3*1?^5RV6,;7ZW18/UV"&8XE;K,@.!DLL'A)
M^2)VX<I>4&,)3,>TT=(6.X\C-697OX-C(T;AC99G:9.KO1Y8K3TI52Q#_):G
MB.J.V]6@FCEXKZ<ELJT92U.'8S[?<GEP.X;&5%/[X/S\<Y)BJS/_:8ZRUG33
M@E8P!_^N)L8B^4*W%=D'>XE W.>VO.05*)>KE\DOT!5L;,CS<LOOAA<]]IOR
M8Q)#H?/NN+C=Z=OBJM,R.IYV:?))IJ@PXGF%6-#8!%$Q4-F^&5+JIC#$=)S
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MMK4D1PJ$C/>*E:T+M-M#W=+EJ+28GP#U4<_9[S,G3 8(AMX(+)#]RY?PL]Z
MR@X*:3C8?9ENNPI;$"0TV>5R"Y20)446IY^ZI1:TH]M\-RCHY.4J3.C,K)96
MPR$4)Z\V<&&LLR;_&TJQR#*I8[N*4>3'3_P0HCGODN4SZ07+D[B"ECF%P,>"
M>O@YECY'T*B)V")!"IZ; %UD W!/&^?S%D"1)2E9M0ASD80#( 4X<%?J5Y8
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MB] <U6*$PBYNBU(N:Y;NDXG#CBGW"GKB'6#7"'LUZ(?LU+[;XX6^OU"[>HL
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MM3.%8C6 >F6S7[:!W_3;#E$*JDV5_& %3S[TX+4]P1"D_>P3=N<ELSU!0*X
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M56>OHQ8PM!;D+MK^REM%0J$*;3Q.]EU&,FF(X!_Q.R_@CW'SBT6KT#!Y)L,
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MH8>9=6^SLDWR(?WL4_=TLU355>5!\_L=4$L#!!0    ( %&#G5HW80(:Z0$
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MW%9]5522<===I:I3( TQN)\2N?FQV)6_4$L#!!0    ( %&#G5H[&4B,F0$
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M)T%[>C"D]5J'F7G=H2(+2W3&WU[#6F*<O_J?&_1_7HN>#,X&60H<MU;_B@^
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M-R4#8RI6,H?S4Z2@T\_QC$S2$O_Z,P4=7^:4,*!,@7O2:*]%-TE*C*HJ15%
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M90S'53[WB,L8NE49P_LH&[6\IX@M_8"NP9%_U<"G/0L5WW'@Y!P[\NZP;>Y
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M*;R#?\LZOG4O2#%O$VCNVBW/U%1\(Q&?V^;Z]YKZ-JSQF\+H7%6D8N%36A"
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ML);R:O0EI4(H"$)!M=1.Q65ZH*0("M9EG+Z$M107.._5?VTZSS:M[F)"2(Z
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MQQ:-\,&0C)YT958!%_<IDP%J 9W+-)F,L!8J+WNZ+(32D7"R%"PEG2@V@7#
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MP1+2(M0^4Q5<YD%ASD^<K9K C+8J")].:(I9@L0NE-V<N*SU[0NVDDH37UA
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M#LQ 5LD L>40=L;XIJ;+&?4]VVWL"8/%PKY?J."GMHCOYAL@J.#+LW)$<S0
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MM=B U1KU>L=01<BP  9I1=*;!E+LGNZAI#LDQI.TJPT5(:V^10ZPP(Z[>!F
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M_/E272+JZ2-^ C11)X0E*=>B2Z%2PD>@(8*>K**=\'L5[B2V+6.>VFNN ^3
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M15#BGH5@/^.F0<<%E@A^^.JY,%A@L,^?CPRL2T^]UBJ.)Z__+=/&Q!/8@QG
M+.A^#U0R#O;3PSM&NI%#8A3QNK'[WV .O\5_Z"Y&90<!=$T*Y8B])P/8F<L#
MV25.^%\:M?I!'F1.\!'XLHY?GO"!'R%&XM,Z9/3S2%I0X#(" (0/EA1>V 6!
M-Z1*_N1]XD/83"@N+^F*7_;)HQ5C!P]105UL.9XJQB+5WP(&&T8!14';0*X(
M/7*;$5&)-#*ZSQ(P%+T.V="<VB%, R]\0T>=EB@&1S.A;!H9$(TI9<(4# QY
MDZ;V=QO[O=0-:1XFZ?O,A1A&7)C.0R#N68Y\+J)?$^+X!/K%M,I^Y<FE*/JQ
M\.8@:?3WQ;7I!E($R5YRUPT>G#O8L<D^ S"OAV//(]0 Y?:ZBO<\ F^X&.(K
M(*?I>G>F-I#8K\D^@BZ,+V#S#V]B#R7BW$0C %WR^#K>\3R3Y\\Q&(PY[/]I
M6J<B4^63%(Q6D6FCK0)T9GGM-7<1^Y:9Q)#$KW%79+;Q)" <T'^L=BC8[H].
MBCO#'$2:^LPD/K*?8?(Y) 2O&)GE)-//G5?I,!A ?O/@BR;QIL%.W6&5[9[W
MKH][__TS^WQZTM]+28@Z04+]TLD"(L7JU%R6MD=-"M&P.D>M-_2Q:2)3Z^09
M\R@]7ZIW:WN!7/V01Z1;P@.@EDVXA9"B#1&ESFQ3RP*U@RP,[Z7ZL-3)723)
MIF;(O@)'X]^SBTJ@^O7JYG_V4+S=.MX 1AK87@A\T 4+Z?8A$6<S\*EULC((
M(":#Y60@'.JBXG8;=@@D]8VV_CLP4 RQILN6>XXY+X&,PN(F9L/I)Z1&D=(M
MM8!&"AUKG3R@J:L,/+(86+B*:W/$@?]>I!-SS[ U@.O:T60&8$*X!1CA8N8'
MYGWM?S[J'??5FN4U!CX=1$,,"AQ%%%"DKDID.@P6+PJY&_D\B[_8AR@@IBZD
M !P-"*@)9ID]B -)2Q)DI[^":AJ,8==2?B"O$\_^=V3#SJ:VB3$QL,U;&2$(
M#_4M^<R1.1GXMG7+U2/K*"B6D0H+[.JT9*"&PS*I9+Z!\/*&FZ'=:"'[51=:
M=&NF%JY:W2@F'RAC8 ZC?_YB*!-4>-G'(JAIS!U+RKMS&$?IH3)I,E?\F!FU
M7Y><*<6_-:/>MG)DC?:ZD0&+F$8$ %E^=)OB*;@^R>S\!""4NLEO4>M4YM)#
M+.749C+S(&T+"^XBSL97YI&)G9U\$^]U@Z&-P5W =.65+'XA[U7WE(25MADI
M[VIJ0V>HVEI-<5H&B]D!-EUSHQ'HQ8*IR#BRT/><9-JCLZ-XUG>,N#SQPZ0Z
M@1$S+SI$L&A&GF-[6J08JMR6$J2(7L!40!45C=_P)?WJ.A$D5?;'V 9>*:$R
M>UZA;P\B&=Q)<!M@@)5,0M;- H&ZM[YW3_%N"#SBJ-_!I @YX8^\-L98/=67
M+/ZVTTY_&T34@PS9?<!9$QMJ6V1QY2!<SLH3#-!H2T.!_M3^]\.$*U5&'H3\
M-#Z,V%8$NPMC^RSU'G)]84B(FAE#[N!1<77A3J$"PJ9 &4$QSAC, ,@1$N(;
M[*;WOU_[5Z>_ ZOMMMY3,GAX[P%A#(6$!^ZHXAVU+<?KEO(NEZ%0_[AXVP9(
M&.JZ+?#@3*+)'VA2XN)#=HYWTT%H^A@IZ9M3DJV!@ UI()PZ^N%7L>;!T!X&
MR\K^MXBW!/L/C"ZEH=HN/$U1=MA[$*U1RT8SG1N:])6E1BAN%*,LL,^A2W:Q
MVK#GWX(N]V^E-*'^+ ,K6.\;'X!=EE[P5P_L3!>8#[$97-AG>\3!<!-TCCL*
MIK:,>H IIUF-,%\I,]A'[COP^6=S@&:KYY-^>0R&N&UQ"5830]*&WWS/"JNL
M-T^_RZ"I(R,S9OF=("=A7-,Q2;P*4HB%S_0C'Q@%*!6@=,BP%*7**=P22?$*
M]XC%XVG1YR*3[H&B;,THH-B:(5C20-@C>^"#= DRPHT<7;'R<Z18W;N/,VK0
MK%']AQU0^TNW<@E;"V+P*9N:Y!P*?1SZU!4(,$PFF3?N$6 B[!Q,=0-42!?.
MAM]ZU5F>8 &)W+IFJ 3?">BYWKTR%S5>H03OI=[F[MH#3(()=TDAV9/HVEVE
M,K:FL8;=,M:P&"Z:1V,-CR[.+OOGUY0Z6X1XPQ<(5[J.)A-TN:)2RMU L'_J
MP+C^&URJD2=5FT!S5\!AJ,-A3J1DZAGSWO0QF)%J9(EB$MD>P',[<Q)_%TJS
M-"U0LX$%12C,1)_@U(6)U,7.^Q>!5,3HHSK\BZ[Z1]Z.+QAR+A!4?@7J61,/
MI.$8>(FCP0.&R8D.%7VR82Y7YOG-G8%<)R#FAY&H#Y*3P'05P;FT:@U-1Z.Z
M-)7?XUUFNRO/ 6RA8RC+3J=/J++Z"OW'EJS(*V'>K%</ .C9[4YLRW+XF]>"
MQ6A3Z0!1E!>'%N[6]QX+NRQDWT %^?UJO3" 7ZJYX)_ D5;67'!)6,X%WQHW
MEEPGG+@V'50K=AN/TF*1,6,-EE@B[\LC[\64!$EB"11NA;U[*K*PVRS)JR2O
M=2.O<\^M]/^.T$U78!([=?$KM.0N';/0S"#EPRCP.G=;);<JN=6Z<:ND;56!
M26MM6$"[9 $E"U@W%K!4YZ$76VA>/ZJR^]2;>AQ_\\8NU73 D.3CA1F,*^[#
M\V;$(O>6AA/>093=N?2Y#U;?FJD-Q-ANM@O3FJE$@%6WV6T  K0.2@386@3H
M'!B-SGZ) -N* )5*>?;;>O9UH];L&,UVHS H4!HKJPV/L ^3L&^9_DYA[TGF
MBXQZ%]DSI2TSSY9IEK;,&S.S5K=A- ]*579K$:#>;!D'M5J) -N* (U:U]AO
M=TH$V%8$*&V9[3W[_7K;J+>+X\HLD"7S2.7'C;!DKK##;\A^TVI/_^9790F
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M3G;\77N/FH:)^F_XS9+E%61?9D-TMGNL+^F2@^)ZY(+BI*@GKNG8'HVB@+I
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M,EGP"O!OL;AS/(!Z0[7M-".+.GJC484EWHFZ1K':'(3P 0DI!4$:!/MM]ER
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MYXI*YK"TXR15<F0'0Q6S-#]CDHKJ*^!1&4X%/9QIS:.MYP;>?<;X1>P/+"N
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MQTK3UYS3B&801!-9*S<2Y77% AVP-2O7P['GP &?>19W\*MS#X!=;ZAMF-C
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M-Z@FZZS$\N![K($+RC0/ M@X5=.WP/0*Y[ 6ZA'@/DB-:AKY4R_@5?9%\95
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MIK5 UL>M%L4RA7"&?48..K!)M,_#U41\"ZFMT#<?3BGQ?)-NHI5W*-0XJP:
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MX5H!M8>PS/"!C3W'PCUH[=2UKNGBA(K6*_WEW0],_=_LO" )-Y<AX=WO>^M
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M,#J?TKO:-(#+0WOJP%:0BA'A;:0E-[!AA/_/WILVQVUD::.?9WX%PM>>("-
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M\-Y8DCIRJOL&%]RX)25*/@%VY&7-9@I5OG2?*Y*/ZM#"X23[\B:99:@PWM-
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M2= V;[B[MKYQX/%O:HW!>2EXKFYNPA&;A8\"^9"G&61J]V&K#2L6&#VI/)V
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M"7Y5FHO%9*!$2M[2E7-;O[?*%WC">EXA. ^AZHT81&*JF\&4U0U(LY%/MJQ
M0%_UB'<4%N\>D59(_AXGTY['4H]K^IGWO+UW=UWN]8$==6Q$@ G,[':R:4]3
M'8R<J0X1'U-:.4LGFLM9'F;R\N(V9A<^<%^"CDE1Q9^(J/!1GG;PD7\*]I6;
M9U?,\I.<)5G.;<11%50EQ7]RZF#LHEV]K8ULE#-3B>%-7K2AK;K3KY-LD#7U
MICGPM.X#-(B*,,ZUS,;@9ZT@YP-"[]<ZCE_A,[W+=W>V_H<9=\PW8&)ZB)ZN
M)I?@E.%[N 7IX.<Z.GK[]\-/$<;<X!K8G\F L)*-]^Q+U)&>GY]OU^EP^[0\
M\^M)MTW'MO&\*CBJHO/&Z$'ZP,7?1QZ7LHX2B94A*-+::H2]J8*5OLF6I<[,
MHNDNX(#C\+55FL!3I)$\@O4Y>")#-GA!>0PN36;:,R/3I1+(X2//LB1*MZ:P
M&A*[^7KQ_X+^.2NGZ6@;/$Z4.KQ&KWA#O1(1_)A@YO[C]C$&9+]&S_9W=D 6
M/G+PIT#,WJ<)DC6]JW/4/3M[KY[M;/%%ATT#*_(&W_(>!.M=,=R.S)+OXCQ&
MOZ6G()^D26^[5/>F%-8_RGF=.E#(EBVI?8\?I^5^@HRT@Z3X O;.H"J_:):;
M@YET:J7,H@VVC#%'F.O":4!,E!EB1V.A&QLF4L4R<2;84&SYUJ36--+,,\>M
M[@^DJ9<R!^)4PR/>59EMEZ!L:U$,-WG&%(S>UO+5 FZ>SO,FF^6I?ZTR"9M/
ML(IHE.9H8>"73&<8/W(H W5\0DH]*H=S!5&3RG',2E%*K /NRZ97A*&[VZG3
MF6<03Q#.(_@<#9"Y4Y#9$-FE%TFDB3E\R%)K3QR^/E,::(HSZPK*JXDLDW1J
MGGU)W4'Z<H211+.^L>IAY&!-AFPX.Z^UH'/8,[IE8DL#&]PQL=>G0<:/8J@O
MF=<:]C00).U,3?;A! =;S/&4?PPFXINR9IS:^Q3L&P*SG% )<_-X"3J<3 T)
MN_.]:&KACH[;Q;B6-ME0+K-[E)R2SD01D@>1LD"I)[NF8V4.+L3$T9I:K'N/
MHP8,51(N_NMIA7!"44!&I*TQR[H8-(%;;4G*D!PE9;NDC 'O#*Q<1J8;KW 3
M2\1&,'-UK-M%@'@9N/<93&HJ]-%5Y^0)1=S5)(8_D3],_6=W@K6>V  Q@]7+
M[2=;75^EV70PKZ@Z!1QW/2GCX+?$G8^Q6#]C'X)5OU6.MV;PFK2QUB)<)3T*
M0I3KJW[E ]<1@=WS+UP;I3!"2M*JH09C?TZ8V;:LB,;MHIP3JQ8=M&C$CP+1
MP1@N2=%/,;4L%V2\:ZZ'7H-UYB4W?0;7O,[$(Y*B>GI*G9T6])=1(GSA5 O3
MH+4/JT,/93-G*($@HOG'W[W#+5BDW!M>]Z!F01,W)*6.AO><#QSZ^02G<V4*
M>@[9<S/<%GSD&NMU.X(Y9(W1H$C_5<H1&XA;,R-5@5X9J(,S9(88T]QR&"L'
M.1Y=T%66?^HV98YYVSBK\]_?[7P7(5ALANJU.#7_!O=QJ/^^O(ARQH9R1&[V
M*YDWY6LO^44_^>[G__R/__R/__BI&92CBY]_:BKX-_YSI&^F;.@PR25K,LU&
MHSR5E^R]V'[Y@_.)S>@R=^^^W#[X@08 M]S(@?W+171<.0!EB6N.37JCYF6Y
ML0%<(H#P8_UC],]R4@@R_OWVVVT-)*S^$%V(]7WK^^[_?3>[]SJ;Z69W.M6W
M+R]D8;SKC)6>*$SX$]7N?\*?K(5_I&/B =M!W_U\.*O $I?4R,%/@^K'G__S
M%W">$.WU/JEK)!"OTZ:I'P-BY.% \9^MH?B+H?AX?_^$XSZ?(J]:\]_?95-P
M$7>W_YJ=PI"KH?>#'W]V'^B_^*'*X:+I6PO0505HKRU >P$!NEV<VW=M>7UX
M:WO/@&KW],!>#H8[_/CQZ,/;=_]?=/A (YLK\9TRO6\_L^^R;[_^<3T"LV5]
M7#SZTK]%0ASI_U]V-AKR:-_RENJ.YNJ[_9Y$!+O(=.UXL@.;HA/6ZPG(14TY
MTQ"<C=K)L_=>T'#[G>:E<MH6TZ53L[O==HX#XS*!R]L;UR5B'!^Y[24%LO.D
MD&"']'EQEOZ>!P"NW(K'53Y_S6ODHE[4GT>$#+%>,SMSA.ST$ON\8;D7R3O3
MR8=:X6S@U8+8P!\(4F.3&.?**!F=$;\U7J754$PFY+W ?8H#WJ8'$3L4W-3.
M3*:8$LO\2E=S\<E\4&<C2:1Q6@<1)IIL03@F=HW.QEF[=6RI78F).3(;.HFX
M12]1&A#&M.@4>6RS!A'6:54+<P5?\L5V+(0C])R:+A+*<YPU3H:F,Y)BB!E"
M!HVY4 'JMRJ9WYRS3MUUZ S(I R]RSH+T$S@E#^=1.4,LVKS@AL%$:"9Y<2!
M^3"]G#/NAY#U>9PZ?N_AZ_BWZ3@K,JF*6>OW%?6[P_A"Q<J62AWW)2(TL "Y
MS9)NVMU* 2P^'4QN!-E?>#R;A&4W?3D_TRM&N%"@T]*\3L^),5^T !T<_@#J
M9&I&H;H%(<QZ^9UC$VYYR?:V=UVA[ONO8?Q>??L<CK# (8T.APR:HAVD^$I&
M3=+),E2,48+-W4V+7:<L1)IF((4;GP](+FO;[<6F/5Y:F]*@O^955F(38/A=
ME2$4"!N,SZKTK_E(@#45&@TT1#D,O8/(/?T$WF>.X0N'3>YO,D$;R2:-22IF
M08;'E"?B-@&V7=NR1RL(4R#?"!M);%<\F*;6W?Z="B',FCC:&&R"[7*:G#(*
MA++A^87;R""G#XF4:Q'A)D0(!28%GJQL,O!6@FD[=8E6;2L3,CVHH%\/] &B
M2!RRV?YOA9\@!RQ-_!@4.DR<TPY%^HE,LMD*CQ).A:Q2+@*<!@>7AG(_2TGX
MN8%](B@VI@0GN!280.96\V.&G,"=</73TPY[-Z0="*415 IA#,=]HT^_]878
MOZ&%>)/,D8P]L!#RK"%>8)H_V--6%(?3!\- ,BW=(-;Z(0;PHD442,>MVWH>
MM=(8Z^K(3P@](/V:@6J6]N4X0E6Y"$Z#3XVC<97,1W$TS6K3@5 :$V !TK__
MG9M'(CA^D!(0G(X*5BB@SJ8S)EC G\4&7C],ZM1P)<GH%YP-J'CQ9V#2).?C
M.1TUPXIXQAWM2L4\:,7",145"0/)41L2?U.!O"=<P$>L?G; @TJ+M9)H-&]H
M!/!G)LT68L?)4FU/ S9L/MP6Q.EA8U1M8&4L$SDV^L&Z GH5+=C&B =K'B5#
MZYSE6@5E1"56GS=&78Q$+71&N8=FABN:U(ABU','^:EH4@C-6FS)R</HRF++
M YMZ$J0,E_:'/@NJ'CD+#RKO2[4(2V1SV>GT]-35P4VIJPE"NU%HW^ A7N8]
MAB7A0AN_>%IYYW</MG=UR=#F?VW*&N)H4I[#G40ZC,:/\.\D1L%)NV;\$>DR
M=#>XHPY5RI25XP E46>TEB'(+68GV.Z%E4/;AX#./1WWLYU7AZ#S-O8V-PXW
M-\XVK=B-Z!T4>B#[\:S,F,%+(/T@L4WR55K_N(]S'R%41H&/K2<)M[PF_#R5
MIV02T>E^(6[H)FOFQ%V%7>[D][;W :I#N;A-ID35]\%[PB2HTFDLT..N[RNW
M;<*MG0)?Y_WN JYTN+6[SA]>(7]XL]FS>WBD/+^I(P6T0J\GPJ405 @(!\I<
ME"WHD]U7+Y^[':\T)'5(-!7(QDWIB)*,O*'O^H\"$:H!=FH#XV3$9")$;0+W
M^H\J/#LZW'VSL4>2-N($38V5\B45HBCE7F!43\],>7%C,B7AD5[!0N4S8ZO6
MYD22$3@)X.9P*$0%A,3,5%XZALR^:\4\O<5[>8.+IT1\O>OGU?BUS9A9(EFQ
M3D<M4VO+Y;*T1;]DQ<AI<J3L.M:?AJTZKSCQQ0X+LP>2_>62!DKA.]M/HX56
MT?83EYU7-R<[* )!L?%2T<C?9+H7^ET4.UJ;5#KJ_[ :V-O=?O&T5W-WYUJ7
MD"(2,+"P;ZFA>8JM^]RU-I@AZ84,EN_")O@WE(0WH=)-^.^11*C9\]%PY^;2
M*!/YIV[N <4(DP4]=;GE>"S:ID[RM,^=\A0-M5CCWE!5DC'/CM,IFKI<#3:C
M44GO#><7B'ZBY!@--A(A0 021%!C\1;>(3",)RC*O?FX*XBRRE./(%N2;A-T
M?X(3WIOBN-*$UX*@Z34<1N82H[.=4"F'OVN)$V&XL\G3SE5.IL]Y'';CG2IY
M0%-WVC+F97&ZA9E2]R:J1^_&+SU-DZ)..7.,4C>V6\5NY)X>QZ%ZT@3ULL _
ME8_#F))"B^JXS]WB:4*])BZ4)O.=0-G>WD:ZN;'O!<@6!OG@94V5#>;J$,$W
M6/C9(1(:(+VADC3VA98(BE9EIZ<46J;.6=$1""15YW]*8>A9ZD34K:Q(Y(V6
MQJ8W3 :\^PQ\$TU0CE0L-B<#[UP6]WI"&[LW97:%C6W[K+U-FK!7QR3_^UP,
M&2D&CSDJB1PRJ:W/CSP1""ZB) UL$9#-3GK?GH<N7>C36\=GU[F.G;U4!Q<3
M32HU3P2R2IX9$?LS1X;J!_:]CF>2F<)0N5IUM;&2%C[K0UEL(?G4O$%KT7N>
M0TS3TDCP*CG'W1?&3LJ<*I2-,?L4):<W"W45R9$I[D4R.3W5!-E+32/ZP+UD
M\+< +*,4\YW<C9JS6,8]Z&88O?RD(7RL2B($0K=?8H'EV,8FK;]!YPP[#!)K
M]#]A-*^T][7T=)N0%5]/Z)RC<#:CFO&[JC1IEL&3^(O".)R8"#-55 VAFOOY
M9C8X@>R[6IBYAV7#MYRFQ= X3$(1A6;41>0X7[VCC",E-:V(OH9IJ9G%I]TY
M#Z;!Z]!@8&@CPZF,''ZQ&$+>M>#/5R5A 5+ZES.?";.N8EQG*T_.%\F ,[NR
M7DH7"@OFK+HS:+/N0R(98KR<ZXB*6468AW+LN9CPTCQ-SG@YX&,PK-1S=C%
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M"<J[E'JXWJ#A-FTF'0?"9DN$5M-FGP+4EG6(#]6M;W'E2>W-WL(.CY+5?E:
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MF09T^L6&!.&:9(-,^.6<( P2::N.7X9&$*T4I NL>#? H),\Y6@,BTE] 3;
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M@SM_%8NG_>7W-M4>2IJL,LN+DJ+O!/I\YA0N5VE9G2:%E,_$?>D+. &26=;
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M>##"!HF52]1$)Z%23^C;:/3U%#+-QA,7Q+^._J:'P([RHF[[,A*&'F\);WU
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M/][XMY$C!\D<6D3H+H%"&<3$58IF&,H7N)6=/9'I;." =9EVIR4WUV1(=Z(
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MY"MV\$:A>WT2]:PQ0L[, =2LY+ (L=!8P)E&-"<0=?0J\Z>YT9CD!^/O1D*
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M0SP_'$NO\VM& /1P,H@R2;'.,KEOM+&6S3(Q<D<:I$%(#$,DBU-I<"@'E1
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M#4%"'FQW0R!!LFWF%>US\PC-G/$-2]+O7-(=I/!7%?MBQ0*D8!,T E:?]!H
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M#0L+DX&YN\K\%>B_TO_KA/\$_;OGR?S=[E_%(W##W<,EQ"=8X*_<7.$^\)!
M@2!_%U=W >G_U8C_VPO_XW-(6;I[N >Z^Q%7V!"M#.;G252WGQLL& ;W$X#Y
M_>^4^-]<]K_0/^V:2*SE!( -*@,PC;$!I/M? #)66H#4L8@X OI7O=VDM@'^
MWCQ;\/8_[?X?!/J_[TJ2]?<G".;YCW6ZEE8"KB&!H?\<^WLM 7* !F $V  N
M@!\0!L0!:4 !4 4T@6N 'F ,F %6@!W@#+@"7H O$ B$ =' 0R 12 ,> 4^
M0J 8* >J@%J@ 6@%.H$>8! 8!KX"T\ BL 9L C\ #' "G!&='26('L0*X@*!
M0:(@29 "2 VD#=(#W019@NQ =T&>(#]0""@:% =* ^6 "D$EH"I0/>@]J ?T
M"30.F@>A03N@0] ?$E(2.A(V$CZ2RR2R)&HD.B0F)%8D3B2>) $DD23Q))DD
M3TE*2=Z2M)#TD R33).LD?P@.28%2&E).4@%2:5)U4AU2<U([4D]2 -)$:2I
MI'FDI:2UI.VD0Z23I&ND>Z2_R2C(6,D$R*3)-,D,R:S)7,D"R!!DZ62%9*_)
M6LCZR2;)T&08,@(Y/3DON22Y!KD1^1UR3_(P\D3R//)7Y,WD ^33Y)OD)Q04
M%!P48A2J%(84=A3W*:(HTBE>4-11=%.,4VQ0'%-24G)12E)>I32C=*$,IDRD
M+*!\2XFBG*#<I,11T5*!J12H]*GLJ?RH8JGRJ-Y0=5%-4&U3G5$S48M2:U";
M4;M11U!G49=3MU./46]2G]$PTXC17*6QHKE/\Y#F*4TMS0#-$LT1+2VM$*TZ
MK04MC/8![5/:=[0?:=&TO^E8Z*[0Z=(YTH709=)5TG73S=,=T=/37Z:_1F]/
M'TR?25]%WT>_0H]C8&6083!B<&- ,CQC:&&88/C)2,THRJC#Z,P8R9C'V,@X
MQKC'1,UTF4F7R84)P?2,Z3W3+-,Q,RNS/+,9LR]S.O,;YD_,WUDH62ZSZ+&X
ML<2SE+'TL6RPDK(*L^JRNK+&L9:S#K!NLE&PB;$9L=UG2V.K81MEP["SL"NQ
MV["'LS]C_\"^QD'*<9G#B,.'(XNC@6.&XP\G'Z<.ISMG"F<MYP3GZ26>2]<N
MN5]*O51W:?K2'RX!+CTN;ZYLKE:N96XR[BO<%MQAW$7< ]Q[/&P\FCRN/*D\
M#3P+O"2\5W@M>:-XRWB_\![S\?,9\/GS%?#U\>WQ<_!?X[_/_YB_BW\'S K6
M!L/ C\$H\*X NX".@(_ 4X%^ 8P@KZ"A8(A@B>"HX)F0F)"U4*Q0G="R,(VP
MFK"'\&/A7F&,"%C$5"1:I%ID091:5$W42S1?=$CT]++89=O+29=;+W\7NR1F
M)!8I5BVV)$XO#A$/$"\5GY*@D%"3\)9X(?'U"LD5Y2M>5YY=&9,DD521A$F^
MD!R7(I=2E_*3*I6:E::3UI$.E:Z61LMPR-R4B95IE?DI*R)K+YLM.R1+D%.6
M\Y$KEUN49Y$WEH^5;Y<_5+BBX*KP3&%*D5Y17Q&IV*:(59)4<E<J4II39E4V
M54Y2[E4^5U%5"52I5=E1%5&]J_I<=5:-3<U<+5WMHSJY^G5UI'JG^F\-%8U@
MC0:- TUI36_--YK?M<2TW+7*M3:N"EUUN5IR=4U;0/NN]DOM-8@@Q 52"EF_
M)GS-[=JK:]LZ$CKW==[J_+PN=SWP>O/U4UT-W1C=[AND-PQNI-X8U6/1L]8K
MU%O1%]+WU*_6QQ@H&T09=!N2&YH89AO.&O$9N1I5&6&,58UCC/M-Z$QNFQ2:
MK-^\<C/P9KLIB:FQ::[ITBW16WZW6LT ,R.S7+-E<S'S /,."PH+<XMG%EN6
M\I;1ED.W66]#;[^Y?6)UW2K+:M%:W#K$NM>&T<;1ILKFU/:&;8[MVAW9.S%W
MANVX[6!V;?:4]C;VK^R/'?0<GCAL.BH[)CK..(DYA3M]<N9V]G'^ &6$ND ;
M[Y+?M;W[YB[>Q<REU.7XGM&]Y_<PKKJN^:X_W*ZY/7;;<;_JGN.^[7'5(\?C
MN^=5SUS/'2^(5Y[7'DP75@C#WC>\7WS_U-O,N]+[PL?6I\Z7RO>N[WL_%C]O
MOWXX/SP</NXOZ9_HOQ:@$? D !-H$O@J"!3D%-06S$9,IKZ$B(<DA*!#M4.?
MA>+";,(:PYG#_<*_1%R)2(G8CM2/K(@BBW*-ZHT6C'X8C8[1B2E!@!#W$+U(
M860\<O.!P8/7#VD>>C\<B96+S8G]%6<;UQ[/%_\@?B/!(*$ZD2$Q,'$V23.I
M.)DL&98\FJ*84I!"2'5+_9PFEY:7AD]W3?^<(9_Q-.,BTR-S-$LEJ^@1Q2._
M1S/9D.S7.<PYD3D;N::Y+8\%'J<^_O4$^N13GE)><3Y-?DC^VM.;3]L*1 H>
M%> +O0JGGUU_5O><]WG*\],7;B\FBJX5U1;S%:<5_WD)>SE78E#24GJY-*^,
MHBRT;*O<IGRH0JVBZA7WJ[17YY5^E6NO+5_W5ZE65;WA?9-535(=4KWSUO'M
MUYH;-6VUTK4E=1QU:>^ =R'O=NOOUL\TF#3T-JHUUC:)-CUO9FU.;0&U1+1@
M6KU:U]KLVL;?&[_O;==L;^Z0Z:CL%.Q\]H']0U8735=\UP4J$G7<[=^]U^/9
ML]$+[5WLN],WU6_1/SI@,O!Q4'^P;TAG"/7QZL?.3QJ?WG]6^]PZK#+<\D7Y
M2_.(\DCSJ,IHRYCJ6-M7]:_MXUKC71.0B9[)&Y.#4T93P].WIL=GK&?F9AUG
MU^;<YK[/^\QC%T(7SA8?+)$OI2XS+>>M\*Z4KDJLUJVIK'U WT!_6;^]OKCA
MNO'C6] W_&;\%OU6WC9XN^J[PO?.'?V=K[L.NYL__'^<[27N,^\__RG^L^G@
MVL$7S!W,)C80>W&8?L1U5/E+Z5?OL?GQRHGOR=EI*HX+]_JWVN^A/[9_ML_"
M\)3XI^<2Y^T$$\+2A>_%!;$>8?F7BH0$(#NC""16&XN +D " OW]_E]$2D[Z
MERC(R$C)*2F((8S8J*AIJ:FH:*@H*6GH:6AHZ8A$2<W 2$_'\!?_W>3O\K^K
MB%\Z*DHJNO\R770#S%1D-TDM24%"  DSB)09=-$/@(EY#CGH'_0O20Z(A)2,
MG()X)!I:XH1F)N+Q24E)B(<E)R/F.* 8XCA QDS.(BBO0\%JX4(I%,"F\#"[
MA$KX>GT/N^4X1D3Q7F L-0T'YR4N;M'+8N(25Y245535U#5T;^CI&Q@:&=^V
MLK:Q)29?KF[N'IY>L/M!P2&A8>$1D7'Q"8E)R2FI.;F/G^3E/RTH+"TKKWA5
M^;KJ34-C4W-+:]O[]MZ^_H'!H8^?/D],3DW/S,[-+Z#7-[YM;FU_W]G%'A[]
M.CXYQ?W^\Y<O$$ *^A?Z#_EB)O)%0M0!&>5?OD D87\G,).1"\I3L.A84+H$
ML HI/*1BNYY=4M]#+:QHB6&_%SA.PR&BA!;%_F7M'YS]YQB+_6]Q]J^,_1M?
M"P =*8BH/%)F  *<XTM3Q8'_<TW#'*07M,H2K5,='M1M/UA6,M?W9C?4)F?,
MVU.DRWC9\(WQ$(K2;UW^.:]'&W*N[N0%N/ET;QH]EDQJF'LMW\'H1@O+S<MG
M6MG&6#4&8$E5L*=;N[3IQ/($,5FR2-?5^2YG2!_2D?Z8IWW"TK1&=5K?_K?B
MC%==+D+R NC1C]99>R&[4517$BY\$RN3@C'>71C=O3%SDY/S\%)9WG<R>78S
M43?"D=^"/JBN#,$;?1V:7,RH!&<V()U?]+:/YLX1*?=+5+]G!XCX&])_XK6>
MZK-Z];Z\Z0)X&%3-E^WZ+E@XN?_Z>&[#M"KBSNB(6,C/45GKV4\OI-FQ0\G(
MM=<+,REG8"<\+*[;WJ\"G:QUZX]5@(/WZH=\4X=7S9R_Y1+(RRV2&Q V9*WV
M?W*ML4L:G/&UQ]7SZ*;Z^L:</S#1WS9J3U1SAMZ1%O>F/KW_J%5A>7'+QJ4/
MAV=SE=+3= Z,;4P[10^/\/'_*((@D@STHI$Q%P"Y#%8E[DP++XQ[\CI:HUF#
ML?_<;_9F@<]QCU3[#55XRPRR4)0EKX_#(J,S,&AH',Q#D-?!J*Y= *F=+J^?
M!7FB8V2V+1\;B>7S))=YT'90<@G(^/L[' 7U6:49U2SGOZ'ST,GLN\7V0]?N
MLWE&X9--SF'1\);:XIB?A>-E;:5=3E,0.)(U_-;1FO@LGM;=&X;M<FM4M/O!
M'S$N(YIN2L(T+ON<6^632RO,YI(:V9^D?;LS X,S:<(8OR1V<[F3LZ^OI2B8
M(V?D)"!"4:/<_Z!GP>FIN-K52,L\[M+'KO TO=.Y*QB"-KN7N7]GM4J))V?H
M*W2[;[1134QHXU7CU-^S5N>-T49KJ(4@M&=?'3-.868&DLIM.C"E49%9=?+X
MW8?6Y&'E>OT46@&GI[G"FH0#BG;4(NE)4?Z)"TYK1:1E\FUSAO'![?KQIF6-
M]:.]M)B0,/]'I;\[H'Y?OVQO:@F;8X[9RCA:%P_9&N@"JZ]GB6[:.7,$1 \7
MFB^K=(DW'30W7T6D8I#Q%T#S5OT&XR+K()+R^(!ZJ&PU'*K?,NO;K.E[S7%Q
ME^-(SJS=PNZ2NONV^IP9K^?MDX?GKV6UF?#V.->U?4GCR9 7MNNWJ@*\LI>A
MSW0]O>&D9LH?2505?,T!LWS1!TN*!M-O@@X='*#?;C9H^00P][9%320UV0\N
M/7^.G_U0,UR]V](\YE;:J7@2=%ZGS)B!Y.^Z@H=,:RD4,E1@>D]6.-HRS_U*
MIM!M!N'N%LWV"A:Z[.J#Z!$OO.EY11U>\LP*QXI.S*J$12:LIC8M+KN:%VT=
MO_25F5@:+)F12W?W#!.TO:*M_VD]*>EUY<>9%M2P?W7V!FS=F</_=.IJV;3R
MIT_[ZK4O:H;KT._WK&P3"$.KS2N59R8KN O =!HOOL(^@^##Y< 9H-=DR9=N
M-XB[/>&]LJ;P3DVXK3KR=-_H]070!ZWLS6#4GSCFJM&261&>EJV<*N2HEY;4
M@P/)^HN=0T">E$KM+>IND7='EO[>5AKS'!IYEU]QE$MK!&SEO?FL<NOT0[.I
M@Y-?SM1)H60?\I[LPI\?)QTXH[!US54&,,TNMTUC5 ET9]6;\QY/FB?-HAM-
M1Y)V7,E^; 0J%=S*F=RIBA5>7TW"2Z.EQ?I_8++Z0A?V\0W>$+><]8@<(\1'
MUL_NEN_Z1^^T8@6&M)037F_M+%JCT 0/U.Z*Z_'"^ZC*^X^[)#]+R$;*SY@N
MVAE+(CYD5;RNTSA_@="4W6?'B/5JJS4VY)HF#43Z<.?8?^S5?Z#VR;2/IWY,
M[9<RNDOF HC-PL4.K7$.7 #)[8RQ335AUW$.=4LPN;V95*.W.O=W6\. "!%]
M<[DK!;YS?@9<@@E5E]?S1L=F3L3H^^;^X K0$GVK\5.BH4\J)0)%0R=F;.U5
M&Z.$?T1*YN%BL,S12,R&+I8-=J(9$W:K=6K\LD 3M9*).'VF0LD[LUOT_L7U
MJ_NJKQ'38-I:+>CEW%<[]GJC55&>Y3S>1Z'PFIJ?_,S^JQWFSSYS4*E&E_/.
M(#[;P%N2&*?D^3]7>()#GUGDYX8U'$<WG!7L/3979[/QO&2AQP;\_[F91UKH
M?#.G,$M^GD%SYC?>LG+3\Z4F?;3G!4!F\N$"B(>O@=.C>?7+A3#P%+X\AP9V
M]\2?,[3E7D-NO^??R6G[G"J?(%.ZS1BAV.)?$=1#9XDH;90GY)+J'A8KNT%F
M$A"#<L;IH"\ 3GLC!<[ZQ"U)CH:%M.E3U>S).H&CU%\8!(&_1KMV).;DW*P%
MW6;"GNMZ>+[TX?'$@;C9DPB\LNC41YQ\F6I_\7SE2==9R')_Y6#[E&J#*2^(
MAG;1D$>^9,/+CM,O\H&B\\891_2]MF:B 5EXV1\]>^:DVZ?-VSD9]%K21&RA
MAM_!;4GCG2QW1N5SIDJ*MK$$ AL<P!F<Y(W?R I<4*E"=RAY.KU=ORII:N[0
MLI'^_"[=>N,%X/GC">:T#YYZ =#8Q-P2AF.[O78"PCA^B[5T=<9BXR7Q GI;
M+^8&08C(V1*'O(#'4<:RWTIS\>/'[U]89_7:EIY_'ZRA28%ASL1[G30JR2\
MOQH&31/<=2U3HG@5WV,\SNKD?K2V^_@)V[1YI#D\\V"C\_/0Z?XY]\/YC'%
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M!Y5G+VV&'BH7('A_0)KKXES;IH3R[::#G_W@JLW]DGX!^-H/^+DFRG_2['_
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M/XD%.LONPDFZOKT($_A62Z7^J^[+B,95H5D"0\DC+Q0LE;"]MEC,_/9:<E&
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MG4OY/"[.H"/OQ,3.)J;+\5J'C+!H2R8;Z\(#B/__5.'^'VBIW^6OL06:;1Y
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MPT"A#XB5#EY#"96$$&[$+6-E;[_G1F2@P93&RCP=PZ\^5S[]="@2U?)3Y*<
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MO. GAY2?+:&^]+@5YY!6V\;JD?#^M#KBI*5K$7\IPNA@?EBYME1H[C;'<+
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M6DD;N&4NW*B:4#'_RXQ1/BK-VNN&U6N?F@$1V'Z'HQ=9.@:R;<1+7N"E4>.
ML7;RW)U0M8K;Y%%L@ SR8V=&_>+<7)AIAK"RPO<2?AGLGID^#%2O$+]$_P^*
MY5SX0QL$SWU,<.[,$'3ZEQHBON$*/$$A'CXL%8!#+3,#;<H3:J4*]C8A 8[
MT][4YH<IXP5[[OT_+R&W4U SFOW09,J\):9W$/B],+,$ F92HR5Z'@+O;!YG
M7X7SEK_C$?/7>)8U,\G9OU87<:]BU9/F Q=(ET\Z7K7URU)F7OLJ4:D83'I&
MC"V#]9/<@)%M4\CZLGPGVSO-EG]ACA^;WUP G,,#AL5<SSAGP_(D.7O[KEB6
M'9HL'>,@^(/EXRYN2"</Z]100=G&E94FH^IAEWA^O5?Q.K9/J94E2E^D\?]0
MN+;6JJ5O4Y9$^T ?H,+K#)XQ%7V9F/%^YAQ$FHXV5.Q9(B2)F-#UB_9,>AGK
M#ICR5*KHN2=5.*1(%A2BTRX -<,=0;D!X[PW/&,C;!DGD0'\L\Y6Y&QLM!=4
M&?+/RE0J3G!LG:&7+>KQ*[J5-A;9/\M\:V@]B=48'1BT$ZV$L\9-=4FR&A+6
MXC!EK08"DRAU5S?/UXYU#=8:T-63RMO2=;15*UF[E!X$+0%CZ<!>H-Y*]QMN
MA_PIC358>IBXP]][6+&QE5I>R?35FHR"71MQ37EL?'.U323%I11/-*<_^*PS
M)UJ0[]H<D'@%#\2-O"[9O'2"##'@$4V75?1>KQ35NQFJX/RQP\L46(0*A!2O
MQF!?&M=CU,9CK)Y0)5=JZ;0OMRF0'A&H8M<(H>T0.KIMD>X9=-?V,$?[AU/X
MS[S,^R J46G4].K;EAM'CMZI<5'N8'N2V3E2C1=.15B+Q,0R;7<:39">EAV]
MTRP_T&90_7E3=9]?YG&L>.GUQ-)DOIMO%^M9._O:E/KQ$W6KD=W?&8:=H44L
M&%*"4NCP[,K)@M$>+:B!<IT-Z9PL4VO'8^5=;0"/!^<"=7ZXJ3EIW-(=[9#/
MHY03&G189E/7=PV^IRGG[2._6QF'WVW)A:"Y250L3;DP\^Y<J1!>.KA<KC/>
M=F.*9>KCPN9I:^O?<9:J9HH/F[?*0X]]**->,;9$MXKT&F%X9ZELSG-=5566
ME=2X8!$7@)>C.ZM!G<<?G>UC4HHZF:(=&(=TWB8/O)OHZ\&E_E#BM80Q'AT0
M39?_'0LLZ^) 1,8;B+1[88_-FIJJFQKV*]+=='\K4T@8K=;WACUXT\@NIW=
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M: C],(LHD^B)XJI;=:OPW'8V!GMDE_S=2WO$$2OK*P</O0#0(LX,ULF&=1<
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MVLV3R/S?MYO:%KN\=LMX\E1][0O&O5X(8]^$@!<&W#.B^]0(KP=A(ECS"+@
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MB <"?UF)D_)/<>LWFCHY[&Q+:;]_D,[2A$== *JI<+)Y(D<57Z]< (S_@T%
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M[>ODT;^P&1VJ<4;*.YGK\T4MLN*:KH='M5:-Q.JRGY4.\#DK3%_S'Z&F\5=
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M_^H)S[41FP0(!<^J@9B$%$T5Z5B#W6#AAJV)>Y^9E'>XKS]7&_4BP.-*_E4
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M1)B4K_LYU(4NT%_N-M]]2\,;WY[GQ$HRQ##IL+>P RP,]"]^] .U%8@;&!
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MV: )!'_B&S?4)$G:UW6\W2',V]<T9SUUG(1S^-J0D'6+I_#I<!>;8^VNT3F
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MKHK&/L9J\'BA(#]CW-'Q[IWS1=P.\+U&O.%"%6HVB&2K"2$#G 9M&>9DD71
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M@7Q_=1](P19O83]RT^.](0B SWBF:FVZ@]'I5<EN^ERJMH=Z9YE<P?+"IH^
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MQ&(I<Y6UE5G]7]8+89@]9FC_]()S+Y=C]L5 &W54AS[6J5^1;?>*04K;=QU
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M72E<QJD*[C!;;N6L9[GK/6H-<S?%RR_XG3C\*TYS%JNE^D9T83: 9 8[@R/
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M)!GFB0[6-LBS=&?N.:?([#Q-SR%W2\7Y&14H!.!#TUH7>4QJO3%FD5>$ &*
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MG:3L0+C5OA0F>0_01H5 8Q],*;.&/%LU/%S<FZM;EO+#83!N(@\W;*>OWYT
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MQ/"F<?3@9PC@S09^?0"J/@!M\%%RJ33*RCJ!@.&G^P!I2P#2E1S0@Z]JA,;
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MZW'!+\)6:0(^;;S#FLO@F2;]*8DM>R-[WY?RWV(HL4I,/:#]KX;,17_W%G1
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M;$-7@A.KQL2:>!6J^?U=G[KS+1,^RS;5\D:1+@E%>S+ZZ3<3Q-($IEF$N(<
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M]=B''Z86KLE?LR06)IV>]%4Y#+.\P2?_9/ZE^,3%(<P5YW2N%HB'[V(%!M+
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M2(>W34K5U\>FBM[+3M8A[7/)>=4&"IU&A#X3VE <:R4C&P$2;HIK' BZ">,
MT!_JOFBN1J_81SI4&#UF]C4&DSKL).X=,@M/&Q-/CI YV>'^]7I@#79BPVSB
M*0[H46B9Y[[AR3'P.N;90K=,XH-VR]2TP+7/IJ]F1QH=NT/N9:TQJ,,G)AX_
MTK%43Q :^#!YM'Y8+G(AO&1/?+ H_T3#^YN/]SWZS(G_L;:Q5Q#]4CO8/O@-
M%4)B+LU4.?]Z_,?6H;'+$J-S7TG*;7Y(3I'77[G.VWA1Y*A[1D+X[HN=(D$2
MU28@;3J:),*LAF7.UYR]Y^W9K^4E';BK-WO2-+5S7F+-H!E]<W YJ:CP-I9U
M1=ZX#7HH:_^HG-;CQ.\>'JUAG*>/FN4DE0C$I1NXU!1^)J^@O=9+%;N=[OH_
MQ!/7KQN-+A4GX@ZTOYQJP&<A2FW6$[/]'!>XFB&Q-H>(#)WBX+:W5<A^(;KI
MI+^+9:8>*=RPX&Q%FIQ[YJ%Q@\_\#BF#RBOCK?NHM7M>$HNBEE6AWUQP7&WU
M04;FU  _TE7A]U4^$<$OYET2]?#2NF+9!GMG*<]+S^UO>@) *1+ (CQF4A@#
M%,\0-#K']%O?OZPG D:'X5ZOK T.EG0\IZ[ZSVR;PGTERL1SX2TH(K2'[WN3
M:B\"$HS?D:1,CT0V&&O$;70?LC@UF.O685!B_P"!.7;BKAZG'LMUXR C</2#
M6^EC0YMU?KZ8XCY?B$N[9Y/>8M"3B +A&VD/'J??F C0O.;._1A-N+OS[,5C
MT[EZ3]?7)"O<UT8<&I"!-!.\+$D28Y66$U_?BSTME GPS3KQ[%9GET%'B#/L
MB[Q<=,91SM!;G51>\688IS83#LR'N$S22Y>*19B5?F=I_BF9\V 28:Q:3ZV
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M>J5.9;V4+L_3,L)R]VQR1OQT$X(YIC& E&.4MB[QYPI7W/U<%9)Z#7H<0-W
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MY>3MY^ _L?<ODT,1_ZC;[=\;#&2WP?Q!U?J[H,VGQ<+_B:C?W=6G8O^)("Y
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M8H+.$4B\C@P :=,C/:>#(N[ ^&O6]AZA#>QIWZI!U'OF1I\]C0:1,JF'60R
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M\RWYJ6\)5 NAR%]03CF$RFT%1+%HIA%O_!RXMD X *YT3FV Q@8N1AAG7ZT
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M^T_?S.DI5NK98?E-**]_]OGJH4U,S".GNDM#30G><Y0K?C#'=-$%2B A-C!
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M,9Y>[V1V)YUCI/VA/]MKXGG6+6)^""'&(D;2?EQ@DO!%L_,P>Q RQYZ+#O:
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M!X3H"G^2GZ3V(E-&Z.NYG&M/#W&0 2^3^':P[6MHI@*UIV--! &E\!8EU\P
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M96^-K9[VJ5B[)R8Y"WWU\*T=X,XG[L'# #G ??95# L,;^T#8C$2984ME'U
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MI42'G-:0/CKJMKI=1LJGG6,:%R2?JCPY8.2BTO#Q\WFAR7U ^^>)?<#/$_N
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M(/V/GVIT(B'WF@9YEI#"HZ<15A/^<,VO7STB#=24]5TSRC>/#UVVJ%U*FC/
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M'R#TY.+ ,;8(8X!0+\*7KD@<)"@2G?#S&.'%#EM*3X*7RTB-A2SX:6).D$C
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M9.2_=JUY[HL[7'=K,G!';-Q5N<X,$GTQMO;CY;A23R5Q(#;:4PCK5$$PK%F
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MJ?*0;;*VJ:0::D_4;]S9J/[.R-^F?$T6="$O4;OE<RGGJKH -Y;O"BS3UL:
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M0:SP:11"P4DT6E%=>@7>QI=06^1F/UL<L_;XY6<[G%@=6]DI2I?[4'\T#?
M>1OF%%<7>06 ZQ&1-.%"WD=4 TP-KB76YEUNR:"Y$Y'HW]&QZKTI(Y! W\)-
M:/+GFUS".[:87H['4T0.O+;SD@O(K_EQQ17 O21-QL]4ZW5+NTGCS)+YNAN0
M4I#+,AHQ5$!_ZSD/5X!I!-(=2?U'A=&HVX])UD*F71GL]+VM+<1V<;VFHMW5
MM)':84%XIJ7U[CLY@(QVG1P^Y@IP2PS1@->3J2G&4_2RF!1(L7C#(=YSS2X<
M1#H?5^K>-(?M9IU3A[#^-1.S(X5GB@T]ZS0^-/$<XD$J/;D<5X"/>;:34B<0
M=,Y[)6,PI]57:&3WAM#)#1'A'::)T7 )WF&>A[2%_(?M7;#OL-AIP^GB202/
M'\H?K-GD4.1R.@'"?4B,$A[[-(==!;)G?XXZ"A/-<0_3"39)?KJBY#>@TCS^
M,9C1LO(/3C#_3XR/=]MHQ.R_F@:SFD)+I9[JQ.%,=YYVN$,B]Y0VW\:-8NKV
M;MA]@CHV=[S/E\B&(1#9DK0ZLW7KYZ6-*'&G4ST^PAT_DY>?[]BN1I^69[[Q
MX@[39+DV#'BO"TI\@_%\[>&_@.=-6314>P90%\L%L' 19@S>/_2V(W)M!N'9
M/D*:>I;?7I\40.KTQ/,?;.%B8)[S+L(84H&W.>IGDI\+K0!9.$5L6\MW>7>8
M6$+1<49FFZF#,>9%>9(Q+':_JM(-#\D:\#RX%&QI405!]EM*_[11_;SB6W_4
MJIUYZT<S:V&$/+@7>P:G.EE>U5%TH=2*2*#\*/JY7"E\DY'(U8R)(?[HG)8R
M9V^V=97=J^-(=N'Q2T'9/35_\*(RPO?N32;>B*4?''07!@05!+9Y@.;VKLP:
M>W:O? ^>S*QINN[YI^L\07YP8K4;PU1P\FUY6_D^(J#8&OD$OFD#JP@>@]'Y
M0*BA6JHS1'9;5U\.LC %\,NA@'??\ E1T8W+9XHACBN3V0'^MJ>%2MLO[CUX
ML(^@NW@=J(.]'5J)SZF12J6.0"\@:,!%*TNLHG@=Y0FP1FGEM+B$>4S$##77
MPK*IAYPCZ_7--D 3WP;L[4(%R1R]GO=V)2_MG"68HZXSEKH/54)W3@I(EZVA
MVKZK@T_BQMAP':U)NC: ;3T!9H^,Z>3*8IK8S]94%Z)?# _^!$^V%Y$^,P7R
MW=\_/CBJJ4'ZM3*/=J>4]W[PBR<RK_Q1^3X>(S5.21"[CE%'*J!%)(Z&:H45
M]*5F\H"PRS3I<,'E>[PEZ.QP[/"$1?UB]U; >,^H!0T#5/T%,MP@SAR._!ZY
M0Z5V[W7BN<RS(8GR#<&P^R33/N[26=\WA<C^_CW7)^OAI+D".(I&RP0SSPDU
M02A=_+*(]8H34!Z+MIF#=]FHK3N>'N]\H9RG%$T%R6^;3,T!M#HAK;4M!++.
M; UX2SU>53FI8,FZ\4-FI&:1*]*Z52;XN1^:3G1Q0D/N1+&;Z!KFN+S#71,$
MN<SC^, &\U,TC&.\&;:,[/C:! CDJR;^1#+XC$<NP<*D1:G67:=WG:Q37\]G
M&X28_Z$)4I002&\SD,PT$L'YZ"464QY262J+7Z9(_Q%=(I&VINB2^082<TW@
M3_=SS/C$GVF'&Z>Q:N-:J6%T!T-6^N,B'=Z/?"&!-/;GW5\->09#2,['&^!(
MW0Z%NMK"H,I7  L _MW11K5* W-8X .?VM_ROID;%T$,/3*YCZ8IY[ 6?[(^
MTKJH[3W^F<CE?U.IZ(L(&V\I^2;U:+W>J  .-(^ 7#P*%-$5)2?W46+M(CZJ
MCUU#:\_]>NEZ(?<.'L'W*<IZ.]DO<4$XQ,O63:]8U8<DUGG.>?F!.:/8TRT/
MS:=E)6$"O@)R0UM9@+,GTSCQR NUAHP_75G68V7E@>HS/C4^VRERRHN.#"8R
M>H\=N5^;M$;1O6<>E=.7-3&-4K$'TBX0?P:+8().(]_D7?CI8CI'94!O6F*/
MS]<4?&?83^M-/HT\$.;YVJJOJLAR(;GOVAC_S6BYZ>$W-:_QBM-\FD2?ND6M
M7J)@BYZ"R80A>N#"8C300&J>#F$CT=_N"FUVNWGH'38L5ZCL87*Y&V.<K.G7
M*1T\+(8O0P^K%N-9^B%4*Z!@VNDLYY2U1YT#I7]2K(#.5P#9SW:)*[U=8@;I
M=\.TN\Z+S0M3-#5!R$7LKY9? F2 "WVRO@_S^\F;@XK@DIZ2XB6!J'WIN)FI
M_.FI>4A4D?SLZ-3*\T.=AD1+@=B'..?50>#C=,9P:X$!8*3%%> :^ZE@W1S,
M<P=N;CZ7T@@'KR?6;W99&IGJ')R/GX096#A^;S5<EU2*NS<8'7O>N_!00(XK
M//G?'P-X,LFG%NM:S]8TP&C\!L-O"0\%^PFR[K:R_>S-)KQFAB'>_=0H]H^9
MGYXX6*HW^Q7WY%M)51>'"T9-\W"Y5J<4X\'/7'X.=9#+$*23M2Z*IMMD)M"\
M2,,!RV#=F@NAM=5Y O0OSVO4Y0UV&]0.]*_5*CV9YN\@+&C^B3QKW?HDX:)=
M2%LZ^97&Z!DU^_\4)SI160;F+?Q!#P)2 EFK 62&P3VR-Q!Y1/)/7M=D$'^9
M\R$)7R#5=>WR33HC\44; :(QZ]321U0NFIYET"1@R]3A3]'OJI18J5?&WSQ\
M6[NZNG8Z:?%.U]]]BH5U<P)V.9@PR(/,"UWG3C;,9:49J"VH9"?WDWG7_:7D
M_ N5NT4 ?;+?5BGDJ9Z_!3>N 'B>Y=N793#P"JTGMO,W;%M^+OW:&2?E,5AK
M7_O4]<N*VP%QERHJYT";Q>LFSJ\ 84&@O&^FD000FXTT-JF7/0!-%LW9F[73
MBM9Y&] ^4D3I\>M4.RXA.=$SY;WSS=\6> 4B-5FRUOX()LV=+= 5\U;Q<O*R
MX&O>X/R:]'7[&/VZA0#U2Z0RV3)4U )+$TW@7W)OMD,+RYI-;"6(2OU9EJ/H
M>7)D8A0&)/7I.@@C.;JWHP(/7;W@(1BQ7P%0U'/BX[9_'U1MK^.]3GO7SY6.
MEJZ9[.;?*P!1J]+F&KK"1*[9H2^7<T:J!HB;OBP3_7M@N*:K6P4Z\CZ-A=H;
M)K&*+F*,TSYI%1P\XVBX'N.+*T":%G$,B>,&(<_Y7/=>G-0M C?X4R\>!X_G
M4N$=\G7]O0KPK-KA6O6YV-E#_EC&NP\& >Y/AW[<_$I]ZX,P() 3JT4T$<=K
M70'LM:RO -,U'4$H6S[BTCKF)?D5P+5NB;G["L#@#8F#T0?30Y>[E_C&HXIF
M%'F4$.^M%D8E7DXBLUF33VIU[J_(7 %\6U3^SY'ED_V?)^OL_Z^3=>I"?"#X
MA[B*S3HZJ DLVK9)X. FEE45TQPM%*C%$55K8]:4/CK[M=M9]UZ(!&KF/;6'
M]I%ML,7AL2::PH_K#><'0,I_F\I?14R  9]4N^JR&Y$1:PJ8]1X@WOC<)H%-
M<E??Q?8=-F%E%V?6U^MGZY2[(OAE"LN;<]-=KS+,L'8YI*ZX^%T^N%^G+[ =
M,X++Q&I]5.: >@UT*LU[7]KV!(NTSW!!:_[.PF'4<="C6N/9Y.SQI*$&GS?K
M,@<1L!CGF_=4'&HL^WS;[&65J:+T,.58/7A^)W-KUNW(@?USC0/$/)!%X?D?
MI95/G1,Z@3&\^N8_L*L".',LS<=@,7-G>OP34!/8%/6AJ\2J9(M2BMU-HTS=
MLU+R@>2.EE=3KL^J^*.[460\OX_N_/>830H98S+/U,F 63V*"]1Y5^<?5 K*
M2D^?3[8OE#F90LNQ/"@65'RF_D " BX#0(2QL@1&]2XB)Y8S5@I?(]($5N_&
M6M'4+ZPM92__B0,9LI93M7Y29.5X?O<$K$,.+F/5!?AS]M$L>J$%XH,?XFL%
M@10K[**6<4;PF9TP76VP3\M62YBN4XK7X_:VY+#6&T!AX5?X3=:[=/5D78\)
M/!?&KARTT_M2HZ+=2/I_"TT!!Q*+A1KANM-<C2ER)HL2]()?,BS]5BK)U9-R
M8I2:XV#N5&:[<[@E8%B3DHIUIE73M$;)ZBABI/S,H@_^I;R/01 EH]3KDM(Y
ML>BX_+$'M SK4@VD#^8SQ[N@E ?JOEP!&J3-'!!PW1J9LU)H$9S._41$?X2M
MTC'"0JJ[GHOI$8DI:KZKPZAG'>Y8@;Y/>.A5NGNJ5ZX75+4&=,.^<N 9DIFG
M^[XRS/:FJ6E*RH,M^O,M RO8 '(1:(.U*=NDH77.I?XV@]"HQF^LE?2>WF&<
MMU#!L?G^C.BI\M=$BRG_-#?1TEB32>F9\5Y/4!;!CUS(6^#'M2:;@%&X4]R?
M"M&E:@;;6;YOKM"=F(TFN)-IAAZ*TJTO3?"MSA,-( 5QTD8(*]I+$R[O?2Z3
M"2F";JK/0/X%M/O/H6[]%-?$6/X@X;7W3^)_3_OQV9C.&Q(4'7&0J(RMZYXN
M=0EFZDRA$H'16SLSR<=G,)6]9)87$EOX?'"0-PB_ NC)WN(Q@?!U@G^$_&OP
MN6"%'H]L6@X55[=Q?C0U;0RBIWATP.:<:^6;8FW-FR(>8""G8^<8P6%NI8R%
M \4NZ; GUEB!R&KA6N^$@.>8SB3G2-T$M<.?Z^->7CN:&3CQ90>=D[BG0L5#
MZ<:JK:>B*03QRY)@@6O=ZE&A\;&,L[ZIA<0W@SV&BJP*VZ#L-9ZX,">3ZT[9
M \72']XK5HTTY@^1ACG!0G,?8O(.Q'P2@-UA4P'@F\;3_R",4I@6+-_,>7K-
M3\I*MN'A;X(BN_=>I!\/#$<#J3;K%M71CA78N#[FR56;T8!R%U,_%IO:/,>F
ML$F!O*"T)'GQMNQ]\0K]^$K:;\_74I7EDSB#%]9X\&\QPB(\00K66+ZQ2K!W
MCHFVR=2RR=2[ $_/JONR;U_[U] _@?/!A.?)"0%E [:Q@ICP'[)K/"E=30_+
MTE5IVV+GI%:Z;HY(%6M1"N:,\WA4WNGJ?W1S.\$2]QQ?5@W-G6V\^%-'N78%
M<.B#V 4P6 Y*Z;88&G>DK=&[JZW]_"-.]U#R-K\Z:QT%&A9&?#1Q0#!0"5>F
MV,MZ-(^@J\3K"8%]7)\F]!<I^N([DBF[G[YUC.CZ0J'[^,E8R+&2Y4;2P:_B
M0'=\*+AP5YEC)J)F>M1Y?GI5 S%*_2_C>9Q"68,YMS-QELY>M#F$W6R'. V#
M.UP!NJT-)Z7 %*_SM*<1P-NA-2[UQ0SWMU.&#H-'20VUJT>;#L8_JP)STKP&
M 6BIHT6_/B)CFY[E,TP\BTT92DFKEV7L<YBEJUD3:VM3E6ZYYW8]>N^GU?.Q
M94O*O>7W5):8I/T\+(,Z?AG%;G/R.E<7VI=8X>]%ZOO]"N"T(O3=RN53=N;E
M<=P71T$XHZ#$KX"'^JX(S/H!8DVT,_/%%(*A:APMY\Y!I?+26G/5!BBDH,=V
MV$NA&YWLITA/M9"BU![.1#EU!7 [JZXC&/I0T1CF2,6='5DL:+"7],<56>Z>
M@_M&^WXD=_H7I%R 8E[AQ@ *[Y\)!KKAF=&VK 3W#H2>Z,6+=?U,O8R!U_[O
MZ)SA,F?$R7J']YR7<E:E,R8ZSZ-^"F[?Q2)I@GN(0IBUHHW6QB,R<[/%70O?
M.*8F5T?<-YC+\N*NOJI764XQ&?60$)?<@M<,#X/-&K)Y)QD$0<>-6JHB)O<#
ME80\-(0/+A&4CAG;PF\3=]DJZB5&N!E!G9I \9[@@PC'%>*:&!['2=,<)C4D
M_=0>RY1:! W7!VWDCFL'9/^#0],SGHE0//E).G&H>E%T<OOA,SE;.N)HKAB6
M.0[! T-=TE\!?N2RACQ9=)YDE=O"-(8;9NVX)NP/[#NZFFCCS&/4DK<V^.]O
M$AY=)OG01-G2$WA@(,S/!5<C%YG3\\YJAX:LV5F(8XJI_VG<B&M:0G]?1.Z#
M>3?#)U4RZQ;8HX.,=1K$6W3"$TX*UTXN&!7,V79]14NXJ=$B*.$CBW<S=<FR
M=QGX.,W*_5T*9?E=/=$E5UP>-J][/$Z9>@HAB?H39*HY[U93R^N8Q=>:H2.=
M(//S>>QANY^ZO\"8Y5TS605M+D:DVWJ8Q;4A8/3'Y3)#[FMX.I0N[PJRKXB+
M1AZ]F8GH&T5)M-V34-VNM5L9Q7D^(+$?.FF!.0 9"%KX/$RS)E8KQ*D5XQ?*
M/RO\K[U&\W N@-W G2_%;/CY]P>\\0YR/IPRJJ\D;6J"K@"WJ#%)D?^$>8#S
MX%<)E=:O,"YP/UD<VEJZ")'QX^R%F=+1N95(7HO)0\96P#V3>?SRA0O4"Q>
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MC5$ZBE1TO; -GN)X@ADK?2>;95+B4S;BZK,]G%+Z]UBN-SI>:>::CVTRQ[Y
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M'K(OKP /C>7D-,E#@_VQIG'!DG@(VK>HT/D\LM6S=/>T7@NUW&$3,,3;V1H
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M88K,[_?F//M<A?P\AOECG8L>84/98K.-9V<^LH9[Y?TG2"JHS'U1U#5NK G
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MD57C>#FIX!P\[7M]#CH3%M)2ONHCC.4^OJ*V"-YAW8#V5Z2U<+L2%,A,'A4
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MLG6$A!5?Y)%;ZHS(7=Q*N@XX79B#XF[2I)OCIR"WBH0E5D>+,U[:4I.DB^\
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M=^IJ)RO,<V 8J.3L2IX#2FY(?&<A_H&V$WMF_X++%;Q?ZHH&<VC>[1[+N>[
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M:@R5I$]ZV#_O)M"IK3^RR9)*77(;Q&M>GX=@2B]LG&/J^,Q7J.4# M2C+HH
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M:HSCV3BVXE_(?7QX+-;!820SS^M,L<(K?<R)+2@<1!57%$49C:V-*@RJ2?6
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M7MC.OHS>J^CB!1NAH:\A^BA)ZY$)*?DYR558BQF\9GQI8-M0"GW]>W(_?:>
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MW=*:PP#R>M/C :Q\J_IUB"PO%J.01 3P5EPG J*$"-^7?WG":>#HVPS8AT3
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M337!QGV+TE[SS.(_4R'%M)&P\:\9T<VLE*A=I"0:N$D0O0%GV),@Z>0-U4@
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M6-T"]-U)R M?QI".6,_V]%KH5,J (30'T";+J6I3QK._?L4<=?AV[WA5OE<
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M!5$"RC>E_O<\!]>/VNM@EIYSBJT359;!C:J/-&@U?\':*QN^[B72KOVY#X?
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MEN1<9F6I!L2(,:L2B3N7#O'< I2/:R<.[&G_WJDVN)T F:\#VFT\5#URXQ9
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M*@IHK.I7]AP8CPO78ZMF*\OJ:4MZVUE\H#"ABOC@5*EE-FF+LY;V6B/EOIQ
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M9(CI"1=I$E*!+F^SX#<^?$)J#1^S#%\M%MA1;]/\ JQ]>W<+L)NZRONYBO%
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M  J(!1*!-. ^D <4 B7 ,^ E4 ?4 RU )] ## +#P#@P RP"*\ W8!,@ /O
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M6XG;'-N/=V1W&G<-=S\2' C?B"'$DQ_I/P5^5OY2_]6[=WEO:3]P_^@@%10
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M__7;ZMKW]0WBCY^_]O8/P-^'?^2" %#(O]%_*A<'12XJB@VHZ?[(!:&*_#.
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MQ,"6K&ZOL4^YYF!LV7&23?[[7R< 3]3RF\XB[^6SUQPDTG> NR["^8IN:2<
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M30=>?:VZ\.'Z34S/BB=+'UP-W:/3O=*Y) B6$+C>^N!M_;M$B>B4L&5V_]P
M(A@4P,;TN2)/\L=GXV!=M>!\>9.4DJ!O2P.4WP)>4,2CJ+5'J@D!RHQVU+CZ
M1R)8'+*8G4"X=3#+=].E39LX.C^AR]-*WK0^;0]^NY>:_K ?_JQJ,?3 B3*-
M2L\2!__4O<+6!^="KAF>C>P]YAL2-'@36JFP>F=L^]M#I_<!G;>^JB>/PH2:
M7[D-WM7GVL^E+#G9@X-]VNR+D0*- U^LBXJA4\C<A,2.<K#C?$#TN47K6>:0
M(>WXF'-C@:<MN!])U)D:0;I%NU<:!6-JCUQ)LF PI2'SYW6J'$@@T*5II!U3
MA3YWJS*2<#6N7 KB:.KG3)XXRNBOJH_K&^NDH1A1EIB5T,7@[!M8BQ(?#^\&
M'419B?)&V&U69UW>AG'52^NI12D[.\^BO$[9R0F9GWO,]62,%=TCT"4#:NTG
M$Z)'LOJ#J1$H68+/8/58.F^$UEG7_MN_LF[7:PPT?*AQ-W#).7-1]C-,P>CR
M,^CZ;F8WX=IR KJA<EL UH?@_(S,"Z?G?+NQ,%"<H3&;@FWISBNKSR2OJS;O
MZMVE^7Q&Z^7UJE"7DKYE4'&LISL%QJ]N3;?@=P)PW/A*I$O?C8$Y!? 5"^<H
MBC1U>(@%P!L33W_$J5ZMP,9I<8]$%6Q31E(G$).VV8[,4-9=XZ0 ;"T=-GAH
M##23 F.](CWT1]NXVQ46<;R<$LG7N4Z=KT%(J6Y!/1E'0$H-1!U S(KEPR:P
MX789AF%WNPS\EWE7KUK,CU1^>70^(GO'309Q)DB&X?'*85S0A[7OQSQ<'X8S
M'Y=,EFM=8M 'W$)CXR\<SBNEJ5]#-ZE^X%[YZM-L0KNR_<[]M^UMJL@(D]33
M[</BN3D=H>G7"[9U],Y(O,07%GL%E.9.7);JN4GO?E<5^?)Z].;CM<*GK1NR
M97<9_Q]FCJ\<Z<5K/+^_4,*WW)]OUP5TOX)M'V._[TG/- 7?RU]FVD49OP1O
M]\Y^"L(H4SJ*[1NE3Z0>T+K&Q=@C;71ZM#%OR!+@)9@HR&4_OA.DK*C85*U3
M(UTX&4I-E'S=>&/BG8X9),6.3*GP,*-/S,@LI#:P <LT(H,K&8)Q(3<"97IL
M0*%>I[)UAH [SQV+P-WR?+)IH3'Z['MJ:.1._*E6O5=_039.@$8TB1?1BVY(
MRHR1^JY53$L<;(LF3/5W\1$^XBUY)RVJQC#G?BP4>49!/&#Y5QYL2R4O;@^!
M+616@ "[VRE75_&:<#1PUCX3I4$IOWLCR1R=,XU%=Y*+>_L17UQJAS^GV66(
M>PJ=+UIRY%1G_@@9FZ&T\,G%,F *#BT$)@W"!16;ECG!W<$E5F)%:60 EN=U
MG)R>@=250&ZFD!Z//*]KS [U"AZWLNNGQ]+@!*-^XAJE8Q,"YRS!E&<.R*$!
M48-IDE^%B[\;1Y9]P^33:?7IU\63EHY*5-:G^''%\ED/AA3\(^[3B\$<00RN
M.QGMGS7?SL9#'B.+$[83F_"UG(M7"(--=0OO]?.>V4/X/Q+-<CS-/Q$JY5=E
M6?)&4 *$AOT!<)F89 &> .6@&KZ$)+G,TL6 S.QW(5UI(=SK*L=9V8T[="[D
MEU0L+#H76>QXM)E/"#P5&U+1S;PVM&A@<)R-,@H_@HX1;'L0''L81O]-+$C2
M#\1;;-NLV<2=J<IUH4Y^VW6G@B"@F>"G"ED<2T']^0C6&65[_/@$\#ZF>^O&
M JZ5(<^ \K:-TYWZ\"04]XV:7<::ZDC6!JC;N\/[K4N9UH^X%+)IAY4_ /IW
MR PZ1^? X?U&RE-NHU3 )'SI<S8>9(%USIVYU[+BK9_TLH<TI[T=OB(G1/#4
M-[*?W&Q=,(BF#&X@3Z(%T=>7.;K3?V6E&0A.!>ZY(DS&NP119QHGKG>T$@<^
MMJ@H/6OY82ED_22'O+7P7O I/?_NK1+'XS2TUU@R[%56<@P?292 NK^)@*)4
M5HY-T>P![>DJTJ51F!&4=/HY7JL/&:N?V[*&%]*^9:ED&KX]+J7XPT-*R"%K
MDI?M$*+J8VG%?(TE?6=OKQ=SCW<:K>3/;I%4QL?"@\E/.(^K[+X\:O:4GH%^
MH[UK$ QJ40Z7 OB;F+9?^?K5A,8QJW:7 EB$HXLE:6#?!%@G^Y*Y.@DDS6V/
MB"EC_O:2.P*HKSY]0:Z4MCX>@^XQZC) F@TM\Y(YD=8XZY0N]<](*Y)<Q1=P
MJC>&M;ZKBU#7$HD:KOK4%\PL3]-O&1!\ZY5Y^KI<'_S#8DSJ1/=*6DL,+;A8
M!V)Z2[AITV@>+\G-HIC\PZ *9+99E FWRK*;W@G@2[LN\>-AG\#5>4^=B(6*
M\N-'\)7L92ZX5\FGR9_8M<08 [\%(;,HVA;W.M\8)DW!VOVJ@E-^2AI1Q?O&
M+_JT/X;TH\H^F,ZY/KU,UTU)>CJ4)SX1VL\ZSE&'<WY?TB.R]7MPST78'U8F
MJS]4?^(DWUJ!5IW=F5W2QB?ZAKS.N_J]*DI&!K<+RK&1^ KZT9!.(7PP VB&
M3<KHY")*+U^P\C%\0Q369&/RJZXR\5+<:CX7JM]&\84VBVS7].1OFK289K0[
M9O['\KXRR &_QV<GN-]2$]!>DH(RJJG%S)=/:\C_7HKZE@GLB*7S7CW/O&BG
M\5ZQM20ABR3$$W@'>V=;<Q.O>= ZKF'%*_^5D&!\N2UGTR[)QK+C4]>XTXZ7
M[_F@2U_>F4X^_ K=#%[\N?\4+"5XD!E"<;LIQ<P$[_)RE-FKB<"@.;/.3,5+
MF^=5+05=AL5:%+DQ@4P6*J<=V?)&[3562P@7ET%96'H,G-)OY@7X'I0T4J/9
MR-(R";]. .[UT/7V&^VCV7HW/[0_&'X8^"[6*["7H]WDVGQ".JPB1@+%3*P<
M4/ZDBN_A*^'<@[,B-Z(U99T'*5XH>..^F^FU_O'%@NC7:K(L'*%M G,W1\V*
M8\80K]"IW=YP:C 3P40RFD1CKZ/,B#5N*D1,<E"G2M>PK=2I3-S"[/L@PR:[
MS#.OVW+./9**+P1 B4%*LT I7M). "9*^;*<S/;".:"8;S:8+/G]K%F"5'U+
MZO Y-',/]).K5*_)?HJ3S:1 ONF"<=UX4=3A$)E!Z,@>=0X<(M+ANON6DPWD
MVHAOUF+5=QD#F@M_[=LUVZM*-Y6;H/9'1!JO#-H(=+[-RAAPH1W5$HVTHYQN
MBMD'2CCU[,)/ 'Y7?SC+GB;1=3\)VZH^%1Q5Z@9FRGIT/\*@<$$<>CGNQH+W
M?K+B5ICOV).X=LD,Q^%' JY@MPN1+PU'7$O7"Q7-]4&_7%Q'?-(D?O*+X)B?
M[VW&.9K:J?M$?BF(8OWS/] JB7?(C.&5)-[C5R@10HD+&(BO%H*+@+%ZBN7(
M.OS6_?D-P7A#'P.KCH]*WUJ,7@M^N_XCODL5.:9UY(/N\23)'7&0_(CH^*82
M %SNMUC1AYH3-5NJ_!0]Q1KKIS787DELY7M&>#TJ.'TWM],#*GE35),BH^B&
MJ/AQ4S!9;?T$X%%4W*,#TV#]0I+3>M(M<_OU9M?WWU<6=3?*"TE&<$I>J-(6
MKS]7_YT\A2"8LK&39P^Z.30P/"BG5UG]W5P&,"2ZIS!OIN#>Q8@)%[_V*G_E
M.\+2WY(=4[G9=PW<(H.#'D!^V6]9'06NPYLO51*E)Z?Z#*0(B4V$C@$UT-9I
MJBDQSNSHG&E.=76/9/9]C^Q+XY]LS/7FQM $^]T%_""ZX038OG*DA[0^#V;C
MT(DQ'$3<YC9.WZQOB2>MWRGW.&>)(3!?WKNYU?L8K]K\[CW]UM#.U]LME!;Y
MB G9O>\'#A!A_<4"8%J%8L$ 6XH5/CJD]V>?J4\ ;:-EQ!3VP:4.J67!UL?5
MM_(HS7#J\V/*.5[FBYE$-,)[EE/(=&!2!0I.M.Z%5$=G-+&QB@0M_/+G70\Z
M*N=C][CA/__UQ]O]K] Q W%TC^7UXPRT1R#=4.2"_0 F<T&=EV^AH@&W^89U
MJH\M()"FSXR<R_)AX=2H2\TMYR&^(MG+/9>, FY3^EWKOL.U(1'CMVZTH#M1
M!B=:^<Q/T*WV18:4@EV ^,OYVNUD9\<@SJAR66**MXGO]C!JB\Y-:Q]+L:,:
MV+)_F&8X3;I%S#)N)6H^67GCT7-P .VALE*UC99#8K85EK:[AL,Y$]+?2=ZO
M?_D_:'O/H*:^Z&TTBG0PTIL0E*;2?DA31 (B340$I L1Z02(- D2B?0.@@H"
M"BI-1$1Z"PDMH*+26V@I2B\)(AQ-"#?^Y_WPW@]WYLZ=^W[8,_EP)GN?M==Z
MUO/LL@[!)J5_"H\ Y*ZCQ;$J#/G)B.P4 >,RE%K#2.XI."D:CCBA10BTE)D-
M<M!Q?MW4YD?Q?U7@"SG+]4E\F#,WYAN4ZC9OU\,*3FL<B&$(X$FJ9K:T@6QM
MU;O\Y_G5;48;/VD/7A)M+2:O@?5(MEQ!I2:/Y&N7K?Z[&<OHFU][D,\0*^G:
M;\8)1L!X4?JTQ0S4*6I+SWT#K0E]B\I!3]$7@>I:BRVNL4O7:Y<U^@R<[)*/
M]R5>F?CDCZ,:=;I:'Y0P(8 >.*U=I+^<FNPT&8R2>K=FP)ZVIZRJZV!A,E'S
MK73N3]CW^B^*2<1  7T;$I<MV*,4W2UR9Q@KS!R)$6D"BJINSS)0U)@<DGDM
M8O?Y4OL(L_?.GL^:I]2;V_I?EZZ\JV-?N;#TZ++NGBK+O"]9/@L9N.S8!:4^
M0E*Z]'ZW)(0?@DXZ*V*"G&"KCE]MSX;P?1@Q(#$_7->YV+7J#J5[+Z)"J1"&
M<#HQN1<'9@XS54?T56E?UOLTO_E#DAHMGY#&QS8H;4E2_@I-OCF6@N45:EVA
MQ^&S:!\$H.1Q4(*#5P)E*'="&Y0O')',7RG]GR'WV&+DK/[B?X>@]X>@XN@8
MV+8D*VK]U*<GF-HQ,X>@HTS5VA1< YIT7=KO$.0M!=&"L]DTNGK2YRE?-!+G
M#!SFQ[(:C] &-C99-" =!UA2ZX>NT\)A M@+R 8'&CIKMTAJ97<>8MKJI*^3
M\^W\I]1S5VY==7H?SS?K>L[ OM:"6LD0:R E=1 1XD"^ [4D2U^]#' E,9_1
M3G^W7-FTA!-\2F7C9F0%OLXJ1.=^?/?E9JZQ=#7^+N#)Y+J[(#6^"^^E72QW
M@[@!R1_.'8)ZH"U#!LJ-=-VGZ)B0/;LD%O57?>"A-QE<= CB. 2MVJ)T)_4U
M:AG&K;BZ20/^%1SO]<<KS*N/;Z]&HN'QMR!8V:6;";,E3Q-EVSB%C_P6VU"E
MAP&>>U0@J)8EJAN++"90"C76K^#M6NV)Y?35J9QS'S-NNPRJ"):6EJKD=)Q=
M?A$'_S&4Q7)BMQI._&)#=@J1ZO",@N9&&;50:S.T7?\X3/;\7>_*?O55M2+O
M5J$1^YC^^SCMS)<W-K @^8<>=,Z8@;_)&V@B^@0A8.%,(\VAB9QYU\K]=^/\
M<7[PM3&F2=:E:.4+Z>*R5XUZ/\N)JH1R"*-ZW_V3XJ_'47#ZE0 -AFEC\RA3
M8T5R*9DT?U'__#LLNYO+3S6$O)D0VSVW,95*G[#QXV?8E"@##-$.O S_07',
M.?^%HT 4!2J"W"8I]6Y"^O1P&8C38^21P&_,'.G=R)83!>.YO-XU)+YE\$>1
MF]8F5!R3-QE!&IIQ)(NE,J*IL_UY!@J 0BG2@=*W]X9R(S?(NZDQI3<L^.[3
M_I0>(TUED7.UF:]CV6K&6$PSZ_XJL98@9]))V_R&QPW4LJ\8'(>G:"4DN4'H
MFA:2: *'E_>3KQY+@3V;/T/G)'>V4Z!40YPHPP3P)6^#/].6"'THRQ',Y0J@
M[17UVOD P143NQM^;&ZB+2FN97 5CX*R/ W9< >-8<[W,;,PJH/"02$F+(1X
M,0:"7#<MZ1N&^<N(TS+(WU2"(VZ-*6),DP@6,6-: L\R78A7/19F0Y&</P]!
M,PU,7C,:)PE_"$K6MZ.Y'X+L:?FQG%TLT0S4NJ7U]'SG5HG@A]G!+V7:I-SR
MR;0TE10>XG]ZX_AE7XHUX\05Z_3%QN54K!S+)<?B%NGH?FMRGV4M3\U">4!-
M^>"=\-\8^I6/C=::7[/^2SLB'M2GS-..8PB>'MMS -C)\Y8VX_KVM+L2,<?\
M<1Q3O0N2U*T(Y<GF9XR.E?Q-N=R=:O%!4*Q$>DX7Z.\@";+95LF( -)I@[T+
MXM3O'6\MJ98V;J)+JV5)XDT'QAMQ/S=5]UN]O.92W WK\NX9BW!"E!E76 BT
M!, IV1M-E)?&I#(9+6I_9P4*@@&>Z+3FZ3B&(F\.A"B\O__MV'>YUE9-$[6C
M>2D)%SUR8%=9OG86[8T39@Y"ZF(27S-,.XI<6(3?^8.^!25]9LNDK^5!.24X
M/SK./DTV[?3G1$\!V5"+/X<@$H)Q0F^6A.O>)D!Z;%$F]1B(!.J2;@+F<H18
MDB@;,>B<9<?@:[]87T6RAL+T!07N'<?'_X$XHRD(0%FA=F.Y#"4;C\<> >(_
M^!OH)_<^\,+J^@6J;"R/1SAY:J1L+GBH=K.G?]L+#T]H'IVS/P3-=NP1@&=4
MMG\+]3J,"]3*A"T6ZSJ.,I/\2OAQ?X<@/X7V;F:WE5"*V$G$LC2X1=?Y-^].
MJ3XSL*,9,[DX%@686M- !U.TD7?/D7JK2F0YT79K:0)S\:3-\YI@JRZXGUI"
MC%?.NQ>7O/+8.%>AA$/0GOPDU"^; ".V]&WS ]\7>V1. ="(*G%*YXAIE7^5
MR]H)>3&-IX)]GY7RRN0+3EENG>L[8@@YC>Z&XHCMH2N'H 98;Q06ZH]5SUW'
M%\+2M.V!>-67B<WYU9F2SDO%%S9)$4\"7-_;O"^^Z:P@%7K#ZF'D_UJA? Y
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MB+Y-R,V%HZW.PM4^-X]6!2[S&HZV[2^<J65Q8)]_Y?X.M@=@:3@>QJF'U*\
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MD*=G\KZ0_LC<B31PX<^/7:C6%?:'UJPWA)*&@%,#\?J7JE?V0Y!3^/+&(-B
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MS#W70)+^?/(W,$2N9(CQ4L#]BP0I4NTC!CL)S+OB4E% 4[<<T:8_E!MX'$"
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MCZ'<QF/^<VW,F66+0#_P.N_R>0<D*^/1#8%VVAVTXX@9Q2</V@V4@71\)%0
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MET%*C&I((AW(O0IJY3W2-66MSTF>(CYOKJ7"99ZQF=Z1\A2 ##F'D;AQ*E_
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M[F7PFH@:APH^/Q>>+W)5/'E@"$)G(U$,C8]B0$Q>EDAQRO<FBJW^2)L9(:S
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M;AJ_R1=<]%HK>8FXD5."^&I+;NIAS]%<,(GK,H'%_XD\?"CO'NFP9ZDB:S+
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MTB*) Q=4S>YQ;MLF4R&[1]04$C0"R[31!CN\A5@@'*57DR&]HA/?Z[BJ3E7
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MYUQ<4+)18N-3G9YNE.JYG/4XQG0JKC*R;*HV;DS@H=<MFU"]A% 0/RCB=K%
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M^F/IWN5KZ3F((GW!GL22%9&O4D5U;'&YH54RS( F6D8[4:>E!$FR(VP*KT+
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M*0RP(;@'2@8L<G<Z^U:AI$*>OHZ.&-%:/?50HGQ3]G2.UUFNM*K$;V_HL.I
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M^CPOW,SJ_:V]X.MZ\3;_4_J">[1^K2;N@:5M*<[K*BMD'[38STQVMY]NFIV
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M=W9H/+=G813Z(/Z:Y^]N4\\OP,-C53P96;)+7>[AZ&S']F*T?T7)H#:"CY,
MP]R7L3%3/2(Q81;79I^'A_'U= >K.+F*OEA_;X\:;W:Q'L5Q),,=1R\[_K%F
M1$1R#_98JEZ:(2>TP]4YXI JD_ %:[KVM_#>LP4.J<X<;_*3;PDH4;<)9R?-
MQIH^*!OX-'^<T]0+@+%;.G%Y\+^3W#?_A>0>AXW=/A/YKND/'B2BO?G4#@).
MQR8#;OT7DEM^Y>#S!QN;<]J8JZF!D*N&4PJ/(?W9*Z@#\EY<\!@.99IAPQ1;
ME]$!]SV(14:.8 &4[GG\PP$SNFJ=1LW2<-?8:G<>O#.U=MI@HU*O0!U3.?)W
MCFOUA^-F]RI(=)_8DT,_L!I\F=5W;+VJV%]7-22W52'?Q!?5FG-_.KW_V3N+
M(BCS:8)^]X[OQ&(<!\QN&Y]FXW$TRUSO;2+?C M@2(V@B9)MRYO;++<;-X^.
MO8-:ERY(I(^LZOA9PX +&+EA2KI20Q#UW<J+\1QZ]2KBVKIEA_ VRQTPF#A@
M$G[3_D8^7&.%T;?-X6FR[5<EMD"CM:QJ9,UMX\/0P*+-<YS./M?Q^/"1,]-@
M?O;&.H=P&1-J.%J'>B7R)F(+%-"D0W_*M\VGYW4DS'WEFJM2>F\G/7E:1WB4
M7)MR@D-NB@,E+:MGJEFJNI:F"VU.Y1QY >'4G#?;E%8=B9OXH_B(0:@)A=#'
MTUN@;=JJ.3(*2J[[CS;;S><X $I0XK3A2Y<X\-R<!RRVTW+/^1'5O\ K*F?/
MK*+L)BQ<[_E-7/I^L2R+^=/OC-<7=1]Z.7J.P#ZW!>HL3.["7OZ;A'V(JYQ*
M67>(8DN V^GL'B?/-,1V[-,=]V#T9E7N$)][GC1Y7\N>B-!^NX0CVC##KZ_4
MN5M24Y<=;WX(5.QA%-[AZE7FT%K"HF^ORC:&<&4U_D7#[K^\V+#Y-PU+"D&-
M*9A_"//[0^DB$B_GP0R0:D_>X'/H^>%U)8P7'EFD#\64@=Q#+B\Y]+G=X[''
M'S%)?)Q"-?Y#9.9;4OPF(,T8/8W5B#Y_N_O/G\O/$892_T.;/RP9_8?[2$'L
ML;.;%45_=,T\UNYC0SBU<.F:LMYBR.RT%N.UQW+0LV(_1FADX?G:*B@OV_AT
M@.!U*6J6$B;$8UH!KC\?+LU;/[QH*9V>9NM\IB3YKO?]^XNJ]$?0OWL04G]O
M"_3B;RY\A*Z<RE@]]Y"I")#R'?A[.,U4P+MZ]-BQ593#L2KR]K.$F&'Z',.N
M#DHM1!E9T/63\KNI>9#O,1?'P,OA'K7Z^L3+].(0QJZ(H&^&>7?[*S*TYB#E
M$6?!J\L<S$=/@]T;T7V:?YCL4=NQ)V=\/?68AY=3NN%"4;* K68 )^0G9ZDB
M]DG3@H_88R]NKE=BJ&\;]"FEHNF<YL!?O!2HRZN?7#=>R>G$W!S>[#?&;LTI
MZS0Y+-FNLW^*]CRD_S]]&+4PBF;MX/S(D72*S1CZ_.CKME!.Q.#D+[Z>/G7W
MB9J$_5SGZ0J!.SAZQN3"YL5TAG\4Z4!AZD.,7*<*'(\C2D"]P(<6EU;OWODU
MG$#O_6Q1GB2OYWZ7E@ K>6.AY/'[K]FQ2>=FW_];OA]C3T"\,I5' 0,:$5GM
MH+D?L!;3_<_N^;&API ]-O8[0LT6N("6O^ >9Y5;=S@NH*X1.J27T][-'/FF
M=7<8*R0NLUU8#-&KNQ'2?YT),=Y 6,)M R.U$Q>8KI$\_4</%H\*<LDAK$5=
MEZY7)R,G3>>MVKG$L]%8Z.C./,ANYITGDZ>5(;"'Z^$R=]PR4.LSU[!*=[5,
M%B8X+>SW[.. QTXR_I$^_YD6:+>N9?;"-G%EIHIDTB?VNL_;H9OS@4G"Z/OI
MLQS:ZK1-6U5Z-N(GJKQE[&QO%H<Q[@BY'1^:8XO/=3RUZ7UR[AA@??NSO_[&
M< \Y[&)[,%?Q'8;H:I<\HY^5S&M(L_@+6)14W_5C9?^]1>M12K:/%,5Q1)6^
M?D7\S&IV,ZXFYR8<GSR[TK%TGZ/C+V72Y\8*VK;I7 BY:=7+IRZ=")U\\\.Q
M.O:/.#79;IL<@1_H,KO^8N3ETB1[[3]34)5<^MOO[W5LCQH[\-O/Q9&:249(
MV:MS*NO=GN:S\)&YGLYM+)TD?2BD_,!99?UA0FG?SY:$\S7#&FZ9[9LW'I>0
MNW7^[F?RLW7[ZPFM2<G;0G'O/=[=4H4F^G]]\J5^ATMS_3^K*Z)'%_PGZC</
M"%DBU1Z6C2]B&B#PKK_CZ=OKK.J'E6%EZ&T@Q'FH\@00C4V^S8X]Z<CIW'<^
MZ)[?.+M%83S8PK'7&59R*.2+R5\*&?V7VH)Q:LO[?UE;W [;.F0Y5!5-M$?>
M@B].35LV2'QU#PBU'>= Y3=*R_:S/B?L-CT]V7X8LCTCGWWO69,"D8UU3D9
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M@=P^B[]EDAQ"D((&;(&B865;H'M,$U*Q//,D%1.-U".U)VM'6MOA+(M^'\J
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M4NDO6=EOSU5*Z3[ SUW_,D.Z<8J@R)TFN#ITSZ00="=?W*M:9!\RD-K;@E,
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M8[2ZICHGN$BVS[+NYHR^IEC=Q9:.?HU>;#))'G6@'-V/.0B51N)IKURQ<:'
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M#2!"IAL;8Z"DQC2A)%:_3*_1X1F]/"[-?']"B'SPY66I)G7&V](XG1\Z/3A
M'=Y.P;*5&&79-%CBCO\(0>+NE >6MR $^E_3F*"D26ITSL(OB,*=H.;LL"LW
MQ$N^#3S!,>Q$GF"XC#WG/V#(2K)Y=M_82L@@S"$DFOK'J.)K8:FMP8NME]8J
MO-?F$=H"QP]<$.@&H:W9@TJ:S'*Z"H,7G%*D 20N! )KL(!JS0Y'J%C1YOD&
M(P5%HQL9 @^3Y:Z0_#KEE."GZG-O3\KI[8AQ %(9J*#M^6Z]WRM$<_WPT!HG
M"+Q$>7T8J]';"R;75S<U'S'T+I[I1@0;56II:K[[)7OBZ5N$_8%[VTI&G#2%
ML@? XD0(!5AP9H#>,Y5>XZ>1;_VSG4DI,P%-:]6*/Z>K.GF>K5W[*BK#)?34
M"F^_5P*[NW$ /484:!I$117KUWI[1BF5>NH:A#K/K>19;_LVM3P>1JIVJ(0%
ME20H+XH?YV*2>MBZS&!Z=?#NB8$%>!+T+'N20:$+5;"T;!VNC)JGC>>.@?V=
M&QTOV594U/&DE]OE^7LV2)_;+=A:1]JQI#6W9&^EF9]>\-KM/*3L+Q8Z0!W
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MS4XF7/LQ4RDX'S=SC<_+'+7!W&;SF\]O3/;1OCZGND>9,7_7!ACFXHK[\)/
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M_[SOO(+6;1K]<SY,/W^NSXDCQ#?[K-3X(6++0F?GG^*%08+W#VQ_D&+"VG4
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MA2A>RQX>JZD.M\H7@HYS[[V:>1%Y^Z" 8 S2>-Y)9]<*TV%%D-C50CD"X:7
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M3' \06V!KM)C6!ZOBQ.9717[P";D1AUJR3@C6?'T[!VHW4<K2#YH'N9- 33
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M<\NE-R3B;-V)NHR_=ZRNH^H5&ZZXGI0F-@#!_RZ(!8R8OCVM!O$$$Z91^]1
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MZACFAAYAD8*@<OP+WV;!94I\E4:]PYC-H.@/\WPSTO*2V0<\]3[_L:O:KVB
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M3,M,$&S%3-^PB4;SRYYA5WX51RCW6N'W]-Y#G/]7;8638=JF(T4_X_4F#(U
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M^,I_, N-'>JHB[J\AO]T_E=S_)\K]\XP$- QGDZ*'%MB$JGX<P=VJ%6P'"=
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M"-'=A)$W-&)^/3C7E;EX-^0T7C_O&D6T8ZU_*BJ2J'ZU3&?FJ^?1<_W<?XO
M2 Z?+3A@#KV-U'E0UE?ERQ$<J2<*_\R:]@\VSNVMP6(+T"[H&<7F)YJ>G/=M
M0?66(J=S%J1^>7*ML\YOOVB7PZ6?RW&HAA[0\Y85!&+K\W_1W!HR>7U.N)P;
M47T\>R60_^(M/EG^$2"\A\:/-XZ:L!'H0<I,.FQ^(E>E/2\WN5TWH_IDVM/3
MH_DPO3#X5]P^$=X"^ !*B-BIB%1V*8O1@@M#CCVSIX#?B>UROH1#DT> R;0
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M#(HG K:4*3BC+T\B%GG&I1FOVUS=\"9Q!56GC75HFCCI,>NF=R--*OFU!_R
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M0ZY@DBT?6W_"IBG:JQ&HTXWWID3>$5T,G_2VS=7KKNW9^THLA?O)2IBM:A3
MTXV2P45N3H"V?:E$.JU',_YN4+PA7SD:;]O8UFKC8SNQ$E":O(7:XKE#^",N
M&>@5?M\XI;:O#3\XM^X:(*SO2=#&7 (VLLG>F[_#/KJBWQ6Z'2]R4KQUT/Q*
M%/RP?&02[!=Q)I)%3"8($H9^W_V76BZPV*X!:F_W-#R.T7?+4GZYJ>"S9U6I
MT<(\6\_CRQ;7ZTW>V$>GW,'VU((%U-XBZ"QHO1LE>=H-<.D7@&?R)S^R38II
M/X7Z6'+H*Q.")9_&YQX4\W^T#O9_YW11<>W%'H=C ,HZ."D)K95[:<X@OK
M/FB[!)?%2T-[@#.;=T$:%9&<KPA(1+>JEKA![;OJ^N9"!A1OEX0Y;72D3.15
MCY] -SFX21FO9)PPF+>Y09H*&=B![9?YI(W@QG.!CE2,K EXI-6^BFU;1\$^
ME^B>E8OTP;[T>O9.ZNA;HH;H]1ON,@6W9@AWM^6E;QKK2GV=-/P17=I]+CU/
MX-V_.7D[,'KE#@S60)3#$YLGR,@#N&B68SS>&LB["J#B7XRJ!6SL80P+N[@D
M*K9D*(>*)[S_'HUK+8S9:R$VCP(NVDY%ND#V8!%SY2T+(VBVB[@+9$:% $KD
M"UIM=$&XDY%Z8F*CH,7]AY7$]/)WP7=?%JRDR'7(KJ<\=U;DUH;XW ]Y,F '
M3IKK[9)7(S!O\SHXUT.#CKF1R/X(WM:K<HWQ8&EOA,9-MF[IZP?AA9)'3<N_
M8*IU?Z>KX:S<OP30_YB8K2Z1:LNH% GVB=T8*^<&Z9Z'=(/AW>D"T.4U\V8@
MNZ;DZ"."XA@SW;-V.<U8XT@>Y#E[H# XWYRP+6X7G7GF0T3GW"3[[V5!(YW[
MUM5<LKDP-A9RW-J'*^O&B)=R/D%VK&7;3L(1<)4:X#W'$:'P^SG;SBQ7<5<'
M*6?9CHX'5#&B!QL=$[-P2F>B?_!__-<[Q LEPN:'@HB[VZJ/WU\!M;!(B1PY
MW.WW:H6-<39</4+4 UDSB@@UXTSTT?Z7L*:'[TJ-NB>7-#][])[M(Q+7DN8V
M=F#1;N*@8_HZ7,S_KG@>D8GB[PD^F/KRR[E:VY*J#A-49M^*Q)6K2G<>I-"?
MW<>'[H(""V$9M#A*G4H'_( %O10,CS4T "VZFO'R8E''5A!V#8U6X^HC9[\H
MI38<B@G[T[^LE$W.=]RT'V_E*X%$^Y!'MI^UVK!(L8YNBN!*>0#0):@\NW@)
M:+W;42^->5IJF']!,:"!'J2V RLB^J8=>LJ[?>4??N'LB^E6&"$_<?TW'T./
MA:8:+)_B0_9$'L17Q Q;B09W+N>.2]\\SXA;2KN[L:N& P0V%4#:@XV@^\YB
MDUVKPHL(T9#=S;*U ;G+7\U+!R6T2D7L?\RRTK*G#=I,D$(] GU\9[]F+8LT
M-#?E5KBHYW2E(NB3/:NQ' F0M-3'1$F[^$J@Q*37J!.S$M5/H >:VC).-S6K
M'C67?%'U"][?]'1"_=M^/F'%S8?SX.K7*$'W!1HO6_<U-&<)&LVF>J 20@30
M>>JZEWSCI]6NOSTEDU 4^*I6\L87@R7,+JU(A*JV]N#/ \2N)X929+;<!$$9
M-].]ZP+8Q^D4;MR+CSWW NCJ@;U,QLKW-RW9QIO\J4:5L_@(S4V%/3<..;[N
MW!+ ](!G\3<I_&B.J,5V!8JA)+TP;ZF-6H)K#NBV$W23S^D9+BL^VXV^.EL'
M<)WO$28]W.\%Q >\FI]]Y&'$1_T;2)]O,-XN.3L#93%6>^YA^G(OY!)2F5N1
MVUP6#<#OA GBH?G?CG<L@F]6A%:66ZYH_#>:?;(P*]CA5L/Z<"\*4EG-8"*F
M^;>,(0,_L6&V>M!>-TC?6I![WZ_Z@0BMLT'?JO? D@[/XT8E:][&E-1BUV>6
MA/-?';QXT?C;)LK9H2Z5NK<P.G3?@4L\K.'=Q[F.D)EAAT+D7<TI!E%0Z5HL
MUO9YP7."HA;IU-G#\0X-K6E#$O9FZ*_&K;>G%*;?H?NS]SRL$!H@G-EE1O^/
MN&__9_K]_Y\HY^0LIU44Y92<<AS)*3&2A%B1<[/D-)E-Y'P*X14Q.1^3LYR&
M.50J0F0.LZW(>>LPS]K,9[U_^OX'WQ_VVVZ[/6_7XW'=#\]KU^.NBT"!5^0.
M,U6HYUPZV@&ME:SM<4$5L\Z =CEV"YQ.^/R[]?(7U]V$IY&WZ^5^J!@$&S;#
M7HW?D>[?L1G5UQ\QL%7^ZJ 9>Q2-<P,!5BR^D]371N84XB.6?B^;PC32( )&
MQJ3M4#L<U2(Q&Q$95>D!([BE\<K89\]"EA1=)-[CSPBU1=PJ_,@&"V?6J(DR
M<)IV;QEE0PW31";AL7Q&PF6NFP6.5M'? B7&ZT]_U>V\*Z&:8F1S9A24Q+DJ
MI;.W2W]X.[U#2&KB4)ZJ@ND17OXOSP] 6%8[".W\;_(!Q@^1C)/&W8N)^#%.
M@J:])$TR/5:VS2UFVL!" 7#OAIOXF.JWH=%1M>_MOB/YEJSHAC<N\XH]Z#ZO
M/O8(J&=H;F*$4#;AXL1!#PQTSDBN#N4PRW2BZ?P"CA0W!?RM2FEX6XUMW_U9
M[9%+&$P!"1MW5\L\!<^+3U.<3P0?WXR??3V1QA8Y1DILZ4U:.@ ]1L%+UY>5
MJ1]KO/4>^KXX5KA,&<_VL7OW<#OLQO&=LEC(F5XEAAI0/2J=E-B/IX:ZTS12
MC%!$_EZK%6(R?9UWFJE2$? 0_1^"E$_MRG^3U4KTXAD4+:*E[Z)@W8 CS<F3
M.I?(DFD:. "E&*!*./YEBC(R?.$&1Z::O#^W$8_)Z3<JVMB$&L(N/R.(W]I6
ME'#;#YO^Q6]W:I3?_:)W:UM'AE<BCYB5F'7IN;(:*3XQ$&B%XYIZ@5CPE;C7
M'EU2H*,XRI])[F^=R9"5HHAEI2DUU=_@N(=V2_G%#)6WY6Z#&DFE/[:9CII'
MK!WY2(C_ZG*^$)\<W?C*XL ,7FR/!,17:ME<%AQ*WC>GS.;%D'D1;<G++(10
MXV/AJ]-O,[9]\I0W;"S_Q)_EFML<;$EI?GK-=$#QP=GZZM%RSOM2 R *Y\+/
M4J$Q1!;V54$&O%T"3'V)"H536Z\"S92BE# $+]+69K9:XF]"7[I;^):T!UE;
MZ-ZG2N:ENQZTJ#]2B^]UT<J80<UV%6PL5C9L/"N!S;=IOY<D5R(?&QFO%)O?
M:N^8::_5V%IPS+&^W97^5"\$,F_;IJB.ZA4YC.Z2,S!![RG(!5P;T@8)$C7L
M'SIPC^&H4#8S0*B-3#^V=<.X G!($G'8TV0F/+G]["]_[VF47>7R*,[/NNK:
MY7?_%;S/2%30.F;IFH#R8QC]>X/1Q R@HK[W:^QC=^]@AS"M+YM)'$?;237B
M2K1+GIH!:J:JBODAS>7%]FO7N63#]S-8'[.B$$51IUN)2NFL6]<JT_TO.ES0
M?"[T<Y-=%LIL H,3N38":\?&GZ;A$E@:2EB?%1FBT(:!1$H%U+N\*K>:$/-R
M^:?3:UC[>J)*S:[MPM"&DFV<F.&;D%::+9L(\K!;0536#I$TD:SJ.4Y>2V9:
M48HA^&6Q:1TUC$-+KM.L_;/0?6R4#![=W#<C\OB)IG6E>KE"UBQNZ_N@U!M.
MP.K*D9+_0/E&7]=>;_]A Q3;<A*_V+H"4&K!X-_K1$[T*90']>,+:A*,ZI*X
M%6ZK9L)PIF;VU 0^6%JPC43(QA&A:6]SM$5-H?.S7.EY7[1^36SQ4KU=]_/0
MZBB'&903VQ>ZO)YCNC0BG2Y!CP447ELR9A$%UU\M+QM_-&\O@YGKYU^#[O(^
MJ/PO=\_6M=X[7P;*==LK^Y[7U=A2SID(R-I?!ZX91PN0V/^'CV*FPJT2[+O>
M\JO[/6C!(#!8G27ACK*CWL()W_/YH42E?K[#>&C;#GOW8R_TS*S3*Y]7#^\'
MS2 FVZXX1UYXI6"LM0N+V_LWX>)?1BE!^;N;X,0CUFDF9 82 ")27_X>-RSF
M)NLE]%KI3/KA.O()3JKT$/6[+B'?WLHFN%[ZYL^Y)T3:&X/QH%QF>^VJ ,2P
M@6][#5+OFH'N:T30^2CMGLE''WK+@5LJG%F75*KT:(F#;\:<1B4W80DERK3=
M=#2(-0EN$QJ&<*.L:'X)RV#"A"5U:32C^M9E[;XKR[_<&^>[$YX\*R[C *FU
M1^2(:8G>E)YCBLV1A=*,'&EI,*K5R$1J"^#G FA0H&+KE%MS]Q1[.V;NZ8C'
M\:=%RUB,/FU.;PC)OV @^/Z\V6TA(GB;9V#B_<6EJ2>!CBUK@B7_C4'6XO^X
MD NV/S N,</V2U@R3.'I-DP:2SEN;A@CH(%6]$#BA_O/V2G"@KP,)=QO_-BN
M8%P_UE T?371^$=:P>DB_R93((!Q!W6UA4TX5<C(JS3B"$0D,,+$B"97F9G]
M @#?;.V>;K.NFJ9TPQ5N3.XTSOY8XO@)9MB8W$[@\'D+XOS=ARB_?32D1%^A
MJ7IM1#O0D?GZC:(?]W'.=5CQ 4@<?1)E0U-B2D#(B"1M#5GD/ I"G29)8"DQ
M"H/2</+(G::->N-W8P(;8CT6*EPNE^]>0)4^YX"5$)288MZ414QK9<).(PU_
M?6HL^;?&H4VWE_5!9,PVW EO%X,)%0<>J%V;?<?K=?CC\UT%<[IC=GL&"&,.
M(S@>'M=E4ZB>E'R;;FEVC5K>X8ZOE)]-PS !UBQ8W.3T1K\0$%/&Q-"^K3W&
MTHN[@,@*)'F4SLO>U*9PS35_PI:EUVL5K0L-1?93]9F.IALZ381IRG(\6\4:
MT\#QV_VGJI-4M:&2XU2&[52O&?EX\/+F57GP3_AOA?*Q(,5<VU5Q'-S21N3"
M8)D"UR$.AF)W^CU3?*)Q\MJ/"CM[O5&]!R%?YDAL>0DH6XTB#J%'<&V.+4 >
M!2K'=*)BXK9TGND$Q6"@-,CC9<.>SYU%-Z?55Q)\6[)/_JR0T$J_U+P[/_CO
MLBW&'Y,.D\4$8..Q/!HL V09'N]6D(X*J%P,+!&G10<2,I82.K+A#_-S UM<
MQP077UV9.K5H+@-W19[,BXA%3V2E>LIBY,9)=V=_O479'<ZB/^^^=JO<<R2H
M]T1QV<=OZ3V'!4RYUHX/CDXLY*;?3?<SR6-NL ;!;;AA07-R=19+<YR-9Q+(
M>LI1+,-D*<A KF^U*I-U^G5[WTQCCF0G**;NXLGX[5,G\W]Z1TD]L6YRH:YM
M,VBM>,@K:-9C'-L!-B.. S+0'EIX0;+,L%O3X[ EKR5WI\B9_G'QMM,1#762
M[QD:!.DS]QXK<M*C3?>KF!SD&J,@]6+R!PDZ)$GRPCSPHJQ+0/MX6;JM8B1X
MT<>\*W[RQAP^*Y4E#PRN&"N,F$A^ANOL"F[2ZV.J V\\X%5K.GDG+ULJ_)K^
M$9P:6[D6ZG6'[VVML^MZK,"6]KC?9-III) :/QPZP345^+U;I.;9UX0;>EY'
M^&,YO2/T=7X(;<TS3)GNDQ@_V"' ;P4QAA$'$HP@5/4YLFYCN?L'\1%<PNZO
MM"\#TX<&8D?$9DM0"*Z,9^]46N\&EPI]3]D5%BNYK_]WCH,$(2R0"K)0B$H
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MPX_4@^PG['J>K2TR; [XH7CLE/*/S]<UN30C!'9L?)L^PI)ATI6O)B'^0A(
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MB.WK\NT2"E://-RF2\K45R)IS'-2YM(UV%H=*\_D)>^;>TP;J<"I*K 9M'S
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MM!;3DMJ>-# ^ 7I+ZI.!SKQ(LNN(L1Z4PU_)D)%,KK>^ZA.G9;+*59?:QS!
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M<4WEQ8P.PT[!ON3'#_]&-36O@.J2 (F+*QD/7)=2AFI .5#0H6B7E>HM=T8
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M#-L^9*5AJ:X'H$. %>DG<&X!1E,::!(.R/U 3NC*F9+1WYT]>]<Y?E4+Q"B
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M3_ $29N45]F%Q]1@_,?@_&U.*=FW;T[?,6L>-]2-B+W \7=/8P#'Z_$VXB<
M'?HILV]I[/75I( SIHIN%!6)>/JG^I: ]0,*)W=J%<07"U+M_&C$N9*^X3@A
MN*QMZQ!<WG5[C_?D#Y9/7JR?X).O/JVP?'!')U.BE8+%"V64G'L%^)!A226J
MG]3F1FP0XM@XG;/;82F_5,*ZHC5C5)OY-T>=0PSPDGF(U>KW:ZG;O?].55J
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M:UU>?[^ >5C07'&)YFQYTN)$6*G09SD("1*'4I9R!6!#!M"BJ@.05XM5M?O
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M'#V<E GA+/.; "ZQS3HPC^7 ;JTX,#C<GOWG:<E5JURALK>:/SI4TFG_%I+
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MI/8(- 9$Y1 .0RVF:=K/M/ R$1^_^ZH%UW?+L8&O5=5N9QNGB<-.&J(1#Q#
MM=Y,]U<VVV$'L(7%WN0>;B"0+N;GH++NS@^Z'4&<I[1YKON<&_7 AOHKY5MG
MGK2W7%(\_D,95Z0*03@W&O&"I]8!H&C 2)!Y *>0M.%O_TT+$S?4>&,?KG0$
M<>CX?F"7Y4!*2>RYUM6[EY*$T8V%7_30K^N<(A4=W.PSS]][\!Y#A#'[T+;[
MEC,=".Z &Y0' VL!/2O0&</.[&E&2C2S>=6@'G%@O4]$=WFG3=KM%Z0K,1RM
M.)[P&>$GKE3J(![L[A;;W\O7XPG@]F"@![DI-:IAN&,]BX]@KQ/U^??@L'^0
M^I2PH&B(93C/0Q=%.:'\QQ_9O2MI1L!X"I7Y&E6M,85\@!+Z]G($%?/<9?%B
MT7[N,UNID \G++X>RV0[SV3&?NPI%<:(;39P?DC1988F2W9U<)"QT-V/LNO9
M-WF'U8"M:8@<+I/G<06=8MI_&CR!VDN@ ,,VDZ FEBP=ZY+%3D&B\=8W!IO!
MAUM1N,PPQR?9EJW(PZ3KW%:LCID<5Y+$-,A1\\O_9DHLN?W<<SY\_+UM%"8,
MNO27%'RO]:Y<#,"?G-H-<RQ$%B=Z>+QJN:$]VR_9\[K(ST?<AXL'$E6"D0!F
M8L5G[VL#$\E%%^<^EP2:6TO<17C-N'D6N_FU;^<^_O&AK]#0?QY[G*:+ FCH
M.S9\7V4) DNEL.T$;X[I0J+8CRLLD;%NYY<[A/]$ -QT+L*!1>R4PQ&$F7:J
M^IL,$S"?1HM9YY,!'1QFPG*X5IBE]*7.CK).+!1^$O/E^BX!U2Z*>N#H4=]/
MUV"PAQ-=#]M_$7$[)Q4O60)+*9=IF<2S!<2J4M],+ 1)!-Y_]\S5_VMA@/P1
MQ%2I<.-6\T/-E^X%49#8F34,/W#UJ4==?RCI",(^X=U "!3^:Y0;Y(FWNLW:
M];Z:Z_TIKHJS?8G,F<'VC48<:(03U88F)XB^,="AOUAB4#WK?B5N]_CDL&>Z
M^_FZF*])!2[AQG+'F)J2CB"HB24S(@E+$XCNTS\&=DWTZT\,[K+ZTR6G?T?W
M_+'WNX]MO;5C^!E]"ETI+EE=#H]HNO._&=O&'VDQ1Q"6$O!TET*M?YU. KG>
M%7K=4?XG3\'VN:8RU*F=TR*0[,4G?$\">WVQ+ L\QR^0FCA&&-5 3U-PY=TI
MM:(#&?/ \;W7-BN:Y^3^6[+44X3/=&"9X-!G8.O6O P_4/5W]W$18BG/7V<G
MRB>+RQQ6<@W_Z^)[23W(P_.-X^F0GULVBRE](LYJ-:50PA'DF+E'S3?H4J%]
MW5/GAC=EBUNA$BP#8T<0ZQ-LI- A?W0**2(1XT*Q??$-+PC@ZU[<@:"^_ZJ/
M_(X-H7LA>KS4#CK^3/_/5><GC64<#A"Q;\OY#TMHG!0$+Q@U;/GK""*"7"I*
M_1U<=UD]ZW"55F.5?/NF^O3#[F-Q;?="+!4=K X?T:%^^JZS!3D/>H2]O:.]
M[H]F(&-XYY0:U;A;2B/LC"4$M\<^,TCBJH9E(ST=\JD*A)%3J KY+Z#'T7>W
MC*#M.E%NU8=E?$N_%LXZO(NW[J;DL&0],^Z7%8[:(N\51U"Z V-^-2A8QTXM
M;C^=E6LS>Q//=GM,<+0C9-B"Y<E)0::&OTK,QZ;)WXO\*:-9,??+3FD?U'NU
ME-ZTNN2R2#93;>YYO>9YW(I%$?+X]PL+K"^,V<3;L N$]J>APIXU-L#/5+IP
M?$<))ZB-YL#8;O<)G!H]IL&+[*IX<'X3SPI>WAIR7RZ2$0+:QE^C9'OIT_E6
M<4U&DU(^Y[]H%*QY79(7_MEYD\2O[*K+*)FU7 ZC-D8&Z!+-KZFV:@UC;*7'
M42\>:^#:A*_YD!]A/K^^8U"RI?2$%]M/Y&W-2<$+=TQJ24N:?[P?;6Q/M)D.
MO#XWMVHI7R";J?Q,+K]/7%&A&:-Y<!XMU*\_E/VT BW:7Z)-+]@HE2R5EEA:
M<T'H&MW.FF16H)4M6ZSF/][H?J[$G AMB7@PLQH(P.)GU@BAJ!"SM "C26'"
M[NNL(TC$3[FFG_J/4X)<M!>^EER1X,U'>2./B\RUY[XX:\+%DG["-LG4=N 9
M!,(.@; Z5SS@4OK_#_%@CO+3M><-6^87YN.W<,"5B029T_GNR FV%R-#1KIM
M8,YS[. 4U73\36!K?V0<;+3C#GTG6'Q$&4GT>ZO%]-.LB!$W.2!W)>9R-S4&
M%V<TVN2VNJ7;I(QTH-\,^;:W$_BL]=Z?M9NQF"O][<JD9H_DC58C*+8?%LN-
M43XL1-&Y_&2X7:#)407K 4*;:L_7+E,^O9.JAT?PG"D_8V]Q)\SKGFV^2L)8
M#)^9'_,([<P!#^8LX+X]68>1?@D$%4$),3Y+&_.V4Q*6WO0I4;FVP0XA _'J
MDHN#K8V?W_6OYMY23.DE/42T["?#V2D3/"YHCG?5X)KA.>WPKKG?W/6=..N+
M[;J<P7([6II]G(NJ5[-[0ON::GXR'O89R\M@.7&L;P[[M[_A3ZMHB'RKF=:R
M&)JM?XP_A>>RRMLVSM/9XKAQH=TSRI?*O>X.R>FI5K7X5@%$FN ^"9?(\(2_
M@2EQ@9[3>-'E+9%RJ8Z\OQM^=RMF9^=MS<P>IEW:DDW8"%KN_KSL?M'GW]^E
M]A]! '/$XCHC#S'U. #3-F 82ZP M?.5Q">-@(Y7JP%GO$_FC>MT^5^AG!<W
M+TPGW_1BBC<-PC"2>+P[Y@2X$[->VGL"K7)P\2?%>J/@&?)G34,D2G5?_U:@
M=")5*Z0NWL(VO=[DY<,1N?F/Q>(C49K&4 4,!Z-U\ IH0N>2I\!RRI5PA*PP
M#S(:PTY:-E1='0UFRY5,^?F;\[MTYGS@ YS2DK"E?/$K0Q,*=!L*]%)0.QQ&
M2M_H(BXXB3)!&YZ5-?6GH2?TR\M.7\Y"AMW-XU"77=9Z+5@92,R-9Y(9*=$L
M@5!M%J%TSM^,3"XY^=L%D>PFF$+(:$B]3H]X\QK?U9/-ZAVO6!(1<>Y2X_NT
MLF><$"8KH'(/ CH!!GO)U)$A!#?HZ(_7 _]KQ,O-7'T:JA]@\$E0BB"7)8$A
M07,=IJNC;4]&5&HQ_9A(QI(R<2T1B7#F=9OC"QB52<ID#S:@77\0AHU4T7ZU
MPOU?1]+2]3V@>B#M^OG+RKT?('H-BT<04F$O*PQ_$C08$L5SZS>VD0R0*J[*
M,39.>+R#"^SLXKN0O/?O(K1X5+-.=!RSE%4KN(W\6J)I+!,=>7 .U+4_K-+"
M9>A&Z96.=(FDZ*:HAIF$*?VXZU/@4PA3TBV,L'@>(:QZ[H%QH\K>XW][0-"D
M#E_"PY 4&!145T/:=31+W.K@_Q81SF[[2C M=B2\_<?IU644:T\=X8DJ$?9A
M<1\S60+Y>>8(XM5T;(*Z; (RXH_C]XM8+8"8\AFH*8T^,64NW%BD\B(GX"4;
M__9:1L[#E\R0N*$[H,D>'^A-<E^LO0D:U(+V\J#GBX9M72.9DKW(G4NZV;O!
M7*B0R<$/W_OY'R2EW7)H83SG#Y+0"YCM+NX3$%PT?](S#%]8,'DBM?*J#7]_
M)$7:[+O+[^E//U6+Q@O#<T44N(1M'RP]O7J3R77V7ZFW1=:I/KC23XW'LCNO
MT(S;[I>K_&E2EV%];<'ZRBWFO]Y%^MQ+)L&5R%B_J[IWWC1I76-/I<4R((FA
M*1_6&9WVDSE#W4_8IIF^0/O)A:/49J@FJK8K:A_NK0QDG^Y*4[Q4X%DF;3<<
M7(XLIO+1!'U)#NFQHK= C=U^P9JX8(K+$43T1/L\:J=1]#K>P>K==?2&DZV"
MI9QY*J+0[OW.\E#,F8?FSHP ,*+]6_GN3N,#6^K0.E]<P;"G8Z*$K?-:JUP#
M<Y8O?H%W204*\5-(Q[+;G?%ZE9:"9R8G72.82B8 QB %0TF^24;R+NCZ*\#-
MDM@Z?TK_>GU8B@M>)#QJ?-&ND=+^$_.?JF)1B#)+8%^!O /4TLM7?(,1Z^G3
M=(Z?!P:+[ACC<EARN\ H56?\P&;^5H"NUYLW/W=[TE?$SP7D&XD/]1:*/; Y
MZ5!!TSG,Q$-I"F K/(Q\!.$K,QA2')B+/8XDMH_!:)=?++2U=9J%X$Y]B=7%
M413>W$F' "A.;+^.$0]:9>_1#/VL/YWU90>84K\R$6U4N]>=XACDFVAB^.&L
MYJ,[Y8YX2[E+]O?.6@K/8J0.'\*9 +X]M$V2D0BP6EU$ #VZ6ZTE(N6ZDYYV
MY5FJ"Y38^WCGUCQ\:$E^>18R4CN9^TV)><-:A<[)?&#TE<@19L-\ ?C!_&1+
MOZ&P(TRNZ\VOKHPU)U:7,ZQ;EX-NNE0DIMD;-S?:&;,D.-Q@(*])'R^9?W"W
M1S,, -Y5. 7\36XM)"YWI?Y4F)%0P&<["*64K(4G"\D)BJ31VM[/S[3Z/( S
MCQ"!*\0$=Z%M_.EEI!M76^$\Y;W_.;"&.WJK%-TT?YE#Z[>=N2U'HMD#CG@V
M+F8OKJ^] ;"%#'+O3BE93?$BF,7XMH,@[!.N38<'B.K<<++YW&I:6;@Z9<HC
MV:7Q?:D_]>1\HPCSZ^HG?*=!\P,>VEE0B*J'<6<(5DY'=(13#D$'SYNZ9'EZ
M^4*5B\54O]_#H!^YMJO9=B92/RP:-2F[-,$$DN^(>_9UC#E5-WZCFQHV2\?5
MK;JZ;!7M/5Q;6>"_NU'.4>/HG2<%>?'UZOG-H9A3Y7Y/^' ]##7.\@[47C>$
MCDC$[";*_X@]!98@))":%UZXN=S"OTH70)TJ.6-OY7],23SIX>UR/;TY*H(F
M=$ VS\!Z/8IE=47K#$.3SEU !>"AS>4NYR_=^]!2NWO:.S_B<=QB1U#XNSN6
MVCNW$]8R/[(GT_Z]-PW'*!SB3E'OH",&IE8LUTO/U2 [HN;J(QK< G0\Q%DK
M;2+E7F7<DSZ"W'\AJCXBKM>H2< !9MC%B0%W]M]\QQ8PVFT)A+]EA\FU]\R:
M,/MCP;>'7I2A)#SOQ?-\D+5[J,Q^&\+R/ZL9Q8!V_UL6?0ZX,10K,H?1)$W6
M!AAQSK9EA9J6M;F\HX]&UIO5/;ML;^F(*'E6B?RDKO%$T'(<=&*T*@#9 8?U
M\C*JR@".[VXKG]BFZ'Q74M)08V7$7C0GZEKUQ^25][>S]9C/G7O.>GSH <L&
M/K_B 5R2,D\3\B3-CS3E./L.[HJ!$J.NU,8<Z9YK:]81]UY>5?OD'Y@Y]YXB
M7B(:[K=TR<>LGX7_W"(#D4*X.* Y&&LP"U>KPOH0,9?G<(-&I_];M8+M96T-
M-VM5&? 7FS('0'KN3VA__;/!0',<T6).$ZPDY6RGK4=#!=!\_=/^78VYK$/M
MA?M=J_1:F>PB]K"1Q=.=)18[2S<(K9>KB^(MY*01"0C &I& :]D=FJ%^2<2<
MO)\C;-;US&IH5GV#^[ VI,/AM:6<]^&GKPW3GX=%_2AO=F7/3V@QT+S_D9&J
M_F,HA?O2[B,.+VFZ4U5%%,.DN:*&C(SNTD2=HNL]^SI[;W\(MV0[5?F[!B9Z
MK*3HW>:8Z&+8_!*&I91\M91$)3FXZEZF<E+OBB(;OW'6ESG6F40K5"@<W,H_
M(:\+K_W$%/OU&+YT3/P)WV,:)\,,]: 0T#V,/T>520*V;%[-8<("8WR?W^+>
M*N8B8&R6/3L<'C8\'W=L23W&=IOOFC(Q$TMZU,L&CP T^Q$\;5#V3B"'4._A
M35YH:(L>M1K3(+[SDQ'N2K9[/"2G>OV2/]?;VN-\PK]X3C!-H(7(<P7 R("^
M>PK-L'K!KT0D[6YAH8B(K:K.WL,G2[D52A (A%;_%F[(Z-8HJ$W&@>:LN(0K
M)@-XS6XPK>;+S2ZLK%O7ZI?5QV\C@M:.(*<^>,*5FIYHIC,X_\S77L 4N]A"
M6&.B1B1MX\4<G?WP>A:W9]=S[-YHM/4X6$5*MVH41RPO5[]7C1>[K+!-_2FU
MAP5VL D95 CX#&UHAL?<,Y(]?!:@>ZD,[7)8NI.$&>O]AK\AHQ.Q7(Y<"[UP
M,N()7RE-DM&Y&E 2V!\J*>^N0@L$A@4ZCSI/-]:ZNE%[OFJG)2ZE[_A?SM&W
M*3WIK7_*V:>3<?U_(#/%4)+\O10+?!\_N IZU+I\71)^\3=KV5CU28%/\M(&
M0C-P^XR&:H;TVUR3K(6Q&/G74>G.$&",G<XY!D0/$%MEFJE71_OV>-:S[KG&
MU'S?^!9=ZA7=:K$KESQGCD3+O;:8]<Y3FJVZ9B+(6>_>HKO-#1#V#&;"D!,I
M1J(I%WKF\E2B2].:&L,X*]M2FY/'V5_G?A!I+@IY:&:OI7JOXDVMEJ\6$PG+
MUTLJP;+11<!I E[V(TU*]7<3%U*?F-K:.5X7 5M$M178S50M30E[G+7]\5+Y
MT1_A //_*1[H$239V/U!PL!Y\(J<H#1'@(.CG%M,1S%MXOP1I IS!,$NUPKO
MBC,*-<22P1X20.VX YXWP)CU-[('H0-1_0_6' ]K7+"Z;XL5,[YD%0S+9?&Q
M/[[]25 E"6Q@X+<"GJ,2UNE95(.A6.;I-IS85]LE BI2>W5@Z/2R@>5=[PX'
M_@\?WPZM:U2>\,R-9XUN]QN#8 P/F!EJ7[0'>J !?G&B'D&RM7KYT"V44/2R
M&U4][<7RN]#/_G-_DT:*)1YYG98-E?#&["3-2*F0N'ZCCF'[E>G,-"WJ;@;&
MNHJF/<G6L/ZHZ?:<T2Q\/WR'9TOT3;J8?'CZJKI48>X=.UYCQ8<J7U\%FT(P
MD]Z,_F:"K)Y Q@W@+, U]N3;7T;2#%4;;L$:5>V'7[!_?R'JIV2!R->XTW8/
M59$/GQP+K0-$Z9P)@,.>#UB$7(>R@-J_; 2=3.I<^B,.&R)#/*TOWG_=+59H
MS_).U6]15E:,Y=B%OWP,<56&N7!8!!>G(M;YXNDGD?KGNZE80C7>G?<;VS<O
M?>RR!_\M(8G7EKK#)S#?@EL%$L;N0=EZ;_,H$MQ?YH+"5*%;LT9*7Y>JRWYG
M=T8_6UDQU:GE61UL@5^@?2D68"EW]K&_G?M,U4;[E_P)IB]XM<-'/:+KNP]"
M:+!YN*%'/9HK4$&-YU?TJZE+@;*F%M/!!J_24^U^OM90.2;&[!9-Y@,5=/N;
M6&D"U'E"-X)]3#&9KG3Q(_J5U6K0WX/K\[+G."[:Q&@UW2=[7DN%]PF$B(KK
M_15B#"K/_PC2'$$X5*0TQ6.0_N3/K51=PAM6&NRI^TBT1AN^\%MZH!Q3,]SS
MSEE!ME-%]_3DYD8>8'WXV#!:X-AZ3JJ^3KHJQI5ZDB'[!TQCU3<>?H-ZICUM
M-Q!/-W^E(_O);CPD)++)9.P$T_I9>C^6.Y"F1W4W/8(D7IS[8@D2HW6JUZV0
M]74U&4ZO2TX=?V&B]^.GA-)@M/%)!GR8SP?&V/[C-%;*JB29+QG#6O'5#0HX
M).!/FJ_S"2^YK[FM$-%Y\BUY\VQ?NZ_.<[V(DZZ2%-'F,IO,Z?G)\(U9"A\H
MA^M#\-,GC"1 %T7"L@N6#6T$?BLQ;2NOCD"&H<+)<TYC,R&JWW^\R'ZEV:G!
M1O!BRJ"?9<28 X:-.CN?"+T&!E=RP'F\437^]O8M*\Z.I0:1]LAHEU)TE6,C
M*=W+B1$SN0*OC,6U?VDS.+ZX)Y3ACVD@,U64TEB_'N/2=WI]L&2\<>EPIJ[!
MO1^E=N!B6+\2R7DVR96<6["@X!(?"4EKPI+RW"%MKK"^=@=WO@;?%C"L9MEO
MR;3EFT.R^-V&:J>&AB;^RR)_Q:I-<V6[!)5?OA57P.?_2RDLAS4(TF,H5R]R
M(I4N0T5E_U(+.!@L%VC+&S6;N;\K%*!_J5W (L+R\V$>>J\(KAE#>7(L> C6
M/[%0;I, ;6TC9FD=0<20/T$?&*LC6M<*>#.[,_M))WXI4D'WU1A\2KQ13.-D
MR/-ENPZMQ'C\;P:F7XX@O+V@%9F8:J1!'4G"*-: J!&\:LL,@_>SD<5JO[KK
MP4L1HH5[%3>SU_PM[ NML,J6]T+^Z-6U$D%%F\2>&P<2:"AI9+"[[ 8EO)BT
M'(B0:*^,-FQ_&A;C8V(>\\7T9+$\,8\C_Z248*3V+QWS!L8P<4;"_R8.X;DQ
MPE3SI-\Y/*#FMD1*?)BKK\MD3:#S#\_ R/KAYF^"N7(O),<NV;;MLP[?/"-7
MKCN(!4PF%C,&Z6P?:7IAP*NAUEY>_Z(HPSSS>G=3E277J_N"!'B]4EZ8D,7W
M^.MT%YT;_LQ0YR^,J!#7[6-4")9 -)W?;&H]?Z"^DH^O(:X@>Q2FN$V_%A+!
MMXKI;NG&AXZ%]')@[^1 :"Q= !)M;CFC]0C.3-X%35NM3.=ASN^7;58:VG9*
M;IR8\C:3SW4V/D_,5IGW^_^VS_D_.3B^>_RDJ!";QSF,VOY4DJ"@2FTJ_CCM
M+DAX"JY?ICH,/@VF4E#),FQ3/0BDK_ <#KIWQW6(:>4.;W4'S_</H]VJ_0ZR
MO_ 4LW3XLW']^0%KAH/>]3VL6*>2P:0>[  5(=[;PN  HZ_TB0/1/6SQE[")
MB8WUCW=WC07__2-@?#T1O4SGU*3FK^,(.,YO?Q73Z8RD'+"I\?7O0L?CS:BL
MS KQ15KG%0?^0<O0SYUK O&?UA&&H"^=^P+5G"'WAU<]':G[\31D$VA@#(I7
MHK=N !OE)1:E5L6UN4%M_NJ8(=>\@>>;QSH58R<E7K4;50(.-,$\X@#QI<T(
M7UP17;L+WPZ.-8 9]D6."5<=Y:;9&DX%BV55>2@6]*T6K.FS-NF_9O13#KFF
M G0,.L+-J4$#1Q [, D(6"8+K2RA;R[U>PJWOM)RB->\_WGQCK>)##4OJ8-G
M 2+=D8@@M1]!N/"G8F?U$0-C.D1;$XHX>7([;!-UUQZV$_EK=L;S)?*&7M?Q
M4V$FL*)/:4>0L-Y[VAM$P"H'5&6K/;CRCF23/"\C!69098=+DK,QYL_!5Y01
MJZF&NZIRLS"U2QW\(SHS/RXIQUW3M)HYUM\\AQ%B=%;%!2-X6-4Z(;D9:]21
M<[&ENV5>6UJ#CWOY".(7$-6 +^:)&Z_X_J,&)VNZ5]AJ)U:0YG2,ZM!+>O3O
M!ZY_5@G#.!<-\5 YP+<=\9Y ]%*9F)/FB9GOL*%W*+T_@Q2-!TP_@B;.0Z1$
M:<)?Z%R_&S <0,30$80-(SO9XPG-HHLM^^4CW30[I@,;[V.YQIZY7?BT?"6_
MV==_Y\,#_4O?JF<$)7-O_*OKQQC$_NCP*?T,*.G>1IT8W!6TH6I> ^836Y74
M6K-D#(TDU8R6-J(=&S^]SE)P7\N!C9_V+[\@47=^PNX@B!&VPMJ(I5(*=&CG
M!H$H]IW&\Q03W#IIGM&:!C?@?093_U7'OV1YO,;B4[)A1DI6)"QYM2.D\-\V
M2O'R;I@KD[$:CA>HLH0-:*:1_FMJYEX4,2XPK%Y%OO"]@:U@55Z:/44ARR=]
M@_..\HJ&/M58)NW?KD [Y-VD-<3'UG, @5+3C TF'R!.@"53\U89!S?Z]<-6
MEYSZY3\7/?+-,]$LFS1^I2'G/2$^HDUEIW/'D*$IY0I@$S(:^#),W634JK1K
M<-'@%U:1M2Z.6Q*#8UQ+3GT_5L[PP$K&QT[>3#Y?_,F;Q;NDER8PL#^ 5P9B
MJX'I=?-,&JMZ$:D,1MY/"]-*0H7M1%A--TYM"/&L6]3[APQ:2K[[_/9X"+_H
M20G?03[P]$8IE:\?)]4ZRN#BI5M$S$VPU)=J9548PV^#>N+N_.>8DF*'?SOQ
MXH"(I4"FQY0OY!C3$S[164;QTK&F"!(/K/ST'0A9?-?:P<@(8'ZPJ[WMDU7U
M*M'/&5^J]=+&P'(O0>KEXJM3BY*Q!SL"^D47+79BI;#]]UH1B;TMO@.1--L*
MFCE8_6(-H]D*IJWG\/MW>6>UEDM-?0Y+#1 M?'?6SC=DY_.%;FY)@8<J5PET
MCI0&-')H39*J4$;-UIXC Q.I&!CE'"RA8:C@=WLSK$QY89F@=6?HCH&@ML)M
M 8A<?LG(?"\ISD$7>[Q'D3RFLLXSG!! Y-XQ$@3W_."ZPH/EJE-JGWYZHEGR
M=!=JW^7J\IT-C$U\8,SN\1S;'TX3]Z>*VDT_!0/7=ZP&NJ YOW93BMS4VPN'
M?K5$/.,8>SQYYI&5LH7<\8M/E;HMAS\WW6?X#HX^::1TF(<@X7J%8^5 L[FE
MK2$9_H]5O2^=<N7BYTR5:_R%%TVJ;A=S?0EE.77A+M>?OT<0.H=O+8&,%?'K
M\LW!OOJ5A:7LI5 O3@E4:HW57*@>.1Z\6:RY8?WN6,[Y'QHA+Z+^,B*CCY@.
M;9_81E#SR4W#Q7<QLC'KRX?1)I-?IM4H_@U:>G+G%JQ5D:JI/F=^"O0^-+MX
M[I2QD3Y I(G44G#]NUDEPTWK1%;T_"">]V,LFQ\>/M-C<+OD\D3U^Y\6ZK_]
MU>$,9AQ,WSSV=NR@KT+;^[91"0"CB7PA(P:A2\L70 =/U+-+Y7)=[9,[\ N&
MO_-<LMS6;:PO&L*7.<<64&<&?=Q5!Q4_N'0<=^#[)TMLYVEV9%RJ/5T.[/1^
M'K &!W610%SC#ESY+FF:TE&PI#(IWADS,NIE(D,NO+B<')Z%BW<'3#,0<=#6
M\9QU5]A(L_D3EP![F5,S6MU8GKZ2PNKG2YO-C@_#Q*4_Y]CD5HBRS3JDN9PV
M?L(% 7I!Y0C:B0@*;GO_X#[-!LA)II]]1TK%0(&)JU1$0H]ZB7P2F5K8J_;A
MK=8N\>)/_??/ZC\/?CN"K)Z<GS*2_K>DP'&3R \/)*-$&)HQ-@$V ./:Q,N!
M*12A/?0O%)_:7.[ADSO+<A7A^0Q#F#E>+(05RBFW.-2C7?;D)?AH)WR'>J%0
M]P-SFAR=ZR6 GKQ:CIBT;IA>B:F?4(\((G;<OI#)G'\KB)'[6 8F,2BJP5[E
M+,:ZR;KN*Z*57E3KU]%U5V1X\9=C@ZI7BVH+)^=_[0#IX=/+I'@>2.2_#3)(
M73)",W#YZ#HP@YPSZ,XR^G2H$AEUF-VZ=V?+#-BK5RP(;"3+HW3&=944.2+Z
M)$/5F>]4$8&;(%TQ=MJ]A?ZT*D!&#O =P$F[@M->\^'V0DYHPM4IU<0$>__B
M#WN%_96%%I>SIA7$_SMU/:1'C=%-PWEU#.*%,WIZ_5:Y\FR/2\77<G8J[U,4
M.7%:8GW V:O<=^\*YPF2J?R:L&+GG2\>]U*+WW[#G&.T#--GS\ +F-:!^P>A
M?3A6OO3[.]SF^9?S#$8^_JXW"2CQZKA(*M1)'9,*262MY. XWOV678U,!,\O
MD]9:@(Y;U!-+[*D-02^(%H%0*_K4M'R14_NL5Z&D9&&N^A5[OZE+]G:=?DM\
M&AHDMJ;&6&[Z+(R!9O@;ZNH^82+530QG;95<1)@/%U@-B# [P5-Z#B67NSJB
M@ V3NWK]ZI/UDC_FI B:P.D#T@A#=0F#%Y<IY?DA86J"HP1]. PXL,ZWM#::
M\E37-M"[@EO2%962^_FGV8#%WD9M^-LO;"(6N#P*2\ "UGRB]/&_J!SM^M!U
M ]>;-HV.A#V/JHG8#Q\*=?">,25SJDG9 K(>)MX9YP(@/_48]-F[)C,%]X.+
M/Z,)@Y4H*BO<H1:TI,$"0ZO7W.1G?V=V%"ZB&Z^<:A:2RVU)3DN9R&K(/H(0
M$(!33LK?VIVR6HSPS*\8DTMS;3Q783PV=1//-W\L+X)QVX74ULH3H:4I7K<&
M@D0TF<JN>+S;6G=G[B4114!=ZD1_N99[6M>EA/XU!6 _3?+*%$VFQ+MA<JIU
M<?M*@ @Y7FO84_9MQ#GO.\L9>8;1EHQ0L%P ??=V9XQ@_FYG,RY_U-X55LP.
M4^,B&L>U&8PY.JLU9[7IB5>YL"FW:+]Z<K@I=]Y-B;GA$(\EU?S%;C,%HYYM
M'4%X:&$4*->EP*L-%+7SSOT>M3$5WPS\*DR"55$1]ZQ$SRZG>%]:N:=A+ER#
M[?>CG:$T, _L+]G$P=TC0]>A:5T= V,:(SLBS6__%F3>0#P>JN(X]=](6T@(
MM[JQU+SF_SO%1JYWYP]UV87:#!:QI_2V8U2\R4-MO< 2(ZP7U0*?J7U94EV9
M@"Z67*O1>ZE[]OP*TVV/?[_!I>ZO"8%$TIC[%; S#$K89:%=[P1K/<C()CYS
MM5$WU\J,9]5XH6.CG<OO!P,$G!+8 U\\@<+H[Z# K=Z<<DTP#1AQHF+C:>84
M5VX'$$7!,@H?]13>?!;]Z<6 J2?XM$__:;?J/#25[^;T8K.4E;2C#7G^'LE&
MD'K^P0(CN[,ANWSC8F5!G/D\AI5]L)=_HF;91:N<ZV--[IWL#:K$;:<,D3^G
M5\('/VBP!A-;?&G\&?:@$$72YS4XQ/;F*3JZ3T8.C"$O(T!3D2G*P+QC9]YF
M[>OB(,>KU'>R4BS&?0]TIM#Y= XAPPD"B@N-,@<)$4\6<4E[.$Y,I):;9#K%
M7613Y,>?W!X9KY3M&Y_>EJ8\TNDD/>2!.!PV(4BM@DABRY>1Z*84?8<<N#S[
M@/3U$<O78 ;2M_J;\[T\9#U4;OD"O&_BRU#(BO#A$O]@_%N^*LR_[0;>\2U6
MKHL4D!%I4%9X)-G ^O+(C3FSUK_XW$B6*+/RS'V)S$F7E9[F@6MG3'-O=EL\
M8Z,]&Z+JTO@/KLX@?-R7^,C9Q>LU4UHY6735:9JIO\8FCPHZ@!O1G+K#X?_S
MGH[3\UWYJ^YR4J'2(S1!OI%813"-6G@$&8**]QA28'RTR$A5N U*-ZY8V^^^
M)[<)6[%GS-Y48$6<Q7T9%\7B-^\QPP_4T#?HW#L 8="]!9=!0RDF8VP"FT ;
M^\E?\D!6P6QV=5V KO.@E7IA\VB@5N'6E_C1GUV/RL5M^\)4W%S)[J"R[K#8
M$<03NUQ*N3)75-=(DZ3:S18EW7<-&![7PYP+:F__?J?3<4%UE/F=7-;!B*_=
M'VYO^^Y !)W#'XYKX4N%B]?1G HPU_^.QS6"6/O)'A5DC;\;]/6D4&!^3)Q3
MYK 93+[?OT46[S Z8ECTH)>4J]N%V)X_N *R#R&$OM-LG\5.+26MU=4A_9\2
M/'1*U<:J[NDLV)ME/;B_ E%)6G^V8JQG \;LI/3G)-*/R>B!H>N'GH,)?2)T
M?>KRIHE-EXS@5(EIG+9!KE2_4Q"OKT7%J*KOAIVW<N^%V"EWP):/+?9#"4.#
MZ\Z?[.T":H?>-9YLIFHGR.WI1YO?GI_DY(?J#5)EM[W,;#O4;PK@'AN=9HAN
M/K@EU=QTBMP%KI58;S0#/V!)1/Z@^T2.P7K*&U[.#X6C07D3B@N^%BU"%C7&
M?WR6:B5C<'0N5D:J&&\_9*1$AO.PH;D'Z"HV*<XY#YH"@[1X_'\UU[^K(0A7
MM:.XJO+4,6_E%CZXG!??&H-$,JZFB:[WZ^#XX+(4=] >(1C&S1/1CP6:PSXU
MNZBD823)\UTZ>_O[#Z[JIAEKO C.VQ*3?W#JP:=JAH_.;2&X$$B^)04^L:^B
M4;4#..:FY!<TR=#:U<WV <J7FXF&S]]IM9SQP?^\-/EVZ$X\=X3&]FW+3?Q9
M;/_Q0 S2H\(1-*'<76/ZN&LDYH11HE979R?P+%!E<@+>?PO,?'5G^,ZERGM.
M;(M\K,G?W+-Q@(D*-ATJ$'LJ0,(AY^[])F[T*AP6X?W4'7TO +NPA$LYG<VC
M[ZY=>R$XP,-2MH3S6K&(SR'IE!_S N8,@^:L 41F+ZDL5OVP0FM'U[;K8P^/
M?YU5@U_[OLXTT7G5_SMU9>E/<[?Q-E>RD\C%[.QL21XW?^H\G?L-"?< KSK=
MBNQ-P1O.P\+4V ?^_CJWF3QG*1ZVN22)#+-_*%(@'AMTSQ(B@YRF"3-,09X.
M[+V=(X'AIF+3FGHNH*B\AM;:.RY77W9,V8N^&?_\JCWK2OC'2SHO@@4_7\SZ
M,%@"NNRM,A ]2W,&!HW$J,FX]1UW2E%Z4)@[,_JF207ZLHH.L%=6[:Z9\=M$
MZVFA'.%U4?@76/[+Q&M5.?65C):+:#T\C^NWAQ@XF'@$$5"EGVPBP$"'0.'G
MR.M(K\CX$P]']\)SWAY2'UJVPF[)((_]I'.OD]ZX'9A-TTXQJBV;3.TL*X+S
M?"KJ_E9X<UOG1Q?S+F2@V=S^1)F]^.ES+;[!/(_Z-DR%^6AZ1G182H1$"DUM
M*\U(>X)J&ZNFF.4-;%M[\CYOCGELUG6[R/?A7)]Y6[5BL&K5O3.Q0MA^KE_$
M)!G]A$$=G "L*4QR@A5=3]#_L.^LSZD=8^7>I:NK7RYH:F'':><H?,].=(-=
M+K&\B:I(YVHCP9*A+V%QO7Y6;S0'18TDP/S#4MZ4FC@4*B1(F^'TYNF1\KD>
M<1$\32KXP6%*\"2=EP%&J?_:*1#'4&@2'00L%(UP T=T.EBK)/K:[*9[7S4(
M?O./&%*I'NIY3S+18IW\$R3Z8HF/)K1TP% (5W!<] D1-XWI)2R7GXXS;&_\
M*3G#]8;-K"E^]5UH[:TB\W@[5B=[TX>^9Y3/\KB9 _^JCZPC")<#>61 !<M,
MNX'_"(\$< [S;2Z&_K^4OO]:6)];_]'4$'C_C_QRX'$_V0.-R,9F#>_![D?\
M[#0XH[?[()12E-QSZOE7!$^LW-9F@W^"Z_S._;>!NS",= W^Y=(57=VSIJ<*
ML1K>OIQ!K_0'N5]"I.YA7]K01!"#'72U=@:W!+(/K<G:2-+\J.P$(A]Z8&EN
M8-FZP\^[X,7V%8M-S<1T!9ZSJ4FJ3S-TD.XD&T86O'58VHI@-R'A<B2(R6U6
M:DP8-<H.RGK2GL?&?;IRSFOVE$B>^/L%ZX.1C@ANY9Z["Z:>(Z[ %IVC\PC"
M(4LS6J2*K3;%&6E_PXF.W[=.IJVE(2CN])Z=!;F-H B!?9$'!CG++G2N63)T
M86+]!%W@#>";2?/[*YH\D0EWC2%_;?B<T?]7]_%)E]'JO$L1QY>7O6ZWO\T(
M/P^V[(TP,!FEH0";G3-413,@IOHO6I(@8P"(%%=]<[9K+ O_X1_U..26I615
MY@2\)$]@+R0=?_T)KZ?/"M$Y=A4+6#(4(O((DAU%S&3(-0<BGUI/)*F?!(,Z
M7:@R??:.(GTF"/[+0JZ@K[4X]'1DG)1PZ+ 9,@,D,N)6NQO,HN[;4OF2\4K+
MH&=_U%H':35\EY /HG;V!2S)CQ)%@DW000*%NJG\0^OA[\;OZ4$V45C2ZS7>
MCW@Q,.?Z7 \S!<>+'B7T\CN0GP+EU<_]PW^Z!M0(=YY_@\0U5UDR:6CE*'%W
ML'Q*GSE\C"6]HI\X;*3K@R;][KP8UG4;0>R %3F#3W0E@#KF5>C,^OCG*$IW
M:=2ZH)#3P\O+>&C90#/>_!S5A,Y1@%HOQ:4Z/T<3K>BK5-VA-K#YJ4X=N6#F
M_JK,IR6UJD('^RS]AFV8V-U/-6)US-G1O0L)=$Z/(\AQY('Y+30-8SP#OST/
MY=O&" >S?B\0;IT7ZH]66RGJIMQ^ZOI9^91 5CJ;ZX0<\W!/,(,\(^=[O8X@
MR[M[V5-&)[^N:5 =!A!, 3)";?&,"FZZP7FZ[^4WG5[\ZZZ84:UZ^=&1I&-F
M$!T(,_L</(+1N@CP?4"F?L@'$4.:(R2;]+_8 61?WO(1I-IMC2,SPK_H"'*-
M)>$D^9 U&-NZ3Q-PN7E8:P2GN<_5@",Q9.(QS+T9N&$PI?>X,QC"_OIUQY1
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MT1V6'^5LV%]$G%O:FA3VN#?P1?#=B>I/*\?86-39="6/(.T3-$$]4=+N(%&
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MX-(LY_AV8A1[AR%XD&(<,4=NO>CT='.VUSMPI]M=>GAV:GHM9(V<4</>:GL
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M=\,,C%^K5 0?CYYMWW!W;OPV<5W^Z$Q+9?*5RD,A;^7NW6)8 /\EODOI^(Y
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MD(%V1O _.N]@NI;\5;1H>L,LY%)]0_SKYL,G[O,F,!VT8:;PW<%#T8%QR!-
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ML=@*A_U$R+?/AH<1$YD%-- 2AP;#TK-?)X#\-Q, 0BF\6U3K4.)7ND["!M-
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M'$_\Z?NOZ895,:Q;=^X[,I[Y*"J'FR0=1Q$' QM4UA0R."\6+@] D@Q,WN;
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M0(T8H41_W$A-,#*Q[P*]C($?-'TB09HW$'&GD@$T^(IC5;C6R7+G;D\BY9X
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MQY;- QVL7)\):[K/'JOJ[?R\D_T[\,=/Q8C7""IXMZ#4A=NU2;M#UQQ#8"3
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MCTBNR=5(?*;:A'M<6V;QK-436BWU:W8)UF!F$U<?.X(1.9P=BAPNGP2('I"
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MDRYP/E&GMCKVNOQQU.I>V&J8#%1<LB3\'46?A_D.^2,0P'MW_RGV1T&_^2I
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M\],!PU\9^6%CPMA=O:OH@Y9=_'C"C,:<_.O5.M72!NUJXC!.A]/_T^A%X<T
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M<'9N:2YJ<&=02P$"% ,4    " !1@YU:LA*W"_E+   E:   "P
M    @ %(2   8V%P=G1S<BYJ<&=02P$"% ,4    " !1@YU:/31'P+D#   3
M$@  $0              @ %JE   8W)V;RTR,#(T,3(S,2YX<V102P$"% ,4
M    " !1@YU:-V$"&ND!  #B!@  %0              @ %2F   8W)V;RTR
M,#(T,3(S,5]D968N>&UL4$L! A0#%     @ 48.=6CL92(R9 0  ^@8  !4
M             ( !;IH  &-R=F\M,C R-#$R,S%?;&%B+GAM;%!+ 0(4 Q0
M   ( %&#G5J%^?T.7P$  ,\"   5              "  3J<  !C<G9O+3(P
M,C0Q,C,Q7W!R92YX;6Q02P$"% ,4    " !1@YU:KP4 F>2' 0 ?A@P %P
M            @ ',G0  8W)V;S(P,C4P-#(U7V1E9C$T82YH=&U02P$"% ,4
M    " !1@YU:<RI AQ%( P"DC , "@              @ 'E)0( :6UA9V4Q
M+FIP9U!+ 0(4 Q0    ( %&#G5JN<W%^%H$" #7< @ *              "
M 1YN!0!I;6%G93(N:G!G4$L! A0#%     @ 48.=6EWQU]J+'P  62$   @
M             ( !7.\' &QO9V\N:G!G4$L! A0#%     @ 48.=6ND="N?Y
M$P  #14   @              ( !#0\( &UI;FDN:G!G4$L%!@     +  L
*F@(  "PC"     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>crvo20250425_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:thunderdome="http://www.RDGFilings.com"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="crvo-20241231.xsd" xlink:type="simple"/>
    <context id="d_2024-01-01_2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2024-01-01_2024-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2023-01-01_2023-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="d_2022-01-01_2022-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001053691</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="NonApplicable">
        <measure>thunderdome:item</measure>
    </unit>
    <dei:AmendmentFlag contextRef="d_2024-01-01_2024-12-31" id="ixv-5676">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d_2024-01-01_2024-12-31" id="ixv-5677">0001053691</dei:EntityCentralIndexKey>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="d_2024-01-01_2024-12-31" id="c12">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="d_2024-01-01_2024-12-31" id="c11">true</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:AwardTmgPredtrmndFlag contextRef="d_2024-01-01_2024-12-31" id="c10">true</ecd:AwardTmgPredtrmndFlag>
    <dei:DocumentType contextRef="d_2024-01-01_2024-12-31" id="c2">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="d_2024-01-01_2024-12-31" id="c3">CervoMed Inc.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="d_2024-01-01_2024-12-31" id="c6">false</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="d_2024-01-01_2024-12-31" id="c7">
&lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"&gt;&lt;b&gt;Policies and Practices Related to the Grant of Certain Equity Awards&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"&gt;Our equity awards, which have consisted exclusively of stock options during the fiscal years ended December 31, 2024, 2023 and 2022, are granted in connection with our yearly compensation cycle, regularly scheduled meetings of the Compensation Committee and, as applicable, the Company&#x2019;s compensation policies and procedures.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"&gt;Typically, our practice is to &lt;span style="-sec-ix-hidden:c10"&gt;make&lt;/span&gt; annual award grants to our existing employees in January or February of each fiscal year and to our non-employee directors at the time of our Annual Meeting of Stockholders. In addition, with respect to newly-hired employees, our typical practice is to make award grants on the seventh day of applicable month (or, if the seventh day of the month is not a business day, on the immediately preceding business day). Our &lt;span style="-sec-ix-hidden:c11"&gt;policy&lt;/span&gt; is to not grant stock options or similar awards in anticipation of the release of material non-public information and to &lt;span style="-sec-ix-hidden:c12"&gt;not&lt;/span&gt; time the release of material non-public information based on any equity award grant date, but some awards may be granted close in time to the release of material non-public information to the extent those awards are being granted, for example, upon hiring of new employees or in connection with annual grants being made as part of our director compensation policy, as described further below under &#x201c;&#x2014;&lt;i&gt;Director Compensation&lt;/i&gt;&#x201d;.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;"&gt;During the year ended December 31, 2024, we did not time the disclosure of material non-public information for the purpose of affecting the value of executive compensation, and none of our named executive officers were awarded options with an effective grant date during any period beginning four business days before the filing or furnishing of a Form 10-Q, Form 10-K, or Form 8-K that disclosed material non-public information, and ending one business day after the filing or furnishing of such reports.&lt;/p&gt;
</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="d_2024-01-01_2024-12-31" id="c9">Typically, our practice is to make annual award grants to our existing employees in January or February of each fiscal year and to our non-employee directors at the time of our Annual Meeting of Stockholders. In addition, with respect to newly-hired employees, our typical practice is to make award grants on the seventh day of applicable month (or, if the seventh day of the month is not a business day, on the immediately preceding business day). Our policy is to not grant stock options or similar awards in anticipation of the release of material non-public information and to not time the release of material non-public information based on any equity award grant date, but some awards may be granted close in time to the release of material non-public information to the extent those awards are being granted, for example, upon hiring of new employees or in connection with annual grants being made as part of our director compensation policy, as described further below under &#x201c;&#x2014;Director Compensation&#x201d;.</ecd:AwardTmgMethodTextBlock>
    <ecd:PvpTableTextBlock contextRef="d_2024-01-01_2024-12-31" id="c13">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;PAY VERSUS PERFORMANCE&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;The following tables and related disclosures provide information about (i) &#x201c;compensation actually paid&#x201d; to certain executive officers of the Company during the last three fiscal years ended December 31, 2024, 2023, and 2022, (ii) certain financial performance measures, and (iii) the relationship of the compensation actually paid to those financial performance measures.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"&gt;This disclosure has been prepared in accordance with Item 402(v) of Regulation S-K and does not necessarily reflect value actually realized by the executives or how our Compensation Committee evaluated compensation decisions in light of Company or individual performance. For discussion of how the Company&#x2019;s executive compensation program is designed to support the Company&#x2019;s business strategy, align the interests of our executives with our stockholders, and embody our Company&#x2019;s overall compensation philosophy, please refer to the &#x201c;Executive Compensation&#x201d; section of this Proxy Statement.&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:75%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 4.6%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Summary&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Compensation&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Table Total&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;for PEO(s)&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(1)(2)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Compensation&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Actually&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Paid to PEO(s)&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&#160;(1)(2)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Average&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Summary&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Compensation&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Table Total&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;for Non-PEO&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;NEOs (1)(2)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 8.8%; border-top: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Average&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Compensation&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Actually&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Paid to Non-&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO NEOs&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(1)(2)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.9%; border-top: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Value&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;of&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Initial&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Fixed&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$100&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Investment&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Based&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;On&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Total&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Shareholder&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Return&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(3)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-top: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 7.1%; border-right: 1px solid black; border-top: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Net&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Income&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(Loss)&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(in&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;millions)&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;(4)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;2022&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,424,613&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,302,245&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$400,727&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$318,800&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$32.65&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(5.80)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;2023&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,518,279&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,366,539&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$467,047&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$457,134&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$32.82&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(2.17)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 4.6%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;2024&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$1,036,352&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$953,313&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$732,491&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:8.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$797,375&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:7.9%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$10.06&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 0.6%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:bottom;width:0.6%;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 7.1%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(16.29)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 18pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;(1)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;On August 16, 2023, in connection with the completion of the Merger, the Company&#x2019;s executive officers were reconstituted. At the Effective Time of the Merger, (i) Dr. Alam, the President &amp;amp; Chief Executive Officer of EIP, was appointed as the Company&#x2019;s President &amp;amp; Chief Executive Officer, (ii) Dr. Cobuzzi, the President &amp;amp; Chief Executive Officer of Diffusion, was appointed as the Company&#x2019;s Chief Operating Officer, and (iii) Mr. Elder, the General Counsel &amp;amp; Corporate Secretary of Diffusion, continued as the Company&#x2019;s General Counsel &amp;amp; Corporate Secretary. Mr. Elder was subsequently appointed as the Company&#x2019;s Chief Financial Officer in June 2024. Accordingly, (x) the amounts set forth in the table with respect to PEO compensation include, (i) with respect to the years ended December 31, 2023 and 2022, compensation paid to Drs. Alam and Dr. Cobuzzi, and (ii) with respect to the year ended December 31, 2024, compensation paid to Dr. Alam and (y) the amounts set forth in the table with respect to non-PEO NEO compensation include, (i) with respect to the years ended December 31, 2023 and 2022, compensation paid to Mr. Elder and Kelly Blackburn, the Company&#x2019;s Executive Vice President, Clinical Development, and (ii) with respect to the year ended December 31, 2024, compensation paid to Dr. Cobuzzi and Mr. Elder. For additional information regarding the compensation paid to Ms. Blackburn with respect to the years ended December 31, 2023, and 2022, please refer to our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 29, 2024.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c15"
      unitRef="USD">1424613</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c16"
      unitRef="USD">1302245</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c17"
      unitRef="USD">400727</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c18"
      unitRef="USD">318800</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="INF"
      id="c19"
      unitRef="USD">32.65</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2022-01-01_2022-12-31"
      decimals="-5"
      id="c20"
      unitRef="USD">-5800000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c21"
      unitRef="USD">1518279</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c22"
      unitRef="USD">1366539</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c23"
      unitRef="USD">467047</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c24"
      unitRef="USD">457134</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="INF"
      id="c25"
      unitRef="USD">32.82</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2023-01-01_2023-12-31"
      decimals="-4"
      id="c26"
      unitRef="USD">-2170000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c27"
      unitRef="USD">1036352</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c28"
      unitRef="USD">953313</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c29"
      unitRef="USD">732491</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c30"
      unitRef="USD">797375</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="INF"
      id="c31"
      unitRef="USD">10.06</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="d_2024-01-01_2024-12-31"
      decimals="-4"
      id="c32"
      unitRef="USD">-16290000</us-gaap:NetIncomeLoss>
    <ecd:AdjToPeoCompFnTextBlock contextRef="d_2024-01-01_2024-12-31" id="c33">
&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 18pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;(2)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;The table below shows the adjustments made to the compensation totals presented in the Summary Compensation Table for the NEOs in order to calculate &#x201c;compensation actually paid&#x201d;&#160;in accordance with Item 402(v) of Regulation S-K. Equity values are calculated in accordance with ASC Topic 718, and the valuation assumptions used to calculate fair values did not materially differ from those disclosed at the time of the grant, except as follows:&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 54pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;a.&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;the expected remaining term of vested shares as of each applicable vesting date was estimated using the simplified method based upon the award&#x2019;s original contractual term and the vesting term of such shares;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 54pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;b.&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;the risk-free interest rate for the expected term was estimated based upon the five-year interest rate as reported by the U.S. Federal Reserve Bank of St. Louis on the applicable measurement date; and&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"&gt;

		&lt;tbody&gt;&lt;tr style="vertical-align: top;"&gt;
			&lt;td style="width: 54pt;"&gt;&#160;&lt;/td&gt;
			&lt;td style="width: 18pt;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;c.&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="width: auto;"&gt;
			&lt;p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;"&gt;the expected volatility of the price of the shares underlying the option awards for the award&#x2019;s expected term was estimated based on upon the historical daily average volatility of the Company&#x2019;s current comparable public company peer group during the 5.75 years preceding the applicable measurement date.&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;



&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div&gt;
&lt;table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:72%;margin-left:auto;margin-right:auto;"&gt;

		&lt;tbody&gt;&lt;tr&gt;
			&lt;td style="vertical-align: top; width: 15.5%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 16.8%; border-top: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline; "&gt;2022&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-width: 1px; border-style: solid; border-color: black black rgb(0, 0, 0); vertical-align: top; width: 15.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline; "&gt;2023&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td colspan="2" style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 16.4%; border-top: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;&lt;span style="text-decoration: underline; "&gt;2024&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 15.5%; border-right: 1px solid black;"&gt;&#160;&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Average&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Non-PEO&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;NEOs&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Average&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Non-PEO&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;NEOs&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;PEO&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Average&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;Non-PEO&lt;/p&gt;

			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;NEOs&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Summary Compensation Table Total&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$1,424,613&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$400,727&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$1,518,279&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$467,047&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$1,036,352&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$732,491&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Less, value of Stock Awards reported in Summary Compensation Table&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$166,640&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$33,322&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$451,424&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$60,800&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$228,549&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$103,008&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Plus, year-end fair value of outstanding and unvested equity awards granted in the year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$30,611&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$6,122&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$268,769&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$41,752&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$24,448&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$24,696&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Plus (less), year over year change in fair value of outstanding and unvested equity awards granted in prior years&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(5,761)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(33,258)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$296&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$154&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(90,772)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(40,685)&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Plus, fair value as of vesting date of equity awards granted and vested in the year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$24,721&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$4,941&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$32,961&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$10,239&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$133,708&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$135,062&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Plus (less), year over year change in fair value of equity awards granted in prior years that vested in the year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(5,299)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(26,410)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(2,342)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$(1,258)&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$77,626&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$48,819&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;Less, prior year-end fair value for any equity awards forfeited in the year&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;$0&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 15.5%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Compensation Actually Paid ($)&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom:solid 1px #000000;vertical-align:middle;width:7.8%;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$1,302,245&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 9%; border-left: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$318,800&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.7%; border-left: 1px solid black; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$1,366,539 &lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 7.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$457,134&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$953,313&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
			&lt;td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: middle; width: 8.2%; border-right: 1px solid black;"&gt;
			&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"&gt;&lt;b&gt;$797,375&lt;/b&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;

&lt;/tbody&gt;&lt;/table&gt;
&lt;/div&gt;
</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c35"
      unitRef="USD">1424613</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c36"
      unitRef="USD">400727</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c37"
      unitRef="USD">1518279</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c38"
      unitRef="USD">467047</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c39"
      unitRef="USD">1036352</ecd:PeoTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c40"
      unitRef="USD">732491</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="-1"
      id="c41"
      unitRef="USD">166640</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c42"
      unitRef="USD">33322</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c43"
      unitRef="USD">451424</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="-2"
      id="c44"
      unitRef="USD">60800</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c45"
      unitRef="USD">228549</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-EqtyAwrdsInSummryCompstnTblForAplblYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c46"
      unitRef="USD">103008</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c47"
      unitRef="USD">30611</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c48"
      unitRef="USD">6122</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c49"
      unitRef="USD">268769</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c50"
      unitRef="USD">41752</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c51"
      unitRef="USD">24448</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c52"
      unitRef="USD">24696</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c53"
      unitRef="USD">-5761</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c54"
      unitRef="USD">-33258</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c55"
      unitRef="USD">296</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c56"
      unitRef="USD">154</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c57"
      unitRef="USD">-90772</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c58"
      unitRef="USD">-40685</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c59"
      unitRef="USD">24721</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c60"
      unitRef="USD">4941</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c61"
      unitRef="USD">32961</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c62"
      unitRef="USD">10239</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c63"
      unitRef="USD">133708</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c64"
      unitRef="USD">135062</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c65"
      unitRef="USD">-5299</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="-1"
      id="c66"
      unitRef="USD">-26410</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c67"
      unitRef="USD">-2342</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c68"
      unitRef="USD">-1258</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="0"
      id="c69"
      unitRef="USD">77626</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="0"
      id="c70"
      unitRef="USD">48819</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="-3"
      id="c71"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2022-01-01_2022-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="-3"
      id="c72"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="-3"
      id="c73"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2023-01-01_2023-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="-3"
      id="c74"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-PeoMember"
      decimals="-3"
      id="c75"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="d_2024-01-01_2024-12-31_AdjToCompAxis-FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_ExecutiveCategoryAxis-NonPeoNeoMember"
      decimals="-3"
      id="c76"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="0"
      id="c77"
      unitRef="USD">1302245</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2022-01-01_2022-12-31"
      decimals="-2"
      id="c78"
      unitRef="USD">318800</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c79"
      unitRef="USD">1366539</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2023-01-01_2023-12-31"
      decimals="0"
      id="c80"
      unitRef="USD">457134</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c81"
      unitRef="USD">953313</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="d_2024-01-01_2024-12-31"
      decimals="0"
      id="c82"
      unitRef="USD">797375</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="d_2024-01-01_2024-12-31" id="c83">
&lt;p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"&gt;&lt;b&gt;Relationship of Compensation Actually Paid and Performance Measures&lt;/b&gt;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div style="text-align: center;"&gt;&lt;img alt="capvtsr.jpg" src="capvtsr.jpg"/&gt;&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="d_2024-01-01_2024-12-31" id="c85">
&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;

&lt;div style="text-align: center;"&gt;&lt;img alt="capvni.jpg" src="capvni.jpg"/&gt;&lt;/div&gt;

&lt;p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"&gt;&#160;&lt;/p&gt;
</ecd:CompActuallyPaidVsNetIncomeTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
